data_2knx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2knx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.922 0.391 . . . . 1.0900000000000001 111.055 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.405 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 51.99 67.74 0.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.33000000000000002 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -158.69 4.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.38 112.413 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.5 -41.5 75.42 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.607 2.204 . . . . 0.67000000000000004 111.876 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.19 66.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.89000000000000001 110.315 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 96.4 p -81.82 122.05 27.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 1.0900000000000001 111.29 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 43' ' ' ALA . 48.8 t80 -98.15 144.33 27.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.40000000000000002 110.153 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -104.15 132.47 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.46999999999999997 111.254 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -74.86 131.08 79.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.815 -0.63 . . . . 0.27000000000000002 110.422 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.19 158.78 28.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.573 2.182 . . . . 0.41999999999999998 112.274 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.57 21.86 58.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.47999999999999998 112.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.419 ' CG2' HG11 ' A' ' 19' ' ' VAL . 6.2 t -179.32 168.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.687 0.28 . . . . 0.94999999999999996 110.64 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -110.01 59.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.333 . . . . 1.23 111.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.419 HG11 ' CG2' ' A' ' 17' ' ' THR . 1.4 m -110.35 122.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.788 0.328 . . . . 1.23 110.198 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.78 161.75 18.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 0.28000000000000003 111.067 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -158.57 112.01 1.66 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.88 110.489 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.53 144.7 61.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.259 1.973 . . . . 0.33000000000000002 111.87 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -32.07 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.382 . . . . 0.42999999999999999 110.819 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.38 110.457 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -89.85 -19.34 24.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.45000000000000001 110.988 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.0 mm? -58.84 119.56 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.324 -0.398 . . . . 0.90000000000000002 110.922 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.59 50.69 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.22 110.825 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -104.59 -13.25 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.46000000000000002 111.251 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 -26.31 7.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 0.34999999999999998 112.555 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -94.6 98.47 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.5 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 6.5 mtpt -57.35 88.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.96999999999999997 111.15 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -76.74 -32.31 57.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.46999999999999997 110.643 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.3 t -81.67 144.24 31.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.31 110.507 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.23 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 1.05 111.965 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -115.75 29.35 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.684 0.278 . . . . 0.90000000000000002 111.388 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 53.02 31.3 39.83 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.815 -0.707 . . . . 0.23999999999999999 112.89 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 0.38 111.171 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -56.05 -28.07 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.31 110.941 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.73 11.31 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.27000000000000002 111.379 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 178.01 6.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.872 0.368 . . . . 0.89000000000000001 111.083 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mm -60.92 -20.74 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.52000000000000002 110.951 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.43 -31.73 55.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.392 . . . . 0.98999999999999999 111.205 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . . . -88.3 -20.49 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.26000000000000001 111.243 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.08 4.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.23999999999999999 112.656 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.34999999999999998 110.663 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.45 0.167 . . . . 1.0900000000000001 111.212 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.95 20.07 8.37 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.708 0.289 . . . . 0.33000000000000002 110.876 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.11 -168.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.38 112.421 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.6 137.28 33.43 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.771 2.314 . . . . 0.67000000000000004 112.021 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 t 71.44 29.35 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.89000000000000001 110.945 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 m -102.22 154.23 19.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 1.0900000000000001 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 34.7 t80 -115.83 151.82 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.40000000000000002 110.727 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -118.05 121.03 39.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.46999999999999997 110.41 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HB2' HG11 ' A' ' 19' ' ' VAL . 4.4 m -60.93 143.78 91.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.27000000000000002 110.636 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 70.5 Cg_endo -74.43 136.68 22.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.644 2.229 . . . . 0.41999999999999998 112.537 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.56 -42.06 2.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.756 -0.735 . . . . 0.47999999999999998 112.771 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.429 ' CG2' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -112.58 170.24 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 0.94999999999999996 110.844 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 28.32 4.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.23 111.403 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 14' ' ' CYS . 1.4 p -89.52 131.63 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.345 . . . . 1.23 110.59 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -108.58 164.66 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.28000000000000003 111.108 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' A' ' 26' ' ' LEU . 7.6 p -153.08 125.08 3.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.88 110.8 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.38 150.19 76.56 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.409 2.073 . . . . 0.33000000000000002 112.069 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -51.56 -39.76 58.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.42999999999999999 110.897 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -62.46 -27.68 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.38 110.393 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -87.61 -24.36 23.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.45000000000000001 110.732 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.0 mm? -53.04 125.65 18.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.224 -0.444 . . . . 0.90000000000000002 110.746 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 38.63 58.04 1.72 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.025 0.44 . . . . 0.22 111.327 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -105.34 -7.76 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.46000000000000002 111.241 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -23.76 8.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.34999999999999998 112.624 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.37 109.97 22.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 0.5 110.914 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.7 mtpt -61.02 88.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.96999999999999997 110.975 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.96 -30.06 35.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.46999999999999997 110.866 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.93 175.01 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.31 110.905 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.6 -52.01 50.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 1.05 110.931 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -114.0 32.17 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.90000000000000002 110.851 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.427 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.65 30.2 76.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 0.23999999999999999 112.489 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.42 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.39 -39.28 79.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.38 111.316 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -63.2 -23.47 67.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.31 111.034 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.97 13.94 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.27000000000000002 111.237 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.89 -176.23 3.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.861 0.363 . . . . 0.89000000000000001 111.047 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.7 mm -71.43 -25.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.52000000000000002 110.979 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.64 -26.39 8.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.98999999999999999 111.451 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -94.74 -4.47 47.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.26000000000000001 111.913 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.02 35.61 34.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.579 -0.82 . . . . 0.23999999999999999 112.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.9 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.34999999999999998 110.713 179.842 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.443 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.859 0.361 . . . . 1.0900000000000001 110.695 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.4 m -151.54 69.19 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.33000000000000002 110.662 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.02 -160.48 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.923 -0.656 . . . . 0.38 112.713 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.58 138.41 83.4 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.766 2.311 . . . . 0.67000000000000004 112.239 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p 60.02 46.8 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.89000000000000001 110.932 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.39 140.8 34.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 1.0900000000000001 110.822 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 23.7 t80 -90.58 152.93 20.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.40000000000000002 110.269 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 t -111.01 125.56 53.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.46999999999999997 110.885 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HB2' HG12 ' A' ' 19' ' ' VAL . 4.4 m -71.55 140.98 84.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.27000000000000002 110.677 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.6 Cg_endo -77.34 136.37 15.83 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.649 2.233 . . . . 0.41999999999999998 112.465 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.49 44.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.703 -0.761 . . . . 0.47999999999999998 112.615 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 t 179.4 163.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 110.868 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -98.35 40.12 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.23 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 14' ' ' CYS . 2.4 p -111.26 135.56 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 1.23 110.748 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 p -122.58 156.5 34.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.28000000000000003 110.982 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 25' ' ' TRP . 7.1 p -134.53 133.63 21.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.88 111.152 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 25' ' ' TRP . 22.7 Cg_exo -63.31 150.54 88.28 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.461 2.108 . . . . 0.33000000000000002 112.062 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -31.36 39.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.42999999999999999 110.77 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -70.08 -28.15 65.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.38 110.343 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 24.3 m0 -95.21 4.91 53.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.45000000000000001 111.142 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' CD1' ' CB ' ' A' ' 43' ' ' ALA . 3.1 mm? -76.58 118.54 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.90000000000000002 110.938 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 39.29 69.16 0.3 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.868 -0.605 . . . . 0.22 111.751 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -116.76 -13.68 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.084 -0.507 . . . . 0.46000000000000002 111.174 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.54 32.7 1.19 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.582 -0.818 . . . . 0.34999999999999998 112.779 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.54 91.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 0.5 110.752 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 10.1 mtpt -53.14 92.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.96999999999999997 111.308 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.92 -30.85 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.46999999999999997 110.531 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -174.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.73 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.41 -55.51 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 1.05 110.973 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.91 38.61 3.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.90000000000000002 110.732 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.85 31.33 80.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.23999999999999999 112.425 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.428 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.0 -47.81 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.38 111.155 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -57.86 -27.44 63.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.31 110.809 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.08 8.12 28.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.27000000000000002 111.433 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.9 170.84 13.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.89000000000000001 111.085 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.03 -23.87 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.52000000000000002 110.733 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.3 -27.89 6.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.98999999999999999 111.27 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.443 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -91.05 -19.79 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.26000000000000001 111.483 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.66 12.45 12.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 0.23999999999999999 113.115 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.34999999999999998 110.344 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.822 0.344 . . . . 1.0900000000000001 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.9 m -151.38 74.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.33000000000000002 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.23 -163.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.38 112.45 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.82 -23.78 43.73 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.733 2.288 . . . . 0.67000000000000004 112.246 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 p -123.91 83.05 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.89000000000000001 110.744 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.7 53.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 1.0900000000000001 111.04 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 24.6 t80 -103.56 150.81 23.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.40000000000000002 110.479 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -112.64 128.04 56.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.46999999999999997 110.777 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.438 ' HB2' HG12 ' A' ' 19' ' ' VAL . 4.8 m -69.28 136.14 88.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.27000000000000002 110.559 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.3 Cg_endo -69.88 139.39 39.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.662 2.241 . . . . 0.41999999999999998 112.56 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.87 -42.32 2.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.756 -0.735 . . . . 0.47999999999999998 112.746 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.432 ' CG2' HG13 ' A' ' 19' ' ' VAL . 1.3 t -112.62 171.66 7.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.94999999999999996 111.013 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -104.52 54.53 0.72 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.255 -0.429 . . . . 1.23 111.29 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -113.35 142.93 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 1.23 110.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -112.72 154.07 26.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.28000000000000003 110.894 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 22' ' ' PRO . 2.5 p -145.03 131.14 9.67 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.88 110.691 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 21' ' ' VAL . 57.5 Cg_endo -71.77 146.83 49.2 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.281 1.987 . . . . 0.33000000000000002 111.978 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.0 -38.11 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.379 -0.373 . . . . 0.42999999999999999 111.148 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -27.81 65.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 0.38 110.706 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -96.07 -19.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.45000000000000001 111.109 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.436 HD21 ' N ' ' A' ' 26' ' ' LEU . 4.0 mm? -53.84 123.06 11.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.517 -0.31 . . . . 0.90000000000000002 110.909 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.5 p 36.92 58.49 1.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.089 -0.505 . . . . 0.22 111.403 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -104.25 -9.39 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.851 -0.613 . . . . 0.46000000000000002 111.208 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.88 -25.05 7.69 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.34999999999999998 112.53 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 121.89 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.5 110.714 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.478 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -60.12 84.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.96999999999999997 111.103 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -79.63 -30.34 41.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.46999999999999997 110.24 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.05 156.57 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.615 . . . . 0.31 110.374 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.13 -34.67 66.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 1.05 110.773 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.05 28.82 6.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.90000000000000002 110.813 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.478 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.83 22.64 48.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.817 -0.706 . . . . 0.23999999999999999 112.656 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.449 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -52.01 -42.67 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.38 111.093 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -57.83 -22.49 47.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.31 110.796 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -89.13 11.12 19.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.27000000000000002 111.153 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.11 -165.91 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.857 0.361 . . . . 0.89000000000000001 111.051 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.12 -23.34 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.52000000000000002 110.937 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.76 -33.31 15.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.914 0.387 . . . . 0.98999999999999999 111.332 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -83.67 -24.25 31.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 0.26000000000000001 111.087 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.32 6.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.23999999999999999 112.801 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.34999999999999998 110.636 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.922 0.391 . . . . 1.0900000000000001 111.131 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 13.5 m 53.92 -169.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.33000000000000002 110.854 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.66 -167.34 13.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.644 -0.788 . . . . 0.38 112.53 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.71 -47.07 28.13 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.859 2.372 . . . . 0.67000000000000004 112.189 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.28 55.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.89000000000000001 110.708 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 84.1 p -124.03 147.16 48.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.072 -0.513 . . . . 1.0900000000000001 111.11 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.7 t80 -112.66 149.55 32.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.40000000000000002 110.261 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -111.81 110.95 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.281 -0.418 . . . . 0.46999999999999997 110.738 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.403 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 2.2 m -56.64 148.89 43.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.27000000000000002 111.093 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.08 131.6 24.12 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.706 2.271 . . . . 0.41999999999999998 112.397 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.31 38.55 96.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.47999999999999998 112.669 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 t -174.92 156.51 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 110.999 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.52 -5.77 51.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 1.23 111.323 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 14' ' ' CYS . 2.3 p -55.22 115.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.781 0.324 . . . . 1.23 110.971 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 p -97.02 163.98 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.28000000000000003 110.755 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 25' ' ' TRP . 5.4 p -156.35 123.99 2.78 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.88 110.974 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.96 148.66 83.75 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.374 2.049 . . . . 0.33000000000000002 112.141 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.4 -38.14 51.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.38 . . . . 0.42999999999999999 110.841 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -58.56 -27.95 65.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.423 . . . . 0.38 110.53 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 21.3 m0 -91.67 -24.75 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.906 -0.588 . . . . 0.45000000000000001 110.841 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.2 mm? -53.52 122.73 10.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.269 -0.423 . . . . 0.90000000000000002 110.822 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 p 38.03 59.36 1.38 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.148 -0.478 . . . . 0.22 111.26 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -103.09 -14.14 16.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.765 -0.652 . . . . 0.46000000000000002 111.216 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.52 22.45 4.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.34999999999999998 112.751 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.28 113.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 0.5 110.582 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 1.7 mttt -62.42 83.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.96999999999999997 111.124 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.39 -28.76 41.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.104 0.478 . . . . 0.46999999999999997 110.179 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.6 t -79.23 162.68 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.31 110.737 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.88 78.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 1.05 110.712 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -122.09 29.18 7.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.984 -0.553 . . . . 0.90000000000000002 110.813 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 58.81 23.77 56.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 0.23999999999999999 112.788 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.54 -44.17 36.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.38 111.317 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.95 -23.05 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.31 111.045 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -91.59 13.92 16.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 0.27000000000000002 111.347 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.73 171.33 12.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.818 0.342 . . . . 0.89000000000000001 110.919 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 1.3 mp -61.09 -25.23 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.52000000000000002 110.625 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.21 10.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.98999999999999999 111.23 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -94.33 14.49 20.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.26000000000000001 111.549 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.6 -10.72 73.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.627 -0.797 . . . . 0.23999999999999999 112.635 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.654 0.264 . . . . 0.34999999999999998 110.295 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.59 0.233 . . . . 1.0900000000000001 111.247 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 m -115.57 69.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.868 0.366 . . . . 0.33000000000000002 110.778 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.33 -164.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.792 -0.718 . . . . 0.38 112.449 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.6 -24.18 21.93 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.744 2.296 . . . . 0.67000000000000004 112.159 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -137.39 88.55 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.89000000000000001 110.746 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.7 p -105.59 160.46 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 1.0900000000000001 111.068 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 37.7 t80 -132.37 137.09 47.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.955 -0.566 . . . . 0.40000000000000002 110.472 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 p -106.54 117.43 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.46999999999999997 110.803 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.435 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -49.02 139.16 12.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.044 -0.525 . . . . 0.27000000000000002 111.126 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.78 133.5 45.23 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.71 2.273 . . . . 0.41999999999999998 112.092 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.73 24.36 48.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.47999999999999998 112.257 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.17 146.42 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.94999999999999996 110.815 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 1.13 57.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.23 111.358 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' A' ' 14' ' ' CYS . 2.3 p -61.37 156.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 1.23 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.4 t -122.52 156.04 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.28000000000000003 111.045 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG1' HD21 ' A' ' 26' ' ' LEU . 2.8 p -159.58 118.44 1.65 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.88 110.996 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.94 145.19 99.43 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.35 2.033 . . . . 0.33000000000000002 111.803 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -47.32 -35.19 7.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.462 -0.335 . . . . 0.42999999999999999 111.251 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -59.53 -32.16 70.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.38 110.495 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -88.36 -21.01 24.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.868 -0.606 . . . . 0.45000000000000001 110.941 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.461 ' N ' HD23 ' A' ' 26' ' ' LEU . 4.3 mm? -59.54 113.32 2.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.90000000000000002 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.9 t 48.19 56.27 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.941 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.31 -14.72 15.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.46000000000000002 111.25 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.55 29.18 1.95 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.778 . . . . 0.34999999999999998 112.651 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.39 117.33 4.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.677 0.275 . . . . 0.5 110.662 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 2.6 mttp -62.38 81.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.96999999999999997 111.026 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.83 -25.97 34.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.46999999999999997 110.106 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.02 167.33 20.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.746 -0.661 . . . . 0.31 110.648 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.46 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 1.05 110.162 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.4 33.93 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.90000000000000002 110.483 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.449 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 56.67 23.89 45.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.916 -0.659 . . . . 0.23999999999999999 112.804 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.72 -44.41 48.26 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.822 0.344 . . . . 0.38 111.051 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.404 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 30.4 p-10 -59.03 -23.66 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.31 110.755 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.93 12.53 19.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.27000000000000002 111.361 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 170.9 12.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.89000000000000001 110.909 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.97 -22.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.52000000000000002 110.906 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.4 52.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.98999999999999999 111.079 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -85.9 -21.99 27.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.26000000000000001 111.164 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.27 29.57 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.684 -0.769 . . . . 0.23999999999999999 112.719 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.4 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.347 . . . . 0.34999999999999998 110.867 179.847 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.739 0.304 . . . . 1.0900000000000001 110.71 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.8 m -106.44 -67.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.33000000000000002 110.775 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.15 -178.44 51.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.455 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.69 -44.55 46.88 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.803 2.336 . . . . 0.67000000000000004 112.159 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 m -111.8 90.68 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.89000000000000001 110.714 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.76 163.76 25.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 1.0900000000000001 111.169 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 7.4 t80 -118.08 152.47 35.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.40000000000000002 110.302 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 t -108.67 111.85 23.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.46999999999999997 110.465 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.407 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 1.9 m -59.61 149.35 71.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.27000000000000002 111.168 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.09 132.8 11.82 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.815 2.343 . . . . 0.41999999999999998 112.592 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.37 39.19 97.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.899 -0.667 . . . . 0.47999999999999998 112.972 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 14' ' ' CYS . 2.8 t -176.59 156.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.94999999999999996 111.011 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.69 49.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 1.23 110.881 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 p -119.43 113.13 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 1.23 110.53 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 13.8 p -96.92 164.24 12.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.28000000000000003 111.351 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.5 p -152.12 130.55 6.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.88 110.848 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD2' ' CE3' ' A' ' 25' ' ' TRP . 37.0 Cg_exo -59.01 148.14 86.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.244 1.963 . . . . 0.33000000000000002 111.872 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HA ' HD21 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -52.1 -42.98 63.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.42999999999999999 110.863 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -22.94 66.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.38 110.445 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.439 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 24.9 m0 -87.96 -30.91 19.68 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.166 -0.47 . . . . 0.45000000000000001 110.477 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.435 HD21 ' HA ' ' A' ' 23' ' ' GLU . 3.6 mm? -45.58 121.41 3.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.034 -0.53 . . . . 0.90000000000000002 111.015 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 p 39.31 60.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.22 111.34 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -105.64 -14.7 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.46000000000000002 111.259 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.04 12.25 7.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.747 -0.74 . . . . 0.34999999999999998 112.905 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 104.12 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.5 110.649 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.427 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 2.8 mttp -58.68 86.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.96999999999999997 111.327 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -81.91 -28.73 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.46999999999999997 110.094 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.1 t -77.2 162.24 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.31 110.706 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -38.75 81.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 1.05 110.755 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.06 29.56 6.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.90000000000000002 110.865 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.427 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.29 27.91 58.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.794 -0.717 . . . . 0.23999999999999999 112.871 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.55 -43.85 56.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.38 111.407 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.3 -24.72 63.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.365 . . . . 0.31 110.904 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -88.75 11.59 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.27000000000000002 111.319 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 168.89 15.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.89000000000000001 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.8 mm -59.03 -25.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.52000000000000002 111.054 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.12 9.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.98999999999999999 111.3 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -95.19 13.88 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.26000000000000001 111.609 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.3 19.65 79.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.23999999999999999 112.809 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.5 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.34999999999999998 110.626 179.778 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.886 0.374 . . . . 1.0900000000000001 110.97 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.527 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 64.67 46.41 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.33000000000000002 111.026 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.32 -172.5 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.748 . . . . 0.38 112.501 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.83 -35.92 81.06 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.776 2.317 . . . . 0.67000000000000004 112.111 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.44 68.82 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.89000000000000001 110.493 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 5.9 t -107.04 178.58 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 1.0900000000000001 111.446 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.496 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 19.3 t80 -113.69 153.03 29.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.40000000000000002 110.683 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.63 114.98 27.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.46999999999999997 110.643 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HB2' HG13 ' A' ' 19' ' ' VAL . 7.6 m -60.08 143.33 88.46 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.477 -0.329 . . . . 0.27000000000000002 110.755 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.0 Cg_endo -77.12 137.34 17.1 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.69 2.26 . . . . 0.41999999999999998 112.622 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 -44.06 2.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 0.47999999999999998 112.886 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -109.94 168.88 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.809 0.338 . . . . 0.94999999999999996 111.028 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -97.69 38.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 1.23 111.191 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 14' ' ' CYS . 1.7 p -105.02 144.16 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 1.23 110.657 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -126.21 161.09 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.28000000000000003 110.951 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.406 ' CG2' ' HB2' ' A' ' 25' ' ' TRP . 5.5 p -144.6 130.94 9.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.88 110.998 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.61 149.42 82.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.303 2.002 . . . . 0.33000000000000002 111.981 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.04 -39.63 59.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 0.42999999999999999 110.844 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -26.86 68.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.38 110.528 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.406 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 16.5 m0 -92.03 -22.14 20.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.45000000000000001 110.944 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.423 ' CD1' ' CB ' ' A' ' 43' ' ' ALA . 3.8 mm? -51.96 122.05 7.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.367 -0.379 . . . . 0.90000000000000002 111.034 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p 39.94 57.24 2.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.025 -0.534 . . . . 0.22 111.365 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -104.75 -6.95 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.46000000000000002 111.156 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.46 -22.21 8.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.34999999999999998 112.647 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.49 108.38 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.5 110.858 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -56.83 97.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.96999999999999997 111.119 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -88.7 -30.44 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.46999999999999997 110.792 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 9.6 m -75.43 176.14 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.31 110.819 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.58 -55.61 16.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 1.05 111.015 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.5 32.55 4.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.90000000000000002 110.845 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.27 31.63 81.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.738 -0.744 . . . . 0.23999999999999999 112.5 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.403 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.28 -38.98 78.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 0.38 111.163 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -61.24 -23.59 65.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.31 111.073 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -89.08 10.69 20.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.391 . . . . 0.27000000000000002 111.338 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.75 164.66 22.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.738 0.304 . . . . 0.89000000000000001 110.819 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.39 -24.37 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.52000000000000002 111.031 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.19 -30.31 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.98999999999999999 111.227 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.496 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -86.7 -20.38 27.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.26000000000000001 111.559 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.56 30.69 5.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.23999999999999999 112.478 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.6 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.34999999999999998 110.87 179.868 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.624 0.25 . . . . 1.0900000000000001 110.961 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.427 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 3.2 m -115.22 53.01 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.33000000000000002 110.88 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.8 176.16 0.49 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.717 -0.754 . . . . 0.38 112.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.74 -25.27 20.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.848 2.366 . . . . 0.67000000000000004 112.192 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.03 58.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.89000000000000001 110.678 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.427 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 1.4 m -118.18 143.05 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 1.0900000000000001 111.03 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.437 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 33.3 t80 -92.75 152.05 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.40000000000000002 110.56 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -115.44 123.87 49.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 0.46999999999999997 110.501 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.472 ' HB2' HG12 ' A' ' 19' ' ' VAL . 3.8 m -69.14 144.61 95.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.27000000000000002 110.749 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 67.0 Cg_endo -73.56 147.3 40.51 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.783 2.322 . . . . 0.41999999999999998 112.672 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.56 38.7 95.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.865 -0.683 . . . . 0.47999999999999998 112.727 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 t -179.86 169.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.94999999999999996 110.846 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.74 35.96 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 1.23 110.994 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 14' ' ' CYS . 1.7 p -100.68 126.36 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 1.23 110.513 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.95 164.18 11.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.28000000000000003 111.162 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -156.13 122.83 2.64 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.88 110.66 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.27 148.79 77.14 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.31 2.007 . . . . 0.33000000000000002 112.023 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -30.58 31.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.895 0.379 . . . . 0.42999999999999999 110.72 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HG2' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -69.05 -24.88 64.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.38 110.357 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.448 ' CD1' ' HG2' ' A' ' 24' ' ' ARG . 32.6 m0 -99.4 12.81 35.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.542 . . . . 0.45000000000000001 111.007 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.64 121.31 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.482 -0.326 . . . . 0.90000000000000002 110.479 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 47.13 71.13 0.34 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.954 0.407 . . . . 0.22 110.571 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.12 17.51 4.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.46000000000000002 111.356 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.76 -22.35 31.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.684 -0.769 . . . . 0.34999999999999998 112.832 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.31 98.78 8.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.5 110.925 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 18.8 mtpt -59.12 99.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.96999999999999997 111.001 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.88 -30.24 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.46999999999999997 110.679 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -70.47 171.28 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.31 110.827 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.58 84.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 1.05 110.996 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.8 29.53 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.90000000000000002 110.771 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 64.85 31.3 80.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.23999999999999999 112.58 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.62 -36.06 73.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.38 111.067 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -62.94 -27.91 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.31 110.722 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.67 15.88 13.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.27000000000000002 111.271 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.41 -171.91 2.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 0.89000000000000001 110.972 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.2 mm -69.92 -25.51 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.52000000000000002 110.956 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.61 -29.93 19.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.98999999999999999 111.359 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.437 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -92.52 -19.64 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.26000000000000001 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.54 21.16 7.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.23999999999999999 112.703 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.34999999999999998 110.638 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.839 0.352 . . . . 1.0900000000000001 110.942 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m 62.99 -165.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.33000000000000002 110.886 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.64 -169.28 13.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.38 112.34 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 115.59 2.04 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.792 2.328 . . . . 0.67000000000000004 111.888 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.4 t 64.62 55.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.004 0.43 . . . . 0.89000000000000001 110.436 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 p -99.26 156.99 16.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 1.0900000000000001 111.371 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 29.0 t80 -97.09 153.82 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.40000000000000002 110.331 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 t -118.24 114.35 22.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.46999999999999997 110.654 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.48 134.68 95.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.384 . . . . 0.27000000000000002 110.962 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.5 Cg_endo -71.42 125.23 11.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.643 2.229 . . . . 0.41999999999999998 112.67 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.3 36.18 10.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.784 -0.722 . . . . 0.47999999999999998 113.137 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 t 178.29 161.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.94999999999999996 110.936 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.78 38.82 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 1.23 110.831 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.82 126.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 1.23 110.665 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -119.49 154.07 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.28000000000000003 111.188 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.408 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -141.47 136.27 15.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.88 110.899 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 21' ' ' VAL . 35.9 Cg_endo -64.75 148.17 90.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.505 2.137 . . . . 0.33000000000000002 112.294 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -50.81 -36.74 38.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.218 -0.446 . . . . 0.42999999999999999 111.198 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.74 -24.44 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.366 . . . . 0.38 110.817 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -99.35 -17.71 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.45000000000000001 111.135 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.415 HD23 ' HB3' ' A' ' 12' ' ' PHE . 3.6 mm? -53.19 121.07 6.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.90000000000000002 111.104 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 54.7 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.747 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.97 -10.45 17.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.46000000000000002 111.249 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.9 -22.76 9.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.749 -0.738 . . . . 0.34999999999999998 112.541 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.76 108.66 19.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.5 110.857 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.464 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 8.9 mttt -58.1 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.96999999999999997 111.022 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -66.43 -28.63 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.46999999999999997 110.646 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 t -97.49 159.12 15.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.269 -0.423 . . . . 0.31 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.56 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 1.05 110.917 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.56 -2.35 20.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.90000000000000002 111.207 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 70.67 31.69 67.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.844 -0.693 . . . . 0.23999999999999999 113.033 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -54.89 -38.18 67.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.976 0.417 . . . . 0.38 110.64 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.405 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -58.87 -29.93 67.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.859 -0.61 . . . . 0.31 110.678 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.44 16.87 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.27000000000000002 111.049 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.28 -165.87 1.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.861 0.363 . . . . 0.89000000000000001 110.984 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.6 mp -77.2 -27.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.487 . . . . 0.52000000000000002 111.079 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.98 -32.22 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 0.98999999999999999 111.234 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -81.86 -23.1 36.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.26000000000000001 111.223 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.6 5.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.716 -0.754 . . . . 0.23999999999999999 112.664 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.34999999999999998 110.93 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 7' ' ' CYS . 2.9 p . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.522 0.201 . . . . 1.0900000000000001 110.783 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -139.13 155.86 47.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.33000000000000002 110.65 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.03 -169.24 41.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.38 112.472 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.82 -24.29 13.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.876 2.384 . . . . 0.67000000000000004 112.293 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 72.84 1.43 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.89000000000000001 110.819 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 3.0 m -144.31 178.57 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 1.0900000000000001 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.451 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 26.1 t80 -130.85 151.95 50.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.40000000000000002 110.653 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -116.06 127.84 55.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.46999999999999997 110.622 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.478 ' HB2' HG12 ' A' ' 19' ' ' VAL . 4.8 m -65.53 140.68 97.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.27000000000000002 110.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.2 Cg_endo -72.38 149.44 50.62 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.632 2.221 . . . . 0.41999999999999998 112.427 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.8 38.07 95.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.47999999999999998 112.677 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.8 t -177.99 175.75 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 111.002 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 34.49 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.23 110.819 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 14' ' ' CYS . 1.6 p -102.45 140.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 1.23 110.861 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.94 163.61 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.28000000000000003 110.915 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 26' ' ' LEU . 4.1 p -147.34 125.44 6.02 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.88 111.281 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.59 149.14 91.07 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.412 2.075 . . . . 0.33000000000000002 111.871 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -51.12 -39.18 55.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.42999999999999999 110.997 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -59.57 -29.17 67.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.38 110.444 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -87.96 -25.15 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.589 . . . . 0.45000000000000001 110.778 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.442 HD21 ' N ' ' A' ' 26' ' ' LEU . 4.3 mm? -54.64 113.31 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.90000000000000002 111.025 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.01 62.01 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.22 110.612 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -107.14 -4.95 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.46000000000000002 111.36 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.01 -28.98 6.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.34999999999999998 112.386 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.44 177.34 5.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 0.5 110.552 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 9.1 mtpt -120.22 85.75 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.96999999999999997 111.001 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.39 -31.66 60.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.46999999999999997 110.761 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.7 m -70.9 178.26 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.31 110.866 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.83 -43.52 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 1.05 111.032 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -120.77 34.59 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.90000000000000002 110.864 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.439 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 60.72 31.39 75.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 0.23999999999999999 112.388 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.12 -43.42 78.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.38 111.24 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -57.45 -31.85 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.31 110.788 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -95.02 18.6 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.27000000000000002 111.076 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 -167.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.883 0.373 . . . . 0.89000000000000001 110.977 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.9 mm -72.45 -29.62 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.52000000000000002 111.005 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.38 -33.93 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.98999999999999999 111.28 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -83.56 -23.82 31.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.26000000000000001 111.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.81 42.35 4.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.753 . . . . 0.23999999999999999 112.858 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.34999999999999998 110.652 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.44 0.162 . . . . 1.0900000000000001 111.413 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 59.5 m -103.59 54.81 0.74 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.82 0.343 . . . . 0.33000000000000002 111.084 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.54 -163.49 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.271 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.37 117.21 3.55 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.592 2.195 . . . . 0.67000000000000004 111.975 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p 51.32 60.39 3.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.89000000000000001 110.774 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.521 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 4.9 m -94.89 161.86 13.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 1.0900000000000001 111.316 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.457 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 36.9 t80 -110.83 147.04 35.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.40000000000000002 110.443 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 p -109.71 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.46999999999999997 110.978 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB3' HG12 ' A' ' 19' ' ' VAL . 3.7 t -58.81 130.66 85.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.27000000000000002 110.727 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 142.12 41.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.594 2.196 . . . . 0.41999999999999998 112.428 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.0 -43.49 2.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 0.47999999999999998 112.985 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 169.83 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.94999999999999996 111.106 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.9 41.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 1.23 110.948 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 14' ' ' CYS . 2.7 p -105.42 113.58 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 1.23 110.632 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.21 163.09 22.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.878 -0.601 . . . . 0.28000000000000003 111.401 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 p -151.77 123.62 3.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.88 110.469 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.451 ' HG2' ' CG ' ' A' ' 25' ' ' TRP . 61.4 Cg_endo -73.91 157.74 47.01 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.317 2.011 . . . . 0.33000000000000002 112.081 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -54.29 -30.93 52.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.42999999999999999 110.965 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HG3' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -70.01 -23.23 63.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 0.38 110.495 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.498 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 32.2 m0 -100.53 8.3 43.57 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.261 -0.427 . . . . 0.45000000000000001 110.824 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 43' ' ' ALA . 3.0 mm? -80.92 117.36 21.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.486 -0.325 . . . . 0.90000000000000002 110.499 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.1 p 40.81 72.2 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.0 -0.546 . . . . 0.22 111.287 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.15 5.03 9.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.46000000000000002 111.234 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.82 -28.6 6.96 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.644 -0.789 . . . . 0.34999999999999998 112.768 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -95.3 171.5 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.5 110.941 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -118.74 87.9 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.383 -0.371 . . . . 0.96999999999999997 110.809 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -35.09 60.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.083 0.468 . . . . 0.46999999999999997 110.165 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.2 t -87.18 143.81 27.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.672 -0.694 . . . . 0.31 110.45 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.29 -31.77 1.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.37 . . . . 1.05 111.584 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -120.22 26.22 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.90000000000000002 111.003 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 54.58 28.79 46.51 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.919 -0.657 . . . . 0.23999999999999999 112.866 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.73 -44.15 18.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.38 111.404 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.89 -28.63 62.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.429 . . . . 0.31 110.494 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -84.45 8.62 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.27000000000000002 111.352 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.36 176.04 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.807 0.337 . . . . 0.89000000000000001 110.8 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 1.3 mp -69.89 -19.18 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 0.52000000000000002 110.975 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.17 -34.38 56.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.98999999999999999 111.093 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -87.29 -22.58 25.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.26000000000000001 111.239 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.21 28.96 5.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.619 -0.8 . . . . 0.23999999999999999 112.481 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.328 . . . . 0.34999999999999998 110.73 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.805 0.336 . . . . 1.0900000000000001 110.911 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.411 ' HA ' ' CD ' ' A' ' 22' ' ' PRO . 23.7 p -174.72 -39.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.33000000000000002 111.102 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.69 -160.08 11.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.636 -0.792 . . . . 0.38 112.633 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.98 150.17 74.48 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.811 2.341 . . . . 0.67000000000000004 112.284 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m 61.24 41.93 12.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.89000000000000001 110.746 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 p -83.09 168.8 16.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.501 . . . . 1.0900000000000001 111.151 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 43.1 t80 -137.65 133.12 33.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.40000000000000002 110.406 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -94.7 149.61 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.46999999999999997 110.753 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -88.88 138.58 29.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.27000000000000002 111.169 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.82 132.7 51.43 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.264 . . . . 0.41999999999999998 112.096 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.42 -44.47 2.44 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.751 -0.738 . . . . 0.47999999999999998 112.517 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' HG13 ' A' ' 19' ' ' VAL . 2.0 t -108.7 177.65 4.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.94999999999999996 110.607 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -117.35 48.05 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 1.23 111.054 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.41 HG13 ' CG2' ' A' ' 17' ' ' THR . 0.9 OUTLIER -77.33 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 1.23 110.532 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.7 t -147.59 119.35 8.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.28000000000000003 111.12 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -122.33 136.92 26.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.88 110.631 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.435 ' O ' HD21 ' A' ' 26' ' ' LEU . 66.4 Cg_endo -74.95 144.02 29.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.354 2.036 . . . . 0.33000000000000002 111.601 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -47.44 -36.1 9.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.85 0.357 . . . . 0.42999999999999999 110.923 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -30.14 70.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.38 110.344 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.43 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 30.4 m0 -87.35 -26.9 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.887 -0.597 . . . . 0.45000000000000001 110.72 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.435 HD21 ' O ' ' A' ' 22' ' ' PRO . 3.7 mm? -47.75 106.14 0.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.402 -0.363 . . . . 0.90000000000000002 111.011 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 t 50.64 67.14 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 0.22 110.819 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.63 -4.23 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.58 . . . . 0.46000000000000002 111.33 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.35 -27.59 6.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.34999999999999998 112.559 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.18 144.64 31.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.5 110.715 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.479 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 16.1 mttp -83.55 92.25 7.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.96999999999999997 111.065 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -29.72 21.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.107 0.479 . . . . 0.46999999999999997 109.761 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 168.28 20.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.66 -0.7 . . . . 0.31 110.775 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.72 98.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 1.05 110.655 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.72 29.73 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.90000000000000002 110.664 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 63.32 22.83 65.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.946 -0.645 . . . . 0.23999999999999999 112.822 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.81 -45.02 39.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.894 0.378 . . . . 0.38 110.924 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.44 -22.35 61.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.31 110.806 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -94.83 17.75 13.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.454 -0.339 . . . . 0.27000000000000002 111.194 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.39 -177.24 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.89000000000000001 111.123 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 mp -71.54 -27.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.52000000000000002 110.666 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.31 -32.02 46.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.98999999999999999 111.213 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -90.12 -14.64 33.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.023 -0.535 . . . . 0.26000000000000001 111.517 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.5 24.12 5.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.23999999999999999 112.729 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.34999999999999998 110.887 179.898 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.873 0.368 . . . . 1.0900000000000001 110.926 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 69.2 m 57.66 -84.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.33000000000000002 110.992 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.12 179.76 0.43 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.662 -0.78 . . . . 0.38 112.576 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.54 136.46 57.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.768 2.312 . . . . 0.67000000000000004 112.062 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 t 62.77 53.25 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.89000000000000001 110.607 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 158.57 15.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 1.0900000000000001 111.185 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 33.7 t80 -122.23 151.91 40.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.40000000000000002 110.063 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.1 t -119.03 120.41 37.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.836 0.351 . . . . 0.46999999999999997 110.757 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.454 ' HB2' HG11 ' A' ' 19' ' ' VAL . 6.0 m -64.78 138.62 97.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.27000000000000002 110.657 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.1 Cg_endo -70.1 139.49 39.17 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.649 2.233 . . . . 0.41999999999999998 112.537 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.34 38.46 70.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.799 -0.715 . . . . 0.47999999999999998 112.746 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.5 t 179.37 174.26 0.78 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.94999999999999996 111.035 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -114.21 43.78 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.23 110.747 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 14' ' ' CYS . 1.7 p -111.42 130.88 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 1.23 110.928 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 3.2 p -109.69 163.52 13.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.353 -0.385 . . . . 0.28000000000000003 110.859 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -151.23 125.15 4.39 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.88 110.78 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.79 148.86 81.27 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.298 1.999 . . . . 0.33000000000000002 112.009 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.42 ' HA ' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -50.93 -38.66 51.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.872 0.367 . . . . 0.42999999999999999 110.782 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -28.27 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.38 110.424 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -89.41 -24.47 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.45000000000000001 110.824 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 23' ' ' GLU . 4.1 mm? -52.89 120.92 6.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.90000000000000002 110.802 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.2 p 38.96 57.33 1.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.123 -0.49 . . . . 0.22 111.372 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -104.22 -12.08 16.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.882 -0.599 . . . . 0.46000000000000002 111.325 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.71 19.98 4.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.34999999999999998 112.763 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -148.53 101.44 3.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.812 0.339 . . . . 0.5 110.635 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -55.29 95.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.96999999999999997 111.192 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -91.78 -30.62 16.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.46999999999999997 110.603 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.23 173.94 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.31 110.868 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 1.05 111.052 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -117.61 35.93 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.90000000000000002 110.848 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.408 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 59.16 32.03 70.61 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.724 -0.751 . . . . 0.23999999999999999 112.384 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.426 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.59 -39.8 81.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.38 111.32 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.33 -26.9 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.381 . . . . 0.31 111.072 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -92.97 13.21 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.27000000000000002 111.258 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.63 169.91 14.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.801 0.334 . . . . 0.89000000000000001 110.936 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.38 -23.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.52000000000000002 110.773 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.62 -26.77 14.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.313 -0.403 . . . . 0.98999999999999999 111.186 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -102.56 21.97 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.26000000000000001 111.368 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.99 18.56 70.9 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.679 -0.772 . . . . 0.23999999999999999 112.575 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.916 0.388 . . . . 0.34999999999999998 110.619 179.931 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.787 0.327 . . . . 1.0900000000000001 110.898 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -97.11 -67.81 0.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.33000000000000002 110.982 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.87 -175.26 2.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.654 -0.784 . . . . 0.38 112.369 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.05 124.43 15.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.697 2.265 . . . . 0.67000000000000004 112.012 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t 62.03 83.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.89000000000000001 110.866 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.23 159.18 36.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 1.0900000000000001 110.93 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 43' ' ' ALA . 25.5 t80 -110.17 152.23 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.40000000000000002 110.572 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -111.97 133.13 54.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 0.46999999999999997 110.735 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 0.5 OUTLIER -79.72 137.45 54.61 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.27000000000000002 111.003 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.3 124.12 14.51 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.681 2.254 . . . . 0.41999999999999998 112.472 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.08 37.73 73.15 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.879 -0.677 . . . . 0.47999999999999998 112.84 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 178.63 152.7 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 0.94999999999999996 110.852 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -86.58 -3.77 59.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 1.23 111.509 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.77 89.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.815 0.341 . . . . 1.23 111.074 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 p -82.73 162.71 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.28000000000000003 111.034 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.21 129.23 6.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.88 111.066 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.03 151.9 82.3 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.403 2.069 . . . . 0.33000000000000002 111.886 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 4.4 tt0 -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.42999999999999999 110.801 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -59.76 -27.41 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.38 110.459 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -90.61 -25.24 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.895 -0.593 . . . . 0.45000000000000001 110.917 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 26' ' ' LEU . 3.9 mm? -50.62 122.3 7.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.90000000000000002 110.935 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 p 39.12 61.59 1.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.039 -0.528 . . . . 0.22 111.285 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -108.19 -6.04 16.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.757 -0.656 . . . . 0.46000000000000002 111.219 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.75 -26.18 7.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.34999999999999998 112.589 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.77 103.92 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.5 110.81 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 25.8 mtpt -59.94 85.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.96999999999999997 111.083 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -75.31 -30.84 60.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.46999999999999997 110.637 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -69.0 170.89 9.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.001 -0.545 . . . . 0.31 110.862 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.29 71.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 1.05 110.742 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -120.73 28.41 7.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.90000000000000002 110.811 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.428 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.8 28.22 71.37 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.822 -0.704 . . . . 0.23999999999999999 112.739 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.34 75.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.38 111.008 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.31 110.943 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.48 15.85 16.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 0.27000000000000002 111.264 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.54 172.51 12.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.89000000000000001 110.849 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.55 -21.89 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.52000000000000002 110.811 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.29 -32.11 36.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.916 0.388 . . . . 0.98999999999999999 111.094 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . . . -88.58 -22.38 23.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 0.26000000000000001 111.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.04 28.52 6.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.605 -0.807 . . . . 0.23999999999999999 112.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.299 . . . . 0.34999999999999998 110.546 179.823 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.454 0.169 . . . . 1.0900000000000001 111.28 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.8 m -109.43 75.16 0.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.788 0.328 . . . . 0.33000000000000002 110.963 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.18 -160.54 1.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.675 -0.774 . . . . 0.38 112.354 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.87 122.83 12.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.613 2.209 . . . . 0.67000000000000004 111.977 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t 61.05 58.88 2.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.89000000000000001 110.484 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.21 145.73 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 1.0900000000000001 111.311 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.0 t80 -107.44 151.88 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.40000000000000002 110.345 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.414 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 2.0 t -107.5 126.7 52.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.21 -0.45 . . . . 0.46999999999999997 110.761 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.475 ' HB2' HG12 ' A' ' 19' ' ' VAL . 3.5 m -74.99 142.26 75.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.27000000000000002 110.866 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.7 Cg_endo -72.32 146.03 44.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.719 2.279 . . . . 0.41999999999999998 112.498 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.33 35.49 91.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.47999999999999998 112.593 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 t 179.81 174.59 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.94999999999999996 110.814 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.49 30.75 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 1.23 110.95 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 14' ' ' CYS . 1.7 p -93.72 133.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 1.23 110.681 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 p -109.92 164.25 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.28000000000000003 111.016 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.76 134.19 8.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.88 110.836 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD2' ' CE3' ' A' ' 25' ' ' TRP . 59.0 Cg_endo -72.23 148.96 50.68 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.264 1.976 . . . . 0.33000000000000002 111.721 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -38.69 24.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.42999999999999999 111.061 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -27.73 69.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.345 -0.388 . . . . 0.38 110.466 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.435 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 26.6 m0 -88.17 -25.29 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.45000000000000001 110.677 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.82 122.16 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.268 -0.424 . . . . 0.90000000000000002 110.873 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 37.17 55.21 1.3 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.053 0.454 . . . . 0.22 111.284 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -101.02 -13.57 18.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 0.46000000000000002 111.124 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.21 18.95 4.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 0.34999999999999998 112.784 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.48 108.65 3.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.5 110.643 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.411 ' CE ' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -55.49 92.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.96999999999999997 111.172 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.08 -30.92 18.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.46999999999999997 110.67 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.3 -174.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.31 110.849 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.13 -50.01 21.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 1.05 110.932 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.4 33.48 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.90000000000000002 110.79 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' CA ' ' CE ' ' A' ' 31' ' ' LYS . . . 65.14 27.9 72.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.694 -0.765 . . . . 0.23999999999999999 112.555 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.463 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.55 -41.73 86.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.778 0.323 . . . . 0.38 111.174 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -54.97 -27.69 45.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.31 110.997 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.63 19.23 10.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.27000000000000002 111.005 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.57 -164.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.89000000000000001 110.888 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.9 mm -80.14 -28.19 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.52000000000000002 111.12 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.32 -31.71 22.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.98999999999999999 111.485 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.441 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -86.3 -19.79 29.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.26000000000000001 111.401 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.71 21.03 8.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.636 -0.792 . . . . 0.23999999999999999 112.776 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.464 . . . . 0.34999999999999998 110.69 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.662 0.268 . . . . 1.0900000000000001 111.261 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.401 ' HB3' ' CB ' ' A' ' 11' ' ' SER . 33.5 m -111.76 -41.94 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.33000000000000002 111.255 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.02 -174.6 2.45 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.62 -0.8 . . . . 0.38 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.56 140.97 94.01 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.745 2.296 . . . . 0.67000000000000004 112.226 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 p 50.02 78.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.89000000000000001 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.401 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 64.5 p -118.49 158.81 24.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 1.0900000000000001 111.223 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 10.5 t80 -93.23 152.8 18.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.945 -0.57 . . . . 0.40000000000000002 110.283 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -107.08 123.17 47.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.406 -0.361 . . . . 0.46999999999999997 110.689 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -75.66 135.22 71.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.27000000000000002 111.02 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.71 129.23 22.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.651 2.234 . . . . 0.41999999999999998 112.525 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.0 -43.75 1.9 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.782 -0.723 . . . . 0.47999999999999998 112.988 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.29 160.78 19.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 0.94999999999999996 110.985 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -0.62 49.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 1.23 111.402 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.9 p -63.19 133.01 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.757 0.313 . . . . 1.23 110.757 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -124.58 153.44 42.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.28000000000000003 111.089 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.1 139.81 36.14 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.88 111.141 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.32 146.91 87.03 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.477 2.118 . . . . 0.33000000000000002 111.959 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 2.1 mt-10 -51.02 -40.95 59.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.928 0.394 . . . . 0.42999999999999999 110.824 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -60.7 -27.37 67.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.38 110.599 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -90.46 -24.86 20.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.45000000000000001 110.944 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 26' ' ' LEU . 3.9 mm? -50.01 125.96 13.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.333 -0.394 . . . . 0.90000000000000002 111.062 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 39.89 56.71 2.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.22 111.481 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -105.82 -6.37 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.46000000000000002 111.165 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -20.66 9.49 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.75 . . . . 0.34999999999999998 112.681 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -109.78 116.24 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.5 110.883 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.42 90.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.96999999999999997 110.978 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -66.1 -32.37 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.46999999999999997 110.753 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.76 160.56 15.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.31 110.897 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.92 -28.37 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 1.05 111.053 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -104.79 -4.69 22.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.90000000000000002 111.497 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.4 32.47 64.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.664 -0.779 . . . . 0.23999999999999999 112.779 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.6 91.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.38 110.822 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.58 -26.71 67.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.546 . . . . 0.31 110.996 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -89.3 9.17 27.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.27000000000000002 111.375 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.07 175.88 8.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.858 0.361 . . . . 0.89000000000000001 111.026 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.72 -22.71 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.52000000000000002 111.015 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.64 -30.12 12.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.376 . . . . 0.98999999999999999 111.397 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -90.02 -20.08 23.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.26000000000000001 111.486 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.46 24.11 7.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.23999999999999999 112.631 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.34999999999999998 110.671 179.909 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.767 0.317 . . . . 1.0900000000000001 110.759 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.6 m -102.95 -72.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.33000000000000002 110.889 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -176.91 34.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.487 -0.863 . . . . 0.38 112.303 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.55 -22.19 73.87 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.67000000000000004 112.481 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.2 p -128.33 101.93 6.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.89000000000000001 111.077 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.48 176.87 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 1.0900000000000001 111.074 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.457 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 17.1 t80 -125.93 152.01 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.40000000000000002 110.452 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 12' ' ' PHE . 4.3 t -108.11 125.99 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.46999999999999997 110.591 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HB2' HG11 ' A' ' 19' ' ' VAL . 3.7 m -74.95 144.6 79.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.27000000000000002 110.943 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 72.9 Cg_endo -74.87 144.76 31.12 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.633 2.222 . . . . 0.41999999999999998 112.471 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.49 73.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.707 . . . . 0.47999999999999998 112.648 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t 179.77 167.81 1.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.348 . . . . 0.94999999999999996 110.95 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.79 27.47 7.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.23 110.918 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 14' ' ' CYS . 2.3 p -91.19 137.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 1.23 110.733 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 p -118.32 162.92 17.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.28000000000000003 111.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 25' ' ' TRP . 5.7 p -145.42 134.82 11.38 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.88 110.736 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HG2' ' CG ' ' A' ' 25' ' ' TRP . 56.6 Cg_endo -71.0 148.14 56.41 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.391 2.061 . . . . 0.33000000000000002 111.946 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -48.16 -39.86 22.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.361 -0.381 . . . . 0.42999999999999999 111.002 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -58.13 -29.47 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.38 110.555 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . 0.422 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 33.9 m0 -92.34 -24.32 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 0.45000000000000001 110.867 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.418 ' CD1' ' CB ' ' A' ' 43' ' ' ALA . 3.9 mm? -50.96 123.96 10.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.272 -0.422 . . . . 0.90000000000000002 111.037 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 36.73 56.97 1.16 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.163 -0.471 . . . . 0.22 111.324 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -103.53 -13.81 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.615 . . . . 0.46000000000000002 111.218 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.76 -23.99 7.27 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.34999999999999998 112.535 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 118.7 37.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 0.5 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -62.9 107.6 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.96999999999999997 111.074 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.33 -28.05 12.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.46999999999999997 110.558 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.9 m -75.26 -179.69 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.858 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.7 -54.93 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 1.05 111.179 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.43 34.89 4.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.90000000000000002 111.072 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.35 28.51 72.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.23999999999999999 112.638 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.402 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -57.67 -42.44 83.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.727 0.299 . . . . 0.38 111.281 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -56.9 -21.64 31.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.31 111.188 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.49 11.45 17.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.27000000000000002 111.502 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.33 173.06 10.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.763 0.316 . . . . 0.89000000000000001 110.982 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.8 -23.24 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.52000000000000002 110.882 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.78 -23.98 13.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.98999999999999999 111.309 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HB1' ' CD2' ' A' ' 12' ' ' PHE . . . -90.85 -0.2 57.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.26000000000000001 111.844 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.48 -12.12 30.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.616 -0.802 . . . . 0.23999999999999999 112.922 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.737 0.268 . . . . 0.34999999999999998 110.335 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.521 0.2 . . . . 1.0900000000000001 110.765 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.84 -164.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.636 0.255 . . . . 0.33000000000000002 110.431 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.53 177.25 25.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.38 112.62 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.62 -25.42 59.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.808 2.339 . . . . 0.67000000000000004 112.245 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -129.02 48.03 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.89000000000000001 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.24 141.01 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 1.0900000000000001 110.858 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.431 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 38.8 t80 -91.23 137.37 32.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.40000000000000002 110.417 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -105.21 128.19 53.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.161 -0.472 . . . . 0.46999999999999997 110.845 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -57.66 140.61 80.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.27000000000000002 110.774 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 35.6 Cg_endo -64.94 133.19 34.94 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.723 2.282 . . . . 0.41999999999999998 112.48 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.54 31.73 44.79 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.819 -0.705 . . . . 0.47999999999999998 112.562 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.38 155.56 45.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.94999999999999996 110.888 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -98.68 30.65 3.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 1.23 110.774 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.97 138.52 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 1.23 110.788 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -110.79 165.39 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.28000000000000003 110.878 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 p -151.59 132.68 7.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.88 110.805 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.48 151.14 41.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.282 1.988 . . . . 0.33000000000000002 111.907 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -29.12 16.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.42999999999999999 110.848 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.02 -25.37 64.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.38 110.455 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.16 18.25 21.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.45000000000000001 110.91 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -94.42 114.32 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.90000000000000002 110.867 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.27 60.41 3.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.22 110.798 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.82 11.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.46000000000000002 111.369 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.8 -25.8 7.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 0.34999999999999998 112.474 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.61 104.51 15.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.5 110.691 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.0 mtpt -57.54 96.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.96999999999999997 111.086 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.17 -32.45 19.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.46999999999999997 110.689 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -176.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.31 110.651 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.74 -46.0 33.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.406 . . . . 1.05 110.889 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.75 31.22 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.90000000000000002 110.727 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.404 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 68.08 30.92 74.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.832 -0.699 . . . . 0.23999999999999999 112.67 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.462 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -57.94 -43.81 86.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.38 111.008 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -56.59 -28.38 60.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.31 110.739 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.69 17.72 12.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.27000000000000002 111.145 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.61 -169.69 2.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.825 0.345 . . . . 0.89000000000000001 111.027 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 1.5 mp -73.86 -26.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.52000000000000002 110.827 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.62 9.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.98999999999999999 111.401 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB1' ' CD2' ' A' ' 12' ' ' PHE . . . -100.71 13.49 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.26000000000000001 111.594 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.5 66.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.744 -0.741 . . . . 0.23999999999999999 113.05 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.34999999999999998 110.726 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.775 0.321 . . . . 1.0900000000000001 110.769 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 m -100.21 -67.16 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 0.33000000000000002 110.766 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.21 -176.92 9.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.63 -0.795 . . . . 0.38 112.483 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 -43.68 56.27 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.723 2.282 . . . . 0.67000000000000004 112.122 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -103.29 95.57 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.89000000000000001 110.782 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.42 147.42 32.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 1.0900000000000001 111.107 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 11.8 t80 -107.56 150.59 26.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.40000000000000002 110.482 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -106.08 123.98 48.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.46999999999999997 110.834 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.28 146.64 74.74 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.27000000000000002 111.221 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.09 136.84 39.03 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.798 2.332 . . . . 0.41999999999999998 112.598 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.51 88.97 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.857 -0.687 . . . . 0.47999999999999998 112.806 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 t 179.61 153.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.94999999999999996 111.017 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.69 2.65 54.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 1.23 111.342 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.44 123.17 8.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.859 0.361 . . . . 1.23 110.821 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 p -102.94 162.71 12.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.28000000000000003 111.083 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.408 ' CG1' HD22 ' A' ' 26' ' ' LEU . 3.2 p -154.96 133.93 7.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.88 110.649 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.18 147.01 52.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.386 2.058 . . . . 0.33000000000000002 111.984 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -49.07 -39.13 26.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.354 . . . . 0.42999999999999999 110.968 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -58.24 -29.47 65.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.983 0.42 . . . . 0.38 110.453 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -88.86 -25.94 21.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.923 -0.58 . . . . 0.45000000000000001 110.572 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.415 HD21 ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -56.52 113.43 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.90000000000000002 110.952 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.1 m 56.23 53.52 8.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.026 0.441 . . . . 0.22 110.941 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -105.73 -18.13 14.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.46000000000000002 111.136 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.37 -15.57 9.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.803 -0.713 . . . . 0.34999999999999998 112.655 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.08 107.32 17.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.744 0.307 . . . . 0.5 110.81 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.457 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -59.17 85.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.96999999999999997 111.112 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.74 -26.32 60.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.46999999999999997 110.449 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.2 t -83.76 164.48 19.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.31 111.011 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.29 82.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 1.05 110.773 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.58 18.07 12.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 0.90000000000000002 111.04 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 66.42 25.83 72.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.23999999999999999 112.947 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.6 -38.07 52.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.93 0.365 . . . . 0.38 110.89 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.72 -22.99 64.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.31 110.812 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.74 20.31 13.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.306 . . . . 0.27000000000000002 111.22 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.11 -179.66 5.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.89000000000000001 111.007 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.22 -21.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.52000000000000002 110.864 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.16 -35.31 35.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.98999999999999999 111.14 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -84.71 -22.3 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.576 . . . . 0.26000000000000001 111.152 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.66 39.4 2.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.23999999999999999 112.63 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.34999999999999998 111.064 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.503 -0.239 . . . . 2.3399999999999999 112.503 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.89 73.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 1.1200000000000001 110.859 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -81.57 125.58 30.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.46999999999999997 110.887 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.4 28.86 62.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.721 -0.752 . . . . 0.52000000000000002 112.445 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -82.16 -74.62 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.748 0.308 . . . . 0.5 110.919 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.5 p -61.65 128.14 34.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 1.0900000000000001 111.055 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.405 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 51.99 67.74 0.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.33000000000000002 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -158.69 4.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.38 112.413 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.5 -41.5 75.42 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.607 2.204 . . . . 0.67000000000000004 111.876 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.19 66.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.89000000000000001 110.315 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.405 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 96.4 p -81.82 122.05 27.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 1.0900000000000001 111.29 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 43' ' ' ALA . 48.8 t80 -98.15 144.33 27.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.40000000000000002 110.153 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -104.15 132.47 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.46999999999999997 111.254 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -74.86 131.08 79.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.815 -0.63 . . . . 0.27000000000000002 110.422 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -60.19 158.78 28.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.573 2.182 . . . . 0.41999999999999998 112.274 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.57 21.86 58.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.47999999999999998 112.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.419 ' CG2' HG11 ' A' ' 19' ' ' VAL . 6.2 t -179.32 168.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.687 0.28 . . . . 0.94999999999999996 110.64 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -110.01 59.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.333 . . . . 1.23 111.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.419 HG11 ' CG2' ' A' ' 17' ' ' THR . 1.4 m -110.35 122.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.788 0.328 . . . . 1.23 110.198 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.78 161.75 18.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 0.28000000000000003 111.067 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.4 p -158.57 112.01 1.66 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.88 110.489 179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.53 144.7 61.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.259 1.973 . . . . 0.33000000000000002 111.87 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.82 -32.07 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.382 . . . . 0.42999999999999999 110.819 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.38 110.457 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -89.85 -19.34 24.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.45000000000000001 110.988 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.0 mm? -58.84 119.56 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.324 -0.398 . . . . 0.90000000000000002 110.922 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.59 50.69 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.22 110.825 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -104.59 -13.25 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.46000000000000002 111.251 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 -26.31 7.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 0.34999999999999998 112.555 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -94.6 98.47 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.5 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.413 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 6.5 mtpt -57.35 88.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.96999999999999997 111.15 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -76.74 -32.31 57.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.46999999999999997 110.643 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 37.3 t -81.67 144.24 31.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.31 110.507 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.23 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 1.05 111.965 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -115.75 29.35 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.684 0.278 . . . . 0.90000000000000002 111.388 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 53.02 31.3 39.83 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.815 -0.707 . . . . 0.23999999999999999 112.89 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 0.38 111.171 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -56.05 -28.07 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.31 110.941 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.73 11.31 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.27000000000000002 111.379 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 178.01 6.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.872 0.368 . . . . 0.89000000000000001 111.083 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 46' ' ' LEU . 1.4 mm -60.92 -20.74 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.52000000000000002 110.951 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.43 -31.73 55.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.392 . . . . 0.98999999999999999 111.205 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . . . -88.3 -20.49 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.26000000000000001 111.243 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.08 4.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.23999999999999999 112.656 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.44 66.24 2.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.34999999999999998 110.663 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 41' ' ' ILE . 0.2 OUTLIER -83.48 -45.4 13.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.036 -0.529 . . . . 1.4199999999999999 110.893 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -53.32 119.89 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.52000000000000002 111.159 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.05 -76.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.90000000000000002 110.816 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.59 99.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 1.3500000000000001 111.177 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.254 -0.879 . . . . 1.3400000000000001 110.909 179.946 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.556 -0.218 . . . . 2.3399999999999999 112.556 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -129.19 109.75 11.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 1.1200000000000001 110.808 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.2 61.5 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.46999999999999997 110.89 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.74 27.57 2.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.68 -0.771 . . . . 0.52000000000000002 112.535 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.68 -83.74 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.598 0.237 . . . . 0.5 110.956 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 51.09 -91.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.601 -0.272 . . . . 1.0900000000000001 111.212 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.95 20.07 8.37 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.708 0.289 . . . . 0.33000000000000002 110.876 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.11 -168.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.38 112.421 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.6 137.28 33.43 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.771 2.314 . . . . 0.67000000000000004 112.021 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 t 71.44 29.35 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.89000000000000001 110.945 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 m -102.22 154.23 19.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 1.0900000000000001 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 34.7 t80 -115.83 151.82 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.40000000000000002 110.727 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -118.05 121.03 39.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.46999999999999997 110.41 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.449 ' HB2' HG11 ' A' ' 19' ' ' VAL . 4.4 m -60.93 143.78 91.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.27000000000000002 110.636 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 70.5 Cg_endo -74.43 136.68 22.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.644 2.229 . . . . 0.41999999999999998 112.537 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.56 -42.06 2.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.756 -0.735 . . . . 0.47999999999999998 112.771 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.429 ' CG2' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -112.58 170.24 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 0.94999999999999996 110.844 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 28.32 4.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.23 111.403 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.449 HG11 ' HB2' ' A' ' 14' ' ' CYS . 1.4 p -89.52 131.63 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.345 . . . . 1.23 110.59 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -108.58 164.66 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.28000000000000003 111.108 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' CG1' HD22 ' A' ' 26' ' ' LEU . 7.6 p -153.08 125.08 3.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.88 110.8 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -59.38 150.19 76.56 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.409 2.073 . . . . 0.33000000000000002 112.069 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -51.56 -39.76 58.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.42999999999999999 110.897 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -62.46 -27.68 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.38 110.393 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 24.1 m0 -87.61 -24.36 23.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.45000000000000001 110.732 179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' A' ' 23' ' ' GLU . 4.0 mm? -53.04 125.65 18.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.224 -0.444 . . . . 0.90000000000000002 110.746 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 38.63 58.04 1.72 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.025 0.44 . . . . 0.22 111.327 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -105.34 -7.76 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.46000000000000002 111.241 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -23.76 8.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.34999999999999998 112.624 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.37 109.97 22.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 0.5 110.914 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.7 mtpt -61.02 88.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.96999999999999997 110.975 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.96 -30.06 35.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.46999999999999997 110.866 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.93 175.01 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.31 110.905 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.6 -52.01 50.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 1.05 110.931 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -114.0 32.17 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.90000000000000002 110.851 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.427 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.65 30.2 76.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 0.23999999999999999 112.489 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.42 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.39 -39.28 79.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.38 111.316 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p30 -63.2 -23.47 67.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.31 111.034 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.97 13.94 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.27000000000000002 111.237 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.89 -176.23 3.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.861 0.363 . . . . 0.89000000000000001 111.047 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.7 mm -71.43 -25.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.52000000000000002 110.979 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.64 -26.39 8.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.98999999999999999 111.451 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -94.74 -4.47 47.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.26000000000000001 111.913 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.02 35.61 34.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.579 -0.82 . . . . 0.23999999999999999 112.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.9 t -67.36 -25.52 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.34999999999999998 110.713 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER 69.22 65.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.458 . . . . 1.4199999999999999 111.174 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' CD1' ' O ' ' A' ' 46' ' ' LEU . 31.9 m-85 -149.68 115.39 5.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.535 . . . . 0.52000000000000002 110.69 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -57.22 -61.22 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.90000000000000002 111.044 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -162.77 152.13 15.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 1.3500000000000001 110.926 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.222 -0.894 . . . . 1.3400000000000001 110.912 179.967 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.536 -0.226 . . . . 2.3399999999999999 112.536 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.25 -74.82 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 1.1200000000000001 110.831 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -160.66 29.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.46999999999999997 110.926 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.83 62.56 0.16 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.52000000000000002 112.645 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.03 -60.87 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 0.5 110.758 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.443 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -66.81 -53.74 29.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 1.0900000000000001 110.695 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.4 m -151.54 69.19 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.33000000000000002 110.662 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.02 -160.48 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.923 -0.656 . . . . 0.38 112.713 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.58 138.41 83.4 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.766 2.311 . . . . 0.67000000000000004 112.239 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p 60.02 46.8 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.89000000000000001 110.932 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.39 140.8 34.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 1.0900000000000001 110.822 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.443 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 23.7 t80 -90.58 152.93 20.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.40000000000000002 110.269 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 t -111.01 125.56 53.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.46999999999999997 110.885 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.423 ' HB2' HG12 ' A' ' 19' ' ' VAL . 4.4 m -71.55 140.98 84.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.27000000000000002 110.677 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.6 Cg_endo -77.34 136.37 15.83 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.649 2.233 . . . . 0.41999999999999998 112.465 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.49 44.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.703 -0.761 . . . . 0.47999999999999998 112.615 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.7 t 179.4 163.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 110.868 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -98.35 40.12 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.23 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 14' ' ' CYS . 2.4 p -111.26 135.56 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 1.23 110.748 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 p -122.58 156.5 34.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.28000000000000003 110.982 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' CG2' ' HB2' ' A' ' 25' ' ' TRP . 7.1 p -134.53 133.63 21.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.88 111.152 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 25' ' ' TRP . 22.7 Cg_exo -63.31 150.54 88.28 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.461 2.108 . . . . 0.33000000000000002 112.062 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -52.9 -31.36 39.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.42999999999999999 110.77 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -70.08 -28.15 65.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.38 110.343 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 24.3 m0 -95.21 4.91 53.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.45000000000000001 111.142 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' CD1' ' CB ' ' A' ' 43' ' ' ALA . 3.1 mm? -76.58 118.54 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.90000000000000002 110.938 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 39.29 69.16 0.3 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.868 -0.605 . . . . 0.22 111.751 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' OD2' ' HA ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -116.76 -13.68 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.084 -0.507 . . . . 0.46000000000000002 111.174 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.54 32.7 1.19 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.582 -0.818 . . . . 0.34999999999999998 112.779 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.54 91.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 0.5 110.752 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 10.1 mtpt -53.14 92.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.96999999999999997 111.308 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.92 -30.85 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.46999999999999997 110.531 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -174.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.73 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.41 -55.51 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 1.05 110.973 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.91 38.61 3.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.90000000000000002 110.732 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.412 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.85 31.33 80.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.23999999999999999 112.425 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.428 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.0 -47.81 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.38 111.155 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -57.86 -27.44 63.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.31 110.809 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.08 8.12 28.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.27000000000000002 111.433 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.9 170.84 13.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.89000000000000001 111.085 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.9 mp -60.03 -23.87 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.52000000000000002 110.733 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.3 -27.89 6.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.98999999999999999 111.27 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.443 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -91.05 -19.79 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.26000000000000001 111.483 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.66 12.45 12.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 0.23999999999999999 113.115 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t -63.43 -32.42 73.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.34999999999999998 110.344 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 mt 66.81 -83.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.793 -0.639 . . . . 1.4199999999999999 112.549 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.467 ' O ' ' CG ' ' A' ' 47' ' ' TYR . 24.9 p90 -47.03 106.24 0.08 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.018 0.437 . . . . 0.52000000000000002 112.093 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.0 m-20 29.13 -91.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.421 -0.809 . . . . 0.90000000000000002 112.567 179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.4 m 57.43 26.16 12.23 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.795 0.331 . . . . 1.3500000000000001 110.987 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.261 -0.876 . . . . 1.3400000000000001 110.998 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.51 -0.236 . . . . 2.3399999999999999 112.51 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.69 79.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.339 . . . . 1.1200000000000001 110.825 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 60.18 30.04 19.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.46999999999999997 110.919 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.41 82.27 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 0.52000000000000002 112.518 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 35.97 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.5 110.909 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.03 -38.8 12.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 1.0900000000000001 110.951 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.9 m -151.38 74.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.33000000000000002 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.23 -163.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.38 112.45 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.82 -23.78 43.73 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.733 2.288 . . . . 0.67000000000000004 112.246 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 p -123.91 83.05 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.89000000000000001 110.744 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.7 53.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 1.0900000000000001 111.04 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.432 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 24.6 t80 -103.56 150.81 23.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.40000000000000002 110.479 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -112.64 128.04 56.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.46999999999999997 110.777 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.438 ' HB2' HG12 ' A' ' 19' ' ' VAL . 4.8 m -69.28 136.14 88.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.27000000000000002 110.559 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.3 Cg_endo -69.88 139.39 39.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.662 2.241 . . . . 0.41999999999999998 112.56 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.87 -42.32 2.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.756 -0.735 . . . . 0.47999999999999998 112.746 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.432 ' CG2' HG13 ' A' ' 19' ' ' VAL . 1.3 t -112.62 171.66 7.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.94999999999999996 111.013 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -104.52 54.53 0.72 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.255 -0.429 . . . . 1.23 111.29 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.438 HG12 ' HB2' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -113.35 142.93 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 1.23 110.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -112.72 154.07 26.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.28000000000000003 110.894 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.403 HG21 ' HD2' ' A' ' 22' ' ' PRO . 2.5 p -145.03 131.14 9.67 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.88 110.691 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.403 ' HD2' HG21 ' A' ' 21' ' ' VAL . 57.5 Cg_endo -71.77 146.83 49.2 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.281 1.987 . . . . 0.33000000000000002 111.978 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -48.0 -38.11 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.379 -0.373 . . . . 0.42999999999999999 111.148 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -27.81 65.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 0.38 110.706 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -96.07 -19.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.45000000000000001 111.109 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.436 HD21 ' N ' ' A' ' 26' ' ' LEU . 4.0 mm? -53.84 123.06 11.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.517 -0.31 . . . . 0.90000000000000002 110.909 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.5 p 36.92 58.49 1.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.089 -0.505 . . . . 0.22 111.403 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -104.25 -9.39 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.851 -0.613 . . . . 0.46000000000000002 111.208 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.88 -25.05 7.69 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.34999999999999998 112.53 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 121.89 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.5 110.714 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.478 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -60.12 84.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.96999999999999997 111.103 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -79.63 -30.34 41.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.46999999999999997 110.24 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.05 156.57 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.615 . . . . 0.31 110.374 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.13 -34.67 66.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 1.05 110.773 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.05 28.82 6.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.90000000000000002 110.813 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.478 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.83 22.64 48.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.817 -0.706 . . . . 0.23999999999999999 112.656 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.449 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -52.01 -42.67 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.38 111.093 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -57.83 -22.49 47.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.31 110.796 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -89.13 11.12 19.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.27000000000000002 111.153 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.11 -165.91 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.857 0.361 . . . . 0.89000000000000001 111.051 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 mp -76.12 -23.34 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.52000000000000002 110.937 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.76 -33.31 15.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.914 0.387 . . . . 0.98999999999999999 111.332 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.432 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -83.67 -24.25 31.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 0.26000000000000001 111.087 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.32 6.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.23999999999999999 112.801 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.67 -52.59 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.34999999999999998 110.636 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.8 77.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.044 -0.526 . . . . 1.4199999999999999 111.307 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -174.03 36.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.52000000000000002 110.972 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.35 136.46 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.90000000000000002 110.917 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 68.98 10.84 8.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 1.3500000000000001 111.461 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.238 -0.887 . . . . 1.3400000000000001 111.376 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.478 -0.249 . . . . 2.3399999999999999 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t -140.89 67.4 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.372 . . . . 1.1200000000000001 110.853 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -176.42 -43.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.46999999999999997 110.788 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.75 41.63 2.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.837 -0.697 . . . . 0.52000000000000002 112.416 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.75 -16.85 61.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.58 0.228 . . . . 0.5 111.312 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.2 p -50.27 130.92 23.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.922 0.391 . . . . 1.0900000000000001 111.131 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.441 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 13.5 m 53.92 -169.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.33000000000000002 110.854 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.66 -167.34 13.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.644 -0.788 . . . . 0.38 112.53 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.71 -47.07 28.13 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.859 2.372 . . . . 0.67000000000000004 112.189 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.28 55.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.89000000000000001 110.708 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.441 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 84.1 p -124.03 147.16 48.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.072 -0.513 . . . . 1.0900000000000001 111.11 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.489 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.7 t80 -112.66 149.55 32.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.40000000000000002 110.261 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -111.81 110.95 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.281 -0.418 . . . . 0.46999999999999997 110.738 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.403 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 2.2 m -56.64 148.89 43.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.27000000000000002 111.093 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.08 131.6 24.12 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.706 2.271 . . . . 0.41999999999999998 112.397 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.31 38.55 96.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.47999999999999998 112.669 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.1 t -174.92 156.51 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 110.999 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.52 -5.77 51.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 1.23 111.323 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.403 ' CG1' ' HB2' ' A' ' 14' ' ' CYS . 2.3 p -55.22 115.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.781 0.324 . . . . 1.23 110.971 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.2 p -97.02 163.98 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.28000000000000003 110.755 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.411 ' CG2' ' HB2' ' A' ' 25' ' ' TRP . 5.4 p -156.35 123.99 2.78 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.88 110.974 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -58.96 148.66 83.75 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.374 2.049 . . . . 0.33000000000000002 112.141 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -51.4 -38.14 51.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.38 . . . . 0.42999999999999999 110.841 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -58.56 -27.95 65.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.423 . . . . 0.38 110.53 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 21.3 m0 -91.67 -24.75 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.906 -0.588 . . . . 0.45000000000000001 110.841 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.437 HD22 ' N ' ' A' ' 26' ' ' LEU . 4.2 mm? -53.52 122.73 10.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.269 -0.423 . . . . 0.90000000000000002 110.822 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 p 38.03 59.36 1.38 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.148 -0.478 . . . . 0.22 111.26 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -103.09 -14.14 16.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.765 -0.652 . . . . 0.46000000000000002 111.216 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.52 22.45 4.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.34999999999999998 112.751 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.28 113.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 0.5 110.582 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 1.7 mttt -62.42 83.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.96999999999999997 111.124 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.39 -28.76 41.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.104 0.478 . . . . 0.46999999999999997 110.179 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.6 t -79.23 162.68 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.31 110.737 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.88 78.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 1.05 110.712 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -122.09 29.18 7.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.984 -0.553 . . . . 0.90000000000000002 110.813 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.426 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 58.81 23.77 56.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 0.23999999999999999 112.788 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.54 -44.17 36.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.38 111.317 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.8 p30 -59.95 -23.05 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.31 111.045 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -91.59 13.92 16.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 0.27000000000000002 111.347 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.73 171.33 12.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.818 0.342 . . . . 0.89000000000000001 110.919 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.426 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 1.3 mp -61.09 -25.23 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.52000000000000002 110.625 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.21 10.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.98999999999999999 111.23 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.489 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -94.33 14.49 20.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.26000000000000001 111.549 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.6 -10.72 73.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.627 -0.797 . . . . 0.23999999999999999 112.635 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.86 164.5 17.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.654 0.264 . . . . 0.34999999999999998 110.295 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mt -141.49 -59.23 0.48 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.472 -0.331 . . . . 1.4199999999999999 110.964 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.463 ' O ' ' CG ' ' A' ' 47' ' ' TYR . 23.1 p90 -53.47 93.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.099 0.476 . . . . 0.52000000000000002 110.934 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -90.45 -179.83 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 0.90000000000000002 110.971 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 m -122.95 -43.99 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 1.3500000000000001 110.863 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.24 -0.886 . . . . 1.3400000000000001 110.903 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.444 -0.262 . . . . 2.3399999999999999 112.444 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -173.64 -67.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 1.1200000000000001 110.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 60.2 108.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.46999999999999997 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.42 -154.18 16.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.703 -0.761 . . . . 0.52000000000000002 112.509 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.447 ' O ' ' N ' ' A' ' 7' ' ' CYS . 0.2 OUTLIER 66.04 -76.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.606 0.241 . . . . 0.5 110.982 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.2 p 51.98 -85.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.179 -0.464 . . . . 1.0900000000000001 111.247 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 5' ' ' LYS . 9.6 m -115.57 69.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.868 0.366 . . . . 0.33000000000000002 110.778 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.33 -164.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.792 -0.718 . . . . 0.38 112.449 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.6 -24.18 21.93 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.744 2.296 . . . . 0.67000000000000004 112.159 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -137.39 88.55 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.89000000000000001 110.746 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.7 p -105.59 160.46 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 1.0900000000000001 111.068 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 37.7 t80 -132.37 137.09 47.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.955 -0.566 . . . . 0.40000000000000002 110.472 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 p -106.54 117.43 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.46999999999999997 110.803 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.435 ' HB2' ' CG1' ' A' ' 19' ' ' VAL . 0.5 OUTLIER -49.02 139.16 12.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.044 -0.525 . . . . 0.27000000000000002 111.126 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.78 133.5 45.23 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.71 2.273 . . . . 0.41999999999999998 112.092 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.73 24.36 48.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.47999999999999998 112.257 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -141.17 146.42 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.94999999999999996 110.815 -179.649 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 1.13 57.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.23 111.358 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.435 ' CG1' ' HB2' ' A' ' 14' ' ' CYS . 2.3 p -61.37 156.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 1.23 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.4 t -122.52 156.04 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.28000000000000003 111.045 -179.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' CG1' HD21 ' A' ' 26' ' ' LEU . 2.8 p -159.58 118.44 1.65 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.88 110.996 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -60.94 145.19 99.43 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.35 2.033 . . . . 0.33000000000000002 111.803 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 -47.32 -35.19 7.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.462 -0.335 . . . . 0.42999999999999999 111.251 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -59.53 -32.16 70.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.38 110.495 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 23.0 m0 -88.36 -21.01 24.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.868 -0.606 . . . . 0.45000000000000001 110.941 179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.461 ' N ' HD23 ' A' ' 26' ' ' LEU . 4.3 mm? -59.54 113.32 2.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.90000000000000002 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 51.9 t 48.19 56.27 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.941 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.31 -14.72 15.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.46000000000000002 111.25 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.55 29.18 1.95 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.778 . . . . 0.34999999999999998 112.651 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.39 117.33 4.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.677 0.275 . . . . 0.5 110.662 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.449 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 2.6 mttp -62.38 81.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.96999999999999997 111.026 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.83 -25.97 34.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.46999999999999997 110.106 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -80.02 167.33 20.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.746 -0.661 . . . . 0.31 110.648 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.46 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 1.05 110.162 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.4 33.93 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.90000000000000002 110.483 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.449 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 56.67 23.89 45.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.916 -0.659 . . . . 0.23999999999999999 112.804 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -49.72 -44.41 48.26 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.822 0.344 . . . . 0.38 111.051 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.404 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 30.4 p-10 -59.03 -23.66 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.31 110.755 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.93 12.53 19.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.27000000000000002 111.361 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 170.9 12.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.89000000000000001 110.909 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.1 mp -58.97 -22.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.52000000000000002 110.906 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.4 52.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.98999999999999999 111.079 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.447 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -85.9 -21.99 27.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.26000000000000001 111.164 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.27 29.57 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.684 -0.769 . . . . 0.23999999999999999 112.719 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 50.4 t -79.37 -29.76 42.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.347 . . . . 0.34999999999999998 110.867 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 71.75 -67.26 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 1.4199999999999999 111.219 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 48' ' ' ASN . 2.4 p90 -83.95 176.32 8.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.427 -0.352 . . . . 0.52000000000000002 111.098 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.4 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 7.4 p-10 -102.78 150.29 23.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.90000000000000002 110.89 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t -149.3 31.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 1.3500000000000001 110.86 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.268 -0.872 . . . . 1.3400000000000001 110.896 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.455 -0.258 . . . . 2.3399999999999999 112.455 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.85 -73.43 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 1.1200000000000001 110.741 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -110.44 -161.07 0.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.46999999999999997 110.446 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.05 78.46 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.575 -0.821 . . . . 0.52000000000000002 112.225 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' GLU . 0.5 OUTLIER -82.55 1.31 38.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.538 0.208 . . . . 0.5 111.431 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.0 -75.02 0.06 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.739 0.304 . . . . 1.0900000000000001 110.71 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.8 m -106.44 -67.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.33000000000000002 110.775 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.15 -178.44 51.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.455 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.69 -44.55 46.88 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.803 2.336 . . . . 0.67000000000000004 112.159 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 m -111.8 90.68 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.89000000000000001 110.714 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.76 163.76 25.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 1.0900000000000001 111.169 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.467 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 7.4 t80 -118.08 152.47 35.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.40000000000000002 110.302 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 t -108.67 111.85 23.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.46999999999999997 110.465 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.407 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 1.9 m -59.61 149.35 71.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.27000000000000002 111.168 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -78.09 132.8 11.82 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.815 2.343 . . . . 0.41999999999999998 112.592 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.37 39.19 97.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.899 -0.667 . . . . 0.47999999999999998 112.972 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.407 ' CG2' ' HB3' ' A' ' 14' ' ' CYS . 2.8 t -176.59 156.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.94999999999999996 111.011 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.69 49.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 1.23 110.881 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.3 p -119.43 113.13 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 1.23 110.53 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.402 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 13.8 p -96.92 164.24 12.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.28000000000000003 111.351 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 6.5 p -152.12 130.55 6.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.88 110.848 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.439 ' HD2' ' CE3' ' A' ' 25' ' ' TRP . 37.0 Cg_exo -59.01 148.14 86.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.244 1.963 . . . . 0.33000000000000002 111.872 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.435 ' HA ' HD21 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -52.1 -42.98 63.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.42999999999999999 110.863 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -22.94 66.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.38 110.445 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.439 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 24.9 m0 -87.96 -30.91 19.68 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.166 -0.47 . . . . 0.45000000000000001 110.477 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.435 HD21 ' HA ' ' A' ' 23' ' ' GLU . 3.6 mm? -45.58 121.41 3.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.034 -0.53 . . . . 0.90000000000000002 111.015 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 p 39.31 60.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.22 111.34 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -105.64 -14.7 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.46000000000000002 111.259 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.04 12.25 7.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.747 -0.74 . . . . 0.34999999999999998 112.905 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 104.12 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.5 110.649 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.427 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 2.8 mttp -58.68 86.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.96999999999999997 111.327 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -81.91 -28.73 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.46999999999999997 110.094 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.1 t -77.2 162.24 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.31 110.706 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -38.75 81.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 1.05 110.755 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.06 29.56 6.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.90000000000000002 110.865 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.427 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.29 27.91 58.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.794 -0.717 . . . . 0.23999999999999999 112.871 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -50.55 -43.85 56.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.38 111.407 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.3 -24.72 63.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.365 . . . . 0.31 110.904 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -88.75 11.59 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.27000000000000002 111.319 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 168.89 15.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.89000000000000001 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.8 mm -59.03 -25.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.52000000000000002 111.054 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.12 9.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.98999999999999999 111.3 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.467 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -95.19 13.88 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.26000000000000001 111.609 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.3 19.65 79.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.23999999999999999 112.809 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.5 t -74.7 88.32 2.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.34999999999999998 110.626 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.68 64.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.037 -0.529 . . . . 1.4199999999999999 111.141 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -176.95 43.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.52000000000000002 110.806 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -125.74 -174.8 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.90000000000000002 110.946 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.1 t -73.8 173.17 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 1.3500000000000001 110.87 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.237 -0.887 . . . . 1.3400000000000001 110.963 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.482 -0.247 . . . . 2.3399999999999999 112.482 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -102.67 -177.5 3.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 1.1200000000000001 110.899 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 46.07 -169.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.46999999999999997 111.354 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.33 -49.28 71.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.708 -0.758 . . . . 0.52000000000000002 112.398 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.94 -167.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.725 0.298 . . . . 0.5 110.831 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 p 67.44 137.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 1.0900000000000001 110.97 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.527 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 64.67 46.41 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.33000000000000002 111.026 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.32 -172.5 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.748 . . . . 0.38 112.501 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.83 -35.92 81.06 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.776 2.317 . . . . 0.67000000000000004 112.111 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.44 68.82 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.89000000000000001 110.493 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 5.9 t -107.04 178.58 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 1.0900000000000001 111.446 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.496 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 19.3 t80 -113.69 153.03 29.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.40000000000000002 110.683 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.63 114.98 27.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.46999999999999997 110.643 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HB2' HG13 ' A' ' 19' ' ' VAL . 7.6 m -60.08 143.33 88.46 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.477 -0.329 . . . . 0.27000000000000002 110.755 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.0 Cg_endo -77.12 137.34 17.1 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.69 2.26 . . . . 0.41999999999999998 112.622 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 -44.06 2.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 0.47999999999999998 112.886 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' HG11 ' A' ' 19' ' ' VAL . 0.4 OUTLIER -109.94 168.88 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.809 0.338 . . . . 0.94999999999999996 111.028 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -97.69 38.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 1.23 111.191 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 14' ' ' CYS . 1.7 p -105.02 144.16 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 1.23 110.657 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -126.21 161.09 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.28000000000000003 110.951 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.406 ' CG2' ' HB2' ' A' ' 25' ' ' TRP . 5.5 p -144.6 130.94 9.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.88 110.998 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -59.61 149.42 82.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.303 2.002 . . . . 0.33000000000000002 111.981 179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.04 -39.63 59.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 0.42999999999999999 110.844 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -26.86 68.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.38 110.528 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.406 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 16.5 m0 -92.03 -22.14 20.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.45000000000000001 110.944 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.423 ' CD1' ' CB ' ' A' ' 43' ' ' ALA . 3.8 mm? -51.96 122.05 7.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.367 -0.379 . . . . 0.90000000000000002 111.034 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p 39.94 57.24 2.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.025 -0.534 . . . . 0.22 111.365 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -104.75 -6.95 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.46000000000000002 111.156 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.46 -22.21 8.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.34999999999999998 112.647 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.49 108.38 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.5 110.858 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -56.83 97.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.96999999999999997 111.119 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -88.7 -30.44 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.46999999999999997 110.792 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 9.6 m -75.43 176.14 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.31 110.819 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.58 -55.61 16.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 1.05 111.015 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.5 32.55 4.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.90000000000000002 110.845 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.27 31.63 81.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.738 -0.744 . . . . 0.23999999999999999 112.5 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.403 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.28 -38.98 78.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 0.38 111.163 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 25.7 p-10 -61.24 -23.59 65.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.31 111.073 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -89.08 10.69 20.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.391 . . . . 0.27000000000000002 111.338 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.75 164.66 22.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.738 0.304 . . . . 0.89000000000000001 110.819 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.39 -24.37 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.52000000000000002 111.031 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.19 -30.31 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.98999999999999999 111.227 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.496 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -86.7 -20.38 27.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.26000000000000001 111.559 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.56 30.69 5.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.23999999999999999 112.478 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.6 t -63.21 -20.38 65.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.34999999999999998 110.87 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 71.27 -69.28 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.258 -0.428 . . . . 1.4199999999999999 111.443 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.432 ' CE2' ' HB2' ' A' ' 49' ' ' SER . 21.1 p90 -80.39 155.58 27.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.52000000000000002 110.918 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -44.23 -69.94 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.985 -0.552 . . . . 0.90000000000000002 111.81 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.432 ' HB2' ' CE2' ' A' ' 47' ' ' TYR . 1.5 t 68.01 28.12 6.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 1.3500000000000001 110.898 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.221 -0.895 . . . . 1.3400000000000001 110.918 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.557 -0.217 . . . . 2.3399999999999999 112.557 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.45 -164.51 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.302 . . . . 1.1200000000000001 110.835 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 67.28 67.0 0.4 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 0.46999999999999997 110.868 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.37 49.77 11.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.763 -0.732 . . . . 0.52000000000000002 112.482 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -111.77 -28.16 8.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.743 0.306 . . . . 0.5 111.089 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.89 -83.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.38 -0.373 . . . . 1.0900000000000001 110.961 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.427 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 3.2 m -115.22 53.01 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.33000000000000002 110.88 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.8 176.16 0.49 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.717 -0.754 . . . . 0.38 112.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.74 -25.27 20.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.848 2.366 . . . . 0.67000000000000004 112.192 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.03 58.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.89000000000000001 110.678 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.427 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 1.4 m -118.18 143.05 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 1.0900000000000001 111.03 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.437 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 33.3 t80 -92.75 152.05 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.40000000000000002 110.56 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -115.44 123.87 49.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 0.46999999999999997 110.501 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.472 ' HB2' HG12 ' A' ' 19' ' ' VAL . 3.8 m -69.14 144.61 95.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.27000000000000002 110.749 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 67.0 Cg_endo -73.56 147.3 40.51 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.783 2.322 . . . . 0.41999999999999998 112.672 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.56 38.7 95.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.865 -0.683 . . . . 0.47999999999999998 112.727 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.0 t -179.86 169.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.94999999999999996 110.846 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.74 35.96 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 1.23 110.994 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.472 HG12 ' HB2' ' A' ' 14' ' ' CYS . 1.7 p -100.68 126.36 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 1.23 110.513 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.95 164.18 11.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.28000000000000003 111.162 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.7 p -156.13 122.83 2.64 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.88 110.66 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.27 148.79 77.14 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.31 2.007 . . . . 0.33000000000000002 112.023 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -30.58 31.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.895 0.379 . . . . 0.42999999999999999 110.72 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.448 ' HG2' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -69.05 -24.88 64.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.38 110.357 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.448 ' CD1' ' HG2' ' A' ' 24' ' ' ARG . 32.6 m0 -99.4 12.81 35.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.542 . . . . 0.45000000000000001 111.007 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -89.64 121.31 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.482 -0.326 . . . . 0.90000000000000002 110.479 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 47.13 71.13 0.34 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.954 0.407 . . . . 0.22 110.571 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.12 17.51 4.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.46000000000000002 111.356 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.76 -22.35 31.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.684 -0.769 . . . . 0.34999999999999998 112.832 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.31 98.78 8.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.5 110.925 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.415 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 18.8 mtpt -59.12 99.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.96999999999999997 111.001 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.88 -30.24 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.46999999999999997 110.679 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -70.47 171.28 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.31 110.827 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.58 84.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 1.05 110.996 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.8 29.53 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.90000000000000002 110.771 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.415 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 64.85 31.3 80.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.23999999999999999 112.58 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.62 -36.06 73.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.38 111.067 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -62.94 -27.91 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.31 110.722 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.67 15.88 13.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.27000000000000002 111.271 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.41 -171.91 2.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 0.89000000000000001 110.972 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.2 mm -69.92 -25.51 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.52000000000000002 110.956 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.61 -29.93 19.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.98999999999999999 111.359 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -92.52 -19.64 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.26000000000000001 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.54 21.16 7.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.23999999999999999 112.703 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -94.13 118.68 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.34999999999999998 110.638 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.91 68.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 1.4199999999999999 111.233 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.6 p90 179.25 44.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.52000000000000002 110.89 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.69 140.7 58.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.90000000000000002 110.882 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.32 -64.46 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 1.3500000000000001 110.915 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.219 -0.896 . . . . 1.3400000000000001 110.828 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 112.519 -0.233 . . . . 2.3399999999999999 112.519 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.42 15.91 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.597 0.237 . . . . 1.1200000000000001 111.337 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 57.38 165.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.857 0.36 . . . . 0.46999999999999997 111.06 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.19 131.52 10.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.52000000000000002 112.362 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.32 -26.05 13.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.742 0.306 . . . . 0.5 111.04 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.3 150.99 10.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.37 -0.377 . . . . 1.0900000000000001 110.942 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m 62.99 -165.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.33000000000000002 110.886 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.64 -169.28 13.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.38 112.34 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 115.59 2.04 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.792 2.328 . . . . 0.67000000000000004 111.888 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.4 t 64.62 55.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.004 0.43 . . . . 0.89000000000000001 110.436 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.1 p -99.26 156.99 16.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 1.0900000000000001 111.371 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.492 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 29.0 t80 -97.09 153.82 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.40000000000000002 110.331 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 t -118.24 114.35 22.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.46999999999999997 110.654 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 35.3 t -65.48 134.68 95.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.384 . . . . 0.27000000000000002 110.962 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.431 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.5 Cg_endo -71.42 125.23 11.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.643 2.229 . . . . 0.41999999999999998 112.67 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.3 36.18 10.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.784 -0.722 . . . . 0.47999999999999998 113.137 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.5 t 178.29 161.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.94999999999999996 110.936 179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.78 38.82 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 1.23 110.831 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 5.1 p -112.82 126.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 1.23 110.665 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -119.49 154.07 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.28000000000000003 111.188 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.408 HG22 ' HD2' ' A' ' 22' ' ' PRO . 0.8 OUTLIER -141.47 136.27 15.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.88 110.899 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.408 ' HD2' HG22 ' A' ' 21' ' ' VAL . 35.9 Cg_endo -64.75 148.17 90.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.505 2.137 . . . . 0.33000000000000002 112.294 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -50.81 -36.74 38.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.218 -0.446 . . . . 0.42999999999999999 111.198 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.74 -24.44 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.366 . . . . 0.38 110.817 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -99.35 -17.71 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.45000000000000001 111.135 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD23 ' HB3' ' A' ' 12' ' ' PHE . 3.6 mm? -53.19 121.07 6.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.90000000000000002 111.104 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 54.7 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.747 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.97 -10.45 17.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.46000000000000002 111.249 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.9 -22.76 9.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.749 -0.738 . . . . 0.34999999999999998 112.541 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.76 108.66 19.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.5 110.857 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.464 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 8.9 mttt -58.1 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.96999999999999997 111.022 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -66.43 -28.63 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.46999999999999997 110.646 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 t -97.49 159.12 15.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.269 -0.423 . . . . 0.31 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.56 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 1.05 110.917 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.56 -2.35 20.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.90000000000000002 111.207 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.464 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 70.67 31.69 67.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.844 -0.693 . . . . 0.23999999999999999 113.033 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.431 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -54.89 -38.18 67.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.976 0.417 . . . . 0.38 110.64 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.405 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.4 OUTLIER -58.87 -29.93 67.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.859 -0.61 . . . . 0.31 110.678 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.44 16.87 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.27000000000000002 111.049 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.28 -165.87 1.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.861 0.363 . . . . 0.89000000000000001 110.984 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 4.6 mp -77.2 -27.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.487 . . . . 0.52000000000000002 111.079 179.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.98 -32.22 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 0.98999999999999999 111.234 -179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -81.86 -23.1 36.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.26000000000000001 111.223 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.6 5.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.716 -0.754 . . . . 0.23999999999999999 112.664 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -24.47 20.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.34999999999999998 110.93 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mt 69.48 -62.6 0.41 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.243 -0.435 . . . . 1.4199999999999999 111.385 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 64.82 147.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.453 -0.34 . . . . 0.52000000000000002 110.707 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -152.15 107.74 3.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.405 . . . . 0.90000000000000002 111.001 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -164.82 119.18 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 1.3500000000000001 110.792 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.279 -0.867 . . . . 1.3400000000000001 110.915 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.537 -0.225 . . . . 2.3399999999999999 112.537 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.5 t 60.5 172.16 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.847 0.356 . . . . 1.1200000000000001 110.889 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.05 47.93 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.46999999999999997 110.838 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.69 43.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.824 -0.703 . . . . 0.52000000000000002 112.324 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -108.7 -145.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.677 -0.12 . . . . 0.5 110.677 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 7' ' ' CYS . 2.9 p 68.51 -66.22 0.24 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.522 0.201 . . . . 1.0900000000000001 110.783 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -139.13 155.86 47.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.33000000000000002 110.65 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.03 -169.24 41.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.38 112.472 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.82 -24.29 13.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.876 2.384 . . . . 0.67000000000000004 112.293 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 72.84 1.43 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.89000000000000001 110.819 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.42 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 3.0 m -144.31 178.57 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 1.0900000000000001 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.451 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 26.1 t80 -130.85 151.95 50.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.40000000000000002 110.653 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.0 t -116.06 127.84 55.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.46999999999999997 110.622 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.478 ' HB2' HG12 ' A' ' 19' ' ' VAL . 4.8 m -65.53 140.68 97.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.27000000000000002 110.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.2 Cg_endo -72.38 149.44 50.62 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.632 2.221 . . . . 0.41999999999999998 112.427 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.8 38.07 95.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.47999999999999998 112.677 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.8 t -177.99 175.75 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 111.002 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 34.49 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.23 110.819 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 14' ' ' CYS . 1.6 p -102.45 140.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 1.23 110.861 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.7 p -117.94 163.61 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.28000000000000003 110.915 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.407 ' CG1' HD22 ' A' ' 26' ' ' LEU . 4.1 p -147.34 125.44 6.02 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.88 111.281 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -61.59 149.14 91.07 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.412 2.075 . . . . 0.33000000000000002 111.871 179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.407 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -51.12 -39.18 55.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.42999999999999999 110.997 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -59.57 -29.17 67.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.38 110.444 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -87.96 -25.15 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.589 . . . . 0.45000000000000001 110.778 179.654 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.442 HD21 ' N ' ' A' ' 26' ' ' LEU . 4.3 mm? -54.64 113.31 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.90000000000000002 111.025 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.01 62.01 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.22 110.612 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -107.14 -4.95 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.46000000000000002 111.36 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.01 -28.98 6.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.34999999999999998 112.386 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.44 177.34 5.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 0.5 110.552 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 9.1 mtpt -120.22 85.75 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.96999999999999997 111.001 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.39 -31.66 60.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.46999999999999997 110.761 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 3.7 m -70.9 178.26 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.31 110.866 -179.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.83 -43.52 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 1.05 111.032 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -120.77 34.59 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.90000000000000002 110.864 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.439 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 60.72 31.39 75.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 0.23999999999999999 112.388 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.434 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.12 -43.42 78.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.38 111.24 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 29.7 p-10 -57.45 -31.85 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.31 110.788 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -95.02 18.6 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.27000000000000002 111.076 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 -167.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.883 0.373 . . . . 0.89000000000000001 110.977 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.9 mm -72.45 -29.62 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.52000000000000002 111.005 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.38 -33.93 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.98999999999999999 111.28 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -83.56 -23.82 31.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.26000000000000001 111.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.81 42.35 4.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.753 . . . . 0.23999999999999999 112.858 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -47.12 6.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.34999999999999998 110.652 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.6 38.12 5.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 1.4199999999999999 111.343 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.428 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 6.0 p90 -175.81 119.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.951 0.405 . . . . 0.52000000000000002 110.954 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -178.19 -52.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.90000000000000002 110.803 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t 61.53 153.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 1.3500000000000001 110.857 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.254 -0.879 . . . . 1.3400000000000001 110.856 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.456 -0.257 . . . . 2.3399999999999999 112.456 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 p -176.95 158.14 1.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 1.1200000000000001 110.907 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -32.11 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.46999999999999997 110.833 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.2 121.54 2.3 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.722 -0.751 . . . . 0.52000000000000002 112.563 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -60.91 85.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.5 110.662 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.32 -91.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 1.0900000000000001 111.413 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.521 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 59.5 m -103.59 54.81 0.74 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.82 0.343 . . . . 0.33000000000000002 111.084 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.54 -163.49 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.271 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.37 117.21 3.55 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.592 2.195 . . . . 0.67000000000000004 111.975 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p 51.32 60.39 3.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.89000000000000001 110.774 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.521 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 4.9 m -94.89 161.86 13.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 1.0900000000000001 111.316 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.457 ' CD2' ' HB2' ' A' ' 43' ' ' ALA . 36.9 t80 -110.83 147.04 35.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.40000000000000002 110.443 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 p -109.71 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.46999999999999997 110.978 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.447 ' HB3' HG12 ' A' ' 19' ' ' VAL . 3.7 t -58.81 130.66 85.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.27000000000000002 110.727 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 142.12 41.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.594 2.196 . . . . 0.41999999999999998 112.428 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.0 -43.49 2.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 0.47999999999999998 112.985 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -117.61 169.83 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.94999999999999996 111.106 -179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.9 41.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 1.23 110.948 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 14' ' ' CYS . 2.7 p -105.42 113.58 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 1.23 110.632 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.21 163.09 22.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.878 -0.601 . . . . 0.28000000000000003 111.401 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.8 p -151.77 123.62 3.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.88 110.469 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.451 ' HG2' ' CG ' ' A' ' 25' ' ' TRP . 61.4 Cg_endo -73.91 157.74 47.01 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.317 2.011 . . . . 0.33000000000000002 112.081 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -54.29 -30.93 52.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.42999999999999999 110.965 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . 0.498 ' HG3' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -70.01 -23.23 63.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 0.38 110.495 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.498 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 32.2 m0 -100.53 8.3 43.57 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.261 -0.427 . . . . 0.45000000000000001 110.824 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' CD1' ' HB2' ' A' ' 43' ' ' ALA . 3.0 mm? -80.92 117.36 21.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.486 -0.325 . . . . 0.90000000000000002 110.499 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.1 p 40.81 72.2 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.0 -0.546 . . . . 0.22 111.287 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.15 5.03 9.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.46000000000000002 111.234 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.82 -28.6 6.96 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.644 -0.789 . . . . 0.34999999999999998 112.768 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -95.3 171.5 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.5 110.941 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.465 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -118.74 87.9 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.383 -0.371 . . . . 0.96999999999999997 110.809 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -35.09 60.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.083 0.468 . . . . 0.46999999999999997 110.165 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.2 t -87.18 143.81 27.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.672 -0.694 . . . . 0.31 110.45 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.29 -31.77 1.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.37 . . . . 1.05 111.584 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -120.22 26.22 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.90000000000000002 111.003 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.465 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 54.58 28.79 46.51 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.919 -0.657 . . . . 0.23999999999999999 112.866 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.73 -44.15 18.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.38 111.404 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.89 -28.63 62.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.429 . . . . 0.31 110.494 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -84.45 8.62 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.27000000000000002 111.352 179.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.36 176.04 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.807 0.337 . . . . 0.89000000000000001 110.8 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 1.3 mp -69.89 -19.18 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 0.52000000000000002 110.975 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.17 -34.38 56.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.98999999999999999 111.093 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HB2' ' CD2' ' A' ' 12' ' ' PHE . . . -87.29 -22.58 25.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.26000000000000001 111.239 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.21 28.96 5.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.619 -0.8 . . . . 0.23999999999999999 112.481 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.433 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 53.9 t -55.61 -62.12 1.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.328 . . . . 0.34999999999999998 110.73 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt 76.05 -58.66 0.53 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.227 -0.442 . . . . 1.4199999999999999 111.801 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 45' ' ' CYS . 1.6 m-85 -43.78 -47.42 8.01 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.742 0.306 . . . . 0.52000000000000002 111.261 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 62.2 119.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.90000000000000002 111.001 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 m -136.73 113.84 10.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 1.3500000000000001 110.865 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.277 -0.868 . . . . 1.3400000000000001 110.917 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.506 -0.238 . . . . 2.3399999999999999 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -144.28 37.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.823 0.344 . . . . 1.1200000000000001 110.923 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 68.26 -70.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.46999999999999997 110.904 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.02 -134.91 4.26 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.52000000000000002 112.519 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -177.01 78.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.5 110.913 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.01 -54.14 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 1.0900000000000001 110.911 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.411 ' HA ' ' CD ' ' A' ' 22' ' ' PRO . 23.7 p -174.72 -39.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.33000000000000002 111.102 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.69 -160.08 11.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.636 -0.792 . . . . 0.38 112.633 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.98 150.17 74.48 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.811 2.341 . . . . 0.67000000000000004 112.284 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m 61.24 41.93 12.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.89000000000000001 110.746 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 p -83.09 168.8 16.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.501 . . . . 1.0900000000000001 111.151 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.436 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 43.1 t80 -137.65 133.12 33.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.40000000000000002 110.406 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -94.7 149.61 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.46999999999999997 110.753 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -88.88 138.58 29.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.27000000000000002 111.169 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.82 132.7 51.43 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.264 . . . . 0.41999999999999998 112.096 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.42 -44.47 2.44 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.751 -0.738 . . . . 0.47999999999999998 112.517 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.41 ' CG2' HG13 ' A' ' 19' ' ' VAL . 2.0 t -108.7 177.65 4.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.94999999999999996 110.607 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -117.35 48.05 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 1.23 111.054 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.41 HG13 ' CG2' ' A' ' 17' ' ' THR . 0.9 OUTLIER -77.33 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 1.23 110.532 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.7 t -147.59 119.35 8.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.28000000000000003 111.12 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.2 p -122.33 136.92 26.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.88 110.631 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.435 ' O ' HD21 ' A' ' 26' ' ' LEU . 66.4 Cg_endo -74.95 144.02 29.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.354 2.036 . . . . 0.33000000000000002 111.601 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 0.0 OUTLIER -47.44 -36.1 9.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.85 0.357 . . . . 0.42999999999999999 110.923 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -30.14 70.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.38 110.344 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.43 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 30.4 m0 -87.35 -26.9 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.887 -0.597 . . . . 0.45000000000000001 110.72 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.435 HD21 ' O ' ' A' ' 22' ' ' PRO . 3.7 mm? -47.75 106.14 0.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.402 -0.363 . . . . 0.90000000000000002 111.011 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 t 50.64 67.14 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 0.22 110.819 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.63 -4.23 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.58 . . . . 0.46000000000000002 111.33 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.35 -27.59 6.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.34999999999999998 112.559 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.18 144.64 31.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.5 110.715 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.479 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 16.1 mttp -83.55 92.25 7.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.96999999999999997 111.065 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -29.72 21.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.107 0.479 . . . . 0.46999999999999997 109.761 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -74.61 168.28 20.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.66 -0.7 . . . . 0.31 110.775 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.72 98.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 1.05 110.655 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.72 29.73 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.90000000000000002 110.664 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.479 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 63.32 22.83 65.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.946 -0.645 . . . . 0.23999999999999999 112.822 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -48.81 -45.02 39.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.894 0.378 . . . . 0.38 110.924 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -59.44 -22.35 61.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.31 110.806 179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -94.83 17.75 13.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.454 -0.339 . . . . 0.27000000000000002 111.194 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.39 -177.24 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.89000000000000001 111.123 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.3 mp -71.54 -27.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.52000000000000002 110.666 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.31 -32.02 46.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.98999999999999999 111.213 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.436 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -90.12 -14.64 33.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.023 -0.535 . . . . 0.26000000000000001 111.517 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.5 24.12 5.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.23999999999999999 112.729 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.14 105.05 14.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.34999999999999998 110.887 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.36 31.68 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 1.4199999999999999 111.13 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -75.07 -12.79 60.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.368 -0.378 . . . . 0.52000000000000002 111.576 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 66.06 -71.11 0.09 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.733 0.301 . . . . 0.90000000000000002 111.19 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER 68.16 141.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.335 -0.393 . . . . 1.3500000000000001 110.967 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.236 -0.888 . . . . 1.3400000000000001 110.894 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.517 -0.233 . . . . 2.3399999999999999 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.99 121.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 1.1200000000000001 110.917 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.29 -66.27 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.46999999999999997 110.838 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.82 83.52 0.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 0.52000000000000002 112.375 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -35.65 81.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 0.5 111.019 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 p -72.4 143.54 48.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 1.0900000000000001 110.926 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 69.2 m 57.66 -84.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.33000000000000002 110.992 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.12 179.76 0.43 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.662 -0.78 . . . . 0.38 112.576 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.54 136.46 57.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.768 2.312 . . . . 0.67000000000000004 112.062 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 t 62.77 53.25 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.89000000000000001 110.607 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 158.57 15.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 1.0900000000000001 111.185 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 33.7 t80 -122.23 151.91 40.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.40000000000000002 110.063 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.1 t -119.03 120.41 37.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.836 0.351 . . . . 0.46999999999999997 110.757 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.454 ' HB2' HG11 ' A' ' 19' ' ' VAL . 6.0 m -64.78 138.62 97.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.27000000000000002 110.657 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.1 Cg_endo -70.1 139.49 39.17 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.649 2.233 . . . . 0.41999999999999998 112.537 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.34 38.46 70.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.799 -0.715 . . . . 0.47999999999999998 112.746 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.5 t 179.37 174.26 0.78 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.94999999999999996 111.035 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -114.21 43.78 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.23 110.747 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.454 HG11 ' HB2' ' A' ' 14' ' ' CYS . 1.7 p -111.42 130.88 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 1.23 110.928 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 3.2 p -109.69 163.52 13.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.353 -0.385 . . . . 0.28000000000000003 110.859 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.6 p -151.23 125.15 4.39 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.88 110.78 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -58.79 148.86 81.27 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.298 1.999 . . . . 0.33000000000000002 112.009 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.42 ' HA ' HD21 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -50.93 -38.66 51.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.872 0.367 . . . . 0.42999999999999999 110.782 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -28.27 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.38 110.424 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.4 m0 -89.41 -24.47 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.45000000000000001 110.824 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.42 HD21 ' HA ' ' A' ' 23' ' ' GLU . 4.1 mm? -52.89 120.92 6.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.90000000000000002 110.802 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.2 p 38.96 57.33 1.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.123 -0.49 . . . . 0.22 111.372 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -104.22 -12.08 16.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.882 -0.599 . . . . 0.46000000000000002 111.325 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.71 19.98 4.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.34999999999999998 112.763 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -148.53 101.44 3.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.812 0.339 . . . . 0.5 110.635 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -55.29 95.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.96999999999999997 111.192 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -91.78 -30.62 16.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.46999999999999997 110.603 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.23 173.94 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.31 110.868 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 1.05 111.052 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -117.61 35.93 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.90000000000000002 110.848 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.408 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 59.16 32.03 70.61 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.724 -0.751 . . . . 0.23999999999999999 112.384 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.426 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.59 -39.8 81.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.38 111.32 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -60.33 -26.9 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.381 . . . . 0.31 111.072 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -92.97 13.21 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.27000000000000002 111.258 179.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.63 169.91 14.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.801 0.334 . . . . 0.89000000000000001 110.936 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 2.4 mp -58.38 -23.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.52000000000000002 110.773 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.62 -26.77 14.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.313 -0.403 . . . . 0.98999999999999999 111.186 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -102.56 21.97 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.26000000000000001 111.368 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.99 18.56 70.9 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.679 -0.772 . . . . 0.23999999999999999 112.575 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.57 78.52 6.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.916 0.388 . . . . 0.34999999999999998 110.619 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -118.62 24.43 10.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 1.4199999999999999 110.924 -179.862 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -9.24 57.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.418 . . . . 0.52000000000000002 111.459 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 62.78 125.02 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.837 0.351 . . . . 0.90000000000000002 111.004 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -176.73 -39.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.3500000000000001 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.262 -0.875 . . . . 1.3400000000000001 110.903 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.473 -0.251 . . . . 2.3399999999999999 112.473 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 4' ' ' GLY . 85.7 p -120.05 27.31 8.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.573 0.225 . . . . 1.1200000000000001 111.025 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 39.75 -91.39 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.111 -0.495 . . . . 0.46999999999999997 111.757 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 2' ' ' SER . . . -108.54 104.62 2.02 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.674 -0.774 . . . . 0.52000000000000002 112.413 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.26 33.53 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.5 110.946 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -62.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 1.0900000000000001 110.898 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -97.11 -67.81 0.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.33000000000000002 110.982 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.87 -175.26 2.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.654 -0.784 . . . . 0.38 112.369 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.05 124.43 15.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.697 2.265 . . . . 0.67000000000000004 112.012 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t 62.03 83.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.89000000000000001 110.866 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.23 159.18 36.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 1.0900000000000001 110.93 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 43' ' ' ALA . 25.5 t80 -110.17 152.23 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.40000000000000002 110.572 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -111.97 133.13 54.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 0.46999999999999997 110.735 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.421 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 0.5 OUTLIER -79.72 137.45 54.61 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.27000000000000002 111.003 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.3 124.12 14.51 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.681 2.254 . . . . 0.41999999999999998 112.472 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.08 37.73 73.15 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.879 -0.677 . . . . 0.47999999999999998 112.84 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.421 ' CG2' ' HB3' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 178.63 152.7 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 0.94999999999999996 110.852 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -86.58 -3.77 59.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 1.23 111.509 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.7 p -56.77 89.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.815 0.341 . . . . 1.23 111.074 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 p -82.73 162.71 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.28000000000000003 111.034 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 7.5 p -150.21 129.23 6.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.88 111.066 -179.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.03 151.9 82.3 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.403 2.069 . . . . 0.33000000000000002 111.886 179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 4.4 tt0 -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.42999999999999999 110.801 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -59.76 -27.41 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.38 110.459 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 17.0 m0 -90.61 -25.24 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.895 -0.593 . . . . 0.45000000000000001 110.917 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.407 ' N ' HD23 ' A' ' 26' ' ' LEU . 3.9 mm? -50.62 122.3 7.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.90000000000000002 110.935 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 p 39.12 61.59 1.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.039 -0.528 . . . . 0.22 111.285 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -108.19 -6.04 16.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.757 -0.656 . . . . 0.46000000000000002 111.219 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.75 -26.18 7.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.34999999999999998 112.589 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.77 103.92 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.5 110.81 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.428 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 25.8 mtpt -59.94 85.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.96999999999999997 111.083 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -75.31 -30.84 60.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.46999999999999997 110.637 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -69.0 170.89 9.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.001 -0.545 . . . . 0.31 110.862 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.29 71.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 1.05 110.742 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -120.73 28.41 7.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.90000000000000002 110.811 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.428 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.8 28.22 71.37 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.822 -0.704 . . . . 0.23999999999999999 112.739 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.34 75.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.38 111.008 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.31 110.943 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.48 15.85 16.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 0.27000000000000002 111.264 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.54 172.51 12.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.89000000000000001 110.849 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.6 mp -60.55 -21.89 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.52000000000000002 110.811 179.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.29 -32.11 36.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.916 0.388 . . . . 0.98999999999999999 111.094 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 12' ' ' PHE . . . -88.58 -22.38 23.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 0.26000000000000001 111.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.04 28.52 6.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.605 -0.807 . . . . 0.23999999999999999 112.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.407 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 25.1 t -70.36 -71.86 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.299 . . . . 0.34999999999999998 110.546 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.4 mt 67.38 -67.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 1.4199999999999999 111.405 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.472 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -63.91 78.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.081 0.467 . . . . 0.52000000000000002 111.589 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -159.4 32.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 0.90000000000000002 110.83 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.4 m -96.02 -32.68 12.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 1.3500000000000001 110.882 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.251 -0.88 . . . . 1.3400000000000001 110.921 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.538 -0.225 . . . . 2.3399999999999999 112.538 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.2 89.0 3.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 1.1200000000000001 110.991 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 68.52 -67.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.46999999999999997 111.047 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.07 44.35 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 0.52000000000000002 112.466 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -135.02 -55.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 0.5 110.846 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 p 51.42 -91.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 1.0900000000000001 111.28 -179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.8 m -109.43 75.16 0.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.788 0.328 . . . . 0.33000000000000002 110.963 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.18 -160.54 1.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.675 -0.774 . . . . 0.38 112.354 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.87 122.83 12.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.613 2.209 . . . . 0.67000000000000004 111.977 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t 61.05 58.88 2.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.89000000000000001 110.484 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.21 145.73 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 1.0900000000000001 111.311 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.441 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.0 t80 -107.44 151.88 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.40000000000000002 110.345 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.414 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 2.0 t -107.5 126.7 52.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.21 -0.45 . . . . 0.46999999999999997 110.761 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.475 ' HB2' HG12 ' A' ' 19' ' ' VAL . 3.5 m -74.99 142.26 75.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.27000000000000002 110.866 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.7 Cg_endo -72.32 146.03 44.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.719 2.279 . . . . 0.41999999999999998 112.498 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.33 35.49 91.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.47999999999999998 112.593 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.0 t 179.81 174.59 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.94999999999999996 110.814 179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.49 30.75 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 1.23 110.95 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.475 HG12 ' HB2' ' A' ' 14' ' ' CYS . 1.7 p -93.72 133.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 1.23 110.681 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 p -109.92 164.25 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.28000000000000003 111.016 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 4.8 p -152.76 134.19 8.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.88 110.836 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.435 ' HD2' ' CE3' ' A' ' 25' ' ' TRP . 59.0 Cg_endo -72.23 148.96 50.68 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.264 1.976 . . . . 0.33000000000000002 111.721 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -38.69 24.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.42999999999999999 111.061 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -27.73 69.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.345 -0.388 . . . . 0.38 110.466 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.435 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 26.6 m0 -88.17 -25.29 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.45000000000000001 110.677 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -53.82 122.16 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.268 -0.424 . . . . 0.90000000000000002 110.873 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 37.17 55.21 1.3 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.053 0.454 . . . . 0.22 111.284 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -101.02 -13.57 18.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 0.46000000000000002 111.124 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.21 18.95 4.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 0.34999999999999998 112.784 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.48 108.65 3.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.5 110.643 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' CE ' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -55.49 92.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.96999999999999997 111.172 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.08 -30.92 18.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.46999999999999997 110.67 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.3 -174.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.31 110.849 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.13 -50.01 21.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 1.05 110.932 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.4 33.48 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.90000000000000002 110.79 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' CA ' ' CE ' ' A' ' 31' ' ' LYS . . . 65.14 27.9 72.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.694 -0.765 . . . . 0.23999999999999999 112.555 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.463 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.55 -41.73 86.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.778 0.323 . . . . 0.38 111.174 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 39.3 p30 -54.97 -27.69 45.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.31 110.997 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.63 19.23 10.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.27000000000000002 111.005 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.57 -164.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.89000000000000001 110.888 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.9 mm -80.14 -28.19 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.52000000000000002 111.12 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.32 -31.71 22.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.98999999999999999 111.485 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.441 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -86.3 -19.79 29.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.26000000000000001 111.401 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.71 21.03 8.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.636 -0.792 . . . . 0.23999999999999999 112.776 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -98.37 72.06 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.464 . . . . 0.34999999999999998 110.69 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.18 78.1 4.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.846 -0.616 . . . . 1.4199999999999999 111.029 -179.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -107.74 -23.08 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.026 -0.534 . . . . 0.52000000000000002 111.014 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.6 m120 64.19 79.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.90000000000000002 110.879 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.5 p -159.84 138.85 10.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.3500000000000001 110.901 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.224 -0.893 . . . . 1.3400000000000001 110.862 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.547 -0.221 . . . . 2.3399999999999999 112.547 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 p 58.99 -169.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.761 0.315 . . . . 1.1200000000000001 110.944 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -141.99 31.49 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.46999999999999997 110.943 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.08 106.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.684 -0.77 . . . . 0.52000000000000002 112.601 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -177.58 -71.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.272 . . . . 0.5 110.869 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 57.71 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 1.0900000000000001 111.261 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' LYS . 33.5 m -111.76 -41.94 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.33000000000000002 111.255 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.02 -174.6 2.45 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.62 -0.8 . . . . 0.38 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.56 140.97 94.01 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.745 2.296 . . . . 0.67000000000000004 112.226 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 p 50.02 78.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.89000000000000001 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.401 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 64.5 p -118.49 158.81 24.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 1.0900000000000001 111.223 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.466 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 10.5 t80 -93.23 152.8 18.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.945 -0.57 . . . . 0.40000000000000002 110.283 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -107.08 123.17 47.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.406 -0.361 . . . . 0.46999999999999997 110.689 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 5.4 t -75.66 135.22 71.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.27000000000000002 111.02 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.71 129.23 22.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.651 2.234 . . . . 0.41999999999999998 112.525 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.0 -43.75 1.9 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.782 -0.723 . . . . 0.47999999999999998 112.988 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -115.29 160.78 19.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 0.94999999999999996 110.985 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -0.62 49.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 1.23 111.402 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.9 p -63.19 133.01 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.757 0.313 . . . . 1.23 110.757 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -124.58 153.44 42.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.28000000000000003 111.089 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 2.8 p -132.1 139.81 36.14 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.88 111.141 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -65.32 146.91 87.03 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.477 2.118 . . . . 0.33000000000000002 111.959 179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.403 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 2.1 mt-10 -51.02 -40.95 59.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.928 0.394 . . . . 0.42999999999999999 110.824 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -60.7 -27.37 67.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.38 110.599 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 31.1 m0 -90.46 -24.86 20.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.45000000000000001 110.944 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 26' ' ' LEU . 3.9 mm? -50.01 125.96 13.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.333 -0.394 . . . . 0.90000000000000002 111.062 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 39.89 56.71 2.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.22 111.481 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -105.82 -6.37 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.46000000000000002 111.165 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -20.66 9.49 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.75 . . . . 0.34999999999999998 112.681 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -109.78 116.24 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.5 110.883 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.42 90.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.96999999999999997 110.978 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -66.1 -32.37 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.46999999999999997 110.753 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.76 160.56 15.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.31 110.897 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.92 -28.37 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 1.05 111.053 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -104.79 -4.69 22.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.90000000000000002 111.497 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . 71.4 32.47 64.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.664 -0.779 . . . . 0.23999999999999999 112.779 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -61.64 -39.6 91.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.38 110.822 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.58 -26.71 67.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.546 . . . . 0.31 110.996 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -89.3 9.17 27.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.27000000000000002 111.375 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.07 175.88 8.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.858 0.361 . . . . 0.89000000000000001 111.026 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.72 -22.71 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.52000000000000002 111.015 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.64 -30.12 12.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.376 . . . . 0.98999999999999999 111.397 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -90.02 -20.08 23.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.26000000000000001 111.486 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.46 24.11 7.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.23999999999999999 112.631 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 m -93.51 96.78 10.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.34999999999999998 110.671 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.55 58.65 4.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 1.4199999999999999 111.191 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' O ' ' CG ' ' A' ' 47' ' ' TYR . 2.2 p90 -177.04 104.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.52000000000000002 110.862 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -112.14 -162.74 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.90000000000000002 110.887 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.56 -64.64 0.39 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.366 -0.379 . . . . 1.3500000000000001 110.98 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.204 -0.903 . . . . 1.3400000000000001 110.943 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.509 -0.236 . . . . 2.3399999999999999 112.509 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 p -127.21 142.58 51.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 1.1200000000000001 110.943 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.27 -43.57 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.46999999999999997 111.067 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.15 46.33 0.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.67 -0.776 . . . . 0.52000000000000002 112.514 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -98.98 33.5 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.793 0.33 . . . . 0.5 110.923 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -77.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 1.0900000000000001 110.759 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.6 m -102.95 -72.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.33000000000000002 110.889 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -176.91 34.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.487 -0.863 . . . . 0.38 112.303 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.55 -22.19 73.87 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.67000000000000004 112.481 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.2 p -128.33 101.93 6.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.89000000000000001 111.077 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.48 176.87 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 1.0900000000000001 111.074 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.457 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 17.1 t80 -125.93 152.01 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.40000000000000002 110.452 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 12' ' ' PHE . 4.3 t -108.11 125.99 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.46999999999999997 110.591 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' HB2' HG11 ' A' ' 19' ' ' VAL . 3.7 m -74.95 144.6 79.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.27000000000000002 110.943 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.402 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 72.9 Cg_endo -74.87 144.76 31.12 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.633 2.222 . . . . 0.41999999999999998 112.471 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.49 73.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.707 . . . . 0.47999999999999998 112.648 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.3 t 179.77 167.81 1.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.348 . . . . 0.94999999999999996 110.95 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.79 27.47 7.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.23 110.918 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.458 HG11 ' HB2' ' A' ' 14' ' ' CYS . 2.3 p -91.19 137.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 1.23 110.733 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 p -118.32 162.92 17.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.28000000000000003 111.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.414 ' CG2' ' HB2' ' A' ' 25' ' ' TRP . 5.7 p -145.42 134.82 11.38 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.88 110.736 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . 0.422 ' HG2' ' CG ' ' A' ' 25' ' ' TRP . 56.6 Cg_endo -71.0 148.14 56.41 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.391 2.061 . . . . 0.33000000000000002 111.946 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -48.16 -39.86 22.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.361 -0.381 . . . . 0.42999999999999999 111.002 -179.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -58.13 -29.47 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.38 110.555 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . 0.422 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 33.9 m0 -92.34 -24.32 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 0.45000000000000001 110.867 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.418 ' CD1' ' CB ' ' A' ' 43' ' ' ALA . 3.9 mm? -50.96 123.96 10.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.272 -0.422 . . . . 0.90000000000000002 111.037 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 36.73 56.97 1.16 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.163 -0.471 . . . . 0.22 111.324 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -103.53 -13.81 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.615 . . . . 0.46000000000000002 111.218 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.76 -23.99 7.27 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.34999999999999998 112.535 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 118.7 37.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 0.5 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -62.9 107.6 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.96999999999999997 111.074 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.33 -28.05 12.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.46999999999999997 110.558 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.9 m -75.26 -179.69 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.858 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.7 -54.93 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 1.05 111.179 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.43 34.89 4.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.90000000000000002 111.072 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.35 28.51 72.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.23999999999999999 112.638 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.402 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -57.67 -42.44 83.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.727 0.299 . . . . 0.38 111.281 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 10.1 p30 -56.9 -21.64 31.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.31 111.188 -179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.49 11.45 17.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.27000000000000002 111.502 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.33 173.06 10.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.763 0.316 . . . . 0.89000000000000001 110.982 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.8 -23.24 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.52000000000000002 110.882 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.78 -23.98 13.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.98999999999999999 111.309 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.457 ' HB1' ' CD2' ' A' ' 12' ' ' PHE . . . -90.85 -0.2 57.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.26000000000000001 111.844 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.48 -12.12 30.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.616 -0.802 . . . . 0.23999999999999999 112.922 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 145.14 56.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.737 0.268 . . . . 0.34999999999999998 110.335 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.69 -24.12 4.58 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.008 0.373 . . . . 1.4199999999999999 112.008 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' O ' ' CG ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -49.87 117.47 2.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.854 0.359 . . . . 0.52000000000000002 110.904 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.37 126.04 26.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.457 . . . . 0.90000000000000002 111.14 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.1 m -121.39 10.85 10.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 1.3500000000000001 111.169 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.7 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.243 -0.884 . . . . 1.3400000000000001 111.186 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.479 -0.248 . . . . 2.3399999999999999 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.93 177.88 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.783 0.325 . . . . 1.1200000000000001 110.838 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 59.76 -174.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.46999999999999997 110.832 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.72 116.59 8.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.641 -0.79 . . . . 0.52000000000000002 112.369 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 -155.62 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.584 0.231 . . . . 0.5 110.928 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 59.18 -85.68 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.573 -0.285 . . . . 1.0900000000000001 110.765 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.84 -164.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.636 0.255 . . . . 0.33000000000000002 110.431 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.53 177.25 25.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.38 112.62 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.62 -25.42 59.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.808 2.339 . . . . 0.67000000000000004 112.245 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -129.02 48.03 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.89000000000000001 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.24 141.01 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 1.0900000000000001 110.858 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.431 ' CD2' ' HB1' ' A' ' 43' ' ' ALA . 38.8 t80 -91.23 137.37 32.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.40000000000000002 110.417 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -105.21 128.19 53.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.161 -0.472 . . . . 0.46999999999999997 110.845 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 17.8 m -57.66 140.61 80.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.27000000000000002 110.774 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.462 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 35.6 Cg_endo -64.94 133.19 34.94 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.723 2.282 . . . . 0.41999999999999998 112.48 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.54 31.73 44.79 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.819 -0.705 . . . . 0.47999999999999998 112.562 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.38 155.56 45.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.94999999999999996 110.888 -179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -98.68 30.65 3.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 1.23 110.774 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -114.97 138.52 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 1.23 110.788 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -110.79 165.39 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.28000000000000003 110.878 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 3.4 p -151.59 132.68 7.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.88 110.805 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.48 151.14 41.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.282 1.988 . . . . 0.33000000000000002 111.907 179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -29.12 16.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.42999999999999999 110.848 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.02 -25.37 64.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.38 110.455 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.16 18.25 21.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.45000000000000001 110.91 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -94.42 114.32 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.90000000000000002 110.867 -179.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.27 60.41 3.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.22 110.798 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.82 11.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.46000000000000002 111.369 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.8 -25.8 7.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 0.34999999999999998 112.474 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.61 104.51 15.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.5 110.691 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.0 mtpt -57.54 96.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.96999999999999997 111.086 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.17 -32.45 19.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.46999999999999997 110.689 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -65.08 -176.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.31 110.651 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -75.74 -46.0 33.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.406 . . . . 1.05 110.889 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.75 31.22 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.90000000000000002 110.727 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.404 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 68.08 30.92 74.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.832 -0.699 . . . . 0.23999999999999999 112.67 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.462 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -57.94 -43.81 86.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.38 111.008 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -56.59 -28.38 60.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.31 110.739 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.69 17.72 12.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.27000000000000002 111.145 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.61 -169.69 2.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.825 0.345 . . . . 0.89000000000000001 111.027 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.406 ' CD1' ' N ' ' A' ' 41' ' ' ILE . 1.5 mp -73.86 -26.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.52000000000000002 110.827 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.62 9.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.98999999999999999 111.401 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.431 ' HB1' ' CD2' ' A' ' 12' ' ' PHE . . . -100.71 13.49 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.26000000000000001 111.594 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.5 66.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.744 -0.741 . . . . 0.23999999999999999 113.05 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.06 92.92 4.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.34999999999999998 110.726 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.7 mt -97.6 -50.57 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 1.4199999999999999 111.039 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -47.02 -37.29 9.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.225 -0.443 . . . . 0.52000000000000002 111.352 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 56.63 171.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.90000000000000002 111.016 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 p -177.25 66.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 1.3500000000000001 110.886 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.228 -0.891 . . . . 1.3400000000000001 110.901 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.474 -0.25 . . . . 2.3399999999999999 112.474 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m 60.22 33.03 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 1.1200000000000001 110.845 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.43 -169.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.46999999999999997 110.84 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.09 87.7 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.52000000000000002 112.513 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.46 29.85 3.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.309 . . . . 0.5 110.977 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.13 -79.23 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.411 . . . . 1.0900000000000001 110.769 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 16.1 m -100.21 -67.16 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 0.33000000000000002 110.766 179.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.21 -176.92 9.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.63 -0.795 . . . . 0.38 112.483 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 -43.68 56.27 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.723 2.282 . . . . 0.67000000000000004 112.122 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -103.29 95.57 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.89000000000000001 110.782 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -145.42 147.42 32.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 1.0900000000000001 111.107 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . 0.471 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 11.8 t80 -107.56 150.59 26.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.40000000000000002 110.482 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -106.08 123.98 48.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.46999999999999997 110.834 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.28 146.64 74.74 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.27000000000000002 111.221 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.09 136.84 39.03 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.798 2.332 . . . . 0.41999999999999998 112.598 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.51 88.97 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.857 -0.687 . . . . 0.47999999999999998 112.806 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.5 t 179.61 153.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.94999999999999996 111.017 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.69 2.65 54.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 1.23 111.342 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 2.5 p -57.44 123.17 8.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.859 0.361 . . . . 1.23 110.821 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 p -102.94 162.71 12.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.28000000000000003 111.083 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.408 ' CG1' HD22 ' A' ' 26' ' ' LEU . 3.2 p -154.96 133.93 7.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.88 110.649 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.18 147.01 52.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.386 2.058 . . . . 0.33000000000000002 111.984 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -49.07 -39.13 26.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.354 . . . . 0.42999999999999999 110.968 -179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -58.24 -29.47 65.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.983 0.42 . . . . 0.38 110.453 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 28.1 m0 -88.86 -25.94 21.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.923 -0.58 . . . . 0.45000000000000001 110.572 179.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.415 HD21 ' N ' ' A' ' 26' ' ' LEU . 4.4 mm? -56.52 113.43 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.90000000000000002 110.952 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.1 m 56.23 53.52 8.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.026 0.441 . . . . 0.22 110.941 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -105.73 -18.13 14.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.46000000000000002 111.136 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.37 -15.57 9.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.803 -0.713 . . . . 0.34999999999999998 112.655 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.08 107.32 17.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.744 0.307 . . . . 0.5 110.81 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.457 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -59.17 85.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.96999999999999997 111.112 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.74 -26.32 60.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.46999999999999997 110.449 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.2 t -83.76 164.48 19.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.31 111.011 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.29 82.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 1.05 110.773 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.58 18.07 12.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 0.90000000000000002 111.04 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.457 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 66.42 25.83 72.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.23999999999999999 112.947 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -51.6 -38.07 52.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.93 0.365 . . . . 0.38 110.89 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -60.72 -22.99 64.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.31 110.812 179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.74 20.31 13.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.306 . . . . 0.27000000000000002 111.22 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.11 -179.66 5.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.89000000000000001 111.007 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.0 mp -61.22 -21.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.52000000000000002 110.864 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.16 -35.31 35.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.98999999999999999 111.14 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.471 ' HA ' ' CE1' ' A' ' 12' ' ' PHE . . . -84.71 -22.3 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.576 . . . . 0.26000000000000001 111.152 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.66 39.4 2.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.23999999999999999 112.63 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.08 -61.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.34999999999999998 111.064 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 70.72 34.55 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 1.4199999999999999 110.752 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' N ' ' CD1' ' A' ' 47' ' ' TYR . 4.0 m-30 -87.18 -35.03 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.52000000000000002 110.839 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t30 66.07 38.95 4.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.90000000000000002 110.755 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.4 p -60.54 -75.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 1.3500000000000001 110.931 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.214 -0.898 . . . . 1.3400000000000001 110.874 -179.959 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.922 0.391 . . . . 0.37 111.055 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 51.99 67.74 0.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.33 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -158.69 4.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.38 112.413 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.5 -41.5 75.42 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.607 2.204 . . . . 0.57 111.876 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.19 66.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.49 110.315 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 96.4 p -81.82 122.05 27.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.42 111.29 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.711 ' HB3' HD21 ' A' ' 26' ' ' LEU . 48.8 t80 -98.15 144.33 27.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.32 110.153 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -104.15 132.47 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.41 111.254 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -74.86 131.08 79.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.815 -0.63 . . . . 0.25 110.422 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 17' ' ' THR . 19.6 Cg_endo -60.19 158.78 28.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.573 2.182 . . . . 0.36 112.274 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.57 21.86 58.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.4 112.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.67 HG23 HG13 ' A' ' 19' ' ' VAL . 6.2 t -179.32 168.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.687 0.28 . . . . 0.39 110.64 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -110.01 59.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.333 . . . . 1.13 111.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.67 HG13 HG23 ' A' ' 17' ' ' THR . 1.4 m -110.35 122.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.788 0.328 . . . . 0.65 110.198 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.78 161.75 18.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 0.26 111.067 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.636 HG22 HD22 ' A' ' 26' ' ' LEU . 2.4 p -158.57 112.01 1.66 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.22 110.489 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.53 144.7 61.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.259 1.973 . . . . 0.23 111.87 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -48.82 -32.07 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.382 . . . . 0.43 110.819 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.33 110.457 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -89.85 -19.34 24.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.38 110.988 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.711 HD21 ' HB3' ' A' ' 12' ' ' PHE . 4.0 mm? -58.84 119.56 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.324 -0.398 . . . . 0.28 110.922 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.59 50.69 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.22 110.825 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -104.59 -13.25 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.46 111.251 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 -26.31 7.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 0.35 112.555 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -94.6 98.47 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.5 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 6.5 mtpt -57.35 88.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.42 111.15 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -76.74 -32.31 57.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.47 110.643 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 37.3 t -81.67 144.24 31.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.31 110.507 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.23 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.33 111.965 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -115.75 29.35 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.684 0.278 . . . . 0.9 111.388 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 53.02 31.3 39.83 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.815 -0.707 . . . . 0.21 112.89 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.426 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 0.27 111.171 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 1.3 p30 -56.05 -28.07 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.31 110.941 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.73 11.31 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.27 111.379 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 178.01 6.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.872 0.368 . . . . 0.4 111.083 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mm -60.92 -20.74 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.37 110.951 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.43 -31.73 55.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.392 . . . . 0.29 111.205 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -88.3 -20.49 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.26 111.243 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.08 4.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.23 112.656 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.35 110.663 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.45 0.167 . . . . 0.37 111.212 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.95 20.07 8.37 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.708 0.289 . . . . 0.33 110.876 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.11 -168.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.38 112.421 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.6 137.28 33.43 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.771 2.314 . . . . 0.57 112.021 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 t 71.44 29.35 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.49 110.945 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 m -102.22 154.23 19.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.42 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.508 ' HB3' HD21 ' A' ' 26' ' ' LEU . 34.7 t80 -115.83 151.82 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.32 110.727 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -118.05 121.03 39.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.41 110.41 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.761 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.4 m -60.93 143.78 91.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.25 110.636 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 70.5 Cg_endo -74.43 136.68 22.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.644 2.229 . . . . 0.36 112.537 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.56 -42.06 2.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.756 -0.735 . . . . 0.4 112.771 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -112.58 170.24 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 0.39 110.844 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 28.32 4.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.13 111.403 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.761 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.4 p -89.52 131.63 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.345 . . . . 0.65 110.59 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -108.58 164.66 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.26 111.108 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.827 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.6 p -153.08 125.08 3.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.22 110.8 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.611 ' O ' HD23 ' A' ' 26' ' ' LEU . 34.0 Cg_exo -59.38 150.19 76.56 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.409 2.073 . . . . 0.23 112.069 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -51.56 -39.76 58.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.43 110.897 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -62.46 -27.68 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.33 110.393 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.421 ' HB2' HG22 ' A' ' 21' ' ' VAL . 24.1 m0 -87.61 -24.36 23.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.38 110.732 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.627 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.0 mm? -53.04 125.65 18.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.224 -0.444 . . . . 0.28 110.746 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 38.63 58.04 1.72 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.025 0.44 . . . . 0.22 111.327 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -105.34 -7.76 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.46 111.241 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -23.76 8.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.35 112.624 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.37 109.97 22.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 0.5 110.914 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.7 mtpt -61.02 88.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.42 110.975 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.96 -30.06 35.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.47 110.866 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.93 175.01 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.31 110.905 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -66.6 -52.01 50.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.33 110.931 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -114.0 32.17 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.9 110.851 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.65 30.2 76.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 0.21 112.489 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.39 -39.28 79.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.27 111.316 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.827 ' HB3' HG11 ' A' ' 21' ' ' VAL . 5.0 p30 -63.2 -23.47 67.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.31 111.034 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.97 13.94 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.27 111.237 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.89 -176.23 3.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.861 0.363 . . . . 0.4 111.047 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.7 mm -71.43 -25.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.37 110.979 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.64 -26.39 8.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.29 111.451 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.627 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -94.74 -4.47 47.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.26 111.913 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.02 35.61 34.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.579 -0.82 . . . . 0.23 112.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.9 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.35 110.713 179.842 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.859 0.361 . . . . 0.37 110.695 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.4 m -151.54 69.19 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.33 110.662 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.02 -160.48 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.923 -0.656 . . . . 0.38 112.713 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.58 138.41 83.4 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.766 2.311 . . . . 0.57 112.239 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p 60.02 46.8 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.49 110.932 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.39 140.8 34.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.42 110.822 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.506 ' HB3' HD21 ' A' ' 26' ' ' LEU . 23.7 t80 -90.58 152.93 20.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.32 110.269 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 t -111.01 125.56 53.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.41 110.885 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.632 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.4 m -71.55 140.98 84.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.25 110.677 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.6 Cg_endo -77.34 136.37 15.83 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.649 2.233 . . . . 0.36 112.465 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.49 44.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.703 -0.761 . . . . 0.4 112.615 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.857 HG21 ' HB2' ' A' ' 34' ' ' ALA . 1.7 t 179.4 163.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.39 110.868 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -98.35 40.12 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.13 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.632 HG13 ' SG ' ' A' ' 14' ' ' CYS . 2.4 p -111.26 135.56 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.65 110.748 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 p -122.58 156.5 34.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.26 110.982 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.863 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.1 p -134.53 133.63 21.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.22 111.152 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.683 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.7 Cg_exo -63.31 150.54 88.28 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.461 2.108 . . . . 0.23 112.062 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.9 -31.36 39.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.43 110.77 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -70.08 -28.15 65.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.33 110.343 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.465 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 24.3 m0 -95.21 4.91 53.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.38 111.142 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.74 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.1 mm? -76.58 118.54 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.28 110.938 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 39.29 69.16 0.3 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.868 -0.605 . . . . 0.22 111.751 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD2' ' HA ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -116.76 -13.68 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.084 -0.507 . . . . 0.46 111.174 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.54 32.7 1.19 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.582 -0.818 . . . . 0.35 112.779 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.54 91.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 0.5 110.752 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 10.1 mtpt -53.14 92.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.42 111.308 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.92 -30.85 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.47 110.531 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -174.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.73 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.857 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -71.41 -55.51 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.33 110.973 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.91 38.61 3.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.9 110.732 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.85 31.33 80.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.21 112.425 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.0 -47.81 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.27 111.155 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.863 ' HB3' HG11 ' A' ' 21' ' ' VAL . 20.1 p-10 -57.86 -27.44 63.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.31 110.809 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.08 8.12 28.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.433 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.9 170.84 13.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.4 111.085 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.466 HD12 ' N ' ' A' ' 41' ' ' ILE . 1.9 mp -60.03 -23.87 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.37 110.733 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.3 -27.89 6.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.29 111.27 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.74 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -91.05 -19.79 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.26 111.483 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.66 12.45 12.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 0.23 113.115 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.35 110.344 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.822 0.344 . . . . 0.37 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.9 m -151.38 74.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.33 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.23 -163.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.38 112.45 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.82 -23.78 43.73 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.733 2.288 . . . . 0.57 112.246 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 p -123.91 83.05 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.49 110.744 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.7 53.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.42 111.04 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.524 ' HB3' HD21 ' A' ' 26' ' ' LEU . 24.6 t80 -103.56 150.81 23.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.32 110.479 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -112.64 128.04 56.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.41 110.777 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.8 m -69.28 136.14 88.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.25 110.559 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.3 Cg_endo -69.88 139.39 39.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.662 2.241 . . . . 0.36 112.56 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.87 -42.32 2.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.756 -0.735 . . . . 0.4 112.746 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.536 HG23 HG12 ' A' ' 19' ' ' VAL . 1.3 t -112.62 171.66 7.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.39 111.013 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -104.52 54.53 0.72 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.255 -0.429 . . . . 1.13 111.29 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.676 HG13 ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -113.35 142.93 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.65 110.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -112.72 154.07 26.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.26 110.894 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 HD22 ' A' ' 26' ' ' LEU . 2.5 p -145.03 131.14 9.67 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.22 110.691 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.49 ' C ' HD23 ' A' ' 26' ' ' LEU . 57.5 Cg_endo -71.77 146.83 49.2 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.281 1.987 . . . . 0.23 111.978 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.541 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.2 tt0 -48.0 -38.11 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.379 -0.373 . . . . 0.43 111.148 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -27.81 65.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 0.33 110.706 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -96.07 -19.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.38 111.109 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.861 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.0 mm? -53.84 123.06 11.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.517 -0.31 . . . . 0.28 110.909 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.5 p 36.92 58.49 1.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.089 -0.505 . . . . 0.22 111.403 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -104.25 -9.39 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.851 -0.613 . . . . 0.46 111.208 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.88 -25.05 7.69 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.35 112.53 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 121.89 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.5 110.714 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.487 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -60.12 84.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.42 111.103 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -79.63 -30.34 41.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.47 110.24 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.05 156.57 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.615 . . . . 0.31 110.374 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.526 ' HB3' HG21 ' A' ' 17' ' ' THR . . . -56.13 -34.67 66.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.33 110.773 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.05 28.82 6.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.9 110.813 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.487 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.83 22.64 48.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.817 -0.706 . . . . 0.21 112.656 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -52.01 -42.67 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.27 111.093 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.698 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 3.4 p30 -57.83 -22.49 47.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.31 110.796 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -89.13 11.12 19.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.27 111.153 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.11 -165.91 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.857 0.361 . . . . 0.4 111.051 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.557 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.1 mp -76.12 -23.34 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.37 110.937 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.76 -33.31 15.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.914 0.387 . . . . 0.29 111.332 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.861 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -83.67 -24.25 31.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 0.26 111.087 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.32 6.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.23 112.801 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.35 110.636 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.922 0.391 . . . . 0.37 111.131 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 13.5 m 53.92 -169.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.33 110.854 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.66 -167.34 13.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.644 -0.788 . . . . 0.38 112.53 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.71 -47.07 28.13 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.859 2.372 . . . . 0.57 112.189 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.28 55.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.49 110.708 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.453 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 84.1 p -124.03 147.16 48.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.072 -0.513 . . . . 0.42 111.11 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.7 t80 -112.66 149.55 32.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.32 110.261 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -111.81 110.95 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.281 -0.418 . . . . 0.41 110.738 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.779 ' HB2' HG13 ' A' ' 19' ' ' VAL . 2.2 m -56.64 148.89 43.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.25 111.093 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.08 131.6 24.12 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.706 2.271 . . . . 0.36 112.397 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.31 38.55 96.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.4 112.669 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.845 ' OG1' HG12 ' A' ' 19' ' ' VAL . 2.1 t -174.92 156.51 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.39 110.999 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.52 -5.77 51.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 1.13 111.323 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.845 HG12 ' OG1' ' A' ' 17' ' ' THR . 2.3 p -55.22 115.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.781 0.324 . . . . 0.65 110.971 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 1.2 p -97.02 163.98 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.26 110.755 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.546 HG13 HD21 ' A' ' 26' ' ' LEU . 5.4 p -156.35 123.99 2.78 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.22 110.974 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.549 ' O ' HD23 ' A' ' 26' ' ' LEU . 33.6 Cg_exo -58.96 148.66 83.75 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.374 2.049 . . . . 0.23 112.141 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -51.4 -38.14 51.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.38 . . . . 0.43 110.841 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -58.56 -27.95 65.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.423 . . . . 0.33 110.53 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.44 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 21.3 m0 -91.67 -24.75 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.906 -0.588 . . . . 0.38 110.841 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.837 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.2 mm? -53.52 122.73 10.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.269 -0.423 . . . . 0.28 110.822 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 p 38.03 59.36 1.38 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.148 -0.478 . . . . 0.22 111.26 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -103.09 -14.14 16.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.765 -0.652 . . . . 0.46 111.216 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.52 22.45 4.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.35 112.751 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.28 113.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 0.5 110.582 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 1.7 mttt -62.42 83.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.42 111.124 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.39 -28.76 41.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.104 0.478 . . . . 0.47 110.179 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 8.6 t -79.23 162.68 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.31 110.737 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.88 78.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.33 110.712 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -122.09 29.18 7.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.984 -0.553 . . . . 0.9 110.813 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 58.81 23.77 56.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 0.21 112.788 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -48.54 -44.17 36.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.27 111.317 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' HB3' HG11 ' A' ' 21' ' ' VAL . 3.8 p30 -59.95 -23.05 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.31 111.045 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -91.59 13.92 16.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 0.27 111.347 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.73 171.33 12.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.818 0.342 . . . . 0.4 110.919 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 41' ' ' ILE . 1.3 mp -61.09 -25.23 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.37 110.625 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.21 10.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.29 111.23 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.837 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -94.33 14.49 20.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.26 111.549 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.6 -10.72 73.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.627 -0.797 . . . . 0.23 112.635 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.654 0.264 . . . . 0.35 110.295 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.59 0.233 . . . . 0.37 111.247 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 m -115.57 69.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.868 0.366 . . . . 0.33 110.778 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.33 -164.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.792 -0.718 . . . . 0.38 112.449 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.6 -24.18 21.93 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.744 2.296 . . . . 0.57 112.159 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -137.39 88.55 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.49 110.746 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.7 p -105.59 160.46 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.42 111.068 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 26' ' ' LEU . 37.7 t80 -132.37 137.09 47.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.955 -0.566 . . . . 0.32 110.472 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 p -106.54 117.43 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.803 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -49.02 139.16 12.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.044 -0.525 . . . . 0.25 111.126 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.78 133.5 45.23 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.71 2.273 . . . . 0.36 112.092 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.73 24.36 48.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.4 112.257 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.618 ' HB ' HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -141.17 146.42 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.39 110.815 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 1.13 57.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.13 111.358 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 17' ' ' THR . 2.3 p -61.37 156.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.65 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.411 ' N ' HG22 ' A' ' 19' ' ' VAL . 1.4 t -122.52 156.04 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.26 111.045 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.714 HG22 HD22 ' A' ' 26' ' ' LEU . 2.8 p -159.58 118.44 1.65 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.22 110.996 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.442 ' C ' HD23 ' A' ' 26' ' ' LEU . 32.0 Cg_exo -60.94 145.19 99.43 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.35 2.033 . . . . 0.23 111.803 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HA ' HD23 ' A' ' 26' ' ' LEU . 5.5 tt0 -47.32 -35.19 7.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.462 -0.335 . . . . 0.43 111.251 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -59.53 -32.16 70.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.33 110.495 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.41 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 23.0 m0 -88.36 -21.01 24.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.868 -0.606 . . . . 0.38 110.941 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.027 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.3 mm? -59.54 113.32 2.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.28 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 51.9 t 48.19 56.27 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.941 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.31 -14.72 15.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.46 111.25 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.55 29.18 1.95 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.778 . . . . 0.35 112.651 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.39 117.33 4.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.677 0.275 . . . . 0.5 110.662 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 2.6 mttp -62.38 81.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.42 111.026 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.83 -25.97 34.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.47 110.106 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -80.02 167.33 20.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.746 -0.661 . . . . 0.31 110.648 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.46 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.33 110.162 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.4 33.93 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.9 110.483 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 56.67 23.89 45.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.916 -0.659 . . . . 0.21 112.804 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -49.72 -44.41 48.26 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.822 0.344 . . . . 0.27 111.051 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 30.4 p-10 -59.03 -23.66 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.31 110.755 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.93 12.53 19.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.27 111.361 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 170.9 12.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.4 110.909 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 41' ' ' ILE . 3.1 mp -58.97 -22.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.906 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.4 52.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.29 111.079 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.027 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -85.9 -21.99 27.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.26 111.164 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.27 29.57 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.684 -0.769 . . . . 0.23 112.719 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 50.4 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.347 . . . . 0.35 110.867 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.739 0.304 . . . . 0.37 110.71 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 64.8 m -106.44 -67.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.33 110.775 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.15 -178.44 51.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.455 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.69 -44.55 46.88 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.803 2.336 . . . . 0.57 112.159 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 m -111.8 90.68 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.49 110.714 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -129.76 163.76 25.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.42 111.169 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 7.4 t80 -118.08 152.47 35.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.32 110.302 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 t -108.67 111.85 23.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.41 110.465 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.605 ' HB2' HG13 ' A' ' 19' ' ' VAL . 1.9 m -59.61 149.35 71.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.25 111.168 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 97.8 Cg_endo -78.09 132.8 11.82 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.815 2.343 . . . . 0.36 112.592 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.37 39.19 97.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.899 -0.667 . . . . 0.4 112.972 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.535 ' OG1' HG12 ' A' ' 19' ' ' VAL . 2.8 t -176.59 156.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.39 111.011 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.69 49.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 1.13 110.881 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 14' ' ' CYS . 2.3 p -119.43 113.13 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.65 110.53 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 13.8 p -96.92 164.24 12.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.26 111.351 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.896 HG11 ' HB3' ' A' ' 38' ' ' ASP . 6.5 p -152.12 130.55 6.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.22 110.848 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.631 ' O ' HD23 ' A' ' 26' ' ' LEU . 37.0 Cg_exo -59.01 148.14 86.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.244 1.963 . . . . 0.23 111.872 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -52.1 -42.98 63.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.43 110.863 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -22.94 66.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.33 110.445 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.462 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 24.9 m0 -87.96 -30.91 19.68 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.477 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.719 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.6 mm? -45.58 121.41 3.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.034 -0.53 . . . . 0.28 111.015 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 p 39.31 60.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.22 111.34 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -105.64 -14.7 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.46 111.259 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.04 12.25 7.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.747 -0.74 . . . . 0.35 112.905 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 104.12 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.5 110.649 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 2.8 mttp -58.68 86.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.42 111.327 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -81.91 -28.73 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.47 110.094 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 10.1 t -77.2 162.24 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.31 110.706 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -38.75 81.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.33 110.755 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.06 29.56 6.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.9 110.865 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.29 27.91 58.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.794 -0.717 . . . . 0.21 112.871 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -50.55 -43.85 56.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.27 111.407 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.896 ' HB3' HG11 ' A' ' 21' ' ' VAL . 2.5 p30 -59.3 -24.72 63.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.365 . . . . 0.31 110.904 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -88.75 11.59 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.27 111.319 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 168.89 15.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.4 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 45' ' ' CYS . 24.8 mm -59.03 -25.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.37 111.054 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.12 9.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.29 111.3 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.719 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -95.19 13.88 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.26 111.609 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.3 19.65 79.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.23 112.809 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.576 ' O ' HD13 ' A' ' 41' ' ' ILE . 45.5 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.35 110.626 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.886 0.374 . . . . 0.37 110.97 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.54 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 64.67 46.41 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.33 111.026 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.32 -172.5 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.748 . . . . 0.38 112.501 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.83 -35.92 81.06 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.776 2.317 . . . . 0.57 112.111 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.44 68.82 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.49 110.493 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 5.9 t -107.04 178.58 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.42 111.446 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' HB3' HD21 ' A' ' 26' ' ' LEU . 19.3 t80 -113.69 153.03 29.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.32 110.683 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.63 114.98 27.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.41 110.643 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' HG13 ' A' ' 19' ' ' VAL . 7.6 m -60.08 143.33 88.46 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.477 -0.329 . . . . 0.25 110.755 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.0 Cg_endo -77.12 137.34 17.1 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.69 2.26 . . . . 0.36 112.622 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 -44.06 2.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 0.4 112.886 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.707 HG21 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -109.94 168.88 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.809 0.338 . . . . 0.39 111.028 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -97.69 38.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 1.13 111.191 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.681 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -105.02 144.16 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 0.65 110.657 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -126.21 161.09 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.26 110.951 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 38' ' ' ASP . 5.5 p -144.6 130.94 9.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.22 110.998 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' O ' HD23 ' A' ' 26' ' ' LEU . 37.7 Cg_exo -59.61 149.42 82.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.303 2.002 . . . . 0.23 111.981 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -52.04 -39.63 59.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 0.43 110.844 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -26.86 68.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.33 110.528 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.452 ' HB2' HG22 ' A' ' 21' ' ' VAL . 16.5 m0 -92.03 -22.14 20.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.38 110.944 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.768 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.8 mm? -51.96 122.05 7.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.367 -0.379 . . . . 0.28 111.034 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p 39.94 57.24 2.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.025 -0.534 . . . . 0.22 111.365 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -104.75 -6.95 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.46 111.156 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.46 -22.21 8.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.35 112.647 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.49 108.38 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.5 110.858 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -56.83 97.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.42 111.119 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -88.7 -30.44 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.47 110.792 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 9.6 m -75.43 176.14 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.31 110.819 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -65.58 -55.61 16.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.33 111.015 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.5 32.55 4.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.9 110.845 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.27 31.63 81.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.738 -0.744 . . . . 0.21 112.5 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.429 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.28 -38.98 78.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 0.27 111.163 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.788 ' HB3' HG11 ' A' ' 21' ' ' VAL . 25.7 p-10 -61.24 -23.59 65.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.31 111.073 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -89.08 10.69 20.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.391 . . . . 0.27 111.338 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.75 164.66 22.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.738 0.304 . . . . 0.4 110.819 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.39 -24.37 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.37 111.031 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.19 -30.31 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.29 111.227 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.768 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -86.7 -20.38 27.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.26 111.559 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.56 30.69 5.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.23 112.478 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.6 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.35 110.87 179.868 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.624 0.25 . . . . 0.37 110.961 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.437 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 3.2 m -115.22 53.01 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.33 110.88 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.8 176.16 0.49 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.717 -0.754 . . . . 0.38 112.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.74 -25.27 20.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.848 2.366 . . . . 0.57 112.192 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.03 58.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.49 110.678 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 1.4 m -118.18 143.05 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.42 111.03 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.6 ' HB3' HD21 ' A' ' 26' ' ' LEU . 33.3 t80 -92.75 152.05 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.32 110.56 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -115.44 123.87 49.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 0.41 110.501 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.741 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.8 m -69.14 144.61 95.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.25 110.749 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 67.0 Cg_endo -73.56 147.3 40.51 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.783 2.322 . . . . 0.36 112.672 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.56 38.7 95.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.865 -0.683 . . . . 0.4 112.727 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.629 ' CG2' HG12 ' A' ' 19' ' ' VAL . 6.0 t -179.86 169.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.39 110.846 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.74 35.96 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 1.13 110.994 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.741 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -100.68 126.36 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.65 110.513 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.95 164.18 11.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.26 111.162 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.535 HG11 ' HB3' ' A' ' 38' ' ' ASP . 2.7 p -156.13 122.83 2.64 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.22 110.66 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.692 ' O ' HD23 ' A' ' 26' ' ' LEU . 31.5 Cg_exo -58.27 148.79 77.14 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.31 2.007 . . . . 0.23 112.023 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -30.58 31.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.895 0.379 . . . . 0.43 110.72 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HG2' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -69.05 -24.88 64.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.33 110.357 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.475 ' CD1' ' HG2' ' A' ' 24' ' ' ARG . 32.6 m0 -99.4 12.81 35.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.542 . . . . 0.38 111.007 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 22' ' ' PRO . 3.5 mm? -89.64 121.31 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.482 -0.326 . . . . 0.28 110.479 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 47.13 71.13 0.34 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.954 0.407 . . . . 0.22 110.571 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.12 17.51 4.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.46 111.356 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.76 -22.35 31.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.684 -0.769 . . . . 0.35 112.832 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.31 98.78 8.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.5 110.925 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 18.8 mtpt -59.12 99.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.42 111.001 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.88 -30.24 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.47 110.679 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -70.47 171.28 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.31 110.827 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.58 84.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.33 110.996 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.8 29.53 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.9 110.771 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 64.85 31.3 80.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.21 112.58 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.473 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.62 -36.06 73.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.27 111.067 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.664 ' HB2' HD13 ' A' ' 26' ' ' LEU . 2.0 p30 -62.94 -27.91 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.31 110.722 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.401 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 2.7 mt-10 -92.67 15.88 13.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.27 111.271 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.41 -171.91 2.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 0.4 110.972 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 45' ' ' CYS . 20.2 mm -69.92 -25.51 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.37 110.956 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.61 -29.93 19.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.29 111.359 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -92.52 -19.64 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.26 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.54 21.16 7.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.23 112.703 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.67 ' O ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.35 110.638 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.839 0.352 . . . . 0.37 110.942 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m 62.99 -165.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.33 110.886 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.64 -169.28 13.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.38 112.34 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 115.59 2.04 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.792 2.328 . . . . 0.57 111.888 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.4 t 64.62 55.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.004 0.43 . . . . 0.49 110.436 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 4.1 p -99.26 156.99 16.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.42 111.371 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.684 ' HB3' HD21 ' A' ' 26' ' ' LEU . 29.0 t80 -97.09 153.82 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.32 110.331 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 t -118.24 114.35 22.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.41 110.654 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 35.3 t -65.48 134.68 95.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.384 . . . . 0.25 110.962 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HG3' ' HB1' ' A' ' 42' ' ' ALA . 60.5 Cg_endo -71.42 125.23 11.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.643 2.229 . . . . 0.36 112.67 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.3 36.18 10.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.784 -0.722 . . . . 0.4 113.137 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.638 ' CG2' HG12 ' A' ' 19' ' ' VAL . 2.5 t 178.29 161.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.39 110.936 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.78 38.82 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 1.13 110.831 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.638 HG12 ' CG2' ' A' ' 17' ' ' THR . 5.1 p -112.82 126.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.65 110.665 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -119.49 154.07 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.26 111.188 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -141.47 136.27 15.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.22 110.899 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 35.9 Cg_endo -64.75 148.17 90.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.505 2.137 . . . . 0.23 112.294 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.603 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.6 tm-20 -50.81 -36.74 38.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.218 -0.446 . . . . 0.43 111.198 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.74 -24.44 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.366 . . . . 0.33 110.817 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -99.35 -17.71 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.38 111.135 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' A' ' 12' ' ' PHE . 3.6 mm? -53.19 121.07 6.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.28 111.104 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 54.7 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.747 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.97 -10.45 17.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.46 111.249 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.9 -22.76 9.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.749 -0.738 . . . . 0.35 112.541 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.76 108.66 19.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.5 110.857 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 8.9 mttt -58.1 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.42 111.022 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -66.43 -28.63 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.47 110.646 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 t -97.49 159.12 15.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.269 -0.423 . . . . 0.31 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.56 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 0.33 110.917 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.56 -2.35 20.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.9 111.207 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.474 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 70.67 31.69 67.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.844 -0.693 . . . . 0.21 113.033 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.601 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -54.89 -38.18 67.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.976 0.417 . . . . 0.27 110.64 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.637 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -58.87 -29.93 67.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.859 -0.61 . . . . 0.31 110.678 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.44 16.87 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.27 111.049 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.28 -165.87 1.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.861 0.363 . . . . 0.4 110.984 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.6 mp -77.2 -27.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.487 . . . . 0.37 111.079 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.483 ' HB1' ' HG3' ' A' ' 15' ' ' PRO . . . -51.98 -32.22 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 0.29 111.234 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -81.86 -23.1 36.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.26 111.223 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.6 5.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.716 -0.754 . . . . 0.23 112.664 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.35 110.93 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 7' ' ' CYS . 2.9 p . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.522 0.201 . . . . 0.37 110.783 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -139.13 155.86 47.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.33 110.65 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.03 -169.24 41.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.38 112.472 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.82 -24.29 13.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.876 2.384 . . . . 0.57 112.293 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 72.84 1.43 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.49 110.819 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 3.0 m -144.31 178.57 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.42 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.473 ' HB3' HD21 ' A' ' 26' ' ' LEU . 26.1 t80 -130.85 151.95 50.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.32 110.653 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 2.0 t -116.06 127.84 55.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.41 110.622 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HB2' HG13 ' A' ' 19' ' ' VAL . 4.8 m -65.53 140.68 97.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.25 110.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.2 Cg_endo -72.38 149.44 50.62 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.632 2.221 . . . . 0.36 112.427 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.8 38.07 95.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.4 112.677 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.614 ' CG2' HG12 ' A' ' 19' ' ' VAL . 3.8 t -177.99 175.75 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.39 111.002 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 34.49 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.13 110.819 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.616 HG13 ' HB2' ' A' ' 14' ' ' CYS . 1.6 p -102.45 140.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.65 110.861 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 1.7 p -117.94 163.61 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.26 110.915 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.578 HG13 HD21 ' A' ' 26' ' ' LEU . 4.1 p -147.34 125.44 6.02 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.22 111.281 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.567 ' O ' HD23 ' A' ' 26' ' ' LEU . 27.6 Cg_exo -61.59 149.14 91.07 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.412 2.075 . . . . 0.23 111.871 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -51.12 -39.18 55.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.43 110.997 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -59.57 -29.17 67.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.33 110.444 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.425 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 35.2 m0 -87.96 -25.15 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.589 . . . . 0.38 110.778 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.782 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.3 mm? -54.64 113.31 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.28 111.025 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.01 62.01 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.22 110.612 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -107.14 -4.95 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.46 111.36 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.01 -28.98 6.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.35 112.386 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.44 177.34 5.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 0.5 110.552 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.435 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 9.1 mtpt -120.22 85.75 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.42 111.001 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.39 -31.66 60.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.47 110.761 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 3.7 m -70.9 178.26 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.31 110.866 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.83 -43.52 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.33 111.032 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -120.77 34.59 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.9 110.864 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 60.72 31.39 75.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 0.21 112.388 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.463 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.12 -43.42 78.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.27 111.24 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.679 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 29.7 p-10 -57.45 -31.85 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.31 110.788 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -95.02 18.6 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.27 111.076 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 -167.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.883 0.373 . . . . 0.4 110.977 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.9 mm -72.45 -29.62 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.37 111.005 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.38 -33.93 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.29 111.28 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.782 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -83.56 -23.82 31.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.26 111.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.81 42.35 4.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.753 . . . . 0.23 112.858 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.35 110.652 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.44 0.162 . . . . 0.37 111.413 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 59.5 m -103.59 54.81 0.74 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.82 0.343 . . . . 0.33 111.084 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.54 -163.49 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.271 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.37 117.21 3.55 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.592 2.195 . . . . 0.57 111.975 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p 51.32 60.39 3.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.49 110.774 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 4.9 m -94.89 161.86 13.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.42 111.316 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 36.9 t80 -110.83 147.04 35.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.32 110.443 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 p -109.71 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.41 110.978 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.819 ' HB3' HG13 ' A' ' 19' ' ' VAL . 3.7 t -58.81 130.66 85.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.25 110.727 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 142.12 41.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.594 2.196 . . . . 0.36 112.428 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.0 -43.49 2.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 0.4 112.985 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.723 HG23 HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -117.61 169.83 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.39 111.106 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.9 41.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 1.13 110.948 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.819 HG13 ' HB3' ' A' ' 14' ' ' CYS . 2.7 p -105.42 113.58 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.65 110.632 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.21 163.09 22.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.878 -0.601 . . . . 0.26 111.401 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 26' ' ' LEU . 3.8 p -151.77 123.62 3.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.22 110.469 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.616 ' O ' HD23 ' A' ' 26' ' ' LEU . 61.4 Cg_endo -73.91 157.74 47.01 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.317 2.011 . . . . 0.23 112.081 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.5 tt0 -54.29 -30.93 52.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.43 110.965 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HG3' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -70.01 -23.23 63.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 0.33 110.495 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.522 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 32.2 m0 -100.53 8.3 43.57 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.261 -0.427 . . . . 0.38 110.824 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 43' ' ' ALA . 3.0 mm? -80.92 117.36 21.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.486 -0.325 . . . . 0.28 110.499 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 39' ' ' GLU . 28.1 p 40.81 72.2 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.0 -0.546 . . . . 0.22 111.287 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.15 5.03 9.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.46 111.234 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.82 -28.6 6.96 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.644 -0.789 . . . . 0.35 112.768 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -95.3 171.5 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.5 110.941 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -118.74 87.9 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.383 -0.371 . . . . 0.42 110.809 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -35.09 60.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.083 0.468 . . . . 0.47 110.165 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.2 t -87.18 143.81 27.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.672 -0.694 . . . . 0.31 110.45 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.29 -31.77 1.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.37 . . . . 0.33 111.584 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -120.22 26.22 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.9 111.003 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.451 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 54.58 28.79 46.51 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.919 -0.657 . . . . 0.21 112.866 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.73 -44.15 18.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.27 111.404 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB2' HD13 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -56.89 -28.63 62.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.429 . . . . 0.31 110.494 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 20.3 mm-40 -84.45 8.62 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.27 111.352 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.36 176.04 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.807 0.337 . . . . 0.4 110.8 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 1.3 mp -69.89 -19.18 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 0.37 110.975 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.17 -34.38 56.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.29 111.093 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 26' ' ' LEU . . . -87.29 -22.58 25.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.26 111.239 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.21 28.96 5.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.619 -0.8 . . . . 0.23 112.481 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.328 . . . . 0.35 110.73 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.805 0.336 . . . . 0.37 110.911 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' HA ' ' CD ' ' A' ' 22' ' ' PRO . 23.7 p -174.72 -39.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.33 111.102 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.69 -160.08 11.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.636 -0.792 . . . . 0.38 112.633 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.98 150.17 74.48 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.811 2.341 . . . . 0.57 112.284 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m 61.24 41.93 12.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.49 110.746 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 p -83.09 168.8 16.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.501 . . . . 0.42 111.151 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.766 ' O ' HG12 ' A' ' 21' ' ' VAL . 43.1 t80 -137.65 133.12 33.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.32 110.406 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -94.7 149.61 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.41 110.753 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -88.88 138.58 29.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.25 111.169 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.82 132.7 51.43 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.264 . . . . 0.36 112.096 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.42 -44.47 2.44 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.751 -0.738 . . . . 0.4 112.517 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.616 HG23 HG13 ' A' ' 19' ' ' VAL . 2.0 t -108.7 177.65 4.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.39 110.607 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -117.35 48.05 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 1.13 111.054 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.616 HG13 HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -77.33 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.65 110.532 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' N ' HG23 ' A' ' 19' ' ' VAL . 3.7 t -147.59 119.35 8.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.26 111.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.2 p -122.33 136.92 26.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.22 110.631 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.498 ' HD2' HG23 ' A' ' 21' ' ' VAL . 66.4 Cg_endo -74.95 144.02 29.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.354 2.036 . . . . 0.23 111.601 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.561 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -47.44 -36.1 9.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.85 0.357 . . . . 0.43 110.923 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -30.14 70.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.33 110.344 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.45 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 30.4 m0 -87.35 -26.9 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.887 -0.597 . . . . 0.38 110.72 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.864 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.7 mm? -47.75 106.14 0.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.402 -0.363 . . . . 0.28 111.011 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 t 50.64 67.14 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 0.22 110.819 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.63 -4.23 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.58 . . . . 0.46 111.33 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.35 -27.59 6.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.35 112.559 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.18 144.64 31.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.5 110.715 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 16.1 mttp -83.55 92.25 7.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.42 111.065 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -29.72 21.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.107 0.479 . . . . 0.47 109.761 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -74.61 168.28 20.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.66 -0.7 . . . . 0.31 110.775 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.72 98.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.33 110.655 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.72 29.73 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.9 110.664 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 63.32 22.83 65.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.946 -0.645 . . . . 0.21 112.822 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -48.81 -45.02 39.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.894 0.378 . . . . 0.27 110.924 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.409 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 2.5 p30 -59.44 -22.35 61.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.31 110.806 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -94.83 17.75 13.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.454 -0.339 . . . . 0.27 111.194 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.39 -177.24 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.4 111.123 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 41' ' ' ILE . 2.3 mp -71.54 -27.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.37 110.666 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.31 -32.02 46.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.29 111.213 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.864 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.12 -14.64 33.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.023 -0.535 . . . . 0.26 111.517 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.5 24.12 5.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.23 112.729 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.35 110.887 179.898 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.873 0.368 . . . . 0.37 110.926 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 69.2 m 57.66 -84.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.33 110.992 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.12 179.76 0.43 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.662 -0.78 . . . . 0.38 112.576 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.54 136.46 57.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.768 2.312 . . . . 0.57 112.062 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 t 62.77 53.25 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.49 110.607 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 158.57 15.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.42 111.185 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 33.7 t80 -122.23 151.91 40.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.32 110.063 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.1 t -119.03 120.41 37.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.836 0.351 . . . . 0.41 110.757 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.693 ' SG ' HG13 ' A' ' 19' ' ' VAL . 6.0 m -64.78 138.62 97.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.25 110.657 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.1 Cg_endo -70.1 139.49 39.17 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.649 2.233 . . . . 0.36 112.537 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.34 38.46 70.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.799 -0.715 . . . . 0.4 112.746 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.567 ' CG2' HG12 ' A' ' 19' ' ' VAL . 3.5 t 179.37 174.26 0.78 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.39 111.035 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -114.21 43.78 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.13 110.747 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.693 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -111.42 130.88 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.65 110.928 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 3.2 p -109.69 163.52 13.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.353 -0.385 . . . . 0.26 110.859 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.672 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.6 p -151.23 125.15 4.39 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.22 110.78 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.532 ' O ' HD23 ' A' ' 26' ' ' LEU . 31.2 Cg_exo -58.79 148.86 81.27 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.298 1.999 . . . . 0.23 112.009 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -50.93 -38.66 51.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.872 0.367 . . . . 0.43 110.782 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -28.27 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.33 110.424 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.464 ' HB2' HG22 ' A' ' 21' ' ' VAL . 13.4 m0 -89.41 -24.47 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.38 110.824 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.656 ' CD2' HG13 ' A' ' 21' ' ' VAL . 4.1 mm? -52.89 120.92 6.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.28 110.802 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.2 p 38.96 57.33 1.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.123 -0.49 . . . . 0.22 111.372 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -104.22 -12.08 16.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.882 -0.599 . . . . 0.46 111.325 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.71 19.98 4.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.35 112.763 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -148.53 101.44 3.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.812 0.339 . . . . 0.5 110.635 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -55.29 95.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.42 111.192 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -91.78 -30.62 16.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.47 110.603 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.23 173.94 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.31 110.868 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.33 111.052 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -117.61 35.93 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.9 110.848 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.408 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 59.16 32.03 70.61 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.724 -0.751 . . . . 0.21 112.384 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.59 -39.8 81.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.27 111.32 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.672 ' HB3' HG11 ' A' ' 21' ' ' VAL . 3.0 p30 -60.33 -26.9 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.381 . . . . 0.31 111.072 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 3.2 mm-40 -92.97 13.21 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.27 111.258 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.63 169.91 14.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.801 0.334 . . . . 0.4 110.936 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 41' ' ' ILE . 2.4 mp -58.38 -23.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.37 110.773 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.62 -26.77 14.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.313 -0.403 . . . . 0.29 111.186 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.64 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -102.56 21.97 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.26 111.368 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.99 18.56 70.9 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.679 -0.772 . . . . 0.23 112.575 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.916 0.388 . . . . 0.35 110.619 179.931 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.787 0.327 . . . . 0.37 110.898 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -97.11 -67.81 0.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.33 110.982 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.87 -175.26 2.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.654 -0.784 . . . . 0.38 112.369 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.05 124.43 15.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.697 2.265 . . . . 0.57 112.012 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t 62.03 83.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.49 110.866 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.23 159.18 36.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.42 110.93 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.506 ' HB3' HD21 ' A' ' 26' ' ' LEU . 25.5 t80 -110.17 152.23 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.32 110.572 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -111.97 133.13 54.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 0.41 110.735 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.87 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -79.72 137.45 54.61 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.25 111.003 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.3 124.12 14.51 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.681 2.254 . . . . 0.36 112.472 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.428 ' C ' HG22 ' A' ' 17' ' ' THR . . . 70.08 37.73 73.15 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.879 -0.677 . . . . 0.4 112.84 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.87 HG23 ' HB3' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 178.63 152.7 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 0.39 110.852 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -86.58 -3.77 59.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 1.13 111.509 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.8 HG12 ' OG1' ' A' ' 17' ' ' THR . 7.7 p -56.77 89.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.815 0.341 . . . . 0.65 111.074 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 p -82.73 162.71 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.26 111.034 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.909 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.5 p -150.21 129.23 6.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.22 111.066 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.592 ' O ' HD23 ' A' ' 26' ' ' LEU . 24.4 Cg_exo -63.03 151.9 82.3 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.403 2.069 . . . . 0.23 111.886 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.4 tt0 -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.43 110.801 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -59.76 -27.41 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.33 110.459 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' HG22 ' A' ' 21' ' ' VAL . 17.0 m0 -90.61 -25.24 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.895 -0.593 . . . . 0.38 110.917 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.61 ' CD2' HG13 ' A' ' 21' ' ' VAL . 3.9 mm? -50.62 122.3 7.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.28 110.935 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 p 39.12 61.59 1.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.039 -0.528 . . . . 0.22 111.285 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -108.19 -6.04 16.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.757 -0.656 . . . . 0.46 111.219 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.75 -26.18 7.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.35 112.589 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.77 103.92 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.5 110.81 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 25.8 mtpt -59.94 85.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.42 111.083 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -75.31 -30.84 60.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.47 110.637 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -69.0 170.89 9.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.001 -0.545 . . . . 0.31 110.862 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.29 71.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.33 110.742 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -120.73 28.41 7.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.9 110.811 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.434 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.8 28.22 71.37 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.822 -0.704 . . . . 0.21 112.739 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -55.4 -43.34 75.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.27 111.008 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.909 ' HB3' HG11 ' A' ' 21' ' ' VAL . 2.3 p30 -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.31 110.943 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.48 15.85 16.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 0.27 111.264 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.54 172.51 12.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.4 110.849 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 41' ' ' ILE . 1.6 mp -60.55 -21.89 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.37 110.811 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.29 -32.11 36.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.916 0.388 . . . . 0.29 111.094 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.568 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -88.58 -22.38 23.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 0.26 111.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.04 28.52 6.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.605 -0.807 . . . . 0.23 112.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.299 . . . . 0.35 110.546 179.823 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.454 0.169 . . . . 0.37 111.28 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.8 m -109.43 75.16 0.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.788 0.328 . . . . 0.33 110.963 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.18 -160.54 1.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.675 -0.774 . . . . 0.38 112.354 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.87 122.83 12.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.613 2.209 . . . . 0.57 111.977 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t 61.05 58.88 2.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.49 110.484 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.21 145.73 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.42 111.311 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.446 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.0 t80 -107.44 151.88 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.32 110.345 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.414 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 2.0 t -107.5 126.7 52.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.21 -0.45 . . . . 0.41 110.761 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.778 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.5 m -74.99 142.26 75.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.25 110.866 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.7 Cg_endo -72.32 146.03 44.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.719 2.279 . . . . 0.36 112.498 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.33 35.49 91.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.4 112.593 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.56 ' CG2' HG12 ' A' ' 19' ' ' VAL . 2.0 t 179.81 174.59 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.39 110.814 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.49 30.75 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 1.13 110.95 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.778 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -93.72 133.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.65 110.681 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 p -109.92 164.25 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.26 111.016 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.595 HG13 HD21 ' A' ' 26' ' ' LEU . 4.8 p -152.76 134.19 8.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.22 110.836 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.544 ' O ' HD23 ' A' ' 26' ' ' LEU . 59.0 Cg_endo -72.23 148.96 50.68 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.264 1.976 . . . . 0.23 111.721 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -38.69 24.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.43 111.061 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -27.73 69.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.345 -0.388 . . . . 0.33 110.466 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.455 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 26.6 m0 -88.17 -25.29 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.38 110.677 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.804 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.1 mm? -53.82 122.16 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.268 -0.424 . . . . 0.28 110.873 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 37.17 55.21 1.3 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.053 0.454 . . . . 0.22 111.284 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -101.02 -13.57 18.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 0.46 111.124 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.21 18.95 4.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 0.35 112.784 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.48 108.65 3.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.5 110.643 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HE2' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -55.49 92.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.42 111.172 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.08 -30.92 18.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.47 110.67 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.3 -174.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.31 110.849 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.13 -50.01 21.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.33 110.932 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.4 33.48 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.9 110.79 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' CA ' ' HE2' ' A' ' 31' ' ' LYS . . . 65.14 27.9 72.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.694 -0.765 . . . . 0.21 112.555 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.55 -41.73 86.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.778 0.323 . . . . 0.27 111.174 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 39.3 p30 -54.97 -27.69 45.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.31 110.997 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.63 19.23 10.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.27 111.005 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.57 -164.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.4 110.888 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.9 mm -80.14 -28.19 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.37 111.12 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.32 -31.71 22.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.29 111.485 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.804 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -86.3 -19.79 29.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.26 111.401 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.71 21.03 8.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.636 -0.792 . . . . 0.23 112.776 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.464 . . . . 0.35 110.69 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.662 0.268 . . . . 0.37 111.261 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' HB3' ' CB ' ' A' ' 11' ' ' SER . 33.5 m -111.76 -41.94 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.33 111.255 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.02 -174.6 2.45 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.62 -0.8 . . . . 0.38 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.56 140.97 94.01 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.745 2.296 . . . . 0.57 112.226 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 p 50.02 78.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.49 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 64.5 p -118.49 158.81 24.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.42 111.223 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.589 ' HB3' HD21 ' A' ' 26' ' ' LEU . 10.5 t80 -93.23 152.8 18.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.945 -0.57 . . . . 0.32 110.283 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -107.08 123.17 47.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.406 -0.361 . . . . 0.41 110.689 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 5.4 t -75.66 135.22 71.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.25 111.02 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.71 129.23 22.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.651 2.234 . . . . 0.36 112.525 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.0 -43.75 1.9 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.782 -0.723 . . . . 0.4 112.988 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.597 ' CG2' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.29 160.78 19.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 0.39 110.985 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -0.62 49.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 1.13 111.402 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.597 HG12 ' CG2' ' A' ' 17' ' ' THR . 6.9 p -63.19 133.01 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.757 0.313 . . . . 0.65 110.757 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -124.58 153.44 42.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.26 111.089 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 38' ' ' ASP . 2.8 p -132.1 139.81 36.14 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.22 111.141 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.3 Cg_exo -65.32 146.91 87.03 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.477 2.118 . . . . 0.23 111.959 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HA ' HD23 ' A' ' 26' ' ' LEU . 2.1 mt-10 -51.02 -40.95 59.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.928 0.394 . . . . 0.43 110.824 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -60.7 -27.37 67.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.33 110.599 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 31.1 m0 -90.46 -24.86 20.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.38 110.944 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.694 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.9 mm? -50.01 125.96 13.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.333 -0.394 . . . . 0.28 111.062 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 39.89 56.71 2.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.22 111.481 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -105.82 -6.37 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.46 111.165 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -20.66 9.49 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.75 . . . . 0.35 112.681 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -109.78 116.24 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.5 110.883 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HE2' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -65.42 90.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.42 110.978 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -66.1 -32.37 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.47 110.753 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.76 160.56 15.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.31 110.897 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.92 -28.37 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.33 111.053 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -104.79 -4.69 22.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.9 111.497 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' CA ' ' HE2' ' A' ' 31' ' ' LYS . . . 71.4 32.47 64.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.664 -0.779 . . . . 0.21 112.779 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -61.64 -39.6 91.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.27 110.822 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.808 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -60.58 -26.71 67.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.546 . . . . 0.31 110.996 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -89.3 9.17 27.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.27 111.375 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.07 175.88 8.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.858 0.361 . . . . 0.4 111.026 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.72 -22.71 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.37 111.015 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.64 -30.12 12.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.376 . . . . 0.29 111.397 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.694 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.02 -20.08 23.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.26 111.486 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.46 24.11 7.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.23 112.631 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.35 110.671 179.909 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.767 0.317 . . . . 0.37 110.759 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.6 m -102.95 -72.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.33 110.889 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -176.91 34.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.487 -0.863 . . . . 0.38 112.303 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.55 -22.19 73.87 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.57 112.481 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.2 p -128.33 101.93 6.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.49 111.077 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.48 176.87 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.42 111.074 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 17.1 t80 -125.93 152.01 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.32 110.452 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 12' ' ' PHE . 4.3 t -108.11 125.99 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.41 110.591 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.714 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.7 m -74.95 144.6 79.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.25 110.943 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 72.9 Cg_endo -74.87 144.76 31.12 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.633 2.222 . . . . 0.36 112.471 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.49 73.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.707 . . . . 0.4 112.648 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.598 ' CG2' HG12 ' A' ' 19' ' ' VAL . 1.3 t 179.77 167.81 1.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.348 . . . . 0.39 110.95 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.79 27.47 7.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.13 110.918 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.714 HG13 ' SG ' ' A' ' 14' ' ' CYS . 2.3 p -91.19 137.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.65 110.733 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 p -118.32 162.92 17.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.26 111.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' HB3' ' A' ' 38' ' ' ASP . 5.7 p -145.42 134.82 11.38 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.22 110.736 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.528 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.6 Cg_endo -71.0 148.14 56.41 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.391 2.061 . . . . 0.23 111.946 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.493 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.3 tt0 -48.16 -39.86 22.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.361 -0.381 . . . . 0.43 111.002 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -58.13 -29.47 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.33 110.555 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.441 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 33.9 m0 -92.34 -24.32 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 0.38 110.867 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.847 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.9 mm? -50.96 123.96 10.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.272 -0.422 . . . . 0.28 111.037 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 36.73 56.97 1.16 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.163 -0.471 . . . . 0.22 111.324 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -103.53 -13.81 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.615 . . . . 0.46 111.218 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.76 -23.99 7.27 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.35 112.535 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 118.7 37.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 0.5 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -62.9 107.6 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.42 111.074 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.33 -28.05 12.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.47 110.558 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.9 m -75.26 -179.69 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.858 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -65.7 -54.93 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.33 111.179 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.43 34.89 4.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.9 111.072 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.35 28.51 72.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.21 112.638 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.425 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -57.67 -42.44 83.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.727 0.299 . . . . 0.27 111.281 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.753 ' HB3' HG11 ' A' ' 21' ' ' VAL . 10.1 p30 -56.9 -21.64 31.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.31 111.188 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.49 11.45 17.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.27 111.502 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.33 173.06 10.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.763 0.316 . . . . 0.4 110.982 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.8 -23.24 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.37 110.882 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.78 -23.98 13.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.29 111.309 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.85 -0.2 57.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.26 111.844 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.48 -12.12 30.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.616 -0.802 . . . . 0.23 112.922 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.737 0.268 . . . . 0.35 110.335 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.521 0.2 . . . . 0.37 110.765 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.84 -164.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.636 0.255 . . . . 0.33 110.431 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.53 177.25 25.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.38 112.62 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.62 -25.42 59.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.808 2.339 . . . . 0.57 112.245 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -129.02 48.03 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.49 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.24 141.01 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.42 110.858 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.639 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 38.8 t80 -91.23 137.37 32.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.32 110.417 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -105.21 128.19 53.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.161 -0.472 . . . . 0.41 110.845 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.748 ' SG ' HG13 ' A' ' 19' ' ' VAL . 17.8 m -57.66 140.61 80.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.25 110.774 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 35.6 Cg_endo -64.94 133.19 34.94 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.723 2.282 . . . . 0.36 112.48 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.54 31.73 44.79 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.819 -0.705 . . . . 0.4 112.562 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.553 HG21 ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -141.38 155.56 45.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.39 110.888 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -98.68 30.65 3.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 1.13 110.774 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.748 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -114.97 138.52 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 0.65 110.788 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -110.79 165.39 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.26 110.878 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.4 p -151.59 132.68 7.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.22 110.805 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.688 ' O ' HD23 ' A' ' 26' ' ' LEU . 70.4 Cg_endo -74.48 151.14 41.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.282 1.988 . . . . 0.23 111.907 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -29.12 16.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.43 110.848 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.02 -25.37 64.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.33 110.455 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.16 18.25 21.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.38 110.91 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 22' ' ' PRO . 3.6 mm? -94.42 114.32 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.28 110.867 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.27 60.41 3.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.22 110.798 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.82 11.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.46 111.369 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.8 -25.8 7.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 0.35 112.474 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.61 104.51 15.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.5 110.691 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.0 mtpt -57.54 96.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.42 111.086 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.17 -32.45 19.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.47 110.689 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -65.08 -176.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.31 110.651 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.553 ' CB ' HG21 ' A' ' 17' ' ' THR . . . -75.74 -46.0 33.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.406 . . . . 0.33 110.889 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.75 31.22 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.9 110.727 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.401 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 68.08 30.92 74.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.832 -0.699 . . . . 0.21 112.67 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.664 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -57.94 -43.81 86.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.27 111.008 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -56.59 -28.38 60.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.31 110.739 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.69 17.72 12.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.27 111.145 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.61 -169.69 2.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.825 0.345 . . . . 0.4 111.027 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 41' ' ' ILE . 1.5 mp -73.86 -26.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.37 110.827 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.62 9.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.29 111.401 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -100.71 13.49 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.26 111.594 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.5 66.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.744 -0.741 . . . . 0.23 113.05 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.35 110.726 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.775 0.321 . . . . 0.37 110.769 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 16.1 m -100.21 -67.16 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 0.33 110.766 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.21 -176.92 9.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.63 -0.795 . . . . 0.38 112.483 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 -43.68 56.27 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.723 2.282 . . . . 0.57 112.122 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -103.29 95.57 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.49 110.782 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -145.42 147.42 32.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 0.42 111.107 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . 0.536 ' CD2' HD11 ' A' ' 26' ' ' LEU . 11.8 t80 -107.56 150.59 26.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.32 110.482 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -106.08 123.98 48.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.41 110.834 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -77.28 146.64 74.74 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.25 111.221 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.09 136.84 39.03 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.798 2.332 . . . . 0.36 112.598 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.51 88.97 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.857 -0.687 . . . . 0.4 112.806 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.658 ' OG1' HG12 ' A' ' 19' ' ' VAL . 1.5 t 179.61 153.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.39 111.017 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.69 2.65 54.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 1.13 111.342 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.855 HG13 ' HB2' ' A' ' 14' ' ' CYS . 2.5 p -57.44 123.17 8.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.859 0.361 . . . . 0.65 110.821 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 p -102.94 162.71 12.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.26 111.083 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 38' ' ' ASP . 3.2 p -154.96 133.93 7.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.22 110.649 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PRO . . . . . 0.483 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.5 Cg_endo -71.18 147.01 52.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.386 2.058 . . . . 0.23 111.984 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.491 ' HA ' HD23 ' A' ' 26' ' ' LEU . 2.2 tt0 -49.07 -39.13 26.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.354 . . . . 0.43 110.968 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -58.24 -29.47 65.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.983 0.42 . . . . 0.33 110.453 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' TRP . . . . . 0.415 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 28.1 m0 -88.86 -25.94 21.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.923 -0.58 . . . . 0.38 110.572 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.765 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.4 mm? -56.52 113.43 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.28 110.952 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.1 m 56.23 53.52 8.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.026 0.441 . . . . 0.22 110.941 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -105.73 -18.13 14.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.46 111.136 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.37 -15.57 9.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.803 -0.713 . . . . 0.35 112.655 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.08 107.32 17.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.744 0.307 . . . . 0.5 110.81 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -59.17 85.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.42 111.112 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.74 -26.32 60.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.47 110.449 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.2 t -83.76 164.48 19.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.31 111.011 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.29 82.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.33 110.773 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.58 18.07 12.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 0.9 111.04 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.469 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 66.42 25.83 72.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.21 112.947 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.871 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -51.6 -38.07 52.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.93 0.365 . . . . 0.27 110.89 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.59 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.2 p30 -60.72 -22.99 64.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.31 110.812 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.74 20.31 13.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.306 . . . . 0.27 111.22 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.11 -179.66 5.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.4 111.007 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.0 mp -61.22 -21.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.37 110.864 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.16 -35.31 35.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.29 111.14 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.765 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -84.71 -22.3 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.576 . . . . 0.26 111.152 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.66 39.4 2.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.23 112.63 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.35 111.064 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.503 -0.239 . . . . 1.84 112.503 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.89 73.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 0.7 110.859 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -81.57 125.58 30.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.4 110.887 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.4 28.86 62.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.721 -0.752 . . . . 0.52 112.445 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -82.16 -74.62 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.748 0.308 . . . . 0.5 110.919 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.5 p -61.65 128.14 34.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.37 111.055 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 51.99 67.74 0.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.33 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -158.69 4.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.38 112.413 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.5 -41.5 75.42 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.607 2.204 . . . . 0.57 111.876 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.19 66.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.49 110.315 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 96.4 p -81.82 122.05 27.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.42 111.29 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.711 ' HB3' HD21 ' A' ' 26' ' ' LEU . 48.8 t80 -98.15 144.33 27.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.32 110.153 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -104.15 132.47 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.41 111.254 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -74.86 131.08 79.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.815 -0.63 . . . . 0.25 110.422 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 17' ' ' THR . 19.6 Cg_endo -60.19 158.78 28.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.573 2.182 . . . . 0.36 112.274 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.57 21.86 58.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.4 112.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.67 HG23 HG13 ' A' ' 19' ' ' VAL . 6.2 t -179.32 168.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.687 0.28 . . . . 0.39 110.64 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -110.01 59.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.333 . . . . 1.13 111.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.67 HG13 HG23 ' A' ' 17' ' ' THR . 1.4 m -110.35 122.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.788 0.328 . . . . 0.65 110.198 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.78 161.75 18.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 0.26 111.067 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.636 HG22 HD22 ' A' ' 26' ' ' LEU . 2.4 p -158.57 112.01 1.66 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.22 110.489 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.53 144.7 61.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.259 1.973 . . . . 0.23 111.87 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -48.82 -32.07 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.382 . . . . 0.43 110.819 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.33 110.457 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -89.85 -19.34 24.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.38 110.988 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.711 HD21 ' HB3' ' A' ' 12' ' ' PHE . 4.0 mm? -58.84 119.56 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.324 -0.398 . . . . 0.28 110.922 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.59 50.69 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.22 110.825 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -104.59 -13.25 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.46 111.251 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 -26.31 7.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 0.35 112.555 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -94.6 98.47 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.5 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 6.5 mtpt -57.35 88.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.42 111.15 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -76.74 -32.31 57.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.47 110.643 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 37.3 t -81.67 144.24 31.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.31 110.507 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.23 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.33 111.965 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -115.75 29.35 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.684 0.278 . . . . 0.9 111.388 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 53.02 31.3 39.83 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.815 -0.707 . . . . 0.21 112.89 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.426 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 0.27 111.171 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 1.3 p30 -56.05 -28.07 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.31 110.941 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.73 11.31 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.27 111.379 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 178.01 6.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.872 0.368 . . . . 0.4 111.083 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.841 HD12 HD23 ' A' ' 46' ' ' LEU . 1.4 mm -60.92 -20.74 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.37 110.951 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.43 -31.73 55.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.392 . . . . 0.29 111.205 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -88.3 -20.49 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.26 111.243 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.08 4.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.23 112.656 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.44 66.24 2.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.35 110.663 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.841 HD23 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -83.48 -45.4 13.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.036 -0.529 . . . . 0.91 110.893 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -53.32 119.89 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.48 111.159 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.05 -76.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.87 110.816 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.59 99.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 1.33 111.177 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.254 -0.879 . . . . 0.96 110.909 179.946 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.556 -0.218 . . . . 1.84 112.556 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -129.19 109.75 11.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.7 110.808 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.2 61.5 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.4 110.89 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.74 27.57 2.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.68 -0.771 . . . . 0.52 112.535 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.68 -83.74 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.598 0.237 . . . . 0.5 110.956 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 51.09 -91.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.601 -0.272 . . . . 0.37 111.212 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.95 20.07 8.37 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.708 0.289 . . . . 0.33 110.876 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.11 -168.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.38 112.421 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.6 137.28 33.43 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.771 2.314 . . . . 0.57 112.021 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 t 71.44 29.35 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.49 110.945 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 m -102.22 154.23 19.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.42 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.508 ' HB3' HD21 ' A' ' 26' ' ' LEU . 34.7 t80 -115.83 151.82 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.32 110.727 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -118.05 121.03 39.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.41 110.41 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.761 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.4 m -60.93 143.78 91.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.25 110.636 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 70.5 Cg_endo -74.43 136.68 22.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.644 2.229 . . . . 0.36 112.537 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.56 -42.06 2.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.756 -0.735 . . . . 0.4 112.771 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -112.58 170.24 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 0.39 110.844 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 28.32 4.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.13 111.403 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.761 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.4 p -89.52 131.63 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.345 . . . . 0.65 110.59 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -108.58 164.66 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.26 111.108 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.827 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.6 p -153.08 125.08 3.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.22 110.8 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.611 ' O ' HD23 ' A' ' 26' ' ' LEU . 34.0 Cg_exo -59.38 150.19 76.56 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.409 2.073 . . . . 0.23 112.069 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -51.56 -39.76 58.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.43 110.897 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -62.46 -27.68 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.33 110.393 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.421 ' HB2' HG22 ' A' ' 21' ' ' VAL . 24.1 m0 -87.61 -24.36 23.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.38 110.732 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.627 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.0 mm? -53.04 125.65 18.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.224 -0.444 . . . . 0.28 110.746 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 38.63 58.04 1.72 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.025 0.44 . . . . 0.22 111.327 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -105.34 -7.76 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.46 111.241 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -23.76 8.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.35 112.624 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.37 109.97 22.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 0.5 110.914 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.7 mtpt -61.02 88.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.42 110.975 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.96 -30.06 35.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.47 110.866 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.93 175.01 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.31 110.905 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -66.6 -52.01 50.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.33 110.931 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -114.0 32.17 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.9 110.851 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.65 30.2 76.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 0.21 112.489 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.39 -39.28 79.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.27 111.316 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.827 ' HB3' HG11 ' A' ' 21' ' ' VAL . 5.0 p30 -63.2 -23.47 67.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.31 111.034 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.97 13.94 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.27 111.237 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.89 -176.23 3.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.861 0.363 . . . . 0.4 111.047 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.749 HD11 ' O ' ' A' ' 47' ' ' TYR . 46.7 mm -71.43 -25.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.37 110.979 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.64 -26.39 8.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.29 111.451 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.627 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -94.74 -4.47 47.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.26 111.913 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.02 35.61 34.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.579 -0.82 . . . . 0.23 112.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.9 t -67.36 -25.52 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.35 110.713 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER 69.22 65.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.458 . . . . 0.91 111.174 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.749 ' O ' HD11 ' A' ' 41' ' ' ILE . 31.9 m-85 -149.68 115.39 5.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.535 . . . . 0.48 110.69 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -57.22 -61.22 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.87 111.044 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 50' ' ' THR . 0.2 OUTLIER -162.77 152.13 15.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 1.33 110.926 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 49' ' ' SER . 20.0 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.222 -0.894 . . . . 0.96 110.912 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.536 -0.226 . . . . 1.84 112.536 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.25 -74.82 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.7 110.831 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -160.66 29.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.4 110.926 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.83 62.56 0.16 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.52 112.645 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.03 -60.87 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 0.5 110.758 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -66.81 -53.74 29.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.37 110.695 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.4 m -151.54 69.19 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.33 110.662 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.02 -160.48 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.923 -0.656 . . . . 0.38 112.713 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.58 138.41 83.4 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.766 2.311 . . . . 0.57 112.239 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p 60.02 46.8 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.49 110.932 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.39 140.8 34.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.42 110.822 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.506 ' HB3' HD21 ' A' ' 26' ' ' LEU . 23.7 t80 -90.58 152.93 20.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.32 110.269 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 t -111.01 125.56 53.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.41 110.885 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.632 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.4 m -71.55 140.98 84.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.25 110.677 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.6 Cg_endo -77.34 136.37 15.83 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.649 2.233 . . . . 0.36 112.465 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.49 44.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.703 -0.761 . . . . 0.4 112.615 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.857 HG21 ' HB2' ' A' ' 34' ' ' ALA . 1.7 t 179.4 163.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.39 110.868 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -98.35 40.12 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.13 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.632 HG13 ' SG ' ' A' ' 14' ' ' CYS . 2.4 p -111.26 135.56 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.65 110.748 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 p -122.58 156.5 34.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.26 110.982 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.863 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.1 p -134.53 133.63 21.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.22 111.152 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.683 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.7 Cg_exo -63.31 150.54 88.28 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.461 2.108 . . . . 0.23 112.062 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.9 -31.36 39.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.43 110.77 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -70.08 -28.15 65.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.33 110.343 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.465 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 24.3 m0 -95.21 4.91 53.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.38 111.142 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.74 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.1 mm? -76.58 118.54 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.28 110.938 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 39.29 69.16 0.3 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.868 -0.605 . . . . 0.22 111.751 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD2' ' HA ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -116.76 -13.68 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.084 -0.507 . . . . 0.46 111.174 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.54 32.7 1.19 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.582 -0.818 . . . . 0.35 112.779 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.54 91.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 0.5 110.752 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 10.1 mtpt -53.14 92.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.42 111.308 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.92 -30.85 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.47 110.531 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -174.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.73 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.857 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -71.41 -55.51 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.33 110.973 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.91 38.61 3.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.9 110.732 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.85 31.33 80.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.21 112.425 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.0 -47.81 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.27 111.155 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.863 ' HB3' HG11 ' A' ' 21' ' ' VAL . 20.1 p-10 -57.86 -27.44 63.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.31 110.809 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.08 8.12 28.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.433 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.9 170.84 13.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.4 111.085 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 48' ' ' ASN . 1.9 mp -60.03 -23.87 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.37 110.733 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.3 -27.89 6.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.29 111.27 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.74 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -91.05 -19.79 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.26 111.483 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.66 12.45 12.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 0.23 113.115 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t -63.43 -32.42 73.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.35 110.344 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 mt 66.81 -83.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.793 -0.639 . . . . 0.91 112.549 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 47' ' ' TYR . 24.9 p90 -47.03 106.24 0.08 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.018 0.437 . . . . 0.48 112.093 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.498 ' O ' HD11 ' A' ' 41' ' ' ILE . 15.0 m-20 29.13 -91.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.421 -0.809 . . . . 0.87 112.567 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.4 m 57.43 26.16 12.23 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.795 0.331 . . . . 1.33 110.987 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.261 -0.876 . . . . 0.96 110.998 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.51 -0.236 . . . . 1.84 112.51 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.69 79.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.339 . . . . 0.7 110.825 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 60.18 30.04 19.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.4 110.919 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.41 82.27 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 0.52 112.518 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 35.97 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.5 110.909 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.03 -38.8 12.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.37 110.951 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.9 m -151.38 74.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.33 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.23 -163.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.38 112.45 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.82 -23.78 43.73 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.733 2.288 . . . . 0.57 112.246 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 p -123.91 83.05 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.49 110.744 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.7 53.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.42 111.04 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.524 ' HB3' HD21 ' A' ' 26' ' ' LEU . 24.6 t80 -103.56 150.81 23.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.32 110.479 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -112.64 128.04 56.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.41 110.777 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.8 m -69.28 136.14 88.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.25 110.559 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.3 Cg_endo -69.88 139.39 39.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.662 2.241 . . . . 0.36 112.56 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.87 -42.32 2.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.756 -0.735 . . . . 0.4 112.746 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.536 HG23 HG12 ' A' ' 19' ' ' VAL . 1.3 t -112.62 171.66 7.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.39 111.013 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -104.52 54.53 0.72 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.255 -0.429 . . . . 1.13 111.29 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.676 HG13 ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -113.35 142.93 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.65 110.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -112.72 154.07 26.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.26 110.894 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 HD22 ' A' ' 26' ' ' LEU . 2.5 p -145.03 131.14 9.67 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.22 110.691 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.49 ' C ' HD23 ' A' ' 26' ' ' LEU . 57.5 Cg_endo -71.77 146.83 49.2 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.281 1.987 . . . . 0.23 111.978 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.541 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.2 tt0 -48.0 -38.11 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.379 -0.373 . . . . 0.43 111.148 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -27.81 65.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 0.33 110.706 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -96.07 -19.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.38 111.109 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.861 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.0 mm? -53.84 123.06 11.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.517 -0.31 . . . . 0.28 110.909 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.5 p 36.92 58.49 1.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.089 -0.505 . . . . 0.22 111.403 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -104.25 -9.39 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.851 -0.613 . . . . 0.46 111.208 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.88 -25.05 7.69 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.35 112.53 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 121.89 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.5 110.714 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.487 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -60.12 84.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.42 111.103 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -79.63 -30.34 41.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.47 110.24 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.05 156.57 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.615 . . . . 0.31 110.374 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.526 ' HB3' HG21 ' A' ' 17' ' ' THR . . . -56.13 -34.67 66.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.33 110.773 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.05 28.82 6.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.9 110.813 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.487 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.83 22.64 48.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.817 -0.706 . . . . 0.21 112.656 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -52.01 -42.67 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.27 111.093 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.698 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 3.4 p30 -57.83 -22.49 47.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.31 110.796 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -89.13 11.12 19.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.27 111.153 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.11 -165.91 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.857 0.361 . . . . 0.4 111.051 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.557 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.1 mp -76.12 -23.34 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.37 110.937 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.76 -33.31 15.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.914 0.387 . . . . 0.29 111.332 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.861 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -83.67 -24.25 31.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 0.26 111.087 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.32 6.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.23 112.801 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.67 -52.59 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.35 110.636 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.8 77.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.044 -0.526 . . . . 0.91 111.307 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -174.03 36.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.48 110.972 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -167.35 136.46 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.87 110.917 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 68.98 10.84 8.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 1.33 111.461 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.238 -0.887 . . . . 0.96 111.376 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.478 -0.249 . . . . 1.84 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t -140.89 67.4 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.372 . . . . 0.7 110.853 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -176.42 -43.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.4 110.788 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.75 41.63 2.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.837 -0.697 . . . . 0.52 112.416 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.75 -16.85 61.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.58 0.228 . . . . 0.5 111.312 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.2 p -50.27 130.92 23.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.922 0.391 . . . . 0.37 111.131 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 13.5 m 53.92 -169.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.33 110.854 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.66 -167.34 13.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.644 -0.788 . . . . 0.38 112.53 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.71 -47.07 28.13 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.859 2.372 . . . . 0.57 112.189 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.28 55.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.49 110.708 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.453 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 84.1 p -124.03 147.16 48.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.072 -0.513 . . . . 0.42 111.11 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.7 t80 -112.66 149.55 32.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.32 110.261 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -111.81 110.95 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.281 -0.418 . . . . 0.41 110.738 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.779 ' HB2' HG13 ' A' ' 19' ' ' VAL . 2.2 m -56.64 148.89 43.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.25 111.093 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.08 131.6 24.12 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.706 2.271 . . . . 0.36 112.397 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.31 38.55 96.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.4 112.669 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.845 ' OG1' HG12 ' A' ' 19' ' ' VAL . 2.1 t -174.92 156.51 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.39 110.999 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.52 -5.77 51.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 1.13 111.323 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.845 HG12 ' OG1' ' A' ' 17' ' ' THR . 2.3 p -55.22 115.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.781 0.324 . . . . 0.65 110.971 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 1.2 p -97.02 163.98 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.26 110.755 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.546 HG13 HD21 ' A' ' 26' ' ' LEU . 5.4 p -156.35 123.99 2.78 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.22 110.974 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.549 ' O ' HD23 ' A' ' 26' ' ' LEU . 33.6 Cg_exo -58.96 148.66 83.75 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.374 2.049 . . . . 0.23 112.141 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -51.4 -38.14 51.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.38 . . . . 0.43 110.841 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -58.56 -27.95 65.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.423 . . . . 0.33 110.53 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.44 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 21.3 m0 -91.67 -24.75 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.906 -0.588 . . . . 0.38 110.841 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.837 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.2 mm? -53.52 122.73 10.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.269 -0.423 . . . . 0.28 110.822 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 p 38.03 59.36 1.38 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.148 -0.478 . . . . 0.22 111.26 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -103.09 -14.14 16.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.765 -0.652 . . . . 0.46 111.216 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.52 22.45 4.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.35 112.751 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.28 113.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 0.5 110.582 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 1.7 mttt -62.42 83.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.42 111.124 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.39 -28.76 41.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.104 0.478 . . . . 0.47 110.179 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 8.6 t -79.23 162.68 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.31 110.737 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.88 78.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.33 110.712 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -122.09 29.18 7.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.984 -0.553 . . . . 0.9 110.813 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 58.81 23.77 56.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 0.21 112.788 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -48.54 -44.17 36.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.27 111.317 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' HB3' HG11 ' A' ' 21' ' ' VAL . 3.8 p30 -59.95 -23.05 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.31 111.045 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -91.59 13.92 16.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 0.27 111.347 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.73 171.33 12.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.818 0.342 . . . . 0.4 110.919 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 41' ' ' ILE . 1.3 mp -61.09 -25.23 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.37 110.625 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.21 10.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.29 111.23 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.837 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -94.33 14.49 20.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.26 111.549 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.6 -10.72 73.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.627 -0.797 . . . . 0.23 112.635 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.86 164.5 17.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.654 0.264 . . . . 0.35 110.295 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mt -141.49 -59.23 0.48 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.472 -0.331 . . . . 0.91 110.964 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 47' ' ' TYR . 23.1 p90 -53.47 93.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.099 0.476 . . . . 0.48 110.934 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -90.45 -179.83 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 0.87 110.971 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 m -122.95 -43.99 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 1.33 110.863 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.24 -0.886 . . . . 0.96 110.903 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.444 -0.262 . . . . 1.84 112.444 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -173.64 -67.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 0.7 110.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 60.2 108.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.4 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.42 -154.18 16.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.703 -0.761 . . . . 0.52 112.509 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' C ' ' HG1' ' A' ' 6' ' ' THR . 0.2 OUTLIER 66.04 -76.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.606 0.241 . . . . 0.5 110.982 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.494 ' HG1' ' C ' ' A' ' 5' ' ' LYS . 12.2 p 51.98 -85.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.179 -0.464 . . . . 0.37 111.247 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 5' ' ' LYS . 9.6 m -115.57 69.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.868 0.366 . . . . 0.33 110.778 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.33 -164.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.792 -0.718 . . . . 0.38 112.449 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.6 -24.18 21.93 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.744 2.296 . . . . 0.57 112.159 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -137.39 88.55 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.49 110.746 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.7 p -105.59 160.46 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.42 111.068 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 26' ' ' LEU . 37.7 t80 -132.37 137.09 47.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.955 -0.566 . . . . 0.32 110.472 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 p -106.54 117.43 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.803 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -49.02 139.16 12.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.044 -0.525 . . . . 0.25 111.126 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.78 133.5 45.23 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.71 2.273 . . . . 0.36 112.092 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.73 24.36 48.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.4 112.257 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.618 ' HB ' HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -141.17 146.42 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.39 110.815 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 1.13 57.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.13 111.358 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 17' ' ' THR . 2.3 p -61.37 156.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.65 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.411 ' N ' HG22 ' A' ' 19' ' ' VAL . 1.4 t -122.52 156.04 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.26 111.045 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.714 HG22 HD22 ' A' ' 26' ' ' LEU . 2.8 p -159.58 118.44 1.65 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.22 110.996 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.442 ' C ' HD23 ' A' ' 26' ' ' LEU . 32.0 Cg_exo -60.94 145.19 99.43 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.35 2.033 . . . . 0.23 111.803 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HA ' HD23 ' A' ' 26' ' ' LEU . 5.5 tt0 -47.32 -35.19 7.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.462 -0.335 . . . . 0.43 111.251 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -59.53 -32.16 70.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.33 110.495 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.41 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 23.0 m0 -88.36 -21.01 24.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.868 -0.606 . . . . 0.38 110.941 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.027 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.3 mm? -59.54 113.32 2.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.28 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 51.9 t 48.19 56.27 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.941 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.31 -14.72 15.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.46 111.25 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.55 29.18 1.95 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.778 . . . . 0.35 112.651 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.39 117.33 4.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.677 0.275 . . . . 0.5 110.662 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 2.6 mttp -62.38 81.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.42 111.026 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.83 -25.97 34.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.47 110.106 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -80.02 167.33 20.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.746 -0.661 . . . . 0.31 110.648 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.46 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.33 110.162 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.4 33.93 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.9 110.483 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 56.67 23.89 45.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.916 -0.659 . . . . 0.21 112.804 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -49.72 -44.41 48.26 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.822 0.344 . . . . 0.27 111.051 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 30.4 p-10 -59.03 -23.66 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.31 110.755 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.93 12.53 19.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.27 111.361 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 170.9 12.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.4 110.909 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 41' ' ' ILE . 3.1 mp -58.97 -22.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.906 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.4 52.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.29 111.079 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.027 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -85.9 -21.99 27.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.26 111.164 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.27 29.57 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.684 -0.769 . . . . 0.23 112.719 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 50.4 t -79.37 -29.76 42.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.347 . . . . 0.35 110.867 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 71.75 -67.26 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.91 111.219 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 48' ' ' ASN . 2.4 p90 -83.95 176.32 8.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.427 -0.352 . . . . 0.48 111.098 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.4 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 7.4 p-10 -102.78 150.29 23.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.87 110.89 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t -149.3 31.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 1.33 110.86 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.268 -0.872 . . . . 0.96 110.896 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.455 -0.258 . . . . 1.84 112.455 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.85 -73.43 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.7 110.741 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -110.44 -161.07 0.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.4 110.446 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.05 78.46 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.575 -0.821 . . . . 0.52 112.225 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' GLU . 0.5 OUTLIER -82.55 1.31 38.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.538 0.208 . . . . 0.5 111.431 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.0 -75.02 0.06 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.739 0.304 . . . . 0.37 110.71 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 64.8 m -106.44 -67.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.33 110.775 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.15 -178.44 51.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.455 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.69 -44.55 46.88 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.803 2.336 . . . . 0.57 112.159 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 m -111.8 90.68 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.49 110.714 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -129.76 163.76 25.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.42 111.169 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 7.4 t80 -118.08 152.47 35.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.32 110.302 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 t -108.67 111.85 23.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.41 110.465 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.605 ' HB2' HG13 ' A' ' 19' ' ' VAL . 1.9 m -59.61 149.35 71.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.25 111.168 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 97.8 Cg_endo -78.09 132.8 11.82 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.815 2.343 . . . . 0.36 112.592 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.37 39.19 97.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.899 -0.667 . . . . 0.4 112.972 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.535 ' OG1' HG12 ' A' ' 19' ' ' VAL . 2.8 t -176.59 156.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.39 111.011 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.69 49.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 1.13 110.881 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 14' ' ' CYS . 2.3 p -119.43 113.13 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.65 110.53 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 13.8 p -96.92 164.24 12.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.26 111.351 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.896 HG11 ' HB3' ' A' ' 38' ' ' ASP . 6.5 p -152.12 130.55 6.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.22 110.848 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.631 ' O ' HD23 ' A' ' 26' ' ' LEU . 37.0 Cg_exo -59.01 148.14 86.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.244 1.963 . . . . 0.23 111.872 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -52.1 -42.98 63.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.43 110.863 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -22.94 66.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.33 110.445 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.462 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 24.9 m0 -87.96 -30.91 19.68 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.477 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.719 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.6 mm? -45.58 121.41 3.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.034 -0.53 . . . . 0.28 111.015 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 p 39.31 60.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.22 111.34 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -105.64 -14.7 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.46 111.259 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.04 12.25 7.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.747 -0.74 . . . . 0.35 112.905 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 104.12 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.5 110.649 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 2.8 mttp -58.68 86.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.42 111.327 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -81.91 -28.73 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.47 110.094 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 10.1 t -77.2 162.24 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.31 110.706 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -38.75 81.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.33 110.755 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.06 29.56 6.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.9 110.865 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.29 27.91 58.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.794 -0.717 . . . . 0.21 112.871 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -50.55 -43.85 56.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.27 111.407 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.896 ' HB3' HG11 ' A' ' 21' ' ' VAL . 2.5 p30 -59.3 -24.72 63.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.365 . . . . 0.31 110.904 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -88.75 11.59 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.27 111.319 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 168.89 15.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.4 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 45' ' ' CYS . 24.8 mm -59.03 -25.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.37 111.054 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.12 9.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.29 111.3 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.719 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -95.19 13.88 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.26 111.609 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.3 19.65 79.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.23 112.809 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.576 ' O ' HD13 ' A' ' 41' ' ' ILE . 45.5 t -74.7 88.32 2.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.35 110.626 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.68 64.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.037 -0.529 . . . . 0.91 111.141 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -176.95 43.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.48 110.806 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -125.74 -174.8 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.87 110.946 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.1 t -73.8 173.17 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 1.33 110.87 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.237 -0.887 . . . . 0.96 110.963 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.482 -0.247 . . . . 1.84 112.482 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -102.67 -177.5 3.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.7 110.899 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 46.07 -169.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.4 111.354 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.33 -49.28 71.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.708 -0.758 . . . . 0.52 112.398 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.94 -167.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.725 0.298 . . . . 0.5 110.831 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 p 67.44 137.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.37 110.97 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.54 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 64.67 46.41 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.33 111.026 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.32 -172.5 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.748 . . . . 0.38 112.501 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.83 -35.92 81.06 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.776 2.317 . . . . 0.57 112.111 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.44 68.82 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.49 110.493 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 5.9 t -107.04 178.58 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.42 111.446 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' HB3' HD21 ' A' ' 26' ' ' LEU . 19.3 t80 -113.69 153.03 29.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.32 110.683 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.63 114.98 27.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.41 110.643 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' HG13 ' A' ' 19' ' ' VAL . 7.6 m -60.08 143.33 88.46 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.477 -0.329 . . . . 0.25 110.755 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.0 Cg_endo -77.12 137.34 17.1 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.69 2.26 . . . . 0.36 112.622 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 -44.06 2.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 0.4 112.886 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.707 HG21 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -109.94 168.88 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.809 0.338 . . . . 0.39 111.028 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -97.69 38.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 1.13 111.191 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.681 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -105.02 144.16 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 0.65 110.657 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -126.21 161.09 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.26 110.951 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 38' ' ' ASP . 5.5 p -144.6 130.94 9.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.22 110.998 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' O ' HD23 ' A' ' 26' ' ' LEU . 37.7 Cg_exo -59.61 149.42 82.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.303 2.002 . . . . 0.23 111.981 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.459 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -52.04 -39.63 59.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 0.43 110.844 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -26.86 68.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.33 110.528 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.452 ' HB2' HG22 ' A' ' 21' ' ' VAL . 16.5 m0 -92.03 -22.14 20.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.38 110.944 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.768 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.8 mm? -51.96 122.05 7.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.367 -0.379 . . . . 0.28 111.034 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p 39.94 57.24 2.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.025 -0.534 . . . . 0.22 111.365 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -104.75 -6.95 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.46 111.156 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.46 -22.21 8.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.35 112.647 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.49 108.38 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.5 110.858 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -56.83 97.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.42 111.119 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -88.7 -30.44 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.47 110.792 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 9.6 m -75.43 176.14 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.31 110.819 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -65.58 -55.61 16.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.33 111.015 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.5 32.55 4.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.9 110.845 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.27 31.63 81.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.738 -0.744 . . . . 0.21 112.5 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.429 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.28 -38.98 78.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 0.27 111.163 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.788 ' HB3' HG11 ' A' ' 21' ' ' VAL . 25.7 p-10 -61.24 -23.59 65.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.31 111.073 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -89.08 10.69 20.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.391 . . . . 0.27 111.338 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.75 164.66 22.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.738 0.304 . . . . 0.4 110.819 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.39 -24.37 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.37 111.031 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.19 -30.31 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.29 111.227 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.768 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -86.7 -20.38 27.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.26 111.559 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.56 30.69 5.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.23 112.478 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.6 t -63.21 -20.38 65.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.35 110.87 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 71.27 -69.28 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.258 -0.428 . . . . 0.91 111.443 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CE2' ' CB ' ' A' ' 49' ' ' SER . 21.1 p90 -80.39 155.58 27.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.48 110.918 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -44.23 -69.94 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.985 -0.552 . . . . 0.87 111.81 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.42 ' CB ' ' CE2' ' A' ' 47' ' ' TYR . 1.5 t 68.01 28.12 6.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 1.33 110.898 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.221 -0.895 . . . . 0.96 110.918 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.557 -0.217 . . . . 1.84 112.557 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.45 -164.51 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.302 . . . . 0.7 110.835 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 67.28 67.0 0.4 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 0.4 110.868 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.37 49.77 11.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.763 -0.732 . . . . 0.52 112.482 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -111.77 -28.16 8.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.743 0.306 . . . . 0.5 111.089 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.89 -83.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.38 -0.373 . . . . 0.37 110.961 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.437 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 3.2 m -115.22 53.01 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.33 110.88 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.8 176.16 0.49 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.717 -0.754 . . . . 0.38 112.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.74 -25.27 20.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.848 2.366 . . . . 0.57 112.192 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.03 58.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.49 110.678 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 1.4 m -118.18 143.05 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.42 111.03 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.6 ' HB3' HD21 ' A' ' 26' ' ' LEU . 33.3 t80 -92.75 152.05 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.32 110.56 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -115.44 123.87 49.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 0.41 110.501 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.741 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.8 m -69.14 144.61 95.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.25 110.749 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 67.0 Cg_endo -73.56 147.3 40.51 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.783 2.322 . . . . 0.36 112.672 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.56 38.7 95.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.865 -0.683 . . . . 0.4 112.727 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.629 ' CG2' HG12 ' A' ' 19' ' ' VAL . 6.0 t -179.86 169.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.39 110.846 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.74 35.96 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 1.13 110.994 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.741 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -100.68 126.36 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.65 110.513 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.95 164.18 11.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.26 111.162 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.535 HG11 ' HB3' ' A' ' 38' ' ' ASP . 2.7 p -156.13 122.83 2.64 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.22 110.66 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.692 ' O ' HD23 ' A' ' 26' ' ' LEU . 31.5 Cg_exo -58.27 148.79 77.14 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.31 2.007 . . . . 0.23 112.023 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -30.58 31.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.895 0.379 . . . . 0.43 110.72 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HG2' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -69.05 -24.88 64.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.33 110.357 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.475 ' CD1' ' HG2' ' A' ' 24' ' ' ARG . 32.6 m0 -99.4 12.81 35.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.542 . . . . 0.38 111.007 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 22' ' ' PRO . 3.5 mm? -89.64 121.31 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.482 -0.326 . . . . 0.28 110.479 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 47.13 71.13 0.34 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.954 0.407 . . . . 0.22 110.571 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.12 17.51 4.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.46 111.356 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.76 -22.35 31.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.684 -0.769 . . . . 0.35 112.832 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.31 98.78 8.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.5 110.925 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 18.8 mtpt -59.12 99.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.42 111.001 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.88 -30.24 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.47 110.679 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -70.47 171.28 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.31 110.827 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.58 84.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.33 110.996 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.8 29.53 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.9 110.771 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 64.85 31.3 80.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.21 112.58 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.473 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.62 -36.06 73.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.27 111.067 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.664 ' HB2' HD13 ' A' ' 26' ' ' LEU . 2.0 p30 -62.94 -27.91 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.31 110.722 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.478 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 2.7 mt-10 -92.67 15.88 13.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.27 111.271 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.41 -171.91 2.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 0.4 110.972 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 45' ' ' CYS . 20.2 mm -69.92 -25.51 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.37 110.956 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.61 -29.93 19.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.29 111.359 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -92.52 -19.64 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.26 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.54 21.16 7.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.23 112.703 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.67 ' O ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -94.13 118.68 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.35 110.638 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.91 68.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.91 111.233 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.6 p90 179.25 44.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.48 110.89 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.478 ' ND2' ' O ' ' A' ' 39' ' ' GLU . 0.8 OUTLIER -65.69 140.7 58.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.87 110.882 179.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.32 -64.46 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 1.33 110.915 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.219 -0.896 . . . . 0.96 110.828 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 112.519 -0.233 . . . . 1.84 112.519 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.42 15.91 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.597 0.237 . . . . 0.7 111.337 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 57.38 165.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.857 0.36 . . . . 0.4 111.06 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.19 131.52 10.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.52 112.362 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.32 -26.05 13.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.742 0.306 . . . . 0.5 111.04 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.3 150.99 10.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.37 -0.377 . . . . 0.37 110.942 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m 62.99 -165.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.33 110.886 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.64 -169.28 13.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.38 112.34 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 115.59 2.04 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.792 2.328 . . . . 0.57 111.888 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.4 t 64.62 55.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.004 0.43 . . . . 0.49 110.436 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 4.1 p -99.26 156.99 16.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.42 111.371 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.684 ' HB3' HD21 ' A' ' 26' ' ' LEU . 29.0 t80 -97.09 153.82 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.32 110.331 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 t -118.24 114.35 22.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.41 110.654 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 35.3 t -65.48 134.68 95.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.384 . . . . 0.25 110.962 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HG3' ' HB1' ' A' ' 42' ' ' ALA . 60.5 Cg_endo -71.42 125.23 11.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.643 2.229 . . . . 0.36 112.67 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.3 36.18 10.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.784 -0.722 . . . . 0.4 113.137 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.638 ' CG2' HG12 ' A' ' 19' ' ' VAL . 2.5 t 178.29 161.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.39 110.936 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.78 38.82 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 1.13 110.831 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.638 HG12 ' CG2' ' A' ' 17' ' ' THR . 5.1 p -112.82 126.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.65 110.665 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -119.49 154.07 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.26 111.188 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -141.47 136.27 15.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.22 110.899 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 35.9 Cg_endo -64.75 148.17 90.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.505 2.137 . . . . 0.23 112.294 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.603 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.6 tm-20 -50.81 -36.74 38.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.218 -0.446 . . . . 0.43 111.198 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.74 -24.44 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.366 . . . . 0.33 110.817 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -99.35 -17.71 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.38 111.135 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' A' ' 12' ' ' PHE . 3.6 mm? -53.19 121.07 6.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.28 111.104 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 54.7 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.747 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.97 -10.45 17.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.46 111.249 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.9 -22.76 9.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.749 -0.738 . . . . 0.35 112.541 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.76 108.66 19.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.5 110.857 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 8.9 mttt -58.1 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.42 111.022 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -66.43 -28.63 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.47 110.646 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 t -97.49 159.12 15.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.269 -0.423 . . . . 0.31 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.56 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 0.33 110.917 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.56 -2.35 20.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.9 111.207 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.474 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 70.67 31.69 67.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.844 -0.693 . . . . 0.21 113.033 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.601 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -54.89 -38.18 67.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.976 0.417 . . . . 0.27 110.64 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.637 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -58.87 -29.93 67.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.859 -0.61 . . . . 0.31 110.678 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.44 16.87 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.27 111.049 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.28 -165.87 1.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.861 0.363 . . . . 0.4 110.984 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.6 mp -77.2 -27.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.487 . . . . 0.37 111.079 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.483 ' HB1' ' HG3' ' A' ' 15' ' ' PRO . . . -51.98 -32.22 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 0.29 111.234 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -81.86 -23.1 36.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.26 111.223 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.6 5.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.716 -0.754 . . . . 0.23 112.664 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -24.47 20.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.35 110.93 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mt 69.48 -62.6 0.41 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.243 -0.435 . . . . 0.91 111.385 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 64.82 147.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.453 -0.34 . . . . 0.48 110.707 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -152.15 107.74 3.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.405 . . . . 0.87 111.001 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -164.82 119.18 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 1.33 110.792 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.279 -0.867 . . . . 0.96 110.915 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.537 -0.225 . . . . 1.84 112.537 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.5 t 60.5 172.16 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.847 0.356 . . . . 0.7 110.889 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.05 47.93 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.4 110.838 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.69 43.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.824 -0.703 . . . . 0.52 112.324 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' OG1' ' A' ' 6' ' ' THR . 0.8 OUTLIER -108.7 -145.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.677 -0.12 . . . . 0.5 110.677 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 7' ' ' CYS . 2.9 p 68.51 -66.22 0.24 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.522 0.201 . . . . 0.37 110.783 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -139.13 155.86 47.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.33 110.65 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.03 -169.24 41.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.38 112.472 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.82 -24.29 13.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.876 2.384 . . . . 0.57 112.293 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 72.84 1.43 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.49 110.819 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 3.0 m -144.31 178.57 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.42 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.473 ' HB3' HD21 ' A' ' 26' ' ' LEU . 26.1 t80 -130.85 151.95 50.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.32 110.653 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 2.0 t -116.06 127.84 55.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.41 110.622 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HB2' HG13 ' A' ' 19' ' ' VAL . 4.8 m -65.53 140.68 97.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.25 110.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.2 Cg_endo -72.38 149.44 50.62 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.632 2.221 . . . . 0.36 112.427 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.8 38.07 95.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.4 112.677 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.614 ' CG2' HG12 ' A' ' 19' ' ' VAL . 3.8 t -177.99 175.75 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.39 111.002 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 34.49 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.13 110.819 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.616 HG13 ' HB2' ' A' ' 14' ' ' CYS . 1.6 p -102.45 140.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.65 110.861 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 1.7 p -117.94 163.61 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.26 110.915 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.578 HG13 HD21 ' A' ' 26' ' ' LEU . 4.1 p -147.34 125.44 6.02 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.22 111.281 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.567 ' O ' HD23 ' A' ' 26' ' ' LEU . 27.6 Cg_exo -61.59 149.14 91.07 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.412 2.075 . . . . 0.23 111.871 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -51.12 -39.18 55.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.43 110.997 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -59.57 -29.17 67.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.33 110.444 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.425 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 35.2 m0 -87.96 -25.15 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.589 . . . . 0.38 110.778 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.782 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.3 mm? -54.64 113.31 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.28 111.025 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.01 62.01 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.22 110.612 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -107.14 -4.95 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.46 111.36 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.01 -28.98 6.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.35 112.386 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.44 177.34 5.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 0.5 110.552 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.435 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 9.1 mtpt -120.22 85.75 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.42 111.001 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.39 -31.66 60.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.47 110.761 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 3.7 m -70.9 178.26 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.31 110.866 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.83 -43.52 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.33 111.032 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -120.77 34.59 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.9 110.864 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 60.72 31.39 75.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 0.21 112.388 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.463 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.12 -43.42 78.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.27 111.24 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.679 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 29.7 p-10 -57.45 -31.85 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.31 110.788 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -95.02 18.6 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.27 111.076 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 -167.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.883 0.373 . . . . 0.4 110.977 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.9 mm -72.45 -29.62 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.37 111.005 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.38 -33.93 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.29 111.28 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.782 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -83.56 -23.82 31.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.26 111.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.81 42.35 4.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.753 . . . . 0.23 112.858 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -47.12 6.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.35 110.652 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.6 38.12 5.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.91 111.343 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.428 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 6.0 p90 -175.81 119.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.951 0.405 . . . . 0.48 110.954 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -178.19 -52.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.87 110.803 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t 61.53 153.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 1.33 110.857 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.254 -0.879 . . . . 0.96 110.856 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.456 -0.257 . . . . 1.84 112.456 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 p -176.95 158.14 1.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 0.7 110.907 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -32.11 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.4 110.833 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.2 121.54 2.3 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.722 -0.751 . . . . 0.52 112.563 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -60.91 85.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.5 110.662 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.32 -91.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.37 111.413 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 59.5 m -103.59 54.81 0.74 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.82 0.343 . . . . 0.33 111.084 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.54 -163.49 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.271 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.37 117.21 3.55 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.592 2.195 . . . . 0.57 111.975 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p 51.32 60.39 3.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.49 110.774 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 4.9 m -94.89 161.86 13.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.42 111.316 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 36.9 t80 -110.83 147.04 35.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.32 110.443 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 p -109.71 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.41 110.978 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.819 ' HB3' HG13 ' A' ' 19' ' ' VAL . 3.7 t -58.81 130.66 85.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.25 110.727 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 142.12 41.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.594 2.196 . . . . 0.36 112.428 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.0 -43.49 2.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 0.4 112.985 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.723 HG23 HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -117.61 169.83 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.39 111.106 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.9 41.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 1.13 110.948 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.819 HG13 ' HB3' ' A' ' 14' ' ' CYS . 2.7 p -105.42 113.58 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.65 110.632 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.21 163.09 22.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.878 -0.601 . . . . 0.26 111.401 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 26' ' ' LEU . 3.8 p -151.77 123.62 3.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.22 110.469 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.616 ' O ' HD23 ' A' ' 26' ' ' LEU . 61.4 Cg_endo -73.91 157.74 47.01 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.317 2.011 . . . . 0.23 112.081 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.5 tt0 -54.29 -30.93 52.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.43 110.965 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HG3' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -70.01 -23.23 63.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 0.33 110.495 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.522 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 32.2 m0 -100.53 8.3 43.57 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.261 -0.427 . . . . 0.38 110.824 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 43' ' ' ALA . 3.0 mm? -80.92 117.36 21.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.486 -0.325 . . . . 0.28 110.499 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 39' ' ' GLU . 28.1 p 40.81 72.2 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.0 -0.546 . . . . 0.22 111.287 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.15 5.03 9.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.46 111.234 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.82 -28.6 6.96 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.644 -0.789 . . . . 0.35 112.768 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -95.3 171.5 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.5 110.941 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -118.74 87.9 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.383 -0.371 . . . . 0.42 110.809 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -35.09 60.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.083 0.468 . . . . 0.47 110.165 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.2 t -87.18 143.81 27.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.672 -0.694 . . . . 0.31 110.45 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.29 -31.77 1.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.37 . . . . 0.33 111.584 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -120.22 26.22 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.9 111.003 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 54.58 28.79 46.51 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.919 -0.657 . . . . 0.21 112.866 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.73 -44.15 18.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.27 111.404 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB2' HD13 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -56.89 -28.63 62.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.429 . . . . 0.31 110.494 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 20.3 mm-40 -84.45 8.62 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.27 111.352 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.36 176.04 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.807 0.337 . . . . 0.4 110.8 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 1.3 mp -69.89 -19.18 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 0.37 110.975 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.17 -34.38 56.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.29 111.093 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 26' ' ' LEU . . . -87.29 -22.58 25.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.26 111.239 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.21 28.96 5.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.619 -0.8 . . . . 0.23 112.481 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.433 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 53.9 t -55.61 -62.12 1.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.328 . . . . 0.35 110.73 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt 76.05 -58.66 0.53 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.227 -0.442 . . . . 0.91 111.801 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 45' ' ' CYS . 1.6 m-85 -43.78 -47.42 8.01 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.742 0.306 . . . . 0.48 111.261 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 62.2 119.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.87 111.001 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 m -136.73 113.84 10.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 1.33 110.865 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.277 -0.868 . . . . 0.96 110.917 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.506 -0.238 . . . . 1.84 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -144.28 37.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.823 0.344 . . . . 0.7 110.923 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 68.26 -70.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.4 110.904 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.02 -134.91 4.26 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.52 112.519 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -177.01 78.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.5 110.913 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.01 -54.14 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.37 110.911 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' HA ' ' CD ' ' A' ' 22' ' ' PRO . 23.7 p -174.72 -39.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.33 111.102 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.69 -160.08 11.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.636 -0.792 . . . . 0.38 112.633 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.98 150.17 74.48 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.811 2.341 . . . . 0.57 112.284 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m 61.24 41.93 12.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.49 110.746 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 p -83.09 168.8 16.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.501 . . . . 0.42 111.151 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.766 ' O ' HG12 ' A' ' 21' ' ' VAL . 43.1 t80 -137.65 133.12 33.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.32 110.406 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -94.7 149.61 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.41 110.753 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -88.88 138.58 29.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.25 111.169 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.82 132.7 51.43 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.264 . . . . 0.36 112.096 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.42 -44.47 2.44 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.751 -0.738 . . . . 0.4 112.517 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.616 HG23 HG13 ' A' ' 19' ' ' VAL . 2.0 t -108.7 177.65 4.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.39 110.607 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -117.35 48.05 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 1.13 111.054 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.616 HG13 HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -77.33 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.65 110.532 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' N ' HG23 ' A' ' 19' ' ' VAL . 3.7 t -147.59 119.35 8.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.26 111.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.2 p -122.33 136.92 26.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.22 110.631 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.498 ' HD2' HG23 ' A' ' 21' ' ' VAL . 66.4 Cg_endo -74.95 144.02 29.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.354 2.036 . . . . 0.23 111.601 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.561 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -47.44 -36.1 9.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.85 0.357 . . . . 0.43 110.923 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -30.14 70.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.33 110.344 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.45 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 30.4 m0 -87.35 -26.9 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.887 -0.597 . . . . 0.38 110.72 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.864 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.7 mm? -47.75 106.14 0.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.402 -0.363 . . . . 0.28 111.011 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 t 50.64 67.14 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 0.22 110.819 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.63 -4.23 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.58 . . . . 0.46 111.33 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.35 -27.59 6.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.35 112.559 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.18 144.64 31.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.5 110.715 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 16.1 mttp -83.55 92.25 7.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.42 111.065 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -29.72 21.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.107 0.479 . . . . 0.47 109.761 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -74.61 168.28 20.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.66 -0.7 . . . . 0.31 110.775 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.72 98.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.33 110.655 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.72 29.73 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.9 110.664 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 63.32 22.83 65.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.946 -0.645 . . . . 0.21 112.822 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -48.81 -45.02 39.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.894 0.378 . . . . 0.27 110.924 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.409 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 2.5 p30 -59.44 -22.35 61.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.31 110.806 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -94.83 17.75 13.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.454 -0.339 . . . . 0.27 111.194 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.39 -177.24 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.4 111.123 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 41' ' ' ILE . 2.3 mp -71.54 -27.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.37 110.666 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.31 -32.02 46.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.29 111.213 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.864 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.12 -14.64 33.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.023 -0.535 . . . . 0.26 111.517 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.5 24.12 5.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.23 112.729 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.14 105.05 14.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.35 110.887 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.36 31.68 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.91 111.13 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -75.07 -12.79 60.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.368 -0.378 . . . . 0.48 111.576 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 66.06 -71.11 0.09 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.733 0.301 . . . . 0.87 111.19 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER 68.16 141.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.335 -0.393 . . . . 1.33 110.967 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.236 -0.888 . . . . 0.96 110.894 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.517 -0.233 . . . . 1.84 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.99 121.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.7 110.917 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.29 -66.27 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.4 110.838 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.82 83.52 0.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 0.52 112.375 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -35.65 81.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 0.5 111.019 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 p -72.4 143.54 48.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.37 110.926 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 69.2 m 57.66 -84.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.33 110.992 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.12 179.76 0.43 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.662 -0.78 . . . . 0.38 112.576 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.54 136.46 57.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.768 2.312 . . . . 0.57 112.062 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 t 62.77 53.25 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.49 110.607 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 158.57 15.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.42 111.185 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 33.7 t80 -122.23 151.91 40.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.32 110.063 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.1 t -119.03 120.41 37.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.836 0.351 . . . . 0.41 110.757 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.693 ' SG ' HG13 ' A' ' 19' ' ' VAL . 6.0 m -64.78 138.62 97.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.25 110.657 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.1 Cg_endo -70.1 139.49 39.17 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.649 2.233 . . . . 0.36 112.537 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.34 38.46 70.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.799 -0.715 . . . . 0.4 112.746 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.567 ' CG2' HG12 ' A' ' 19' ' ' VAL . 3.5 t 179.37 174.26 0.78 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.39 111.035 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -114.21 43.78 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.13 110.747 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.693 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -111.42 130.88 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.65 110.928 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 3.2 p -109.69 163.52 13.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.353 -0.385 . . . . 0.26 110.859 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.672 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.6 p -151.23 125.15 4.39 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.22 110.78 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.532 ' O ' HD23 ' A' ' 26' ' ' LEU . 31.2 Cg_exo -58.79 148.86 81.27 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.298 1.999 . . . . 0.23 112.009 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -50.93 -38.66 51.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.872 0.367 . . . . 0.43 110.782 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -28.27 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.33 110.424 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.464 ' HB2' HG22 ' A' ' 21' ' ' VAL . 13.4 m0 -89.41 -24.47 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.38 110.824 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.656 ' CD2' HG13 ' A' ' 21' ' ' VAL . 4.1 mm? -52.89 120.92 6.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.28 110.802 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.2 p 38.96 57.33 1.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.123 -0.49 . . . . 0.22 111.372 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -104.22 -12.08 16.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.882 -0.599 . . . . 0.46 111.325 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.71 19.98 4.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.35 112.763 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -148.53 101.44 3.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.812 0.339 . . . . 0.5 110.635 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -55.29 95.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.42 111.192 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -91.78 -30.62 16.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.47 110.603 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.23 173.94 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.31 110.868 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.33 111.052 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -117.61 35.93 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.9 110.848 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.408 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 59.16 32.03 70.61 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.724 -0.751 . . . . 0.21 112.384 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.59 -39.8 81.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.27 111.32 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.672 ' HB3' HG11 ' A' ' 21' ' ' VAL . 3.0 p30 -60.33 -26.9 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.381 . . . . 0.31 111.072 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 3.2 mm-40 -92.97 13.21 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.27 111.258 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.63 169.91 14.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.801 0.334 . . . . 0.4 110.936 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.817 HG23 HD22 ' A' ' 46' ' ' LEU . 2.4 mp -58.38 -23.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.37 110.773 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.62 -26.77 14.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.313 -0.403 . . . . 0.29 111.186 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.64 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -102.56 21.97 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.26 111.368 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.99 18.56 70.9 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.679 -0.772 . . . . 0.23 112.575 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.57 78.52 6.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.916 0.388 . . . . 0.35 110.619 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.817 HD22 HG23 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -118.62 24.43 10.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.91 110.924 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -9.24 57.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.418 . . . . 0.48 111.459 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 62.78 125.02 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.837 0.351 . . . . 0.87 111.004 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -176.73 -39.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.262 -0.875 . . . . 0.96 110.903 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.473 -0.251 . . . . 1.84 112.473 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 4' ' ' GLY . 85.7 p -120.05 27.31 8.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.573 0.225 . . . . 0.7 111.025 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 39.75 -91.39 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.111 -0.495 . . . . 0.4 111.757 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 2' ' ' SER . . . -108.54 104.62 2.02 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.674 -0.774 . . . . 0.52 112.413 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.26 33.53 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.5 110.946 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -62.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.37 110.898 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -97.11 -67.81 0.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.33 110.982 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.87 -175.26 2.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.654 -0.784 . . . . 0.38 112.369 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.05 124.43 15.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.697 2.265 . . . . 0.57 112.012 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t 62.03 83.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.49 110.866 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.23 159.18 36.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.42 110.93 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.506 ' HB3' HD21 ' A' ' 26' ' ' LEU . 25.5 t80 -110.17 152.23 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.32 110.572 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -111.97 133.13 54.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 0.41 110.735 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.87 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -79.72 137.45 54.61 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.25 111.003 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.3 124.12 14.51 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.681 2.254 . . . . 0.36 112.472 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.428 ' C ' HG22 ' A' ' 17' ' ' THR . . . 70.08 37.73 73.15 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.879 -0.677 . . . . 0.4 112.84 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.87 HG23 ' HB3' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 178.63 152.7 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 0.39 110.852 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -86.58 -3.77 59.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 1.13 111.509 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.8 HG12 ' OG1' ' A' ' 17' ' ' THR . 7.7 p -56.77 89.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.815 0.341 . . . . 0.65 111.074 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 p -82.73 162.71 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.26 111.034 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.909 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.5 p -150.21 129.23 6.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.22 111.066 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' O ' HD23 ' A' ' 26' ' ' LEU . 24.4 Cg_exo -63.03 151.9 82.3 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.403 2.069 . . . . 0.23 111.886 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.4 tt0 -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.43 110.801 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -59.76 -27.41 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.33 110.459 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' HG22 ' A' ' 21' ' ' VAL . 17.0 m0 -90.61 -25.24 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.895 -0.593 . . . . 0.38 110.917 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.61 ' CD2' HG13 ' A' ' 21' ' ' VAL . 3.9 mm? -50.62 122.3 7.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.28 110.935 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 p 39.12 61.59 1.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.039 -0.528 . . . . 0.22 111.285 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -108.19 -6.04 16.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.757 -0.656 . . . . 0.46 111.219 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.75 -26.18 7.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.35 112.589 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.77 103.92 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.5 110.81 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 25.8 mtpt -59.94 85.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.42 111.083 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -75.31 -30.84 60.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.47 110.637 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -69.0 170.89 9.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.001 -0.545 . . . . 0.31 110.862 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.29 71.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.33 110.742 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -120.73 28.41 7.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.9 110.811 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.434 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.8 28.22 71.37 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.822 -0.704 . . . . 0.21 112.739 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -55.4 -43.34 75.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.27 111.008 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.909 ' HB3' HG11 ' A' ' 21' ' ' VAL . 2.3 p30 -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.31 110.943 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.48 15.85 16.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 0.27 111.264 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.54 172.51 12.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.4 110.849 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.556 HG13 HD23 ' A' ' 46' ' ' LEU . 1.6 mp -60.55 -21.89 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.37 110.811 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.29 -32.11 36.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.916 0.388 . . . . 0.29 111.094 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.568 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -88.58 -22.38 23.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 0.26 111.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.04 28.52 6.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.605 -0.807 . . . . 0.23 112.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.407 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 25.1 t -70.36 -71.86 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.299 . . . . 0.35 110.546 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.556 HD23 HG13 ' A' ' 41' ' ' ILE . 9.4 mt 67.38 -67.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.91 111.405 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.472 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -63.91 78.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.081 0.467 . . . . 0.48 111.589 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -159.4 32.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 0.87 110.83 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.4 m -96.02 -32.68 12.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 1.33 110.882 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.251 -0.88 . . . . 0.96 110.921 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.538 -0.225 . . . . 1.84 112.538 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.2 89.0 3.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 0.7 110.991 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 68.52 -67.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.4 111.047 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.07 44.35 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 0.52 112.466 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -135.02 -55.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 0.5 110.846 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.406 ' HG1' ' H ' ' A' ' 7' ' ' CYS . 2.1 p 51.42 -91.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.37 111.28 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' H ' ' HG1' ' A' ' 6' ' ' THR . 2.8 m -109.43 75.16 0.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.788 0.328 . . . . 0.33 110.963 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.18 -160.54 1.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.675 -0.774 . . . . 0.38 112.354 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.87 122.83 12.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.613 2.209 . . . . 0.57 111.977 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t 61.05 58.88 2.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.49 110.484 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.21 145.73 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.42 111.311 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.446 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.0 t80 -107.44 151.88 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.32 110.345 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.414 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 2.0 t -107.5 126.7 52.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.21 -0.45 . . . . 0.41 110.761 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.778 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.5 m -74.99 142.26 75.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.25 110.866 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.7 Cg_endo -72.32 146.03 44.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.719 2.279 . . . . 0.36 112.498 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.33 35.49 91.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.4 112.593 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.56 ' CG2' HG12 ' A' ' 19' ' ' VAL . 2.0 t 179.81 174.59 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.39 110.814 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.49 30.75 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 1.13 110.95 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.778 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -93.72 133.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.65 110.681 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 p -109.92 164.25 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.26 111.016 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.595 HG13 HD21 ' A' ' 26' ' ' LEU . 4.8 p -152.76 134.19 8.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.22 110.836 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.544 ' O ' HD23 ' A' ' 26' ' ' LEU . 59.0 Cg_endo -72.23 148.96 50.68 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.264 1.976 . . . . 0.23 111.721 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -38.69 24.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.43 111.061 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -27.73 69.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.345 -0.388 . . . . 0.33 110.466 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.455 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 26.6 m0 -88.17 -25.29 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.38 110.677 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.804 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.1 mm? -53.82 122.16 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.268 -0.424 . . . . 0.28 110.873 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 37.17 55.21 1.3 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.053 0.454 . . . . 0.22 111.284 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -101.02 -13.57 18.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 0.46 111.124 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.21 18.95 4.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 0.35 112.784 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.48 108.65 3.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.5 110.643 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HE2' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -55.49 92.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.42 111.172 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.08 -30.92 18.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.47 110.67 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.3 -174.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.31 110.849 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.13 -50.01 21.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.33 110.932 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.4 33.48 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.9 110.79 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' CA ' ' HE2' ' A' ' 31' ' ' LYS . . . 65.14 27.9 72.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.694 -0.765 . . . . 0.21 112.555 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.55 -41.73 86.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.778 0.323 . . . . 0.27 111.174 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 39.3 p30 -54.97 -27.69 45.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.31 110.997 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.63 19.23 10.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.27 111.005 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.57 -164.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.4 110.888 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.603 HD12 HD23 ' A' ' 46' ' ' LEU . 39.9 mm -80.14 -28.19 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.37 111.12 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.32 -31.71 22.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.29 111.485 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.804 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -86.3 -19.79 29.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.26 111.401 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.71 21.03 8.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.636 -0.792 . . . . 0.23 112.776 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -98.37 72.06 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.464 . . . . 0.35 110.69 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.603 HD23 HD12 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -78.18 78.1 4.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.846 -0.616 . . . . 0.91 111.029 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -107.74 -23.08 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.026 -0.534 . . . . 0.48 111.014 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.6 m120 64.19 79.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.87 110.879 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.5 p -159.84 138.85 10.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.33 110.901 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.224 -0.893 . . . . 0.96 110.862 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.547 -0.221 . . . . 1.84 112.547 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 p 58.99 -169.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.761 0.315 . . . . 0.7 110.944 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -141.99 31.49 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.4 110.943 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.08 106.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.684 -0.77 . . . . 0.52 112.601 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -177.58 -71.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.272 . . . . 0.5 110.869 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 57.71 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 0.37 111.261 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' LYS . 33.5 m -111.76 -41.94 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.33 111.255 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.02 -174.6 2.45 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.62 -0.8 . . . . 0.38 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.56 140.97 94.01 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.745 2.296 . . . . 0.57 112.226 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 p 50.02 78.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.49 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 64.5 p -118.49 158.81 24.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.42 111.223 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.589 ' HB3' HD21 ' A' ' 26' ' ' LEU . 10.5 t80 -93.23 152.8 18.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.945 -0.57 . . . . 0.32 110.283 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -107.08 123.17 47.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.406 -0.361 . . . . 0.41 110.689 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 5.4 t -75.66 135.22 71.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.25 111.02 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.71 129.23 22.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.651 2.234 . . . . 0.36 112.525 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.0 -43.75 1.9 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.782 -0.723 . . . . 0.4 112.988 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.597 ' CG2' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.29 160.78 19.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 0.39 110.985 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -0.62 49.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 1.13 111.402 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.597 HG12 ' CG2' ' A' ' 17' ' ' THR . 6.9 p -63.19 133.01 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.757 0.313 . . . . 0.65 110.757 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -124.58 153.44 42.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.26 111.089 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 38' ' ' ASP . 2.8 p -132.1 139.81 36.14 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.22 111.141 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.3 Cg_exo -65.32 146.91 87.03 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.477 2.118 . . . . 0.23 111.959 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HA ' HD23 ' A' ' 26' ' ' LEU . 2.1 mt-10 -51.02 -40.95 59.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.928 0.394 . . . . 0.43 110.824 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -60.7 -27.37 67.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.33 110.599 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 31.1 m0 -90.46 -24.86 20.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.38 110.944 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.694 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.9 mm? -50.01 125.96 13.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.333 -0.394 . . . . 0.28 111.062 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 39.89 56.71 2.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.22 111.481 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -105.82 -6.37 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.46 111.165 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -20.66 9.49 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.75 . . . . 0.35 112.681 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -109.78 116.24 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.5 110.883 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HE2' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -65.42 90.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.42 110.978 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -66.1 -32.37 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.47 110.753 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.76 160.56 15.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.31 110.897 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.92 -28.37 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.33 111.053 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -104.79 -4.69 22.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.9 111.497 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' CA ' ' HE2' ' A' ' 31' ' ' LYS . . . 71.4 32.47 64.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.664 -0.779 . . . . 0.21 112.779 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -61.64 -39.6 91.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.27 110.822 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.808 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -60.58 -26.71 67.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.546 . . . . 0.31 110.996 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -89.3 9.17 27.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.27 111.375 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.07 175.88 8.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.858 0.361 . . . . 0.4 111.026 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.72 -22.71 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.37 111.015 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.64 -30.12 12.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.376 . . . . 0.29 111.397 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.694 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.02 -20.08 23.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.26 111.486 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.46 24.11 7.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.23 112.631 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 m -93.51 96.78 10.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.35 110.671 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.55 58.65 4.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.91 111.191 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CG ' ' O ' ' A' ' 47' ' ' TYR . 2.2 p90 -177.04 104.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.48 110.862 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -112.14 -162.74 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.87 110.887 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.56 -64.64 0.39 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.366 -0.379 . . . . 1.33 110.98 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.204 -0.903 . . . . 0.96 110.943 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.509 -0.236 . . . . 1.84 112.509 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 p -127.21 142.58 51.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.7 110.943 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.27 -43.57 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.4 111.067 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.15 46.33 0.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.67 -0.776 . . . . 0.52 112.514 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -98.98 33.5 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.793 0.33 . . . . 0.5 110.923 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -77.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.37 110.759 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.6 m -102.95 -72.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.33 110.889 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -176.91 34.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.487 -0.863 . . . . 0.38 112.303 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.55 -22.19 73.87 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.57 112.481 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.2 p -128.33 101.93 6.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.49 111.077 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.48 176.87 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.42 111.074 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 17.1 t80 -125.93 152.01 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.32 110.452 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 12' ' ' PHE . 4.3 t -108.11 125.99 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.41 110.591 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.714 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.7 m -74.95 144.6 79.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.25 110.943 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 72.9 Cg_endo -74.87 144.76 31.12 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.633 2.222 . . . . 0.36 112.471 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.49 73.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.707 . . . . 0.4 112.648 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.598 ' CG2' HG12 ' A' ' 19' ' ' VAL . 1.3 t 179.77 167.81 1.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.348 . . . . 0.39 110.95 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.79 27.47 7.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.13 110.918 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.714 HG13 ' SG ' ' A' ' 14' ' ' CYS . 2.3 p -91.19 137.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.65 110.733 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 p -118.32 162.92 17.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.26 111.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' HB3' ' A' ' 38' ' ' ASP . 5.7 p -145.42 134.82 11.38 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.22 110.736 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.528 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.6 Cg_endo -71.0 148.14 56.41 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.391 2.061 . . . . 0.23 111.946 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.493 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.3 tt0 -48.16 -39.86 22.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.361 -0.381 . . . . 0.43 111.002 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -58.13 -29.47 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.33 110.555 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.441 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 33.9 m0 -92.34 -24.32 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 0.38 110.867 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.847 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.9 mm? -50.96 123.96 10.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.272 -0.422 . . . . 0.28 111.037 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 36.73 56.97 1.16 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.163 -0.471 . . . . 0.22 111.324 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -103.53 -13.81 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.615 . . . . 0.46 111.218 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.76 -23.99 7.27 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.35 112.535 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 118.7 37.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 0.5 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -62.9 107.6 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.42 111.074 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.33 -28.05 12.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.47 110.558 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.9 m -75.26 -179.69 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.858 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -65.7 -54.93 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.33 111.179 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.43 34.89 4.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.9 111.072 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.35 28.51 72.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.21 112.638 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.425 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -57.67 -42.44 83.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.727 0.299 . . . . 0.27 111.281 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.753 ' HB3' HG11 ' A' ' 21' ' ' VAL . 10.1 p30 -56.9 -21.64 31.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.31 111.188 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.49 11.45 17.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.27 111.502 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.33 173.06 10.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.763 0.316 . . . . 0.4 110.982 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.8 -23.24 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.37 110.882 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.78 -23.98 13.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.29 111.309 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.85 -0.2 57.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.26 111.844 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.48 -12.12 30.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.616 -0.802 . . . . 0.23 112.922 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 145.14 56.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.737 0.268 . . . . 0.35 110.335 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.69 -24.12 4.58 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.008 0.373 . . . . 0.91 112.008 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -49.87 117.47 2.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.854 0.359 . . . . 0.48 110.904 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.37 126.04 26.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.457 . . . . 0.87 111.14 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.1 m -121.39 10.85 10.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 1.33 111.169 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.7 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.243 -0.884 . . . . 0.96 111.186 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.479 -0.248 . . . . 1.84 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.93 177.88 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.783 0.325 . . . . 0.7 110.838 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 59.76 -174.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.4 110.832 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.72 116.59 8.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.641 -0.79 . . . . 0.52 112.369 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 -155.62 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.584 0.231 . . . . 0.5 110.928 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 59.18 -85.68 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.573 -0.285 . . . . 0.37 110.765 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.84 -164.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.636 0.255 . . . . 0.33 110.431 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.53 177.25 25.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.38 112.62 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.62 -25.42 59.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.808 2.339 . . . . 0.57 112.245 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -129.02 48.03 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.49 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.24 141.01 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.42 110.858 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.639 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 38.8 t80 -91.23 137.37 32.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.32 110.417 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -105.21 128.19 53.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.161 -0.472 . . . . 0.41 110.845 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.748 ' SG ' HG13 ' A' ' 19' ' ' VAL . 17.8 m -57.66 140.61 80.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.25 110.774 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 35.6 Cg_endo -64.94 133.19 34.94 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.723 2.282 . . . . 0.36 112.48 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.54 31.73 44.79 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.819 -0.705 . . . . 0.4 112.562 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.553 HG21 ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -141.38 155.56 45.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.39 110.888 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -98.68 30.65 3.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 1.13 110.774 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.748 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -114.97 138.52 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 0.65 110.788 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -110.79 165.39 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.26 110.878 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.4 p -151.59 132.68 7.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.22 110.805 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.688 ' O ' HD23 ' A' ' 26' ' ' LEU . 70.4 Cg_endo -74.48 151.14 41.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.282 1.988 . . . . 0.23 111.907 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -29.12 16.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.43 110.848 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.02 -25.37 64.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.33 110.455 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.16 18.25 21.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.38 110.91 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 22' ' ' PRO . 3.6 mm? -94.42 114.32 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.28 110.867 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.27 60.41 3.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.22 110.798 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.82 11.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.46 111.369 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.8 -25.8 7.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 0.35 112.474 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.61 104.51 15.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.5 110.691 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.0 mtpt -57.54 96.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.42 111.086 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.17 -32.45 19.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.47 110.689 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -65.08 -176.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.31 110.651 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.553 ' CB ' HG21 ' A' ' 17' ' ' THR . . . -75.74 -46.0 33.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.406 . . . . 0.33 110.889 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.75 31.22 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.9 110.727 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 68.08 30.92 74.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.832 -0.699 . . . . 0.21 112.67 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.664 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -57.94 -43.81 86.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.27 111.008 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -56.59 -28.38 60.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.31 110.739 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.69 17.72 12.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.27 111.145 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.61 -169.69 2.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.825 0.345 . . . . 0.4 111.027 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.771 HG13 HD23 ' A' ' 46' ' ' LEU . 1.5 mp -73.86 -26.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.37 110.827 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.62 9.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.29 111.401 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -100.71 13.49 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.26 111.594 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.5 66.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.744 -0.741 . . . . 0.23 113.05 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.06 92.92 4.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.35 110.726 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.771 HD23 HG13 ' A' ' 41' ' ' ILE . 1.7 mt -97.6 -50.57 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.91 111.039 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -47.02 -37.29 9.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.225 -0.443 . . . . 0.48 111.352 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 56.63 171.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.87 111.016 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 p -177.25 66.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 1.33 110.886 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.228 -0.891 . . . . 0.96 110.901 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.474 -0.25 . . . . 1.84 112.474 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m 60.22 33.03 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.7 110.845 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.43 -169.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.4 110.84 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.09 87.7 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.52 112.513 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.46 29.85 3.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.309 . . . . 0.5 110.977 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.13 -79.23 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.411 . . . . 0.37 110.769 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 16.1 m -100.21 -67.16 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 0.33 110.766 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.21 -176.92 9.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.63 -0.795 . . . . 0.38 112.483 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 -43.68 56.27 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.723 2.282 . . . . 0.57 112.122 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -103.29 95.57 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.49 110.782 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -145.42 147.42 32.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 0.42 111.107 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' CD2' HD11 ' A' ' 26' ' ' LEU . 11.8 t80 -107.56 150.59 26.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.32 110.482 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -106.08 123.98 48.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.41 110.834 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -77.28 146.64 74.74 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.25 111.221 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.09 136.84 39.03 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.798 2.332 . . . . 0.36 112.598 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.51 88.97 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.857 -0.687 . . . . 0.4 112.806 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.658 ' OG1' HG12 ' A' ' 19' ' ' VAL . 1.5 t 179.61 153.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.39 111.017 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.69 2.65 54.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 1.13 111.342 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.855 HG13 ' HB2' ' A' ' 14' ' ' CYS . 2.5 p -57.44 123.17 8.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.859 0.361 . . . . 0.65 110.821 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 p -102.94 162.71 12.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.26 111.083 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 38' ' ' ASP . 3.2 p -154.96 133.93 7.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.22 110.649 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PRO . . . . . 0.483 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.5 Cg_endo -71.18 147.01 52.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.386 2.058 . . . . 0.23 111.984 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.491 ' HA ' HD23 ' A' ' 26' ' ' LEU . 2.2 tt0 -49.07 -39.13 26.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.354 . . . . 0.43 110.968 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -58.24 -29.47 65.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.983 0.42 . . . . 0.33 110.453 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' TRP . . . . . 0.415 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 28.1 m0 -88.86 -25.94 21.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.923 -0.58 . . . . 0.38 110.572 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.765 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.4 mm? -56.52 113.43 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.28 110.952 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.1 m 56.23 53.52 8.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.026 0.441 . . . . 0.22 110.941 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -105.73 -18.13 14.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.46 111.136 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.37 -15.57 9.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.803 -0.713 . . . . 0.35 112.655 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.08 107.32 17.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.744 0.307 . . . . 0.5 110.81 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -59.17 85.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.42 111.112 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.74 -26.32 60.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.47 110.449 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.2 t -83.76 164.48 19.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.31 111.011 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.29 82.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.33 110.773 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.58 18.07 12.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 0.9 111.04 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.469 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 66.42 25.83 72.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.21 112.947 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.871 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -51.6 -38.07 52.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.93 0.365 . . . . 0.27 110.89 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.59 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.2 p30 -60.72 -22.99 64.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.31 110.812 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.74 20.31 13.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.306 . . . . 0.27 111.22 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.11 -179.66 5.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.4 111.007 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.0 mp -61.22 -21.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.37 110.864 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.16 -35.31 35.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.29 111.14 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.765 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -84.71 -22.3 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.576 . . . . 0.26 111.152 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.66 39.4 2.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.23 112.63 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.08 -61.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.35 111.064 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 70.72 34.55 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.91 110.752 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.0 m-30 -87.18 -35.03 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.48 110.839 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t30 66.07 38.95 4.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.87 110.755 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.4 p -60.54 -75.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 1.33 110.931 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 50' ' ' THR . 2.5 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.214 -0.898 . . . . 0.96 110.874 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.5 p . . . . . 0 C--O 1.231 0.082 0 CA-C-O 120.922 0.391 . . . . 0.37 111.055 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 51.99 67.74 0.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.33 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -158.69 4.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.38 112.413 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.5 -41.5 75.42 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.607 2.204 . . . . 0.57 111.876 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.19 66.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.49 110.315 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 96.4 p -81.82 122.05 27.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.42 111.29 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.711 ' HB3' HD21 ' A' ' 26' ' ' LEU . 48.8 t80 -98.15 144.33 27.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.32 110.153 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -104.15 132.47 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.41 111.254 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -74.86 131.08 79.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.815 -0.63 . . . . 0.25 110.422 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 17' ' ' THR . 19.6 Cg_endo -60.19 158.78 28.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.573 2.182 . . . . 0.36 112.274 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.57 21.86 58.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.4 112.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.67 HG23 HG13 ' A' ' 19' ' ' VAL . 6.2 t -179.32 168.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.687 0.28 . . . . 0.39 110.64 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -110.01 59.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.333 . . . . 1.13 111.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.67 HG13 HG23 ' A' ' 17' ' ' THR . 1.4 m -110.35 122.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.788 0.328 . . . . 0.65 110.198 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.78 161.75 18.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 0.26 111.067 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.636 HG22 HD22 ' A' ' 26' ' ' LEU . 2.4 p -158.57 112.01 1.66 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.22 110.489 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.53 144.7 61.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.259 1.973 . . . . 0.23 111.87 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -48.82 -32.07 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.382 . . . . 0.43 110.819 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.33 110.457 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -89.85 -19.34 24.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.38 110.988 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.711 HD21 ' HB3' ' A' ' 12' ' ' PHE . 4.0 mm? -58.84 119.56 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.324 -0.398 . . . . 0.28 110.922 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.59 50.69 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.22 110.825 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -104.59 -13.25 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.46 111.251 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 -26.31 7.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 0.35 112.555 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -94.6 98.47 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.5 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 6.5 mtpt -57.35 88.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.42 111.15 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -76.74 -32.31 57.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.47 110.643 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 37.3 t -81.67 144.24 31.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.31 110.507 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.23 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.33 111.965 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -115.75 29.35 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.684 0.278 . . . . 0.9 111.388 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 53.02 31.3 39.83 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.815 -0.707 . . . . 0.21 112.89 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.426 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 0.27 111.171 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 1.3 p30 -56.05 -28.07 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.31 110.941 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.73 11.31 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.27 111.379 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 178.01 6.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.872 0.368 . . . . 0.4 111.083 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.4 mm -60.92 -20.74 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.37 110.951 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.43 -31.73 55.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.392 . . . . 0.29 111.205 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -88.3 -20.49 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.26 111.243 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.08 4.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.23 112.656 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.35 110.663 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.45 0.167 . . . . 0.37 111.212 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.95 20.07 8.37 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.708 0.289 . . . . 0.33 110.876 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.11 -168.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.38 112.421 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.6 137.28 33.43 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.771 2.314 . . . . 0.57 112.021 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 t 71.44 29.35 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.49 110.945 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 m -102.22 154.23 19.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.42 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.508 ' HB3' HD21 ' A' ' 26' ' ' LEU . 34.7 t80 -115.83 151.82 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.32 110.727 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -118.05 121.03 39.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.41 110.41 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.761 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.4 m -60.93 143.78 91.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.25 110.636 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 70.5 Cg_endo -74.43 136.68 22.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.644 2.229 . . . . 0.36 112.537 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.56 -42.06 2.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.756 -0.735 . . . . 0.4 112.771 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -112.58 170.24 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 0.39 110.844 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 28.32 4.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.13 111.403 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.761 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.4 p -89.52 131.63 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.345 . . . . 0.65 110.59 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -108.58 164.66 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.26 111.108 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.827 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.6 p -153.08 125.08 3.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.22 110.8 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.611 ' O ' HD23 ' A' ' 26' ' ' LEU . 34.0 Cg_exo -59.38 150.19 76.56 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.409 2.073 . . . . 0.23 112.069 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -51.56 -39.76 58.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.43 110.897 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -62.46 -27.68 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.33 110.393 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.421 ' HB2' HG22 ' A' ' 21' ' ' VAL . 24.1 m0 -87.61 -24.36 23.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.38 110.732 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.627 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.0 mm? -53.04 125.65 18.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.224 -0.444 . . . . 0.28 110.746 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 38.63 58.04 1.72 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.025 0.44 . . . . 0.22 111.327 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -105.34 -7.76 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.46 111.241 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -23.76 8.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.35 112.624 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.37 109.97 22.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 0.5 110.914 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.7 mtpt -61.02 88.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.42 110.975 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.96 -30.06 35.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.47 110.866 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.93 175.01 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.31 110.905 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -66.6 -52.01 50.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.33 110.931 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -114.0 32.17 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.9 110.851 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.422 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.65 30.2 76.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 0.21 112.489 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.39 -39.28 79.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.27 111.316 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.827 ' HB3' HG11 ' A' ' 21' ' ' VAL . 5.0 p30 -63.2 -23.47 67.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.31 111.034 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.97 13.94 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.27 111.237 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.89 -176.23 3.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.861 0.363 . . . . 0.4 111.047 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 46.7 mm -71.43 -25.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.37 110.979 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.64 -26.39 8.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.29 111.451 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.627 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -94.74 -4.47 47.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.26 111.913 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.02 35.61 34.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.579 -0.82 . . . . 0.23 112.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.9 t . . . . . 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.35 110.713 179.842 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER . . . . . 0 CA--C 1.523 -0.064 0 CA-C-O 120.859 0.361 . . . . 0.37 110.695 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.4 m -151.54 69.19 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.33 110.662 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.02 -160.48 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.923 -0.656 . . . . 0.38 112.713 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.58 138.41 83.4 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.766 2.311 . . . . 0.57 112.239 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p 60.02 46.8 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.49 110.932 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.39 140.8 34.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.42 110.822 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.506 ' HB3' HD21 ' A' ' 26' ' ' LEU . 23.7 t80 -90.58 152.93 20.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.32 110.269 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 t -111.01 125.56 53.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.41 110.885 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.632 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.4 m -71.55 140.98 84.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.25 110.677 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.6 Cg_endo -77.34 136.37 15.83 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.649 2.233 . . . . 0.36 112.465 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.49 44.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.703 -0.761 . . . . 0.4 112.615 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.857 HG21 ' HB2' ' A' ' 34' ' ' ALA . 1.7 t 179.4 163.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.39 110.868 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -98.35 40.12 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.13 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.632 HG13 ' SG ' ' A' ' 14' ' ' CYS . 2.4 p -111.26 135.56 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.65 110.748 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 p -122.58 156.5 34.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.26 110.982 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.863 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.1 p -134.53 133.63 21.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.22 111.152 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.683 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.7 Cg_exo -63.31 150.54 88.28 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.461 2.108 . . . . 0.23 112.062 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.9 -31.36 39.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.43 110.77 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -70.08 -28.15 65.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.33 110.343 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.465 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 24.3 m0 -95.21 4.91 53.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.38 111.142 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.74 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.1 mm? -76.58 118.54 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.28 110.938 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 39.29 69.16 0.3 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.868 -0.605 . . . . 0.22 111.751 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD2' ' HA ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -116.76 -13.68 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.084 -0.507 . . . . 0.46 111.174 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.54 32.7 1.19 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.582 -0.818 . . . . 0.35 112.779 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.54 91.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 0.5 110.752 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 10.1 mtpt -53.14 92.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.42 111.308 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.92 -30.85 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.47 110.531 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -174.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.73 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.857 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -71.41 -55.51 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.33 110.973 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.91 38.61 3.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.9 110.732 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.85 31.33 80.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.21 112.425 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.458 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.0 -47.81 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.27 111.155 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.863 ' HB3' HG11 ' A' ' 21' ' ' VAL . 20.1 p-10 -57.86 -27.44 63.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.31 110.809 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.08 8.12 28.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.433 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.9 170.84 13.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.4 111.085 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.466 HD12 ' N ' ' A' ' 41' ' ' ILE . 1.9 mp -60.03 -23.87 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.37 110.733 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.3 -27.89 6.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.29 111.27 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.74 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -91.05 -19.79 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.26 111.483 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.66 12.45 12.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 0.23 113.115 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.35 110.344 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.822 0.344 . . . . 0.37 110.951 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.9 m -151.38 74.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.33 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.23 -163.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.38 112.45 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.82 -23.78 43.73 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.733 2.288 . . . . 0.57 112.246 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 p -123.91 83.05 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.49 110.744 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.7 53.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.42 111.04 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.524 ' HB3' HD21 ' A' ' 26' ' ' LEU . 24.6 t80 -103.56 150.81 23.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.32 110.479 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -112.64 128.04 56.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.41 110.777 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.8 m -69.28 136.14 88.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.25 110.559 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.3 Cg_endo -69.88 139.39 39.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.662 2.241 . . . . 0.36 112.56 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.87 -42.32 2.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.756 -0.735 . . . . 0.4 112.746 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.536 HG23 HG12 ' A' ' 19' ' ' VAL . 1.3 t -112.62 171.66 7.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.39 111.013 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -104.52 54.53 0.72 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.255 -0.429 . . . . 1.13 111.29 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.676 HG13 ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -113.35 142.93 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.65 110.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -112.72 154.07 26.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.26 110.894 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 HD22 ' A' ' 26' ' ' LEU . 2.5 p -145.03 131.14 9.67 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.22 110.691 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.49 ' C ' HD23 ' A' ' 26' ' ' LEU . 57.5 Cg_endo -71.77 146.83 49.2 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.281 1.987 . . . . 0.23 111.978 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.541 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.2 tt0 -48.0 -38.11 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.379 -0.373 . . . . 0.43 111.148 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -27.81 65.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 0.33 110.706 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -96.07 -19.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.38 111.109 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.861 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.0 mm? -53.84 123.06 11.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.517 -0.31 . . . . 0.28 110.909 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.5 p 36.92 58.49 1.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.089 -0.505 . . . . 0.22 111.403 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -104.25 -9.39 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.851 -0.613 . . . . 0.46 111.208 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.88 -25.05 7.69 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.35 112.53 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 121.89 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.5 110.714 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.487 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -60.12 84.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.42 111.103 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -79.63 -30.34 41.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.47 110.24 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.05 156.57 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.615 . . . . 0.31 110.374 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.526 ' HB3' HG21 ' A' ' 17' ' ' THR . . . -56.13 -34.67 66.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.33 110.773 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.05 28.82 6.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.9 110.813 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.487 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.83 22.64 48.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.817 -0.706 . . . . 0.21 112.656 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -52.01 -42.67 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.27 111.093 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.698 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 3.4 p30 -57.83 -22.49 47.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.31 110.796 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -89.13 11.12 19.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.27 111.153 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.11 -165.91 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.857 0.361 . . . . 0.4 111.051 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.557 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.1 mp -76.12 -23.34 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.37 110.937 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.76 -33.31 15.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.914 0.387 . . . . 0.29 111.332 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.861 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -83.67 -24.25 31.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 0.26 111.087 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.32 6.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.23 112.801 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.35 110.636 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.2 p . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.922 0.391 . . . . 0.37 111.131 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 13.5 m 53.92 -169.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.33 110.854 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.66 -167.34 13.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.644 -0.788 . . . . 0.38 112.53 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.71 -47.07 28.13 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.859 2.372 . . . . 0.57 112.189 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.28 55.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.49 110.708 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.453 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 84.1 p -124.03 147.16 48.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.072 -0.513 . . . . 0.42 111.11 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.7 t80 -112.66 149.55 32.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.32 110.261 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -111.81 110.95 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.281 -0.418 . . . . 0.41 110.738 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.779 ' HB2' HG13 ' A' ' 19' ' ' VAL . 2.2 m -56.64 148.89 43.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.25 111.093 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.08 131.6 24.12 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.706 2.271 . . . . 0.36 112.397 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.31 38.55 96.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.4 112.669 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.845 ' OG1' HG12 ' A' ' 19' ' ' VAL . 2.1 t -174.92 156.51 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.39 110.999 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.52 -5.77 51.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 1.13 111.323 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.845 HG12 ' OG1' ' A' ' 17' ' ' THR . 2.3 p -55.22 115.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.781 0.324 . . . . 0.65 110.971 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 1.2 p -97.02 163.98 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.26 110.755 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.546 HG13 HD21 ' A' ' 26' ' ' LEU . 5.4 p -156.35 123.99 2.78 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.22 110.974 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.549 ' O ' HD23 ' A' ' 26' ' ' LEU . 33.6 Cg_exo -58.96 148.66 83.75 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.374 2.049 . . . . 0.23 112.141 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -51.4 -38.14 51.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.38 . . . . 0.43 110.841 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -58.56 -27.95 65.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.423 . . . . 0.33 110.53 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.44 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 21.3 m0 -91.67 -24.75 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.906 -0.588 . . . . 0.38 110.841 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.837 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.2 mm? -53.52 122.73 10.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.269 -0.423 . . . . 0.28 110.822 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 p 38.03 59.36 1.38 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.148 -0.478 . . . . 0.22 111.26 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -103.09 -14.14 16.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.765 -0.652 . . . . 0.46 111.216 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.52 22.45 4.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.35 112.751 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.28 113.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 0.5 110.582 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 1.7 mttt -62.42 83.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.42 111.124 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.39 -28.76 41.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.104 0.478 . . . . 0.47 110.179 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 8.6 t -79.23 162.68 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.31 110.737 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.88 78.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.33 110.712 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -122.09 29.18 7.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.984 -0.553 . . . . 0.9 110.813 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 58.81 23.77 56.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 0.21 112.788 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -48.54 -44.17 36.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.27 111.317 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.497 ' HB3' HG11 ' A' ' 21' ' ' VAL . 3.8 p30 -59.95 -23.05 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.31 111.045 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -91.59 13.92 16.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 0.27 111.347 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.73 171.33 12.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.818 0.342 . . . . 0.4 110.919 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 41' ' ' ILE . 1.3 mp -61.09 -25.23 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.37 110.625 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.21 10.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.29 111.23 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.837 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -94.33 14.49 20.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.26 111.549 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.6 -10.72 73.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.627 -0.797 . . . . 0.23 112.635 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 120.654 0.264 . . . . 0.35 110.295 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.2 p . . . . . 0 N--CA 1.462 0.164 0 CA-C-O 120.59 0.233 . . . . 0.37 111.247 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.6 m -115.57 69.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.868 0.366 . . . . 0.33 110.778 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.33 -164.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.792 -0.718 . . . . 0.38 112.449 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.6 -24.18 21.93 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.744 2.296 . . . . 0.57 112.159 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -137.39 88.55 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.49 110.746 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.7 p -105.59 160.46 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.42 111.068 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 26' ' ' LEU . 37.7 t80 -132.37 137.09 47.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.955 -0.566 . . . . 0.32 110.472 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 p -106.54 117.43 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.803 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -49.02 139.16 12.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.044 -0.525 . . . . 0.25 111.126 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.78 133.5 45.23 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.71 2.273 . . . . 0.36 112.092 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.73 24.36 48.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.4 112.257 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.618 ' HB ' HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -141.17 146.42 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.39 110.815 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 1.13 57.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.13 111.358 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 17' ' ' THR . 2.3 p -61.37 156.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.65 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.411 ' N ' HG22 ' A' ' 19' ' ' VAL . 1.4 t -122.52 156.04 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.26 111.045 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.714 HG22 HD22 ' A' ' 26' ' ' LEU . 2.8 p -159.58 118.44 1.65 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.22 110.996 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.442 ' C ' HD23 ' A' ' 26' ' ' LEU . 32.0 Cg_exo -60.94 145.19 99.43 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.35 2.033 . . . . 0.23 111.803 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HA ' HD23 ' A' ' 26' ' ' LEU . 5.5 tt0 -47.32 -35.19 7.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.462 -0.335 . . . . 0.43 111.251 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -59.53 -32.16 70.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.33 110.495 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.41 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 23.0 m0 -88.36 -21.01 24.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.868 -0.606 . . . . 0.38 110.941 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.027 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.3 mm? -59.54 113.32 2.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.28 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 51.9 t 48.19 56.27 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.941 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.31 -14.72 15.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.46 111.25 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.55 29.18 1.95 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.778 . . . . 0.35 112.651 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.39 117.33 4.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.677 0.275 . . . . 0.5 110.662 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 2.6 mttp -62.38 81.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.42 111.026 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.83 -25.97 34.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.47 110.106 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -80.02 167.33 20.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.746 -0.661 . . . . 0.31 110.648 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.46 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.33 110.162 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.4 33.93 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.9 110.483 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 56.67 23.89 45.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.916 -0.659 . . . . 0.21 112.804 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -49.72 -44.41 48.26 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.822 0.344 . . . . 0.27 111.051 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 30.4 p-10 -59.03 -23.66 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.31 110.755 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.93 12.53 19.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.27 111.361 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 170.9 12.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.4 110.909 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 41' ' ' ILE . 3.1 mp -58.97 -22.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.906 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.4 52.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.29 111.079 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.027 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -85.9 -21.99 27.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.26 111.164 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.27 29.57 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.684 -0.769 . . . . 0.23 112.719 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 50.4 t . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.347 . . . . 0.35 110.867 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.739 0.304 . . . . 0.37 110.71 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 64.8 m -106.44 -67.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.33 110.775 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.15 -178.44 51.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.455 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.69 -44.55 46.88 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.803 2.336 . . . . 0.57 112.159 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 m -111.8 90.68 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.49 110.714 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -129.76 163.76 25.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.42 111.169 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 7.4 t80 -118.08 152.47 35.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.32 110.302 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 t -108.67 111.85 23.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.41 110.465 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.605 ' HB2' HG13 ' A' ' 19' ' ' VAL . 1.9 m -59.61 149.35 71.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.25 111.168 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 97.8 Cg_endo -78.09 132.8 11.82 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.815 2.343 . . . . 0.36 112.592 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.37 39.19 97.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.899 -0.667 . . . . 0.4 112.972 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.535 ' OG1' HG12 ' A' ' 19' ' ' VAL . 2.8 t -176.59 156.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.39 111.011 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.69 49.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 1.13 110.881 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 14' ' ' CYS . 2.3 p -119.43 113.13 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.65 110.53 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 13.8 p -96.92 164.24 12.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.26 111.351 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.896 HG11 ' HB3' ' A' ' 38' ' ' ASP . 6.5 p -152.12 130.55 6.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.22 110.848 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.631 ' O ' HD23 ' A' ' 26' ' ' LEU . 37.0 Cg_exo -59.01 148.14 86.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.244 1.963 . . . . 0.23 111.872 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -52.1 -42.98 63.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.43 110.863 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -22.94 66.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.33 110.445 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.462 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 24.9 m0 -87.96 -30.91 19.68 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.477 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.719 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.6 mm? -45.58 121.41 3.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.034 -0.53 . . . . 0.28 111.015 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 p 39.31 60.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.22 111.34 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -105.64 -14.7 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.46 111.259 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.04 12.25 7.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.747 -0.74 . . . . 0.35 112.905 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 104.12 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.5 110.649 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 2.8 mttp -58.68 86.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.42 111.327 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -81.91 -28.73 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.47 110.094 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 10.1 t -77.2 162.24 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.31 110.706 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -38.75 81.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.33 110.755 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.06 29.56 6.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.9 110.865 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.29 27.91 58.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.794 -0.717 . . . . 0.21 112.871 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -50.55 -43.85 56.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.27 111.407 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.896 ' HB3' HG11 ' A' ' 21' ' ' VAL . 2.5 p30 -59.3 -24.72 63.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.365 . . . . 0.31 110.904 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -88.75 11.59 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.27 111.319 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 168.89 15.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.4 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 45' ' ' CYS . 24.8 mm -59.03 -25.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.37 111.054 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.12 9.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.29 111.3 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.719 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -95.19 13.88 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.26 111.609 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.3 19.65 79.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.23 112.809 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.576 ' O ' HD13 ' A' ' 41' ' ' ILE . 45.5 t . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.35 110.626 179.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 p . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.886 0.374 . . . . 0.37 110.97 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.54 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 64.67 46.41 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.33 111.026 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.32 -172.5 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.748 . . . . 0.38 112.501 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.83 -35.92 81.06 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.776 2.317 . . . . 0.57 112.111 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.44 68.82 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.49 110.493 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 5.9 t -107.04 178.58 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.42 111.446 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.515 ' HB3' HD21 ' A' ' 26' ' ' LEU . 19.3 t80 -113.69 153.03 29.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.32 110.683 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.63 114.98 27.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.41 110.643 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' HG13 ' A' ' 19' ' ' VAL . 7.6 m -60.08 143.33 88.46 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.477 -0.329 . . . . 0.25 110.755 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.0 Cg_endo -77.12 137.34 17.1 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.69 2.26 . . . . 0.36 112.622 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 -44.06 2.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 0.4 112.886 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.707 HG21 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -109.94 168.88 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.809 0.338 . . . . 0.39 111.028 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -97.69 38.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 1.13 111.191 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.681 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -105.02 144.16 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 0.65 110.657 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -126.21 161.09 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.26 110.951 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 38' ' ' ASP . 5.5 p -144.6 130.94 9.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.22 110.998 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.605 ' O ' HD23 ' A' ' 26' ' ' LEU . 37.7 Cg_exo -59.61 149.42 82.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.303 2.002 . . . . 0.23 111.981 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.459 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -52.04 -39.63 59.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 0.43 110.844 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -26.86 68.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.33 110.528 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.452 ' HB2' HG22 ' A' ' 21' ' ' VAL . 16.5 m0 -92.03 -22.14 20.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.38 110.944 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.768 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.8 mm? -51.96 122.05 7.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.367 -0.379 . . . . 0.28 111.034 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p 39.94 57.24 2.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.025 -0.534 . . . . 0.22 111.365 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -104.75 -6.95 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.46 111.156 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.46 -22.21 8.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.35 112.647 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.49 108.38 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.5 110.858 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -56.83 97.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.42 111.119 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -88.7 -30.44 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.47 110.792 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 9.6 m -75.43 176.14 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.31 110.819 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -65.58 -55.61 16.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.33 111.015 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.5 32.55 4.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.9 110.845 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.27 31.63 81.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.738 -0.744 . . . . 0.21 112.5 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.429 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.28 -38.98 78.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 0.27 111.163 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.788 ' HB3' HG11 ' A' ' 21' ' ' VAL . 25.7 p-10 -61.24 -23.59 65.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.31 111.073 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -89.08 10.69 20.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.391 . . . . 0.27 111.338 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.75 164.66 22.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.738 0.304 . . . . 0.4 110.819 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.39 -24.37 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.37 111.031 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.19 -30.31 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.29 111.227 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.768 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -86.7 -20.38 27.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.26 111.559 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.56 30.69 5.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.23 112.478 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.6 t . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.35 110.87 179.868 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.624 0.25 . . . . 0.37 110.961 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.437 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 3.2 m -115.22 53.01 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.33 110.88 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.8 176.16 0.49 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.717 -0.754 . . . . 0.38 112.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.74 -25.27 20.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.848 2.366 . . . . 0.57 112.192 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.03 58.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.49 110.678 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 1.4 m -118.18 143.05 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.42 111.03 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.6 ' HB3' HD21 ' A' ' 26' ' ' LEU . 33.3 t80 -92.75 152.05 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.32 110.56 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -115.44 123.87 49.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 0.41 110.501 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.741 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.8 m -69.14 144.61 95.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.25 110.749 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 67.0 Cg_endo -73.56 147.3 40.51 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.783 2.322 . . . . 0.36 112.672 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.56 38.7 95.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.865 -0.683 . . . . 0.4 112.727 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.629 ' CG2' HG12 ' A' ' 19' ' ' VAL . 6.0 t -179.86 169.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.39 110.846 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.74 35.96 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 1.13 110.994 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.741 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -100.68 126.36 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.65 110.513 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.95 164.18 11.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.26 111.162 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.535 HG11 ' HB3' ' A' ' 38' ' ' ASP . 2.7 p -156.13 122.83 2.64 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.22 110.66 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.692 ' O ' HD23 ' A' ' 26' ' ' LEU . 31.5 Cg_exo -58.27 148.79 77.14 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.31 2.007 . . . . 0.23 112.023 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -30.58 31.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.895 0.379 . . . . 0.43 110.72 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HG2' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -69.05 -24.88 64.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.33 110.357 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.475 ' CD1' ' HG2' ' A' ' 24' ' ' ARG . 32.6 m0 -99.4 12.81 35.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.542 . . . . 0.38 111.007 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 22' ' ' PRO . 3.5 mm? -89.64 121.31 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.482 -0.326 . . . . 0.28 110.479 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 47.13 71.13 0.34 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.954 0.407 . . . . 0.22 110.571 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.12 17.51 4.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.46 111.356 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.76 -22.35 31.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.684 -0.769 . . . . 0.35 112.832 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.31 98.78 8.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.5 110.925 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 18.8 mtpt -59.12 99.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.42 111.001 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.88 -30.24 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.47 110.679 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -70.47 171.28 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.31 110.827 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.58 84.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.33 110.996 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.8 29.53 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.9 110.771 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.416 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 64.85 31.3 80.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.21 112.58 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.473 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.62 -36.06 73.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.27 111.067 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.664 ' HB2' HD13 ' A' ' 26' ' ' LEU . 2.0 p30 -62.94 -27.91 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.31 110.722 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.401 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 2.7 mt-10 -92.67 15.88 13.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.27 111.271 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.41 -171.91 2.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 0.4 110.972 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 45' ' ' CYS . 20.2 mm -69.92 -25.51 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.37 110.956 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.61 -29.93 19.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.29 111.359 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -92.52 -19.64 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.26 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.54 21.16 7.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.23 112.703 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.67 ' O ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.35 110.638 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.839 0.352 . . . . 0.37 110.942 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m 62.99 -165.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.33 110.886 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.64 -169.28 13.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.38 112.34 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 115.59 2.04 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.792 2.328 . . . . 0.57 111.888 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.4 t 64.62 55.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.004 0.43 . . . . 0.49 110.436 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 4.1 p -99.26 156.99 16.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.42 111.371 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.684 ' HB3' HD21 ' A' ' 26' ' ' LEU . 29.0 t80 -97.09 153.82 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.32 110.331 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 t -118.24 114.35 22.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.41 110.654 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 35.3 t -65.48 134.68 95.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.384 . . . . 0.25 110.962 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HG3' ' HB1' ' A' ' 42' ' ' ALA . 60.5 Cg_endo -71.42 125.23 11.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.643 2.229 . . . . 0.36 112.67 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.3 36.18 10.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.784 -0.722 . . . . 0.4 113.137 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.638 ' CG2' HG12 ' A' ' 19' ' ' VAL . 2.5 t 178.29 161.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.39 110.936 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.78 38.82 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 1.13 110.831 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.638 HG12 ' CG2' ' A' ' 17' ' ' THR . 5.1 p -112.82 126.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.65 110.665 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -119.49 154.07 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.26 111.188 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -141.47 136.27 15.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.22 110.899 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 35.9 Cg_endo -64.75 148.17 90.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.505 2.137 . . . . 0.23 112.294 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.603 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.6 tm-20 -50.81 -36.74 38.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.218 -0.446 . . . . 0.43 111.198 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.74 -24.44 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.366 . . . . 0.33 110.817 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -99.35 -17.71 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.38 111.135 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' A' ' 12' ' ' PHE . 3.6 mm? -53.19 121.07 6.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.28 111.104 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 54.7 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.747 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.97 -10.45 17.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.46 111.249 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.9 -22.76 9.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.749 -0.738 . . . . 0.35 112.541 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.76 108.66 19.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.5 110.857 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.474 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 8.9 mttt -58.1 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.42 111.022 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -66.43 -28.63 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.47 110.646 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 t -97.49 159.12 15.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.269 -0.423 . . . . 0.31 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.56 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 0.33 110.917 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.56 -2.35 20.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.9 111.207 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.474 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 70.67 31.69 67.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.844 -0.693 . . . . 0.21 113.033 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.601 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -54.89 -38.18 67.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.976 0.417 . . . . 0.27 110.64 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.637 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -58.87 -29.93 67.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.859 -0.61 . . . . 0.31 110.678 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.44 16.87 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.27 111.049 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.28 -165.87 1.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.861 0.363 . . . . 0.4 110.984 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.6 mp -77.2 -27.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.487 . . . . 0.37 111.079 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.483 ' HB1' ' HG3' ' A' ' 15' ' ' PRO . . . -51.98 -32.22 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 0.29 111.234 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -81.86 -23.1 36.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.26 111.223 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.6 5.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.716 -0.754 . . . . 0.23 112.664 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.35 110.93 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 7' ' ' CYS . 2.9 p . . . . . 0 CA--C 1.528 0.13 0 CA-C-O 120.522 0.201 . . . . 0.37 110.783 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.43 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -139.13 155.86 47.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.33 110.65 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.03 -169.24 41.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.38 112.472 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.82 -24.29 13.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.876 2.384 . . . . 0.57 112.293 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 72.84 1.43 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.49 110.819 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 3.0 m -144.31 178.57 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.42 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.473 ' HB3' HD21 ' A' ' 26' ' ' LEU . 26.1 t80 -130.85 151.95 50.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.32 110.653 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 2.0 t -116.06 127.84 55.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.41 110.622 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HB2' HG13 ' A' ' 19' ' ' VAL . 4.8 m -65.53 140.68 97.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.25 110.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.2 Cg_endo -72.38 149.44 50.62 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.632 2.221 . . . . 0.36 112.427 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.8 38.07 95.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.4 112.677 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.614 ' CG2' HG12 ' A' ' 19' ' ' VAL . 3.8 t -177.99 175.75 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.39 111.002 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 34.49 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.13 110.819 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.616 HG13 ' HB2' ' A' ' 14' ' ' CYS . 1.6 p -102.45 140.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.65 110.861 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 1.7 p -117.94 163.61 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.26 110.915 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.578 HG13 HD21 ' A' ' 26' ' ' LEU . 4.1 p -147.34 125.44 6.02 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.22 111.281 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.567 ' O ' HD23 ' A' ' 26' ' ' LEU . 27.6 Cg_exo -61.59 149.14 91.07 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.412 2.075 . . . . 0.23 111.871 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -51.12 -39.18 55.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.43 110.997 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -59.57 -29.17 67.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.33 110.444 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.425 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 35.2 m0 -87.96 -25.15 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.589 . . . . 0.38 110.778 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.782 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.3 mm? -54.64 113.31 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.28 111.025 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.01 62.01 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.22 110.612 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -107.14 -4.95 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.46 111.36 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.01 -28.98 6.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.35 112.386 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.44 177.34 5.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 0.5 110.552 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.435 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 9.1 mtpt -120.22 85.75 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.42 111.001 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.39 -31.66 60.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.47 110.761 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 3.7 m -70.9 178.26 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.31 110.866 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.83 -43.52 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.33 111.032 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -120.77 34.59 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.9 110.864 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 60.72 31.39 75.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 0.21 112.388 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.463 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.12 -43.42 78.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.27 111.24 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.679 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 29.7 p-10 -57.45 -31.85 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.31 110.788 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -95.02 18.6 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.27 111.076 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 -167.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.883 0.373 . . . . 0.4 110.977 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.9 mm -72.45 -29.62 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.37 111.005 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.38 -33.93 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.29 111.28 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.782 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -83.56 -23.82 31.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.26 111.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.81 42.35 4.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.753 . . . . 0.23 112.858 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.35 110.652 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.212 0 CA-C-O 120.44 0.162 . . . . 0.37 111.413 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 59.5 m -103.59 54.81 0.74 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.82 0.343 . . . . 0.33 111.084 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.54 -163.49 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.271 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.37 117.21 3.55 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.592 2.195 . . . . 0.57 111.975 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p 51.32 60.39 3.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.49 110.774 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 4.9 m -94.89 161.86 13.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.42 111.316 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 36.9 t80 -110.83 147.04 35.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.32 110.443 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 p -109.71 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.41 110.978 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.819 ' HB3' HG13 ' A' ' 19' ' ' VAL . 3.7 t -58.81 130.66 85.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.25 110.727 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 142.12 41.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.594 2.196 . . . . 0.36 112.428 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.0 -43.49 2.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 0.4 112.985 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.723 HG23 HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -117.61 169.83 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.39 111.106 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.9 41.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 1.13 110.948 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.819 HG13 ' HB3' ' A' ' 14' ' ' CYS . 2.7 p -105.42 113.58 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.65 110.632 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.21 163.09 22.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.878 -0.601 . . . . 0.26 111.401 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 26' ' ' LEU . 3.8 p -151.77 123.62 3.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.22 110.469 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.616 ' O ' HD23 ' A' ' 26' ' ' LEU . 61.4 Cg_endo -73.91 157.74 47.01 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.317 2.011 . . . . 0.23 112.081 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.5 tt0 -54.29 -30.93 52.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.43 110.965 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HG3' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -70.01 -23.23 63.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 0.33 110.495 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.522 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 32.2 m0 -100.53 8.3 43.57 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.261 -0.427 . . . . 0.38 110.824 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 43' ' ' ALA . 3.0 mm? -80.92 117.36 21.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.486 -0.325 . . . . 0.28 110.499 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 39' ' ' GLU . 28.1 p 40.81 72.2 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.0 -0.546 . . . . 0.22 111.287 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.15 5.03 9.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.46 111.234 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.82 -28.6 6.96 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.644 -0.789 . . . . 0.35 112.768 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -95.3 171.5 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.5 110.941 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -118.74 87.9 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.383 -0.371 . . . . 0.42 110.809 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -35.09 60.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.083 0.468 . . . . 0.47 110.165 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.2 t -87.18 143.81 27.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.672 -0.694 . . . . 0.31 110.45 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.29 -31.77 1.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.37 . . . . 0.33 111.584 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -120.22 26.22 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.9 111.003 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.451 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 54.58 28.79 46.51 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.919 -0.657 . . . . 0.21 112.866 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.73 -44.15 18.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.27 111.404 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB2' HD13 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -56.89 -28.63 62.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.429 . . . . 0.31 110.494 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 20.3 mm-40 -84.45 8.62 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.27 111.352 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.36 176.04 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.807 0.337 . . . . 0.4 110.8 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 1.3 mp -69.89 -19.18 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 0.37 110.975 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.17 -34.38 56.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.29 111.093 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 26' ' ' LEU . . . -87.29 -22.58 25.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.26 111.239 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.21 28.96 5.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.619 -0.8 . . . . 0.23 112.481 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 53.9 t . . . . . 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.328 . . . . 0.35 110.73 179.84 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.805 0.336 . . . . 0.37 110.911 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.419 ' HA ' ' CD ' ' A' ' 22' ' ' PRO . 23.7 p -174.72 -39.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.33 111.102 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.69 -160.08 11.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.636 -0.792 . . . . 0.38 112.633 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.98 150.17 74.48 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.811 2.341 . . . . 0.57 112.284 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m 61.24 41.93 12.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.49 110.746 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 p -83.09 168.8 16.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.501 . . . . 0.42 111.151 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.766 ' O ' HG12 ' A' ' 21' ' ' VAL . 43.1 t80 -137.65 133.12 33.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.32 110.406 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -94.7 149.61 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.41 110.753 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -88.88 138.58 29.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.25 111.169 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.82 132.7 51.43 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.264 . . . . 0.36 112.096 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.42 -44.47 2.44 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.751 -0.738 . . . . 0.4 112.517 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.616 HG23 HG13 ' A' ' 19' ' ' VAL . 2.0 t -108.7 177.65 4.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.39 110.607 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -117.35 48.05 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 1.13 111.054 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.616 HG13 HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -77.33 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.65 110.532 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.514 ' N ' HG23 ' A' ' 19' ' ' VAL . 3.7 t -147.59 119.35 8.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.26 111.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.2 p -122.33 136.92 26.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.22 110.631 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.498 ' HD2' HG23 ' A' ' 21' ' ' VAL . 66.4 Cg_endo -74.95 144.02 29.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.354 2.036 . . . . 0.23 111.601 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.561 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -47.44 -36.1 9.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.85 0.357 . . . . 0.43 110.923 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -30.14 70.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.33 110.344 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.45 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 30.4 m0 -87.35 -26.9 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.887 -0.597 . . . . 0.38 110.72 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.864 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.7 mm? -47.75 106.14 0.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.402 -0.363 . . . . 0.28 111.011 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 t 50.64 67.14 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 0.22 110.819 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.63 -4.23 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.58 . . . . 0.46 111.33 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.35 -27.59 6.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.35 112.559 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.18 144.64 31.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.5 110.715 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 16.1 mttp -83.55 92.25 7.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.42 111.065 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -29.72 21.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.107 0.479 . . . . 0.47 109.761 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -74.61 168.28 20.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.66 -0.7 . . . . 0.31 110.775 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.72 98.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.33 110.655 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.72 29.73 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.9 110.664 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 63.32 22.83 65.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.946 -0.645 . . . . 0.21 112.822 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -48.81 -45.02 39.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.894 0.378 . . . . 0.27 110.924 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.409 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 2.5 p30 -59.44 -22.35 61.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.31 110.806 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -94.83 17.75 13.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.454 -0.339 . . . . 0.27 111.194 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.39 -177.24 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.4 111.123 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 41' ' ' ILE . 2.3 mp -71.54 -27.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.37 110.666 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.31 -32.02 46.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.29 111.213 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.864 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.12 -14.64 33.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.023 -0.535 . . . . 0.26 111.517 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.5 24.12 5.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.23 112.729 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t . . . . . 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.35 110.887 179.898 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 p . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.873 0.368 . . . . 0.37 110.926 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 69.2 m 57.66 -84.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.33 110.992 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.12 179.76 0.43 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.662 -0.78 . . . . 0.38 112.576 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.54 136.46 57.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.768 2.312 . . . . 0.57 112.062 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 t 62.77 53.25 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.49 110.607 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 158.57 15.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.42 111.185 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 33.7 t80 -122.23 151.91 40.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.32 110.063 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.1 t -119.03 120.41 37.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.836 0.351 . . . . 0.41 110.757 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.693 ' SG ' HG13 ' A' ' 19' ' ' VAL . 6.0 m -64.78 138.62 97.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.25 110.657 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.1 Cg_endo -70.1 139.49 39.17 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.649 2.233 . . . . 0.36 112.537 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.34 38.46 70.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.799 -0.715 . . . . 0.4 112.746 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.567 ' CG2' HG12 ' A' ' 19' ' ' VAL . 3.5 t 179.37 174.26 0.78 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.39 111.035 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -114.21 43.78 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.13 110.747 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.693 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -111.42 130.88 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.65 110.928 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 3.2 p -109.69 163.52 13.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.353 -0.385 . . . . 0.26 110.859 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.672 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.6 p -151.23 125.15 4.39 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.22 110.78 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.532 ' O ' HD23 ' A' ' 26' ' ' LEU . 31.2 Cg_exo -58.79 148.86 81.27 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.298 1.999 . . . . 0.23 112.009 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -50.93 -38.66 51.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.872 0.367 . . . . 0.43 110.782 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -28.27 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.33 110.424 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.464 ' HB2' HG22 ' A' ' 21' ' ' VAL . 13.4 m0 -89.41 -24.47 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.38 110.824 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.656 ' CD2' HG13 ' A' ' 21' ' ' VAL . 4.1 mm? -52.89 120.92 6.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.28 110.802 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.2 p 38.96 57.33 1.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.123 -0.49 . . . . 0.22 111.372 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -104.22 -12.08 16.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.882 -0.599 . . . . 0.46 111.325 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.71 19.98 4.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.35 112.763 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -148.53 101.44 3.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.812 0.339 . . . . 0.5 110.635 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.408 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -55.29 95.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.42 111.192 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -91.78 -30.62 16.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.47 110.603 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.23 173.94 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.31 110.868 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.33 111.052 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -117.61 35.93 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.9 110.848 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.408 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 59.16 32.03 70.61 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.724 -0.751 . . . . 0.21 112.384 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.59 -39.8 81.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.27 111.32 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.672 ' HB3' HG11 ' A' ' 21' ' ' VAL . 3.0 p30 -60.33 -26.9 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.381 . . . . 0.31 111.072 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 3.2 mm-40 -92.97 13.21 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.27 111.258 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.63 169.91 14.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.801 0.334 . . . . 0.4 110.936 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.434 HD12 ' N ' ' A' ' 41' ' ' ILE . 2.4 mp -58.38 -23.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.37 110.773 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.62 -26.77 14.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.313 -0.403 . . . . 0.29 111.186 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.64 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -102.56 21.97 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.26 111.368 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.99 18.56 70.9 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.679 -0.772 . . . . 0.23 112.575 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.6 m . . . . . 0 C--N 1.33 -0.251 0 CA-C-O 120.916 0.388 . . . . 0.35 110.619 179.931 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.787 0.327 . . . . 0.37 110.898 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -97.11 -67.81 0.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.33 110.982 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.87 -175.26 2.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.654 -0.784 . . . . 0.38 112.369 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.05 124.43 15.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.697 2.265 . . . . 0.57 112.012 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t 62.03 83.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.49 110.866 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.23 159.18 36.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.42 110.93 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.506 ' HB3' HD21 ' A' ' 26' ' ' LEU . 25.5 t80 -110.17 152.23 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.32 110.572 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -111.97 133.13 54.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 0.41 110.735 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.87 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -79.72 137.45 54.61 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.25 111.003 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.3 124.12 14.51 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.681 2.254 . . . . 0.36 112.472 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.428 ' C ' HG22 ' A' ' 17' ' ' THR . . . 70.08 37.73 73.15 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.879 -0.677 . . . . 0.4 112.84 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.87 HG23 ' HB3' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 178.63 152.7 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 0.39 110.852 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -86.58 -3.77 59.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 1.13 111.509 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.8 HG12 ' OG1' ' A' ' 17' ' ' THR . 7.7 p -56.77 89.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.815 0.341 . . . . 0.65 111.074 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 p -82.73 162.71 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.26 111.034 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.909 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.5 p -150.21 129.23 6.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.22 111.066 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.592 ' O ' HD23 ' A' ' 26' ' ' LEU . 24.4 Cg_exo -63.03 151.9 82.3 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.403 2.069 . . . . 0.23 111.886 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.4 tt0 -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.43 110.801 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -59.76 -27.41 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.33 110.459 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' HG22 ' A' ' 21' ' ' VAL . 17.0 m0 -90.61 -25.24 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.895 -0.593 . . . . 0.38 110.917 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.61 ' CD2' HG13 ' A' ' 21' ' ' VAL . 3.9 mm? -50.62 122.3 7.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.28 110.935 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 p 39.12 61.59 1.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.039 -0.528 . . . . 0.22 111.285 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -108.19 -6.04 16.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.757 -0.656 . . . . 0.46 111.219 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.75 -26.18 7.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.35 112.589 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.77 103.92 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.5 110.81 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 25.8 mtpt -59.94 85.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.42 111.083 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -75.31 -30.84 60.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.47 110.637 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -69.0 170.89 9.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.001 -0.545 . . . . 0.31 110.862 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.29 71.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.33 110.742 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -120.73 28.41 7.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.9 110.811 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.434 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.8 28.22 71.37 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.822 -0.704 . . . . 0.21 112.739 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -55.4 -43.34 75.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.27 111.008 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.909 ' HB3' HG11 ' A' ' 21' ' ' VAL . 2.3 p30 -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.31 110.943 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.48 15.85 16.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 0.27 111.264 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.54 172.51 12.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.4 110.849 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.409 HD12 ' N ' ' A' ' 41' ' ' ILE . 1.6 mp -60.55 -21.89 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.37 110.811 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.29 -32.11 36.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.916 0.388 . . . . 0.29 111.094 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.568 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -88.58 -22.38 23.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 0.26 111.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.04 28.52 6.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.605 -0.807 . . . . 0.23 112.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.1 t . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.299 . . . . 0.35 110.546 179.823 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.1 p . . . . . 0 CA--C 1.531 0.217 0 CA-C-O 120.454 0.169 . . . . 0.37 111.28 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 2.8 m -109.43 75.16 0.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.788 0.328 . . . . 0.33 110.963 -179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.18 -160.54 1.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.675 -0.774 . . . . 0.38 112.354 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.87 122.83 12.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.613 2.209 . . . . 0.57 111.977 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t 61.05 58.88 2.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.49 110.484 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.21 145.73 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.42 111.311 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.446 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.0 t80 -107.44 151.88 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.32 110.345 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.414 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 2.0 t -107.5 126.7 52.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.21 -0.45 . . . . 0.41 110.761 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.778 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.5 m -74.99 142.26 75.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.25 110.866 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.7 Cg_endo -72.32 146.03 44.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.719 2.279 . . . . 0.36 112.498 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.33 35.49 91.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.4 112.593 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.56 ' CG2' HG12 ' A' ' 19' ' ' VAL . 2.0 t 179.81 174.59 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.39 110.814 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.49 30.75 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 1.13 110.95 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.778 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -93.72 133.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.65 110.681 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 p -109.92 164.25 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.26 111.016 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.595 HG13 HD21 ' A' ' 26' ' ' LEU . 4.8 p -152.76 134.19 8.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.22 110.836 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.544 ' O ' HD23 ' A' ' 26' ' ' LEU . 59.0 Cg_endo -72.23 148.96 50.68 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.264 1.976 . . . . 0.23 111.721 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -38.69 24.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.43 111.061 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -27.73 69.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.345 -0.388 . . . . 0.33 110.466 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.455 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 26.6 m0 -88.17 -25.29 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.38 110.677 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.804 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.1 mm? -53.82 122.16 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.268 -0.424 . . . . 0.28 110.873 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 37.17 55.21 1.3 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.053 0.454 . . . . 0.22 111.284 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -101.02 -13.57 18.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 0.46 111.124 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.21 18.95 4.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 0.35 112.784 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.48 108.65 3.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.5 110.643 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HE2' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -55.49 92.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.42 111.172 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.08 -30.92 18.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.47 110.67 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.3 -174.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.31 110.849 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.13 -50.01 21.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.33 110.932 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.4 33.48 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.9 110.79 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.411 ' CA ' ' HE2' ' A' ' 31' ' ' LYS . . . 65.14 27.9 72.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.694 -0.765 . . . . 0.21 112.555 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.55 -41.73 86.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.778 0.323 . . . . 0.27 111.174 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 39.3 p30 -54.97 -27.69 45.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.31 110.997 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.63 19.23 10.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.27 111.005 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.57 -164.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.4 110.888 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.9 mm -80.14 -28.19 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.37 111.12 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.32 -31.71 22.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.29 111.485 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.804 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -86.3 -19.79 29.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.26 111.401 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.71 21.03 8.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.636 -0.792 . . . . 0.23 112.776 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.464 . . . . 0.35 110.69 179.794 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.462 0.14 0 CA-C-O 120.662 0.268 . . . . 0.37 111.261 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.414 ' HB3' ' CB ' ' A' ' 11' ' ' SER . 33.5 m -111.76 -41.94 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.33 111.255 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.02 -174.6 2.45 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.62 -0.8 . . . . 0.38 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.56 140.97 94.01 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.745 2.296 . . . . 0.57 112.226 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 p 50.02 78.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.49 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 64.5 p -118.49 158.81 24.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.42 111.223 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.589 ' HB3' HD21 ' A' ' 26' ' ' LEU . 10.5 t80 -93.23 152.8 18.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.945 -0.57 . . . . 0.32 110.283 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -107.08 123.17 47.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.406 -0.361 . . . . 0.41 110.689 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 5.4 t -75.66 135.22 71.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.25 111.02 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.71 129.23 22.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.651 2.234 . . . . 0.36 112.525 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.0 -43.75 1.9 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.782 -0.723 . . . . 0.4 112.988 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.597 ' CG2' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.29 160.78 19.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 0.39 110.985 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -0.62 49.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 1.13 111.402 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.597 HG12 ' CG2' ' A' ' 17' ' ' THR . 6.9 p -63.19 133.01 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.757 0.313 . . . . 0.65 110.757 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -124.58 153.44 42.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.26 111.089 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 38' ' ' ASP . 2.8 p -132.1 139.81 36.14 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.22 111.141 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.602 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.3 Cg_exo -65.32 146.91 87.03 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.477 2.118 . . . . 0.23 111.959 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HA ' HD23 ' A' ' 26' ' ' LEU . 2.1 mt-10 -51.02 -40.95 59.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.928 0.394 . . . . 0.43 110.824 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -60.7 -27.37 67.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.33 110.599 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 31.1 m0 -90.46 -24.86 20.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.38 110.944 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.694 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.9 mm? -50.01 125.96 13.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.333 -0.394 . . . . 0.28 111.062 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 39.89 56.71 2.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.22 111.481 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -105.82 -6.37 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.46 111.165 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -20.66 9.49 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.75 . . . . 0.35 112.681 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -109.78 116.24 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.5 110.883 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HE2' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -65.42 90.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.42 110.978 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -66.1 -32.37 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.47 110.753 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.76 160.56 15.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.31 110.897 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.92 -28.37 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.33 111.053 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -104.79 -4.69 22.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.9 111.497 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' CA ' ' HE2' ' A' ' 31' ' ' LYS . . . 71.4 32.47 64.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.664 -0.779 . . . . 0.21 112.779 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -61.64 -39.6 91.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.27 110.822 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.808 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -60.58 -26.71 67.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.546 . . . . 0.31 110.996 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -89.3 9.17 27.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.27 111.375 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.07 175.88 8.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.858 0.361 . . . . 0.4 111.026 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.72 -22.71 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.37 111.015 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.64 -30.12 12.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.376 . . . . 0.29 111.397 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.694 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.02 -20.08 23.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.26 111.486 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.46 24.11 7.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.23 112.631 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.35 110.671 179.909 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.767 0.317 . . . . 0.37 110.759 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.6 m -102.95 -72.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.33 110.889 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -176.91 34.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.487 -0.863 . . . . 0.38 112.303 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.55 -22.19 73.87 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.57 112.481 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.2 p -128.33 101.93 6.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.49 111.077 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.48 176.87 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.42 111.074 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 17.1 t80 -125.93 152.01 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.32 110.452 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 12' ' ' PHE . 4.3 t -108.11 125.99 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.41 110.591 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.714 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.7 m -74.95 144.6 79.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.25 110.943 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 72.9 Cg_endo -74.87 144.76 31.12 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.633 2.222 . . . . 0.36 112.471 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.49 73.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.707 . . . . 0.4 112.648 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.598 ' CG2' HG12 ' A' ' 19' ' ' VAL . 1.3 t 179.77 167.81 1.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.348 . . . . 0.39 110.95 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.79 27.47 7.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.13 110.918 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.714 HG13 ' SG ' ' A' ' 14' ' ' CYS . 2.3 p -91.19 137.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.65 110.733 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 p -118.32 162.92 17.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.26 111.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' HB3' ' A' ' 38' ' ' ASP . 5.7 p -145.42 134.82 11.38 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.22 110.736 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.528 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.6 Cg_endo -71.0 148.14 56.41 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.391 2.061 . . . . 0.23 111.946 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.493 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.3 tt0 -48.16 -39.86 22.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.361 -0.381 . . . . 0.43 111.002 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -58.13 -29.47 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.33 110.555 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.441 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 33.9 m0 -92.34 -24.32 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 0.38 110.867 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.847 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.9 mm? -50.96 123.96 10.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.272 -0.422 . . . . 0.28 111.037 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 36.73 56.97 1.16 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.163 -0.471 . . . . 0.22 111.324 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -103.53 -13.81 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.615 . . . . 0.46 111.218 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.76 -23.99 7.27 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.35 112.535 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 118.7 37.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 0.5 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -62.9 107.6 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.42 111.074 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.33 -28.05 12.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.47 110.558 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.9 m -75.26 -179.69 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.858 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -65.7 -54.93 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.33 111.179 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.43 34.89 4.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.9 111.072 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.35 28.51 72.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.21 112.638 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.425 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -57.67 -42.44 83.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.727 0.299 . . . . 0.27 111.281 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.753 ' HB3' HG11 ' A' ' 21' ' ' VAL . 10.1 p30 -56.9 -21.64 31.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.31 111.188 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.49 11.45 17.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.27 111.502 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.33 173.06 10.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.763 0.316 . . . . 0.4 110.982 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.8 -23.24 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.37 110.882 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.78 -23.98 13.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.29 111.309 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.85 -0.2 57.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.26 111.844 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.48 -12.12 30.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.616 -0.802 . . . . 0.23 112.922 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-N 116.737 0.268 . . . . 0.35 110.335 179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.521 0.2 . . . . 0.37 110.765 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.84 -164.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.636 0.255 . . . . 0.33 110.431 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.53 177.25 25.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.38 112.62 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.62 -25.42 59.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.808 2.339 . . . . 0.57 112.245 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -129.02 48.03 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.49 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.24 141.01 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.42 110.858 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.639 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 38.8 t80 -91.23 137.37 32.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.32 110.417 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -105.21 128.19 53.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.161 -0.472 . . . . 0.41 110.845 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.748 ' SG ' HG13 ' A' ' 19' ' ' VAL . 17.8 m -57.66 140.61 80.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.25 110.774 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 35.6 Cg_endo -64.94 133.19 34.94 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.723 2.282 . . . . 0.36 112.48 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.54 31.73 44.79 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.819 -0.705 . . . . 0.4 112.562 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.553 HG21 ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -141.38 155.56 45.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.39 110.888 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -98.68 30.65 3.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 1.13 110.774 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.748 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -114.97 138.52 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 0.65 110.788 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -110.79 165.39 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.26 110.878 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.4 p -151.59 132.68 7.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.22 110.805 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.688 ' O ' HD23 ' A' ' 26' ' ' LEU . 70.4 Cg_endo -74.48 151.14 41.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.282 1.988 . . . . 0.23 111.907 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -29.12 16.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.43 110.848 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.02 -25.37 64.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.33 110.455 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.16 18.25 21.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.38 110.91 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 22' ' ' PRO . 3.6 mm? -94.42 114.32 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.28 110.867 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.27 60.41 3.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.22 110.798 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.82 11.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.46 111.369 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.8 -25.8 7.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 0.35 112.474 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.61 104.51 15.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.5 110.691 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.0 mtpt -57.54 96.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.42 111.086 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.17 -32.45 19.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.47 110.689 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -65.08 -176.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.31 110.651 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.553 ' CB ' HG21 ' A' ' 17' ' ' THR . . . -75.74 -46.0 33.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.406 . . . . 0.33 110.889 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.75 31.22 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.9 110.727 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.401 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 68.08 30.92 74.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.832 -0.699 . . . . 0.21 112.67 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.664 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -57.94 -43.81 86.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.27 111.008 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -56.59 -28.38 60.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.31 110.739 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.69 17.72 12.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.27 111.145 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.61 -169.69 2.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.825 0.345 . . . . 0.4 111.027 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.493 ' N ' HD12 ' A' ' 41' ' ' ILE . 1.5 mp -73.86 -26.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.37 110.827 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.62 9.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.29 111.401 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -100.71 13.49 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.26 111.594 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.5 66.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.744 -0.741 . . . . 0.23 113.05 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.35 110.726 179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.775 0.321 . . . . 0.37 110.769 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 16.1 m -100.21 -67.16 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 0.33 110.766 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.21 -176.92 9.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.63 -0.795 . . . . 0.38 112.483 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 -43.68 56.27 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.723 2.282 . . . . 0.57 112.122 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -103.29 95.57 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.49 110.782 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -145.42 147.42 32.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 0.42 111.107 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . 0.536 ' CD2' HD11 ' A' ' 26' ' ' LEU . 11.8 t80 -107.56 150.59 26.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.32 110.482 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -106.08 123.98 48.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.41 110.834 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -77.28 146.64 74.74 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.25 111.221 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.09 136.84 39.03 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.798 2.332 . . . . 0.36 112.598 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.51 88.97 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.857 -0.687 . . . . 0.4 112.806 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.658 ' OG1' HG12 ' A' ' 19' ' ' VAL . 1.5 t 179.61 153.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.39 111.017 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.69 2.65 54.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 1.13 111.342 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.855 HG13 ' HB2' ' A' ' 14' ' ' CYS . 2.5 p -57.44 123.17 8.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.859 0.361 . . . . 0.65 110.821 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 p -102.94 162.71 12.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.26 111.083 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 38' ' ' ASP . 3.2 p -154.96 133.93 7.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.22 110.649 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PRO . . . . . 0.483 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.5 Cg_endo -71.18 147.01 52.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.386 2.058 . . . . 0.23 111.984 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.491 ' HA ' HD23 ' A' ' 26' ' ' LEU . 2.2 tt0 -49.07 -39.13 26.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.354 . . . . 0.43 110.968 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -58.24 -29.47 65.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.983 0.42 . . . . 0.33 110.453 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' TRP . . . . . 0.415 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 28.1 m0 -88.86 -25.94 21.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.923 -0.58 . . . . 0.38 110.572 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.765 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.4 mm? -56.52 113.43 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.28 110.952 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.1 m 56.23 53.52 8.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.026 0.441 . . . . 0.22 110.941 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -105.73 -18.13 14.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.46 111.136 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.37 -15.57 9.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.803 -0.713 . . . . 0.35 112.655 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.08 107.32 17.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.744 0.307 . . . . 0.5 110.81 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -59.17 85.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.42 111.112 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.74 -26.32 60.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.47 110.449 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.2 t -83.76 164.48 19.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.31 111.011 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.29 82.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.33 110.773 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.58 18.07 12.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 0.9 111.04 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.469 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 66.42 25.83 72.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.21 112.947 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.871 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -51.6 -38.07 52.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.93 0.365 . . . . 0.27 110.89 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.59 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.2 p30 -60.72 -22.99 64.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.31 110.812 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.74 20.31 13.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.306 . . . . 0.27 111.22 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.11 -179.66 5.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.4 111.007 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.0 mp -61.22 -21.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.37 110.864 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.16 -35.31 35.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.29 111.14 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.765 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -84.71 -22.3 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.576 . . . . 0.26 111.152 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.66 39.4 2.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.23 112.63 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.35 111.064 -179.953 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.189 0 N-CA-C 112.503 -0.239 . . . . 1.84 112.503 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 60.89 73.68 0.47 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.844 0.354 . . . . 0.7 110.859 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -81.57 125.58 30.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.4 110.887 179.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 58.4 28.86 62.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.721 -0.752 . . . . 0.52 112.445 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 1.5 mmtp -82.16 -74.62 0.33 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.748 0.308 . . . . 0.5 110.919 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 5.5 p -61.65 128.14 34.83 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.271 -0.422 . . . . 0.37 111.055 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.414 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 51.99 67.74 0.92 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.058 -0.519 . . . . 0.33 111.094 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -72.65 -158.69 4.39 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.694 -0.765 . . . . 0.38 112.413 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -56.5 -41.5 75.42 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.607 2.204 . . . . 0.57 111.876 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -114.19 66.02 0.67 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.03 -0.532 . . . . 0.49 110.315 179.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 96.4 p -81.82 122.05 27.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.987 -0.551 . . . . 0.42 111.29 -179.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.711 ' HB3' HD21 ' A' ' 26' ' ' LEU . 48.8 t80 -98.15 144.33 27.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.32 110.153 179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 t -104.15 132.47 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.04 0.448 . . . . 0.41 111.254 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.0 t -74.86 131.08 79.84 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.815 -0.63 . . . . 0.25 110.422 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' O ' HG22 ' A' ' 17' ' ' THR . 19.6 Cg_endo -60.19 158.78 28.95 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.573 2.182 . . . . 0.36 112.274 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.57 21.86 58.35 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.731 -0.747 . . . . 0.4 112.59 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.67 HG23 HG13 ' A' ' 19' ' ' VAL . 6.2 t -179.32 168.93 1.48 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.687 0.28 . . . . 0.39 110.64 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 18.8 p80 -110.01 59.18 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.798 0.333 . . . . 1.13 111.66 -179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.67 HG13 HG23 ' A' ' 17' ' ' THR . 1.4 m -110.35 122.74 65.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.788 0.328 . . . . 0.65 110.198 179.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.78 161.75 18.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.938 0.399 . . . . 0.26 111.067 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.636 HG22 HD22 ' A' ' 26' ' ' LEU . 2.4 p -158.57 112.01 1.66 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.934 -0.576 . . . . 0.22 110.489 179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -54.53 144.7 61.82 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.259 1.973 . . . . 0.23 111.87 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.495 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -48.82 -32.07 8.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.382 . . . . 0.43 110.819 -179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 20.8 tpp85 -61.26 -31.05 70.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.33 110.457 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 13.6 m0 -89.85 -19.34 24.75 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.38 110.988 179.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.711 HD21 ' HB3' ' A' ' 12' ' ' PHE . 4.0 mm? -58.84 119.56 7.39 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.324 -0.398 . . . . 0.28 110.922 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.59 50.69 16.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.22 110.825 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 37.5 p-10 -104.59 -13.25 16.05 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.46 111.251 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.93 -26.31 7.21 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.816 -0.707 . . . . 0.35 112.555 -179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -94.6 98.47 10.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.847 0.356 . . . . 0.5 110.774 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 6.5 mtpt -57.35 88.86 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.189 -0.459 . . . . 0.42 111.15 -179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -76.74 -32.31 57.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.197 -0.456 . . . . 0.47 110.643 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.426 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 37.3 t -81.67 144.24 31.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.31 110.507 179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -46.75 -37.23 8.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.15 -0.477 . . . . 0.33 111.965 -179.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -115.75 29.35 8.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.684 0.278 . . . . 0.9 111.388 -179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 53.02 31.3 39.83 Favored Glycine 0 CA--C 1.518 0.245 0 C-N-CA 120.815 -0.707 . . . . 0.21 112.89 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.426 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -55.17 -47.26 75.44 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.872 0.367 . . . . 0.27 111.171 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.617 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 1.3 p30 -56.05 -28.07 55.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.145 -0.479 . . . . 0.31 110.941 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -95.73 11.31 33.94 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.234 -0.439 . . . . 0.27 111.379 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.51 178.01 6.78 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.872 0.368 . . . . 0.4 111.083 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.841 HD12 HD23 ' A' ' 46' ' ' LEU . 1.4 mm -60.92 -20.74 22.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.37 110.951 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -54.43 -31.73 55.93 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.924 0.392 . . . . 0.29 111.205 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -88.3 -20.49 25.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.04 -0.527 . . . . 0.26 111.243 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 109.48 28.08 4.45 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.699 -0.762 . . . . 0.23 112.656 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -96.44 66.24 2.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.017 0.437 . . . . 0.35 110.663 179.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.841 HD23 HD12 ' A' ' 41' ' ' ILE . 0.2 OUTLIER -83.48 -45.4 13.65 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.036 -0.529 . . . . 0.91 110.893 -179.749 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.406 ' O ' ' CG ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -53.32 119.89 5.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.48 111.159 -179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.05 -76.69 0.18 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.172 -0.467 . . . . 0.87 110.816 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 53.59 99.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.248 -0.433 . . . . 1.33 111.177 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.1 m . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.254 -0.879 . . . . 0.96 110.909 179.946 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.556 -0.218 . . . . 1.84 112.556 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 66.2 m -129.19 109.75 11.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.826 0.346 . . . . 0.7 110.808 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.2 61.5 4.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 0.4 110.89 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -140.74 27.57 2.46 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.68 -0.771 . . . . 0.52 112.535 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.68 -83.74 0.09 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.598 0.237 . . . . 0.5 110.956 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER 51.09 -91.17 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.601 -0.272 . . . . 0.37 111.212 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -124.95 20.07 8.37 Favored 'General case' 0 C--O 1.231 0.127 0 CA-C-O 120.708 0.289 . . . . 0.33 110.876 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -60.11 -168.75 0.38 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.759 -0.734 . . . . 0.38 112.421 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_endo -49.6 137.28 33.43 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.771 2.314 . . . . 0.57 112.021 179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 8.2 t 71.44 29.35 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.244 -0.435 . . . . 0.49 110.945 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.2 m -102.22 154.23 19.22 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.358 -0.383 . . . . 0.42 110.822 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.508 ' HB3' HD21 ' A' ' 26' ' ' LEU . 34.7 t80 -115.83 151.82 34.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.149 -0.478 . . . . 0.32 110.727 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.5 t -118.05 121.03 39.55 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.035 -0.53 . . . . 0.41 110.41 179.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.761 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.4 m -60.93 143.78 91.26 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.298 -0.41 . . . . 0.25 110.636 -179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 70.5 Cg_endo -74.43 136.68 22.03 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.644 2.229 . . . . 0.36 112.537 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.56 -42.06 2.71 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.756 -0.735 . . . . 0.4 112.771 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.648 HG21 ' HB2' ' A' ' 34' ' ' ALA . 0.0 OUTLIER -112.58 170.24 8.32 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.853 0.359 . . . . 0.39 110.844 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -98.77 28.32 4.37 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 1.13 111.403 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.761 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.4 p -89.52 131.63 36.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.442 -0.345 . . . . 0.65 110.59 179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -108.58 164.66 12.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.26 111.108 -179.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.827 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.6 p -153.08 125.08 3.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.983 -0.553 . . . . 0.22 110.8 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.611 ' O ' HD23 ' A' ' 26' ' ' LEU . 34.0 Cg_exo -59.38 150.19 76.56 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.409 2.073 . . . . 0.23 112.069 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.452 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -51.56 -39.76 58.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.262 -0.426 . . . . 0.43 110.897 179.85 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -62.46 -27.68 69.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.334 -0.394 . . . . 0.33 110.393 179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.421 ' HB2' HG22 ' A' ' 21' ' ' VAL . 24.1 m0 -87.61 -24.36 23.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.015 -0.539 . . . . 0.38 110.732 179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.627 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.0 mm? -53.04 125.65 18.0 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.224 -0.444 . . . . 0.28 110.746 179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 38.63 58.04 1.72 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 121.025 0.44 . . . . 0.22 111.327 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -105.34 -7.76 18.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.939 -0.573 . . . . 0.46 111.241 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -23.76 8.36 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.803 -0.713 . . . . 0.35 112.624 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 10.7 m-20 -106.37 109.97 22.05 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.79 0.329 . . . . 0.5 110.914 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.7 mtpt -61.02 88.33 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.275 -0.42 . . . . 0.42 110.975 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -80.96 -30.06 35.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 0.47 110.866 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.7 m -71.93 175.01 6.21 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.093 -0.503 . . . . 0.31 110.905 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -66.6 -52.01 50.08 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 0.33 110.931 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 14.9 p-10 -114.0 32.17 6.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.028 -0.533 . . . . 0.9 110.851 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.422 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.65 30.2 76.04 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.748 -0.739 . . . . 0.21 112.489 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.445 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.39 -39.28 79.23 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.27 111.316 -179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.827 ' HB3' HG11 ' A' ' 21' ' ' VAL . 5.0 p30 -63.2 -23.47 67.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.284 -0.416 . . . . 0.31 111.034 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -92.97 13.94 19.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.415 -0.357 . . . . 0.27 111.237 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.89 -176.23 3.86 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.861 0.363 . . . . 0.4 111.047 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.749 HD11 ' O ' ' A' ' 47' ' ' TYR . 46.7 mm -71.43 -25.78 25.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.114 -0.494 . . . . 0.37 110.979 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.64 -26.39 8.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.425 . . . . 0.29 111.451 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.627 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -94.74 -4.47 47.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.226 -0.443 . . . . 0.26 111.913 -179.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 78.02 35.61 34.27 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.579 -0.82 . . . . 0.23 112.517 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 51.9 t -67.36 -25.52 66.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.35 110.713 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.414 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.5 OUTLIER 69.22 65.31 0.27 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.191 -0.458 . . . . 0.91 111.174 179.592 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.749 ' O ' HD11 ' A' ' 41' ' ' ILE . 31.9 m-85 -149.68 115.39 5.6 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.024 -0.535 . . . . 0.48 110.69 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -57.22 -61.22 2.62 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.268 -0.423 . . . . 0.87 111.044 -179.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.475 ' O ' HG23 ' A' ' 50' ' ' THR . 0.2 OUTLIER -162.77 152.13 15.38 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.442 . . . . 1.33 110.926 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.475 HG23 ' O ' ' A' ' 49' ' ' SER . 20.0 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.222 -0.894 . . . . 0.96 110.912 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.536 -0.226 . . . . 1.84 112.536 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.25 -74.82 0.6 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.77 0.319 . . . . 0.7 110.831 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -160.66 29.83 0.15 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.233 -0.44 . . . . 0.4 110.926 179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 125.83 62.56 0.16 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.71 -0.757 . . . . 0.52 112.645 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.03 -60.87 1.46 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.819 0.342 . . . . 0.5 110.758 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.446 ' O ' ' HD3' ' A' ' 22' ' ' PRO . 0.0 OUTLIER -66.81 -53.74 29.67 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.37 110.695 179.761 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.4 m -151.54 69.19 0.92 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.949 -0.569 . . . . 0.33 110.662 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.02 -160.48 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.923 -0.656 . . . . 0.38 112.713 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.58 138.41 83.4 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.766 2.311 . . . . 0.57 112.239 179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.4 p 60.02 46.8 10.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.49 110.932 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.39 140.8 34.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.42 110.822 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.506 ' HB3' HD21 ' A' ' 26' ' ' LEU . 23.7 t80 -90.58 152.93 20.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.162 -0.472 . . . . 0.32 110.269 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.7 t -111.01 125.56 53.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.286 -0.415 . . . . 0.41 110.885 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.632 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.4 m -71.55 140.98 84.81 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.225 -0.443 . . . . 0.25 110.677 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.6 Cg_endo -77.34 136.37 15.83 Favored 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 122.649 2.233 . . . . 0.36 112.465 -179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 78.78 31.49 44.14 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.703 -0.761 . . . . 0.4 112.615 179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.857 HG21 ' HB2' ' A' ' 34' ' ' ALA . 1.7 t 179.4 163.33 0.92 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 0.39 110.868 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -98.35 40.12 1.2 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 1.13 110.954 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.632 HG13 ' SG ' ' A' ' 14' ' ' CYS . 2.4 p -111.26 135.56 50.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.146 -0.479 . . . . 0.65 110.748 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 2.0 p -122.58 156.5 34.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.277 -0.42 . . . . 0.26 110.982 179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.863 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.1 p -134.53 133.63 21.64 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.13 -0.486 . . . . 0.22 111.152 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.683 ' O ' HD23 ' A' ' 26' ' ' LEU . 22.7 Cg_exo -63.31 150.54 88.28 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.461 2.108 . . . . 0.23 112.062 179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.41 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -52.9 -31.36 39.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.885 0.374 . . . . 0.43 110.77 179.824 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 26.8 ttm180 -70.08 -28.15 65.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.33 110.343 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.465 ' HB2' ' HD2' ' A' ' 22' ' ' PRO . 24.3 m0 -95.21 4.91 53.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 0.38 111.142 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.74 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.1 mm? -76.58 118.54 19.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.28 110.938 -179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 7.5 p 39.29 69.16 0.3 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 115.868 -0.605 . . . . 0.22 111.751 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' OD2' ' HA ' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -116.76 -13.68 10.76 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.084 -0.507 . . . . 0.46 111.174 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.54 32.7 1.19 Allowed Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.582 -0.818 . . . . 0.35 112.779 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -157.54 91.89 1.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.777 0.322 . . . . 0.5 110.752 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 10.1 mtpt -53.14 92.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.38 -0.373 . . . . 0.42 111.308 -179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.92 -30.85 15.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.08 -0.509 . . . . 0.47 110.531 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.3 m -65.22 -174.91 0.19 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.73 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.857 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -71.41 -55.51 7.8 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.3 -0.409 . . . . 0.33 110.973 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -116.91 38.61 3.45 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.158 -0.474 . . . . 0.9 110.732 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.85 31.33 80.02 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.772 -0.728 . . . . 0.21 112.425 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.458 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.0 -47.81 77.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.809 0.338 . . . . 0.27 111.155 -179.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.863 ' HB3' HG11 ' A' ' 21' ' ' VAL . 20.1 p-10 -57.86 -27.44 63.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.31 110.809 179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -88.08 8.12 28.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.177 -0.465 . . . . 0.27 111.433 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -129.9 170.84 13.41 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.817 0.341 . . . . 0.4 111.085 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.498 HD11 ' O ' ' A' ' 48' ' ' ASN . 1.9 mp -60.03 -23.87 28.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.229 -0.441 . . . . 0.37 110.733 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.3 -27.89 6.91 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.932 0.396 . . . . 0.29 111.27 179.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.74 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -91.05 -19.79 22.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.991 -0.549 . . . . 0.26 111.483 -179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.66 12.45 12.92 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.676 -0.773 . . . . 0.23 113.115 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 2.7 t -63.43 -32.42 73.86 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.036 0.446 . . . . 0.35 110.344 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 5.8 mt 66.81 -83.4 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.793 -0.639 . . . . 0.91 112.549 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.467 ' CG ' ' O ' ' A' ' 47' ' ' TYR . 24.9 p90 -47.03 106.24 0.08 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.018 0.437 . . . . 0.48 112.093 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.498 ' O ' HD11 ' A' ' 41' ' ' ILE . 15.0 m-20 29.13 -91.51 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.389 0 CA-C-N 115.421 -0.809 . . . . 0.87 112.567 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 57.4 m 57.43 26.16 12.23 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.795 0.331 . . . . 1.33 110.987 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.261 -0.876 . . . . 0.96 110.998 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.219 0 N-CA-C 112.51 -0.236 . . . . 1.84 112.51 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -164.69 79.79 0.36 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.811 0.339 . . . . 0.7 110.825 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 60.18 30.04 19.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.215 -0.448 . . . . 0.4 110.919 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 67.41 82.27 0.15 Allowed Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.728 -0.749 . . . . 0.52 112.518 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -107.5 35.97 2.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.782 0.325 . . . . 0.5 110.909 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -92.03 -38.8 12.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.37 110.951 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.9 m -151.38 74.91 1.15 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.254 -0.43 . . . . 0.33 110.972 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -59.23 -163.77 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.778 -0.725 . . . . 0.38 112.45 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.82 -23.78 43.73 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.733 2.288 . . . . 0.57 112.246 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.3 p -123.91 83.05 2.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.261 -0.427 . . . . 0.49 110.744 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -107.67 132.7 53.05 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.256 -0.429 . . . . 0.42 111.04 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.524 ' HB3' HD21 ' A' ' 26' ' ' LEU . 24.6 t80 -103.56 150.81 23.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.036 -0.529 . . . . 0.32 110.479 179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 35.0 t -112.64 128.04 56.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.148 -0.478 . . . . 0.41 110.777 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.676 ' SG ' HG13 ' A' ' 19' ' ' VAL . 4.8 m -69.28 136.14 88.94 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.298 -0.41 . . . . 0.25 110.559 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.3 Cg_endo -69.88 139.39 39.69 Favored 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.662 2.241 . . . . 0.36 112.56 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.87 -42.32 2.66 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.756 -0.735 . . . . 0.4 112.746 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.536 HG23 HG12 ' A' ' 19' ' ' VAL . 1.3 t -112.62 171.66 7.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.782 0.325 . . . . 0.39 111.013 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 3.1 m-70 -104.52 54.53 0.72 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.255 -0.429 . . . . 1.13 111.29 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.676 HG13 ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -113.35 142.93 24.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.967 0.413 . . . . 0.65 110.696 179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 1.1 t -112.72 154.07 26.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 0.26 110.894 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 HD22 ' A' ' 26' ' ' LEU . 2.5 p -145.03 131.14 9.67 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 115.886 -0.597 . . . . 0.22 110.691 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.49 ' C ' HD23 ' A' ' 26' ' ' LEU . 57.5 Cg_endo -71.77 146.83 49.2 Favored 'Trans proline' 0 C--N 1.346 0.396 0 C-N-CA 122.281 1.987 . . . . 0.23 111.978 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.541 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.2 tt0 -48.0 -38.11 16.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.379 -0.373 . . . . 0.43 111.148 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -58.66 -27.81 65.12 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.277 -0.42 . . . . 0.33 110.706 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 31.0 m0 -96.07 -19.92 19.06 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.019 -0.537 . . . . 0.38 111.109 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.861 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.0 mm? -53.84 123.06 11.34 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.517 -0.31 . . . . 0.28 110.909 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.5 p 36.92 58.49 1.13 Allowed 'General case' 0 N--CA 1.467 0.395 0 CA-C-N 116.089 -0.505 . . . . 0.22 111.403 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.3 p-10 -104.25 -9.39 18.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.851 -0.613 . . . . 0.46 111.208 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.88 -25.05 7.69 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.764 -0.731 . . . . 0.35 112.53 -179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -104.0 121.89 44.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.84 0.352 . . . . 0.5 110.714 179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.487 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -60.12 84.15 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.42 111.103 -179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -79.63 -30.34 41.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.965 0.412 . . . . 0.47 110.24 179.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -77.05 156.57 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.846 -0.615 . . . . 0.31 110.374 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.526 ' HB3' HG21 ' A' ' 17' ' ' THR . . . -56.13 -34.67 66.32 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.947 0.403 . . . . 0.33 110.773 179.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -124.05 28.82 6.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.915 -0.584 . . . . 0.9 110.813 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.487 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.83 22.64 48.28 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.817 -0.706 . . . . 0.21 112.656 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.471 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -52.01 -42.67 63.19 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.841 0.353 . . . . 0.27 111.093 -179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.698 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 3.4 p30 -57.83 -22.49 47.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.119 -0.491 . . . . 0.31 110.796 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -89.13 11.12 19.48 Favored 'General case' 0 CA--C 1.529 0.167 0 CA-C-N 116.278 -0.419 . . . . 0.27 111.153 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.11 -165.91 1.6 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.857 0.361 . . . . 0.4 111.051 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.557 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.1 mp -76.12 -23.34 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.123 -0.49 . . . . 0.37 110.937 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.76 -33.31 15.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.914 0.387 . . . . 0.29 111.332 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.861 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -83.67 -24.25 31.41 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.041 -0.527 . . . . 0.26 111.087 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.94 25.32 6.85 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.689 -0.767 . . . . 0.23 112.801 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -79.67 -52.59 7.78 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.846 0.355 . . . . 0.35 110.636 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 54.8 77.06 0.22 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.044 -0.526 . . . . 0.91 111.307 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 47' ' ' TYR . 0.1 OUTLIER -174.03 36.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.298 -0.41 . . . . 0.48 110.972 179.675 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -167.35 136.46 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.87 110.917 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 68.98 10.84 8.13 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.12 -0.491 . . . . 1.33 111.461 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 70.5 p . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.238 -0.887 . . . . 0.96 111.376 179.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.158 0 N-CA-C 112.478 -0.249 . . . . 1.84 112.478 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.4 t -140.89 67.4 1.35 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.88 0.372 . . . . 0.7 110.853 -179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -176.42 -43.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.149 -0.478 . . . . 0.4 110.788 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.75 41.63 2.1 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.837 -0.697 . . . . 0.52 112.416 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -72.75 -16.85 61.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.58 0.228 . . . . 0.5 111.312 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.2 p -50.27 130.92 23.76 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.922 0.391 . . . . 0.37 111.131 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.453 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 13.5 m 53.92 -169.04 0.06 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.039 -0.528 . . . . 0.33 110.854 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.66 -167.34 13.04 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.644 -0.788 . . . . 0.38 112.53 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -51.71 -47.07 28.13 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.859 2.372 . . . . 0.57 112.189 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -97.28 55.52 1.29 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.49 110.708 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.453 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 84.1 p -124.03 147.16 48.05 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.072 -0.513 . . . . 0.42 111.11 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.491 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.7 t80 -112.66 149.55 32.7 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.117 -0.492 . . . . 0.32 110.261 179.362 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.3 t -111.81 110.95 21.58 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.281 -0.418 . . . . 0.41 110.738 179.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.779 ' HB2' HG13 ' A' ' 19' ' ' VAL . 2.2 m -56.64 148.89 43.93 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.989 -0.55 . . . . 0.25 111.093 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -68.08 131.6 24.12 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.706 2.271 . . . . 0.36 112.397 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 63.31 38.55 96.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.734 -0.746 . . . . 0.4 112.669 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.845 ' OG1' HG12 ' A' ' 19' ' ' VAL . 2.1 t -174.92 156.51 2.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.829 0.347 . . . . 0.39 110.999 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -92.52 -5.77 51.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.139 -0.482 . . . . 1.13 111.323 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.845 HG12 ' OG1' ' A' ' 17' ' ' THR . 2.3 p -55.22 115.01 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.194 0 CA-C-O 120.781 0.324 . . . . 0.65 110.971 179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 1.2 p -97.02 163.98 12.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.434 . . . . 0.26 110.755 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.546 HG13 HD21 ' A' ' 26' ' ' LEU . 5.4 p -156.35 123.99 2.78 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.205 -0.452 . . . . 0.22 110.974 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.549 ' O ' HD23 ' A' ' 26' ' ' LEU . 33.6 Cg_exo -58.96 148.66 83.75 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.374 2.049 . . . . 0.23 112.141 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.521 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -51.4 -38.14 51.9 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.365 -0.38 . . . . 0.43 110.841 179.895 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 18.1 ttt180 -58.56 -27.95 65.05 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.987 0.423 . . . . 0.33 110.53 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.44 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 21.3 m0 -91.67 -24.75 19.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.906 -0.588 . . . . 0.38 110.841 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.837 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.2 mm? -53.52 122.73 10.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.269 -0.423 . . . . 0.28 110.822 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 p 38.03 59.36 1.38 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-N 116.148 -0.478 . . . . 0.22 111.26 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -103.09 -14.14 16.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.765 -0.652 . . . . 0.46 111.216 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.52 22.45 4.05 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.757 -0.735 . . . . 0.35 112.751 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -148.28 113.82 5.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.745 0.307 . . . . 0.5 110.582 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 1.7 mttt -62.42 83.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.242 -0.436 . . . . 0.42 111.124 -179.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -79.39 -28.76 41.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.104 0.478 . . . . 0.47 110.179 179.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.549 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 8.6 t -79.23 162.68 25.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.68 -0.691 . . . . 0.31 110.737 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.27 -37.88 78.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.345 -0.389 . . . . 0.33 110.712 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -122.09 29.18 7.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.984 -0.553 . . . . 0.9 110.813 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 58.81 23.77 56.54 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.797 -0.716 . . . . 0.21 112.788 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.549 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -48.54 -44.17 36.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.795 0.331 . . . . 0.27 111.317 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.497 ' HB3' HG11 ' A' ' 21' ' ' VAL . 3.8 p30 -59.95 -23.05 63.26 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.31 111.045 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -91.59 13.92 16.52 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.481 -0.327 . . . . 0.27 111.347 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.73 171.33 12.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.818 0.342 . . . . 0.4 110.919 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.46 HD12 ' N ' ' A' ' 41' ' ' ILE . 1.3 mp -61.09 -25.23 35.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.153 -0.476 . . . . 0.37 110.625 179.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.88 -25.21 10.96 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.29 111.23 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.837 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -94.33 14.49 20.27 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.149 -0.478 . . . . 0.26 111.549 -179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.6 -10.72 73.6 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.627 -0.797 . . . . 0.23 112.635 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.86 164.5 17.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.654 0.264 . . . . 0.35 110.295 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.1 mt -141.49 -59.23 0.48 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.472 -0.331 . . . . 0.91 110.964 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.463 ' CG ' ' O ' ' A' ' 47' ' ' TYR . 23.1 p90 -53.47 93.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.099 0.476 . . . . 0.48 110.934 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -90.45 -179.83 5.68 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.498 . . . . 0.87 110.971 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.5 m -122.95 -43.99 2.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.083 -0.508 . . . . 1.33 110.863 179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.24 -0.886 . . . . 0.96 110.903 180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.193 0 N-CA-C 112.444 -0.262 . . . . 1.84 112.444 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 m -173.64 -67.51 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.84 0.352 . . . . 0.7 110.905 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 58.4 mm-40 60.2 108.95 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.4 110.88 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 108.42 -154.18 16.59 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.703 -0.761 . . . . 0.52 112.509 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.494 ' C ' ' HG1' ' A' ' 6' ' ' THR . 0.2 OUTLIER 66.04 -76.05 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.606 0.241 . . . . 0.5 110.982 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.494 ' HG1' ' C ' ' A' ' 5' ' ' LYS . 12.2 p 51.98 -85.86 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.179 -0.464 . . . . 0.37 111.247 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.447 ' N ' ' O ' ' A' ' 5' ' ' LYS . 9.6 m -115.57 69.18 0.72 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.868 0.366 . . . . 0.33 110.778 179.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.33 -164.72 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.792 -0.718 . . . . 0.38 112.449 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.6 -24.18 21.93 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.744 2.296 . . . . 0.57 112.159 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 2.7 p -137.39 88.55 2.35 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.133 -0.485 . . . . 0.49 110.746 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 26.7 p -105.59 160.46 15.17 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.248 -0.433 . . . . 0.42 111.068 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.76 ' CD2' HD11 ' A' ' 26' ' ' LEU . 37.7 t80 -132.37 137.09 47.24 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.955 -0.566 . . . . 0.32 110.472 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.6 p -106.54 117.43 34.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.159 -0.473 . . . . 0.41 110.803 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.634 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -49.02 139.16 12.64 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.044 -0.525 . . . . 0.25 111.126 -179.897 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.78 133.5 45.23 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.71 2.273 . . . . 0.36 112.092 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 56.73 24.36 48.01 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.647 -0.787 . . . . 0.4 112.257 -179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.618 ' HB ' HG12 ' A' ' 19' ' ' VAL . 0.3 OUTLIER -141.17 146.42 36.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.39 110.815 -179.649 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -91.13 1.13 57.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.13 111.358 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 17' ' ' THR . 2.3 p -61.37 156.69 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 120.805 0.336 . . . . 0.65 110.936 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.411 ' N ' HG22 ' A' ' 19' ' ' VAL . 1.4 t -122.52 156.04 34.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.26 111.045 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.714 HG22 HD22 ' A' ' 26' ' ' LEU . 2.8 p -159.58 118.44 1.65 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 0.22 110.996 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.442 ' C ' HD23 ' A' ' 26' ' ' LEU . 32.0 Cg_exo -60.94 145.19 99.43 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.35 2.033 . . . . 0.23 111.803 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.578 ' HA ' HD23 ' A' ' 26' ' ' LEU . 5.5 tt0 -47.32 -35.19 7.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.462 -0.335 . . . . 0.43 111.251 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 7.9 ttp85 -59.53 -32.16 70.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.991 0.424 . . . . 0.33 110.495 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.41 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 23.0 m0 -88.36 -21.01 24.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.868 -0.606 . . . . 0.38 110.941 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.027 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.3 mm? -59.54 113.32 2.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.296 -0.411 . . . . 0.28 110.971 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 45' ' ' CYS . 51.9 t 48.19 56.27 7.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.152 -0.476 . . . . 0.22 110.941 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.31 -14.72 15.68 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.872 -0.604 . . . . 0.46 111.25 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.55 29.18 1.95 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.665 -0.778 . . . . 0.35 112.651 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.39 117.33 4.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.677 0.275 . . . . 0.5 110.662 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.444 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 2.6 mttp -62.38 81.77 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.353 -0.385 . . . . 0.42 111.026 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -81.83 -25.97 34.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.06 0.457 . . . . 0.47 110.106 179.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.5 OUTLIER -80.02 167.33 20.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.746 -0.661 . . . . 0.31 110.648 179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -63.94 -37.46 87.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.028 0.442 . . . . 0.33 110.162 179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -124.4 33.93 5.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.733 -0.667 . . . . 0.9 110.483 179.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.444 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 56.67 23.89 45.72 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.916 -0.659 . . . . 0.21 112.804 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.634 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -49.72 -44.41 48.26 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.822 0.344 . . . . 0.27 111.051 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.547 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 30.4 p-10 -59.03 -23.66 62.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.31 110.755 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -90.93 12.53 19.26 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.258 -0.428 . . . . 0.27 111.361 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.9 170.9 12.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.785 0.326 . . . . 0.4 110.909 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 41' ' ' ILE . 3.1 mp -58.97 -22.43 21.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.194 -0.457 . . . . 0.37 110.906 179.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.72 -34.4 52.38 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.976 0.417 . . . . 0.29 111.079 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.027 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -85.9 -21.99 27.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.962 -0.563 . . . . 0.26 111.164 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.27 29.57 3.67 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.684 -0.769 . . . . 0.23 112.719 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.412 ' HB2' ' HB2' ' A' ' 27' ' ' CYS . 50.4 t -79.37 -29.76 42.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.83 0.347 . . . . 0.35 110.867 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 71.75 -67.26 0.27 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.183 -0.462 . . . . 0.91 111.219 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.4 ' CD2' ' O ' ' A' ' 48' ' ' ASN . 2.4 p90 -83.95 176.32 8.95 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.427 -0.352 . . . . 0.48 111.098 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.4 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 7.4 p-10 -102.78 150.29 23.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.87 110.89 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 8.1 t -149.3 31.55 0.75 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 1.33 110.86 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.268 -0.872 . . . . 0.96 110.896 -179.979 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.455 -0.258 . . . . 1.84 112.455 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -114.85 -73.43 0.65 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.7 110.741 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.401 ' O ' ' N ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -110.44 -161.07 0.74 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.076 -0.511 . . . . 0.4 110.446 179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -64.05 78.46 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.575 -0.821 . . . . 0.52 112.225 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.401 ' N ' ' O ' ' A' ' 3' ' ' GLU . 0.5 OUTLIER -82.55 1.31 38.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.538 0.208 . . . . 0.5 111.431 -179.774 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -59.0 -75.02 0.06 Allowed 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.739 0.304 . . . . 0.37 110.71 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 64.8 m -106.44 -67.12 0.96 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.229 -0.442 . . . . 0.33 110.775 179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 77.15 -178.44 51.39 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.455 -179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -55.69 -44.55 46.88 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.803 2.336 . . . . 0.57 112.159 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 10.3 m -111.8 90.68 3.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.124 -0.489 . . . . 0.49 110.714 179.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.405 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -129.76 163.76 25.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.42 111.169 -179.848 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 7.4 t80 -118.08 152.47 35.51 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.32 110.302 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.2 t -108.67 111.85 23.86 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.182 -0.463 . . . . 0.41 110.465 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.605 ' HB2' HG13 ' A' ' 19' ' ' VAL . 1.9 m -59.61 149.35 71.35 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.475 . . . . 0.25 111.168 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 97.8 Cg_endo -78.09 132.8 11.82 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.815 2.343 . . . . 0.36 112.592 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.37 39.19 97.44 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.899 -0.667 . . . . 0.4 112.972 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.535 ' OG1' HG12 ' A' ' 19' ' ' VAL . 2.8 t -176.59 156.37 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.872 0.368 . . . . 0.39 111.011 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.69 49.86 0.89 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 1.13 110.881 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.605 HG13 ' HB2' ' A' ' 14' ' ' CYS . 2.3 p -119.43 113.13 40.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.985 -0.552 . . . . 0.65 110.53 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 13.8 p -96.92 164.24 12.62 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.26 111.351 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.896 HG11 ' HB3' ' A' ' 38' ' ' ASP . 6.5 p -152.12 130.55 6.27 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.992 -0.549 . . . . 0.22 110.848 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.631 ' O ' HD23 ' A' ' 26' ' ' LEU . 37.0 Cg_exo -59.01 148.14 86.66 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.244 1.963 . . . . 0.23 111.872 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.439 ' O ' ' HB2' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -52.1 -42.98 63.69 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.818 0.342 . . . . 0.43 110.863 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.43 -22.94 66.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.874 0.369 . . . . 0.33 110.445 179.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.462 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 24.9 m0 -87.96 -30.91 19.68 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.166 -0.47 . . . . 0.38 110.477 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.719 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.6 mm? -45.58 121.41 3.04 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.034 -0.53 . . . . 0.28 111.015 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 5.9 p 39.31 60.36 1.54 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.133 -0.485 . . . . 0.22 111.34 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.8 p-10 -105.64 -14.7 15.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.931 -0.577 . . . . 0.46 111.259 -179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.04 12.25 7.11 Favored Glycine 0 CA--C 1.519 0.307 0 C-N-CA 120.747 -0.74 . . . . 0.35 112.905 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -137.52 104.12 5.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.713 0.292 . . . . 0.5 110.649 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 2.8 mttp -58.68 86.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.42 111.327 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 29.6 m-20 -81.91 -28.73 32.71 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.143 0.497 . . . . 0.47 110.094 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 10.1 t -77.2 162.24 27.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.654 -0.703 . . . . 0.31 110.706 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -59.34 -38.75 81.15 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.329 -0.396 . . . . 0.33 110.755 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -123.06 29.56 6.71 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.997 -0.547 . . . . 0.9 110.865 179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.433 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 57.29 27.91 58.39 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.794 -0.717 . . . . 0.21 112.871 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.55 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -50.55 -43.85 56.36 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.756 0.312 . . . . 0.27 111.407 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.896 ' HB3' HG11 ' A' ' 21' ' ' VAL . 2.5 p30 -59.3 -24.72 63.52 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.398 -0.365 . . . . 0.31 110.904 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -88.75 11.59 17.29 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.298 -0.41 . . . . 0.27 111.319 179.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.66 168.89 15.14 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.809 0.338 . . . . 0.4 111.104 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.576 HD13 ' O ' ' A' ' 45' ' ' CYS . 24.8 mm -59.03 -25.83 31.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.168 -0.469 . . . . 0.37 111.054 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.54 -27.12 9.92 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.338 -0.392 . . . . 0.29 111.3 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.719 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -95.19 13.88 23.99 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.115 -0.493 . . . . 0.26 111.609 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 74.3 19.65 79.78 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.715 -0.755 . . . . 0.23 112.809 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.576 ' O ' HD13 ' A' ' 41' ' ' ILE . 45.5 t -74.7 88.32 2.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.917 0.389 . . . . 0.35 110.626 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -105.68 64.73 0.7 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.037 -0.529 . . . . 0.91 111.141 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -176.95 43.29 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 0.48 110.806 179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -125.74 -174.8 3.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.134 -0.485 . . . . 0.87 110.946 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.1 t -73.8 173.17 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 1.33 110.87 179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.237 -0.887 . . . . 0.96 110.963 179.939 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.482 -0.247 . . . . 1.84 112.482 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 t -102.67 -177.5 3.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.763 0.316 . . . . 0.7 110.899 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 46.07 -169.56 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.17 -0.468 . . . . 0.4 111.354 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -63.33 -49.28 71.81 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.708 -0.758 . . . . 0.52 112.398 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 58.94 -167.79 0.15 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.725 0.298 . . . . 0.5 110.831 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.6 p 67.44 137.74 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.37 110.97 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.54 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 4.0 m 64.67 46.41 3.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.996 -0.547 . . . . 0.33 111.026 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.32 -172.5 0.35 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.728 -0.748 . . . . 0.38 112.501 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.7 Cg_endo -53.83 -35.92 81.06 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.776 2.317 . . . . 0.57 112.111 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.44 68.82 1.08 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.082 -0.508 . . . . 0.49 110.493 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.54 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 5.9 t -107.04 178.58 4.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.139 -0.482 . . . . 0.42 111.446 -179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.515 ' HB3' HD21 ' A' ' 26' ' ' LEU . 19.3 t80 -113.69 153.03 29.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.884 -0.598 . . . . 0.32 110.683 179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.63 114.98 27.18 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.173 -0.467 . . . . 0.41 110.643 179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.681 ' SG ' HG13 ' A' ' 19' ' ' VAL . 7.6 m -60.08 143.33 88.46 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.477 -0.329 . . . . 0.25 110.755 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 73.0 Cg_endo -77.12 137.34 17.1 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.69 2.26 . . . . 0.36 112.622 -179.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 92.13 -44.06 2.67 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.837 -0.697 . . . . 0.4 112.886 179.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.707 HG21 ' HB2' ' A' ' 34' ' ' ALA . 0.4 OUTLIER -109.94 168.88 9.09 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.809 0.338 . . . . 0.39 111.028 -179.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 27.1 p-80 -97.69 38.34 1.3 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.154 -0.476 . . . . 1.13 111.191 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.681 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -105.02 144.16 15.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 116.201 -0.454 . . . . 0.65 110.657 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.1 OUTLIER -126.21 161.09 28.51 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.26 110.951 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.788 HG11 ' HB3' ' A' ' 38' ' ' ASP . 5.5 p -144.6 130.94 9.9 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.091 -0.504 . . . . 0.22 110.998 -179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.605 ' O ' HD23 ' A' ' 26' ' ' LEU . 37.7 Cg_exo -59.61 149.42 82.56 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.303 2.002 . . . . 0.23 111.981 179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.459 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -52.04 -39.63 59.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.853 0.358 . . . . 0.43 110.844 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.48 -26.86 68.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 0.33 110.528 179.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.452 ' HB2' HG22 ' A' ' 21' ' ' VAL . 16.5 m0 -92.03 -22.14 20.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.965 -0.561 . . . . 0.38 110.944 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.768 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.8 mm? -51.96 122.05 7.73 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.367 -0.379 . . . . 0.28 111.034 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 30.8 p 39.94 57.24 2.35 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.025 -0.534 . . . . 0.22 111.365 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 41.0 p-10 -104.75 -6.95 19.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.924 -0.58 . . . . 0.46 111.156 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.46 -22.21 8.92 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.788 -0.72 . . . . 0.35 112.647 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -107.49 108.38 19.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.837 0.351 . . . . 0.5 110.858 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -56.83 97.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.42 111.119 -179.945 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -88.7 -30.44 19.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.212 -0.449 . . . . 0.47 110.792 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 9.6 m -75.43 176.14 7.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.182 -0.463 . . . . 0.31 110.819 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.707 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -65.58 -55.61 16.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.267 -0.424 . . . . 0.33 111.015 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.5 32.55 4.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.9 110.845 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.27 31.63 81.4 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.738 -0.744 . . . . 0.21 112.5 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.429 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.28 -38.98 78.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.805 0.336 . . . . 0.27 111.163 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.788 ' HB3' HG11 ' A' ' 21' ' ' VAL . 25.7 p-10 -61.24 -23.59 65.75 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.153 -0.476 . . . . 0.31 111.073 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -89.08 10.69 20.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.341 -0.391 . . . . 0.27 111.338 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.75 164.66 22.52 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.738 0.304 . . . . 0.4 110.819 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 42.3 mm -57.39 -24.37 21.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.316 -0.402 . . . . 0.37 111.031 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.19 -30.31 16.66 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.307 -0.406 . . . . 0.29 111.227 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.768 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -86.7 -20.38 27.81 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.972 -0.558 . . . . 0.26 111.559 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 103.56 30.69 5.17 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.55 -0.833 . . . . 0.23 112.478 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 37.6 t -63.21 -20.38 65.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.752 0.31 . . . . 0.35 110.87 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 71.27 -69.28 0.19 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.258 -0.428 . . . . 0.91 111.443 179.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CE2' ' CB ' ' A' ' 49' ' ' SER . 21.1 p90 -80.39 155.58 27.09 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.904 0.383 . . . . 0.48 110.918 -179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -44.23 -69.94 0.12 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.985 -0.552 . . . . 0.87 111.81 -179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.42 ' CB ' ' CE2' ' A' ' 47' ' ' TYR . 1.5 t 68.01 28.12 6.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.361 -0.381 . . . . 1.33 110.898 -179.713 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 40.9 m . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.221 -0.895 . . . . 0.96 110.918 -179.977 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.187 0 N-CA-C 112.557 -0.217 . . . . 1.84 112.557 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.45 -164.51 1.43 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.733 0.302 . . . . 0.7 110.835 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 67.28 67.0 0.4 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 0.4 110.868 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 74.37 49.77 11.25 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.763 -0.732 . . . . 0.52 112.482 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 5.6 mttt -111.77 -28.16 8.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.743 0.306 . . . . 0.5 111.089 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.89 -83.42 0.1 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.38 -0.373 . . . . 0.37 110.961 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.437 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 3.2 m -115.22 53.01 0.84 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.825 0.345 . . . . 0.33 110.88 -179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -54.8 176.16 0.49 Allowed Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.717 -0.754 . . . . 0.38 112.563 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.74 -25.27 20.19 Favored 'Trans proline' 0 C--N 1.343 0.276 0 C-N-CA 122.848 2.366 . . . . 0.57 112.192 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.03 58.43 0.85 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.261 -0.427 . . . . 0.49 110.678 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.437 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 1.4 m -118.18 143.05 46.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.09 -0.504 . . . . 0.42 111.03 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.6 ' HB3' HD21 ' A' ' 26' ' ' LEU . 33.3 t80 -92.75 152.05 19.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.102 -0.499 . . . . 0.32 110.56 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.7 t -115.44 123.87 49.7 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.092 -0.503 . . . . 0.41 110.501 179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.741 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.8 m -69.14 144.61 95.47 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.204 -0.453 . . . . 0.25 110.749 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.473 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 67.0 Cg_endo -73.56 147.3 40.51 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.783 2.322 . . . . 0.36 112.672 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 60.56 38.7 95.36 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.865 -0.683 . . . . 0.4 112.727 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.629 ' CG2' HG12 ' A' ' 19' ' ' VAL . 6.0 t -179.86 169.68 1.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.752 0.31 . . . . 0.39 110.846 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -109.74 35.96 3.16 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.316 -0.402 . . . . 1.13 110.994 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.741 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -100.68 126.36 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.263 -0.426 . . . . 0.65 110.513 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 21.2 p -104.95 164.18 11.98 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.26 111.162 -179.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.535 HG11 ' HB3' ' A' ' 38' ' ' ASP . 2.7 p -156.13 122.83 2.64 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.98 -0.554 . . . . 0.22 110.66 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.692 ' O ' HD23 ' A' ' 26' ' ' LEU . 31.5 Cg_exo -58.27 148.79 77.14 Favored 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 122.31 2.007 . . . . 0.23 112.023 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.53 -30.58 31.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.895 0.379 . . . . 0.43 110.72 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.475 ' HG2' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -69.05 -24.88 64.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.474 . . . . 0.33 110.357 179.379 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.475 ' CD1' ' HG2' ' A' ' 24' ' ' ARG . 32.6 m0 -99.4 12.81 35.3 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.009 -0.542 . . . . 0.38 111.007 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 22' ' ' PRO . 3.5 mm? -89.64 121.31 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.482 -0.326 . . . . 0.28 110.479 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 47.13 71.13 0.34 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 120.954 0.407 . . . . 0.22 110.571 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.12 17.51 4.11 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.182 -0.463 . . . . 0.46 111.356 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 91.76 -22.35 31.49 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.684 -0.769 . . . . 0.35 112.832 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.31 98.78 8.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.838 0.351 . . . . 0.5 110.925 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 18.8 mtpt -59.12 99.33 0.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.143 -0.481 . . . . 0.42 111.001 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.88 -30.24 20.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.149 -0.478 . . . . 0.47 110.679 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.6 m -70.47 171.28 10.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.043 -0.526 . . . . 0.31 110.827 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.18 -45.58 84.29 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 0.33 110.996 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -119.8 29.53 7.52 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.9 110.771 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.416 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 64.85 31.3 80.46 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.798 -0.715 . . . . 0.21 112.58 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.473 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.62 -36.06 73.46 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.779 0.323 . . . . 0.27 111.067 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.664 ' HB2' HD13 ' A' ' 26' ' ' LEU . 2.0 p30 -62.94 -27.91 69.71 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.256 -0.429 . . . . 0.31 110.722 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.401 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 2.7 mt-10 -92.67 15.88 13.45 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.204 -0.453 . . . . 0.27 111.271 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.41 -171.91 2.67 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.854 0.359 . . . . 0.4 110.972 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.67 HD13 ' O ' ' A' ' 45' ' ' CYS . 20.2 mm -69.92 -25.51 28.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.119 -0.491 . . . . 0.37 110.956 179.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.61 -29.93 19.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.302 -0.408 . . . . 0.29 111.359 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.596 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -92.52 -19.64 21.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.121 -0.491 . . . . 0.26 111.364 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.54 21.16 7.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.726 -0.75 . . . . 0.23 112.703 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.67 ' O ' HD13 ' A' ' 41' ' ' ILE . 0.1 OUTLIER -94.13 118.68 31.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.802 0.334 . . . . 0.35 110.638 179.819 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -112.91 68.74 0.68 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.91 111.233 -179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 48.6 p90 179.25 44.38 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 0.48 110.89 179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -65.69 140.7 58.49 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.87 110.882 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.32 -64.46 0.44 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 1.33 110.915 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.219 -0.896 . . . . 0.96 110.828 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.233 0 N-CA-C 112.519 -0.233 . . . . 1.84 112.519 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 64.42 15.91 9.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.597 0.237 . . . . 0.7 111.337 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 57.38 165.85 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.857 0.36 . . . . 0.4 111.06 179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -87.19 131.52 10.63 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.737 -0.744 . . . . 0.52 112.362 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -102.32 -26.05 13.44 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.742 0.306 . . . . 0.5 111.04 -179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.3 150.99 10.43 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.37 -0.377 . . . . 0.37 110.942 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 3.5 m 62.99 -165.45 0.24 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 0.33 110.886 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.64 -169.28 13.42 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.74 -0.743 . . . . 0.38 112.34 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -50.54 115.59 2.04 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.792 2.328 . . . . 0.57 111.888 179.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 7.4 t 64.62 55.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.004 0.43 . . . . 0.49 110.436 -179.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' HA ' ' HA ' ' A' ' 22' ' ' PRO . 4.1 p -99.26 156.99 16.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.006 -0.543 . . . . 0.42 111.371 -179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.684 ' HB3' HD21 ' A' ' 26' ' ' LEU . 29.0 t80 -97.09 153.82 17.71 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.786 -0.643 . . . . 0.32 110.331 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.1 t -118.24 114.35 22.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.292 -0.413 . . . . 0.41 110.654 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 35.3 t -65.48 134.68 95.61 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.356 -0.384 . . . . 0.25 110.962 -179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.483 ' HG3' ' HB1' ' A' ' 42' ' ' ALA . 60.5 Cg_endo -71.42 125.23 11.06 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.643 2.229 . . . . 0.36 112.67 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 86.3 36.18 10.07 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.784 -0.722 . . . . 0.4 113.137 179.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.638 ' CG2' HG12 ' A' ' 19' ' ' VAL . 2.5 t 178.29 161.33 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.797 0.332 . . . . 0.39 110.936 179.715 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.78 38.82 1.26 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.465 . . . . 1.13 110.831 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.638 HG12 ' CG2' ' A' ' 17' ' ' THR . 5.1 p -112.82 126.51 70.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.65 110.665 179.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' CB ' ' O ' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -119.49 154.07 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.26 111.188 -179.657 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.541 HG11 ' HB3' ' A' ' 38' ' ' ASP . 0.8 OUTLIER -141.47 136.27 15.5 Favored Pre-proline 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.22 110.899 -179.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' A' ' 11' ' ' SER . 35.9 Cg_endo -64.75 148.17 90.02 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.505 2.137 . . . . 0.23 112.294 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.603 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.6 tm-20 -50.81 -36.74 38.79 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.218 -0.446 . . . . 0.43 111.198 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.1 ptp180 -59.74 -24.44 64.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.396 -0.366 . . . . 0.33 110.817 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 11.7 m0 -99.35 -17.71 17.89 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.38 111.135 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.684 HD21 ' HB3' ' A' ' 12' ' ' PHE . 3.6 mm? -53.19 121.07 6.78 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.438 -0.346 . . . . 0.28 111.104 -179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 50.51 54.7 10.7 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 0.22 110.747 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -104.97 -10.45 17.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.46 111.249 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.9 -22.76 9.02 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.749 -0.738 . . . . 0.35 112.541 -179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.76 108.66 19.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.814 0.34 . . . . 0.5 110.857 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.474 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 8.9 mttt -58.1 89.38 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.202 -0.454 . . . . 0.42 111.022 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -66.43 -28.63 68.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.396 -0.365 . . . . 0.47 110.646 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 27.5 t -97.49 159.12 15.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.269 -0.423 . . . . 0.31 111.08 179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -57.76 -33.56 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.006 -0.543 . . . . 0.33 110.917 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -107.56 -2.35 20.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.037 -0.529 . . . . 0.9 111.207 179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.474 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 70.67 31.69 67.62 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.844 -0.693 . . . . 0.21 113.033 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.601 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -54.89 -38.18 67.24 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.976 0.417 . . . . 0.27 110.64 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.637 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 0.4 OUTLIER -58.87 -29.93 67.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.859 -0.61 . . . . 0.31 110.678 179.593 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -95.44 16.87 15.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.27 111.049 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -128.28 -165.87 1.55 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.861 0.363 . . . . 0.4 110.984 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.6 mp -77.2 -27.25 15.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.13 -0.487 . . . . 0.37 111.079 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.483 ' HB1' ' HG3' ' A' ' 15' ' ' PRO . . . -51.98 -32.22 32.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.297 -0.41 . . . . 0.29 111.234 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 38' ' ' ASP . . . -81.86 -23.1 36.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.26 111.223 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 108.98 24.6 5.96 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.716 -0.754 . . . . 0.23 112.664 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -24.47 20.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.745 0.307 . . . . 0.35 110.93 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 3.7 mt 69.48 -62.6 0.41 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.243 -0.435 . . . . 0.91 111.385 179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 64.82 147.35 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.453 -0.34 . . . . 0.48 110.707 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -152.15 107.74 3.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.308 -0.405 . . . . 0.87 111.001 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 m -164.82 119.18 1.33 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 1.33 110.792 179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 9.8 m . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.279 -0.867 . . . . 0.96 110.915 179.958 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.537 -0.225 . . . . 1.84 112.537 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.5 t 60.5 172.16 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.847 0.356 . . . . 0.7 110.889 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 60.05 47.93 9.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.4 110.838 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.69 43.62 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.824 -0.703 . . . . 0.52 112.324 -179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' O ' ' OG1' ' A' ' 6' ' ' THR . 0.8 OUTLIER -108.7 -145.55 0.4 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 110.677 -0.12 . . . . 0.5 110.677 -179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.43 ' OG1' ' N ' ' A' ' 7' ' ' CYS . 2.9 p 68.51 -66.22 0.24 Allowed 'General case' 0 CA--C 1.528 0.13 0 CA-C-O 120.522 0.201 . . . . 0.37 110.783 -179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.43 ' N ' ' OG1' ' A' ' 6' ' ' THR . 0.1 OUTLIER -139.13 155.86 47.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.827 0.346 . . . . 0.33 110.65 179.375 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.03 -169.24 41.52 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.762 -0.732 . . . . 0.38 112.472 -179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -50.82 -24.29 13.18 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.876 2.384 . . . . 0.57 112.293 179.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.1 72.84 1.43 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.258 -0.428 . . . . 0.49 110.819 179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 3.0 m -144.31 178.57 7.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.241 -0.436 . . . . 0.42 111.044 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.473 ' HB3' HD21 ' A' ' 26' ' ' LEU . 26.1 t80 -130.85 151.95 50.71 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.063 -0.517 . . . . 0.32 110.653 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.4 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 2.0 t -116.06 127.84 55.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.083 -0.508 . . . . 0.41 110.622 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.616 ' HB2' HG13 ' A' ' 19' ' ' VAL . 4.8 m -65.53 140.68 97.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.25 110.762 -179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.2 Cg_endo -72.38 149.44 50.62 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.632 2.221 . . . . 0.36 112.427 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 62.8 38.07 95.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.764 -0.731 . . . . 0.4 112.677 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.614 ' CG2' HG12 ' A' ' 19' ' ' VAL . 3.8 t -177.99 175.75 1.24 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.829 0.347 . . . . 0.39 111.002 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -113.05 34.49 4.42 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.141 -0.481 . . . . 1.13 110.819 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.616 HG13 ' HB2' ' A' ' 14' ' ' CYS . 1.6 p -102.45 140.45 20.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.65 110.861 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 13' ' ' SER . 1.7 p -117.94 163.61 16.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.044 -0.525 . . . . 0.26 110.915 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.578 HG13 HD21 ' A' ' 26' ' ' LEU . 4.1 p -147.34 125.44 6.02 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.24 -0.436 . . . . 0.22 111.281 -179.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.567 ' O ' HD23 ' A' ' 26' ' ' LEU . 27.6 Cg_exo -61.59 149.14 91.07 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.412 2.075 . . . . 0.23 111.871 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.478 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.0 OUTLIER -51.12 -39.18 55.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.824 0.345 . . . . 0.43 110.997 -179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.9 ttm-85 -59.57 -29.17 67.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.968 0.413 . . . . 0.33 110.444 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.425 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 35.2 m0 -87.96 -25.15 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.903 -0.589 . . . . 0.38 110.778 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.782 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.3 mm? -54.64 113.31 1.26 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 0.28 111.025 -179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 53.01 62.01 2.9 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.22 110.612 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -107.14 -4.95 18.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.105 -0.498 . . . . 0.46 111.36 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 120.01 -28.98 6.16 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.768 -0.729 . . . . 0.35 112.386 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -99.44 177.34 5.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.728 0.299 . . . . 0.5 110.552 179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.435 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 9.1 mtpt -120.22 85.75 2.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.412 -0.358 . . . . 0.42 111.001 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.39 -31.66 60.52 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.142 -0.481 . . . . 0.47 110.761 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.458 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 3.7 m -70.9 178.26 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.091 -0.504 . . . . 0.31 110.866 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -73.83 -43.52 58.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.33 111.032 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -120.77 34.59 5.16 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.177 -0.465 . . . . 0.9 110.864 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.435 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 60.72 31.39 75.25 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.705 -0.76 . . . . 0.21 112.388 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.463 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -56.12 -43.42 78.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.846 0.355 . . . . 0.27 111.24 -179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.679 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 29.7 p-10 -57.45 -31.85 66.34 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.144 -0.48 . . . . 0.31 110.788 179.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.1 mm-40 -95.02 18.6 11.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.072 -0.513 . . . . 0.27 111.076 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -130.99 -167.02 1.78 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.883 0.373 . . . . 0.4 110.977 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 39.9 mm -72.45 -29.62 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.14 -0.482 . . . . 0.37 111.005 179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -49.38 -33.93 14.89 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.237 -0.438 . . . . 0.29 111.28 -179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.782 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -83.56 -23.82 31.85 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.052 -0.522 . . . . 0.26 111.089 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 92.81 42.35 4.45 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.718 -0.753 . . . . 0.23 112.858 179.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.12 -47.12 6.5 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.932 0.396 . . . . 0.35 110.652 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.6 38.12 5.6 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.063 -0.517 . . . . 0.91 111.343 179.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.428 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 6.0 p90 -175.81 119.37 0.16 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.951 0.405 . . . . 0.48 110.954 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -178.19 -52.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.046 -0.525 . . . . 0.87 110.803 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.8 t 61.53 153.78 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.491 . . . . 1.33 110.857 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 42.6 m . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.254 -0.879 . . . . 0.96 110.856 -179.977 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.203 0 N-CA-C 112.456 -0.257 . . . . 1.84 112.456 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 16.4 p -176.95 158.14 1.53 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.795 0.331 . . . . 0.7 110.907 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.33 -32.11 69.78 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.199 -0.455 . . . . 0.4 110.833 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 131.2 121.54 2.3 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.722 -0.751 . . . . 0.52 112.563 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.405 ' N ' ' HD2' ' A' ' 5' ' ' LYS . 0.4 OUTLIER -60.91 85.12 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.763 0.316 . . . . 0.5 110.662 179.894 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -51.32 -91.61 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.344 -0.389 . . . . 0.37 111.413 -179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.533 ' HA ' ' CB ' ' A' ' 11' ' ' SER . 59.5 m -103.59 54.81 0.74 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.82 0.343 . . . . 0.33 111.084 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -58.54 -163.49 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.673 -0.775 . . . . 0.38 112.271 179.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 10.3 Cg_endo -53.37 117.21 3.55 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.592 2.195 . . . . 0.57 111.975 179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.6 p 51.32 60.39 3.9 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.976 0.417 . . . . 0.49 110.774 -179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.533 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 4.9 m -94.89 161.86 13.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.42 111.316 -179.7 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.588 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 36.9 t80 -110.83 147.04 35.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.93 -0.577 . . . . 0.32 110.443 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.5 p -109.71 120.12 41.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.301 -0.409 . . . . 0.41 110.978 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.819 ' HB3' HG13 ' A' ' 19' ' ' VAL . 3.7 t -58.81 130.66 85.98 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.08 -0.509 . . . . 0.25 110.727 -179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -71.03 142.12 41.63 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.594 2.196 . . . . 0.36 112.428 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 94.0 -43.49 2.41 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.771 -0.728 . . . . 0.4 112.985 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.723 HG23 HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -117.61 169.83 9.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.876 0.369 . . . . 0.39 111.106 -179.711 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -96.9 41.37 1.11 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.127 -0.488 . . . . 1.13 110.948 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.819 HG13 ' HB3' ' A' ' 14' ' ' CYS . 2.7 p -105.42 113.58 42.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.117 -0.492 . . . . 0.65 110.632 179.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -82.21 163.09 22.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.878 -0.601 . . . . 0.26 111.401 -179.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.473 HG22 HD22 ' A' ' 26' ' ' LEU . 3.8 p -151.77 123.62 3.87 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 115.776 -0.647 . . . . 0.22 110.469 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.616 ' O ' HD23 ' A' ' 26' ' ' LEU . 61.4 Cg_endo -73.91 157.74 47.01 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.317 2.011 . . . . 0.23 112.081 179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.434 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.5 tt0 -54.29 -30.93 52.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.272 -0.422 . . . . 0.43 110.965 -179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . 0.522 ' HG3' ' CD1' ' A' ' 25' ' ' TRP . 0.0 OUTLIER -70.01 -23.23 63.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.435 -0.348 . . . . 0.33 110.495 179.538 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.522 ' CD1' ' HG3' ' A' ' 24' ' ' ARG . 32.2 m0 -100.53 8.3 43.57 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 116.261 -0.427 . . . . 0.38 110.824 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.801 HD11 ' HB1' ' A' ' 43' ' ' ALA . 3.0 mm? -80.92 117.36 21.48 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.486 -0.325 . . . . 0.28 110.499 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.417 ' HB3' ' HA ' ' A' ' 39' ' ' GLU . 28.1 p 40.81 72.2 0.17 Allowed 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.0 -0.546 . . . . 0.22 111.287 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -122.15 5.03 9.79 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.873 -0.603 . . . . 0.46 111.234 -179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.82 -28.6 6.96 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.644 -0.789 . . . . 0.35 112.768 179.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -95.3 171.5 8.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.79 0.328 . . . . 0.5 110.941 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.451 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 0.4 OUTLIER -118.74 87.9 2.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.383 -0.371 . . . . 0.42 110.809 179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.52 -35.09 60.82 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.083 0.468 . . . . 0.47 110.165 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.2 t -87.18 143.81 27.13 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.672 -0.694 . . . . 0.31 110.45 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -45.29 -31.77 1.7 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.385 -0.37 . . . . 0.33 111.584 -179.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.0 t0 -120.22 26.22 9.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.189 -0.459 . . . . 0.9 111.003 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.451 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 54.58 28.79 46.51 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.919 -0.657 . . . . 0.21 112.866 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -46.73 -44.15 18.6 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.629 0.252 . . . . 0.27 111.404 -179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.517 ' HB2' HD13 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -56.89 -28.63 62.14 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.002 0.429 . . . . 0.31 110.494 179.759 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.417 ' HA ' ' HB3' ' A' ' 27' ' ' CYS . 20.3 mm-40 -84.45 8.62 15.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.838 -0.619 . . . . 0.27 111.352 179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.36 176.04 8.02 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-O 120.807 0.337 . . . . 0.4 110.8 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.4 ' N ' ' CD1' ' A' ' 41' ' ' ILE . 1.3 mp -69.89 -19.18 22.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.202 -0.453 . . . . 0.37 110.975 179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.17 -34.38 56.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 121.023 0.439 . . . . 0.29 111.093 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.801 ' HB1' HD11 ' A' ' 26' ' ' LEU . . . -87.29 -22.58 25.07 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.885 -0.598 . . . . 0.26 111.239 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 105.21 28.96 5.33 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.619 -0.8 . . . . 0.23 112.481 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.433 ' O ' ' CD2' ' A' ' 47' ' ' TYR . 53.9 t -55.61 -62.12 1.9 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.788 0.328 . . . . 0.35 110.73 179.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.6 mt 76.05 -58.66 0.53 Allowed 'General case' 0 N--CA 1.464 0.242 0 CA-C-N 116.227 -0.442 . . . . 0.91 111.801 179.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 45' ' ' CYS . 1.6 m-85 -43.78 -47.42 8.01 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.742 0.306 . . . . 0.48 111.261 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 62.2 119.53 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.41 . . . . 0.87 111.001 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.1 m -136.73 113.84 10.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.188 -0.46 . . . . 1.33 110.865 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.277 -0.868 . . . . 0.96 110.917 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 N-CA-C 112.506 -0.238 . . . . 1.84 112.506 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.1 m -144.28 37.78 1.26 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.823 0.344 . . . . 0.7 110.923 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.6 tt0 68.26 -70.3 0.13 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.4 110.904 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -125.02 -134.91 4.26 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.752 -0.737 . . . . 0.52 112.519 179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 10.8 tptt -177.01 78.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.779 0.323 . . . . 0.5 110.913 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -119.01 -54.14 2.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.259 -0.428 . . . . 0.37 110.911 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.419 ' HA ' ' CD ' ' A' ' 22' ' ' PRO . 23.7 p -174.72 -39.24 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.216 -0.447 . . . . 0.33 111.102 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 57.69 -160.08 11.58 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.636 -0.792 . . . . 0.38 112.633 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -58.98 150.17 74.48 Favored 'Trans proline' 0 C--N 1.344 0.303 0 C-N-CA 122.811 2.341 . . . . 0.57 112.284 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.5 m 61.24 41.93 12.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.177 -0.465 . . . . 0.49 110.746 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 29.7 p -83.09 168.8 16.55 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.099 -0.501 . . . . 0.42 111.151 -179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.766 ' O ' HG12 ' A' ' 21' ' ' VAL . 43.1 t80 -137.65 133.12 33.93 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.849 -0.614 . . . . 0.32 110.406 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.9 p -94.7 149.61 21.06 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.186 -0.461 . . . . 0.41 110.753 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.591 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -88.88 138.58 29.32 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.098 -0.501 . . . . 0.25 111.169 -179.637 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -57.82 132.7 51.43 Favored 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.697 2.264 . . . . 0.36 112.096 179.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 93.42 -44.47 2.44 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.751 -0.738 . . . . 0.4 112.517 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.616 HG23 HG13 ' A' ' 19' ' ' VAL . 2.0 t -108.7 177.65 4.71 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.748 0.309 . . . . 0.39 110.607 179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.5 m80 -117.35 48.05 1.41 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.364 -0.38 . . . . 1.13 111.054 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.616 HG13 HG23 ' A' ' 17' ' ' THR . 0.9 OUTLIER -77.33 -177.55 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.382 -0.372 . . . . 0.65 110.532 179.855 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.514 ' N ' HG23 ' A' ' 19' ' ' VAL . 3.7 t -147.59 119.35 8.07 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.884 0.373 . . . . 0.26 111.12 179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.2 p -122.33 136.92 26.92 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 116.024 -0.534 . . . . 0.22 110.631 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.498 ' HD2' HG23 ' A' ' 21' ' ' VAL . 66.4 Cg_endo -74.95 144.02 29.95 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.354 2.036 . . . . 0.23 111.601 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.561 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -47.44 -36.1 9.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.85 0.357 . . . . 0.43 110.923 -179.833 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.99 -30.14 70.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.99 0.424 . . . . 0.33 110.344 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.45 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 30.4 m0 -87.35 -26.9 23.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.887 -0.597 . . . . 0.38 110.72 179.505 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.864 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.7 mm? -47.75 106.14 0.09 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.402 -0.363 . . . . 0.28 111.011 -179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.6 t 50.64 67.14 0.98 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.084 -0.507 . . . . 0.22 110.819 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.63 -4.23 18.48 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.925 -0.58 . . . . 0.46 111.33 -179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.35 -27.59 6.9 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.745 -0.741 . . . . 0.35 112.559 179.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.18 144.64 31.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.713 0.292 . . . . 0.5 110.715 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.475 ' HE3' ' HA3' ' A' ' 36' ' ' GLY . 16.1 mttp -83.55 92.25 7.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.42 111.065 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -87.06 -29.72 21.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.107 0.479 . . . . 0.47 109.761 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.521 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -74.61 168.28 20.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.66 -0.7 . . . . 0.31 110.775 179.712 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.12 -43.72 98.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.963 0.411 . . . . 0.33 110.655 179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.5 p-10 -120.72 29.73 7.26 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.935 -0.575 . . . . 0.9 110.664 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.475 ' HA3' ' HE3' ' A' ' 31' ' ' LYS . . . 63.32 22.83 65.84 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.946 -0.645 . . . . 0.21 112.822 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.591 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -48.81 -45.02 39.73 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.894 0.378 . . . . 0.27 110.924 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.409 ' HA ' ' CB ' ' A' ' 43' ' ' ALA . 2.5 p30 -59.44 -22.35 61.37 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.003 -0.544 . . . . 0.31 110.806 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -94.83 17.75 13.07 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.454 -0.339 . . . . 0.27 111.194 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -126.39 -177.24 3.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.858 0.361 . . . . 0.4 111.123 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.554 HD12 ' N ' ' A' ' 41' ' ' ILE . 2.3 mp -71.54 -27.12 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.089 -0.505 . . . . 0.37 110.666 179.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.31 -32.02 46.89 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.205 -0.452 . . . . 0.29 111.213 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.864 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.12 -14.64 33.26 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.023 -0.535 . . . . 0.26 111.517 -179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 112.5 24.12 5.14 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.763 -0.732 . . . . 0.23 112.729 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 41.9 t -106.14 105.05 14.9 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.862 0.363 . . . . 0.35 110.887 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.36 31.68 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.91 111.13 -179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -75.07 -12.79 60.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.368 -0.378 . . . . 0.48 111.576 -179.903 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 45.3 m-20 66.06 -71.11 0.09 Allowed 'General case' 0 C--N 1.333 -0.13 0 CA-C-O 120.733 0.301 . . . . 0.87 111.19 179.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 47' ' ' TYR . 0.2 OUTLIER 68.16 141.03 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.335 -0.393 . . . . 1.33 110.967 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.236 -0.888 . . . . 0.96 110.894 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.517 -0.233 . . . . 1.84 112.517 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 62.99 121.93 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.807 0.337 . . . . 0.7 110.917 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -86.29 -66.27 0.92 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.189 -0.459 . . . . 0.4 110.838 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -148.82 83.52 0.18 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.754 -0.736 . . . . 0.52 112.375 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.67 -35.65 81.38 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.775 0.322 . . . . 0.5 111.019 -179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 4.3 p -72.4 143.54 48.5 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.34 -0.391 . . . . 0.37 110.926 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 69.2 m 57.66 -84.5 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.032 -0.531 . . . . 0.33 110.992 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.12 179.76 0.43 Allowed Glycine 0 C--N 1.332 0.318 0 C-N-CA 120.662 -0.78 . . . . 0.38 112.576 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -52.54 136.46 57.09 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.768 2.312 . . . . 0.57 112.062 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.6 t 62.77 53.25 2.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.262 -0.426 . . . . 0.49 110.607 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -94.21 158.57 15.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.063 -0.517 . . . . 0.42 111.185 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.591 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 33.7 t80 -122.23 151.91 40.55 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.904 -0.589 . . . . 0.32 110.063 179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 30.1 t -119.03 120.41 37.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.836 0.351 . . . . 0.41 110.757 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.693 ' SG ' HG13 ' A' ' 19' ' ' VAL . 6.0 m -64.78 138.62 97.53 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.18 -0.464 . . . . 0.25 110.657 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.446 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 56.1 Cg_endo -70.1 139.49 39.17 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.649 2.233 . . . . 0.36 112.537 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 70.34 38.46 70.83 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.799 -0.715 . . . . 0.4 112.746 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.567 ' CG2' HG12 ' A' ' 19' ' ' VAL . 3.5 t 179.37 174.26 0.78 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.881 0.372 . . . . 0.39 111.035 179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -114.21 43.78 1.81 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 1.13 110.747 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.693 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -111.42 130.88 64.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.974 -0.557 . . . . 0.65 110.928 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 3.2 p -109.69 163.52 13.41 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.353 -0.385 . . . . 0.26 110.859 179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.672 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.6 p -151.23 125.15 4.39 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 116.129 -0.487 . . . . 0.22 110.78 179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.532 ' O ' HD23 ' A' ' 26' ' ' LEU . 31.2 Cg_exo -58.79 148.86 81.27 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.298 1.999 . . . . 0.23 112.009 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.471 ' HA ' HD23 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -50.93 -38.66 51.66 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.872 0.367 . . . . 0.43 110.782 179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.63 -28.27 68.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.33 110.424 179.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.464 ' HB2' HG22 ' A' ' 21' ' ' VAL . 13.4 m0 -89.41 -24.47 21.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.926 -0.579 . . . . 0.38 110.824 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.656 ' CD2' HG13 ' A' ' 21' ' ' VAL . 4.1 mm? -52.89 120.92 6.36 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.311 -0.404 . . . . 0.28 110.802 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 20.2 p 38.96 57.33 1.92 Allowed 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.123 -0.49 . . . . 0.22 111.372 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.6 p-10 -104.22 -12.08 16.87 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.882 -0.599 . . . . 0.46 111.325 -179.752 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.71 19.98 4.74 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.35 112.763 -179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -148.53 101.44 3.22 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.812 0.339 . . . . 0.5 110.635 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.408 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.1 OUTLIER -55.29 95.88 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.253 -0.43 . . . . 0.42 111.192 -179.701 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -91.78 -30.62 16.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.47 110.603 179.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 8.7 m -71.23 173.94 7.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.31 110.868 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -64.25 -48.27 76.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.233 -0.439 . . . . 0.33 111.052 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -117.61 35.93 4.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.167 -0.469 . . . . 0.9 110.848 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.408 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 59.16 32.03 70.61 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.724 -0.751 . . . . 0.21 112.384 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.446 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.59 -39.8 81.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.758 0.313 . . . . 0.27 111.32 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.672 ' HB3' HG11 ' A' ' 21' ' ' VAL . 3.0 p30 -60.33 -26.9 66.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.363 -0.381 . . . . 0.31 111.072 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HG2' ' OD1' ' A' ' 38' ' ' ASP . 3.2 mm-40 -92.97 13.21 21.32 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.426 -0.352 . . . . 0.27 111.258 179.773 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.63 169.91 14.45 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.801 0.334 . . . . 0.4 110.936 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.817 HG23 HD22 ' A' ' 46' ' ' LEU . 2.4 mp -58.38 -23.89 23.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.21 -0.45 . . . . 0.37 110.773 179.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.62 -26.77 14.54 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.313 -0.403 . . . . 0.29 111.186 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.64 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -102.56 21.97 14.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.26 111.368 -179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 67.99 18.56 70.9 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.679 -0.772 . . . . 0.23 112.575 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.6 m -90.57 78.52 6.27 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.916 0.388 . . . . 0.35 110.619 179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.817 HD22 HG23 ' A' ' 41' ' ' ILE . 0.0 OUTLIER -118.62 24.43 10.9 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.076 -0.511 . . . . 0.91 110.924 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -71.22 -9.24 57.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.418 . . . . 0.48 111.459 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.4 t-20 62.78 125.02 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.837 0.351 . . . . 0.87 111.004 179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 78.1 p -176.73 -39.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.16 -0.473 . . . . 1.33 110.896 -179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.4 p . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.262 -0.875 . . . . 0.96 110.903 -179.965 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 N-CA-C 112.473 -0.251 . . . . 1.84 112.473 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 4' ' ' GLY . 85.7 p -120.05 27.31 8.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.573 0.225 . . . . 0.7 111.025 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 39.75 -91.39 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.111 -0.495 . . . . 0.4 111.757 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' A' ' 2' ' ' SER . . . -108.54 104.62 2.02 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.674 -0.774 . . . . 0.52 112.413 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -98.26 33.53 2.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.773 0.32 . . . . 0.5 110.946 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.03 -62.86 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.273 -0.421 . . . . 0.37 110.898 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.7 m -97.11 -67.81 0.83 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.301 -0.409 . . . . 0.33 110.982 -179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.87 -175.26 2.86 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.654 -0.784 . . . . 0.38 112.369 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.05 124.43 15.92 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.697 2.265 . . . . 0.57 112.012 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 41.7 t 62.03 83.84 0.15 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.213 -0.449 . . . . 0.49 110.866 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -129.23 159.18 36.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.45 . . . . 0.42 110.93 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.506 ' HB3' HD21 ' A' ' 26' ' ' LEU . 25.5 t80 -110.17 152.23 26.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.033 -0.531 . . . . 0.32 110.572 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.9 t -111.97 133.13 54.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.138 -0.483 . . . . 0.41 110.735 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.87 ' HB3' HG23 ' A' ' 17' ' ' THR . 0.5 OUTLIER -79.72 137.45 54.61 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.25 111.003 -179.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.3 124.12 14.51 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.681 2.254 . . . . 0.36 112.472 179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.428 ' C ' HG22 ' A' ' 17' ' ' THR . . . 70.08 37.73 73.15 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.879 -0.677 . . . . 0.4 112.84 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.87 HG23 ' HB3' ' A' ' 14' ' ' CYS . 0.0 OUTLIER 178.63 152.7 0.34 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.838 0.351 . . . . 0.39 110.852 179.874 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 2.6 t60 -86.58 -3.77 59.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 1.13 111.509 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.8 HG12 ' OG1' ' A' ' 17' ' ' THR . 7.7 p -56.77 89.1 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.169 0 CA-C-O 120.815 0.341 . . . . 0.65 111.074 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 p -82.73 162.71 21.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.275 -0.42 . . . . 0.26 111.034 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.909 HG11 ' HB3' ' A' ' 38' ' ' ASP . 7.5 p -150.21 129.23 6.24 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.22 111.066 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.592 ' O ' HD23 ' A' ' 26' ' ' LEU . 24.4 Cg_exo -63.03 151.9 82.3 Favored 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.403 2.069 . . . . 0.23 111.886 179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.447 ' HA ' HD23 ' A' ' 26' ' ' LEU . 4.4 tt0 -52.49 -40.38 62.3 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.86 0.362 . . . . 0.43 110.801 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 4.1 tpm_? -59.76 -27.41 66.5 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.304 -0.407 . . . . 0.33 110.459 179.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.473 ' HB2' HG22 ' A' ' 21' ' ' VAL . 17.0 m0 -90.61 -25.24 20.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.895 -0.593 . . . . 0.38 110.917 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.61 ' CD2' HG13 ' A' ' 21' ' ' VAL . 3.9 mm? -50.62 122.3 7.01 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.285 -0.416 . . . . 0.28 110.935 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.9 p 39.12 61.59 1.26 Allowed 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.039 -0.528 . . . . 0.22 111.285 -179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -108.19 -6.04 16.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.757 -0.656 . . . . 0.46 111.219 -179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.75 -26.18 7.32 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.713 -0.756 . . . . 0.35 112.589 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.77 103.92 13.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.785 0.326 . . . . 0.5 110.81 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 25.8 mtpt -59.94 85.42 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.236 -0.438 . . . . 0.42 111.083 -179.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -75.31 -30.84 60.47 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 0.47 110.637 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.54 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -69.0 170.89 9.0 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.001 -0.545 . . . . 0.31 110.862 179.954 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -71.09 -40.29 71.64 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.177 -0.465 . . . . 0.33 110.742 179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -120.73 28.41 7.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.023 -0.535 . . . . 0.9 110.811 179.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.434 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 62.8 28.22 71.37 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.822 -0.704 . . . . 0.21 112.739 179.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.638 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -55.4 -43.34 75.14 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.869 0.366 . . . . 0.27 111.008 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.909 ' HB3' HG11 ' A' ' 21' ' ' VAL . 2.3 p30 -61.41 -27.77 68.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.108 -0.496 . . . . 0.31 110.943 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -94.48 15.85 16.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.318 -0.401 . . . . 0.27 111.264 179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -131.54 172.51 12.14 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.4 110.849 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.556 HG13 HD23 ' A' ' 46' ' ' LEU . 1.6 mp -60.55 -21.89 24.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.212 -0.449 . . . . 0.37 110.811 179.606 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.29 -32.11 36.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.916 0.388 . . . . 0.29 111.094 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.568 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -88.58 -22.38 23.56 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.941 -0.572 . . . . 0.26 111.202 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 102.04 28.52 6.49 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.605 -0.807 . . . . 0.23 112.716 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.407 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 25.1 t -70.36 -71.86 0.23 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.729 0.299 . . . . 0.35 110.546 179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.556 HD23 HG13 ' A' ' 41' ' ' ILE . 9.4 mt 67.38 -67.52 0.17 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.459 . . . . 0.91 111.405 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.472 ' O ' ' CD1' ' A' ' 47' ' ' TYR . 0.0 OUTLIER -63.91 78.04 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.081 0.467 . . . . 0.48 111.589 -179.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -159.4 32.66 0.2 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.078 -0.51 . . . . 0.87 110.83 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 48.4 m -96.02 -32.68 12.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 1.33 110.882 -179.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 3.8 t . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.251 -0.88 . . . . 0.96 110.921 -179.979 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 N-CA-C 112.538 -0.225 . . . . 1.84 112.538 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -124.2 89.0 3.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.778 0.323 . . . . 0.7 110.991 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 68.52 -67.96 0.19 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.205 -0.452 . . . . 0.4 111.047 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.07 44.35 0.25 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.771 -0.728 . . . . 0.52 112.466 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -135.02 -55.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.898 0.38 . . . . 0.5 110.846 -179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.406 ' HG1' ' H ' ' A' ' 7' ' ' CYS . 2.1 p 51.42 -91.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.982 -0.554 . . . . 0.37 111.28 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.406 ' H ' ' HG1' ' A' ' 6' ' ' THR . 2.8 m -109.43 75.16 0.93 Allowed 'General case' 0 C--O 1.232 0.164 0 CA-C-O 120.788 0.328 . . . . 0.33 110.963 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -68.18 -160.54 1.7 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.675 -0.774 . . . . 0.38 112.354 179.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -57.87 122.83 12.4 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.613 2.209 . . . . 0.57 111.977 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 38.0 t 61.05 58.88 2.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.268 -0.424 . . . . 0.49 110.484 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.21 145.73 30.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.072 -0.513 . . . . 0.42 111.311 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.446 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 13.0 t80 -107.44 151.88 24.95 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.897 -0.592 . . . . 0.32 110.345 179.742 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.414 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 2.0 t -107.5 126.7 52.85 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.21 -0.45 . . . . 0.41 110.761 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.778 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.5 m -74.99 142.26 75.96 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.177 -0.465 . . . . 0.25 110.866 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.484 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 60.7 Cg_endo -72.32 146.03 44.47 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.719 2.279 . . . . 0.36 112.498 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.33 35.49 91.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.841 -0.695 . . . . 0.4 112.593 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.56 ' CG2' HG12 ' A' ' 19' ' ' VAL . 2.0 t 179.81 174.59 0.84 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.835 0.35 . . . . 0.39 110.814 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -113.49 30.75 6.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.184 -0.462 . . . . 1.13 110.95 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.778 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.7 p -93.72 133.17 35.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.65 110.681 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.9 p -109.92 164.25 12.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.097 -0.501 . . . . 0.26 111.016 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.595 HG13 HD21 ' A' ' 26' ' ' LEU . 4.8 p -152.76 134.19 8.33 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 116.192 -0.458 . . . . 0.22 110.836 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.544 ' O ' HD23 ' A' ' 26' ' ' LEU . 59.0 Cg_endo -72.23 148.96 50.68 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.264 1.976 . . . . 0.23 111.721 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.01 -38.69 24.14 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.827 0.346 . . . . 0.43 111.061 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.88 -27.73 69.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.345 -0.388 . . . . 0.33 110.466 179.697 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.455 ' CE3' ' HD2' ' A' ' 22' ' ' PRO . 26.6 m0 -88.17 -25.29 23.02 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.38 110.677 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.804 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 4.1 mm? -53.82 122.16 9.42 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.268 -0.424 . . . . 0.28 110.873 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 37.17 55.21 1.3 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.053 0.454 . . . . 0.22 111.284 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.8 p-10 -101.02 -13.57 18.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.892 -0.594 . . . . 0.46 111.124 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.21 18.95 4.85 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.799 -0.715 . . . . 0.35 112.784 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -152.48 108.65 3.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.809 0.338 . . . . 0.5 110.643 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.411 ' HE2' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -55.49 92.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.42 111.172 -179.743 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -89.08 -30.92 18.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.084 -0.507 . . . . 0.47 110.67 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.2 m -66.3 -174.77 0.29 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 0.31 110.849 179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -74.13 -50.01 21.3 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.249 -0.432 . . . . 0.33 110.932 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -118.4 33.48 5.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.118 -0.492 . . . . 0.9 110.79 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.411 ' CA ' ' HE2' ' A' ' 31' ' ' LYS . . . 65.14 27.9 72.89 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.694 -0.765 . . . . 0.21 112.555 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -58.55 -41.73 86.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.778 0.323 . . . . 0.27 111.174 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.531 ' HA ' ' HB2' ' A' ' 43' ' ' ALA . 39.3 p30 -54.97 -27.69 45.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.212 -0.449 . . . . 0.31 110.997 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.63 19.23 10.17 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.171 -0.468 . . . . 0.27 111.005 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.57 -164.75 1.42 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.825 0.345 . . . . 0.4 110.888 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.603 HD12 HD23 ' A' ' 46' ' ' LEU . 39.9 mm -80.14 -28.19 12.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.149 -0.478 . . . . 0.37 111.12 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.32 -31.71 22.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.29 111.485 -179.658 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.804 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -86.3 -19.79 29.34 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.171 -0.468 . . . . 0.26 111.401 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 106.71 21.03 8.47 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.636 -0.792 . . . . 0.23 112.776 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -98.37 72.06 2.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.073 0.464 . . . . 0.35 110.69 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.603 HD23 HD12 ' A' ' 41' ' ' ILE . 0.5 OUTLIER -78.18 78.1 4.66 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.846 -0.616 . . . . 0.91 111.029 -179.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -107.74 -23.08 12.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.026 -0.534 . . . . 0.48 111.014 179.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.6 m120 64.19 79.75 0.25 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.379 -0.373 . . . . 0.87 110.879 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 2.5 p -159.84 138.85 10.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.196 -0.456 . . . . 1.33 110.901 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 4.1 m . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.224 -0.893 . . . . 0.96 110.862 179.949 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.144 0 N-CA-C 112.547 -0.221 . . . . 1.84 112.547 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 11.7 p 58.99 -169.4 0.13 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.761 0.315 . . . . 0.7 110.944 -179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 pm0 -141.99 31.49 1.59 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.249 -0.432 . . . . 0.4 110.943 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.08 106.51 0.19 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.684 -0.77 . . . . 0.52 112.601 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -177.58 -71.11 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.672 0.272 . . . . 0.5 110.869 179.934 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 57.71 -80.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.173 -0.467 . . . . 0.37 111.261 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.441 ' N ' ' O ' ' A' ' 5' ' ' LYS . 33.5 m -111.76 -41.94 3.93 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.346 -0.388 . . . . 0.33 111.255 -179.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 58.02 -174.6 2.45 Favored Glycine 0 CA--C 1.518 0.249 0 C-N-CA 120.62 -0.8 . . . . 0.38 112.546 -179.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -60.56 140.97 94.01 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.745 2.296 . . . . 0.57 112.226 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 3.7 p 50.02 78.27 0.1 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.234 -0.439 . . . . 0.49 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.414 ' CB ' ' HB3' ' A' ' 7' ' ' CYS . 64.5 p -118.49 158.81 24.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.42 111.223 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.589 ' HB3' HD21 ' A' ' 26' ' ' LEU . 10.5 t80 -93.23 152.8 18.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.945 -0.57 . . . . 0.32 110.283 179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.406 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.5 OUTLIER -107.08 123.17 47.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.406 -0.361 . . . . 0.41 110.689 179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.606 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 5.4 t -75.66 135.22 71.76 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 116.212 -0.449 . . . . 0.25 111.02 -179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -64.71 129.23 22.95 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.651 2.234 . . . . 0.36 112.525 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 98.0 -43.75 1.9 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.782 -0.723 . . . . 0.4 112.988 179.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.597 ' CG2' HG12 ' A' ' 19' ' ' VAL . 0.0 OUTLIER -115.29 160.78 19.37 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.858 0.361 . . . . 0.39 110.985 -179.763 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -0.62 49.97 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.202 -0.454 . . . . 1.13 111.402 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.597 HG12 ' CG2' ' A' ' 17' ' ' THR . 6.9 p -63.19 133.01 29.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.757 0.313 . . . . 0.65 110.757 179.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.435 ' HA ' ' O ' ' A' ' 12' ' ' PHE . 0.8 OUTLIER -124.58 153.44 42.17 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.963 0.411 . . . . 0.26 111.089 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.808 HG11 ' HB3' ' A' ' 38' ' ' ASP . 2.8 p -132.1 139.81 36.14 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 115.955 -0.566 . . . . 0.22 111.141 -179.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.602 ' O ' HD23 ' A' ' 26' ' ' LEU . 17.3 Cg_exo -65.32 146.91 87.03 Favored 'Trans proline' 0 C--N 1.347 0.493 0 C-N-CA 122.477 2.118 . . . . 0.23 111.959 179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.45 ' HA ' HD23 ' A' ' 26' ' ' LEU . 2.1 mt-10 -51.02 -40.95 59.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.928 0.394 . . . . 0.43 110.824 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -60.7 -27.37 67.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.237 -0.438 . . . . 0.33 110.599 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.419 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 31.1 m0 -90.46 -24.86 20.59 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.008 -0.542 . . . . 0.38 110.944 179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.694 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.9 mm? -50.01 125.96 13.28 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.333 -0.394 . . . . 0.28 111.062 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 31.5 p 39.89 56.71 2.41 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.016 -0.538 . . . . 0.22 111.481 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.9 p-10 -105.82 -6.37 19.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.46 111.165 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 119.45 -20.66 9.49 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.724 -0.75 . . . . 0.35 112.681 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -109.78 116.24 31.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.819 0.342 . . . . 0.5 110.883 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.41 ' HE2' ' CA ' ' A' ' 36' ' ' GLY . 0.3 OUTLIER -65.42 90.56 0.11 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.445 . . . . 0.42 110.978 -179.998 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -66.1 -32.37 73.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.415 . . . . 0.47 110.753 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.2 t -90.76 160.56 15.73 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.211 -0.45 . . . . 0.31 110.897 179.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -66.92 -28.37 68.25 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.091 -0.504 . . . . 0.33 111.053 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -104.79 -4.69 22.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.242 -0.435 . . . . 0.9 111.497 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' CA ' ' HE2' ' A' ' 31' ' ' LYS . . . 71.4 32.47 64.97 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.664 -0.779 . . . . 0.21 112.779 179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.606 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -61.64 -39.6 91.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.928 0.394 . . . . 0.27 110.822 179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.808 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -60.58 -26.71 67.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.0 -0.546 . . . . 0.31 110.996 179.948 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -89.3 9.17 27.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.327 -0.397 . . . . 0.27 111.375 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.07 175.88 8.54 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.858 0.361 . . . . 0.4 111.026 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 33.4 mm -59.72 -22.71 24.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.123 -0.49 . . . . 0.37 111.015 179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -50.64 -30.12 12.71 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.889 0.376 . . . . 0.29 111.397 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.694 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.02 -20.08 23.65 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.061 -0.518 . . . . 0.26 111.486 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 104.46 24.11 7.63 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.676 -0.773 . . . . 0.23 112.631 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.4 m -93.51 96.78 10.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.845 0.355 . . . . 0.35 110.671 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.55 58.65 4.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.142 -0.481 . . . . 0.91 111.191 -179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.418 ' CG ' ' O ' ' A' ' 47' ' ' TYR . 2.2 p90 -177.04 104.83 0.06 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.48 110.862 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -112.14 -162.74 0.81 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.87 110.887 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 72.56 -64.64 0.39 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.366 -0.379 . . . . 1.33 110.98 -179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.204 -0.903 . . . . 0.96 110.943 179.967 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.201 0 N-CA-C 112.509 -0.236 . . . . 1.84 112.509 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.5 p -127.21 142.58 51.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.838 0.351 . . . . 0.7 110.943 -179.926 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.27 -43.57 0.33 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.4 111.067 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -163.15 46.33 0.33 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.67 -0.776 . . . . 0.52 112.514 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 8.6 ptmt -98.98 33.5 2.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.793 0.33 . . . . 0.5 110.923 179.919 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.98 -77.39 0.09 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.213 -0.449 . . . . 0.37 110.759 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 6.6 m -102.95 -72.58 0.69 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.211 -0.45 . . . . 0.33 110.889 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.41 -176.91 34.05 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.487 -0.863 . . . . 0.38 112.303 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.55 -22.19 73.87 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.57 112.481 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 78.2 p -128.33 101.93 6.44 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.465 -0.334 . . . . 0.49 111.077 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -162.48 176.87 10.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.97 0.414 . . . . 0.42 111.074 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 43' ' ' ALA . 17.1 t80 -125.93 152.01 46.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.928 -0.578 . . . . 0.32 110.452 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CZ ' ' A' ' 12' ' ' PHE . 4.3 t -108.11 125.99 52.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.146 -0.479 . . . . 0.41 110.591 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.714 ' SG ' HG13 ' A' ' 19' ' ' VAL . 3.7 m -74.95 144.6 79.82 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.285 -0.416 . . . . 0.25 110.943 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 72.9 Cg_endo -74.87 144.76 31.12 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.633 2.222 . . . . 0.36 112.471 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 68.49 31.49 73.92 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.816 -0.707 . . . . 0.4 112.648 179.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.598 ' CG2' HG12 ' A' ' 19' ' ' VAL . 1.3 t 179.77 167.81 1.2 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.832 0.348 . . . . 0.39 110.95 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -103.79 27.47 7.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.122 -0.49 . . . . 1.13 110.918 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.714 HG13 ' SG ' ' A' ' 14' ' ' CYS . 2.3 p -91.19 137.82 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.31 -0.405 . . . . 0.65 110.733 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.0 p -118.32 162.92 17.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.26 111.01 179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.753 HG11 ' HB3' ' A' ' 38' ' ' ASP . 5.7 p -145.42 134.82 11.38 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.937 -0.574 . . . . 0.22 110.736 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.528 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.6 Cg_endo -71.0 148.14 56.41 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.391 2.061 . . . . 0.23 111.946 179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.493 ' HA ' HD23 ' A' ' 26' ' ' LEU . 1.3 tt0 -48.16 -39.86 22.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.361 -0.381 . . . . 0.43 111.002 -179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -58.13 -29.47 65.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.945 0.402 . . . . 0.33 110.555 179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.441 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 33.9 m0 -92.34 -24.32 18.97 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.912 -0.586 . . . . 0.38 110.867 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.847 ' CD1' ' HB1' ' A' ' 43' ' ' ALA . 3.9 mm? -50.96 123.96 10.31 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.272 -0.422 . . . . 0.28 111.037 -179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER 36.73 56.97 1.16 Allowed 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.163 -0.471 . . . . 0.22 111.324 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 44.1 p-10 -103.53 -13.81 16.43 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.848 -0.615 . . . . 0.46 111.218 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.76 -23.99 7.27 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.776 -0.726 . . . . 0.35 112.535 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -106.01 118.7 37.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.793 0.33 . . . . 0.5 110.785 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.413 ' CE ' ' N ' ' A' ' 36' ' ' GLY . 0.6 OUTLIER -62.9 107.6 1.02 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.434 . . . . 0.42 111.074 -179.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -103.33 -28.05 12.09 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.179 -0.464 . . . . 0.47 110.558 179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.9 m -75.26 -179.69 4.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.019 -0.537 . . . . 0.31 110.858 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HB2' HG21 ' A' ' 17' ' ' THR . . . -65.7 -54.93 20.7 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.33 111.179 -179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -113.43 34.89 4.26 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.253 -0.43 . . . . 0.9 111.072 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.413 ' N ' ' CE ' ' A' ' 31' ' ' LYS . . . 63.35 28.51 72.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.782 -0.723 . . . . 0.21 112.638 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.425 ' CB ' ' HD2' ' A' ' 15' ' ' PRO . . . -57.67 -42.44 83.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.727 0.299 . . . . 0.27 111.281 -179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.753 ' HB3' HG11 ' A' ' 21' ' ' VAL . 10.1 p30 -56.9 -21.64 31.18 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.337 -0.392 . . . . 0.31 111.188 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -88.49 11.45 17.05 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.396 -0.366 . . . . 0.27 111.502 179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -129.33 173.06 10.87 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.763 0.316 . . . . 0.4 110.982 -179.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.6 mp -63.8 -23.24 32.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.37 110.882 179.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -53.78 -23.98 13.72 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.289 -0.414 . . . . 0.29 111.309 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.847 ' HB1' ' CD1' ' A' ' 26' ' ' LEU . . . -90.85 -0.2 57.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.16 -0.473 . . . . 0.26 111.844 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 110.48 -12.12 30.62 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.616 -0.802 . . . . 0.23 112.922 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -66.19 145.14 56.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.737 0.268 . . . . 0.35 110.335 179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 1.2 mp -123.69 -24.12 4.58 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 112.008 0.373 . . . . 0.91 112.008 -179.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.42 ' CG ' ' O ' ' A' ' 47' ' ' TYR . 0.4 OUTLIER -49.87 117.47 2.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.854 0.359 . . . . 0.48 110.904 -179.857 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -59.37 126.04 26.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.196 -0.457 . . . . 0.87 111.14 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.1 m -121.39 10.85 10.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.171 -0.468 . . . . 1.33 111.169 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 38.7 p . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.243 -0.884 . . . . 0.96 111.186 179.917 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.262 0 N-CA-C 112.479 -0.248 . . . . 1.84 112.479 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.93 177.88 4.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.783 0.325 . . . . 0.7 110.838 -179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 59.76 -174.59 0.11 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.225 -0.443 . . . . 0.4 110.832 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -58.72 116.59 8.86 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.641 -0.79 . . . . 0.52 112.369 179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.69 -155.62 0.65 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.584 0.231 . . . . 0.5 110.928 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 59.18 -85.68 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.573 -0.285 . . . . 0.37 110.765 -179.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.8 m -101.84 -164.79 1.13 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.636 0.255 . . . . 0.33 110.431 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 151.53 177.25 25.12 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.582 -0.818 . . . . 0.38 112.62 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -56.62 -25.42 59.39 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.808 2.339 . . . . 0.57 112.245 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 1.1 p -129.02 48.03 2.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.263 -0.426 . . . . 0.49 110.887 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.24 141.01 40.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.137 -0.483 . . . . 0.42 110.858 179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.639 ' CE2' ' HB2' ' A' ' 43' ' ' ALA . 38.8 t80 -91.23 137.37 32.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 0.32 110.417 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.3 p -105.21 128.19 53.29 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.161 -0.472 . . . . 0.41 110.845 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.748 ' SG ' HG13 ' A' ' 19' ' ' VAL . 17.8 m -57.66 140.61 80.49 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.097 -0.502 . . . . 0.25 110.774 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 37' ' ' ALA . 35.6 Cg_endo -64.94 133.19 34.94 Favored 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.723 2.282 . . . . 0.36 112.48 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 53.54 31.73 44.79 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.819 -0.705 . . . . 0.4 112.562 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.553 HG21 ' CB ' ' A' ' 34' ' ' ALA . 0.1 OUTLIER -141.38 155.56 45.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.818 0.342 . . . . 0.39 110.888 -179.789 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 15.8 m-70 -98.68 30.65 3.2 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.217 -0.447 . . . . 1.13 110.774 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.748 HG13 ' SG ' ' A' ' 14' ' ' CYS . 1.0 OUTLIER -114.97 138.52 44.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.062 -0.517 . . . . 0.65 110.788 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 31.1 p -110.79 165.39 11.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.025 -0.534 . . . . 0.26 110.878 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.523 HG12 ' O ' ' A' ' 12' ' ' PHE . 3.4 p -151.59 132.68 7.67 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.067 -0.515 . . . . 0.22 110.805 179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.688 ' O ' HD23 ' A' ' 26' ' ' LEU . 70.4 Cg_endo -74.48 151.14 41.93 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.282 1.988 . . . . 0.23 111.907 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.61 -29.12 16.31 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.892 0.377 . . . . 0.43 110.848 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 2.2 ttt180 -69.02 -25.37 64.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.33 110.455 179.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . . . . . . . . . 39.9 m0 -102.16 18.25 21.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.023 -0.535 . . . . 0.38 110.91 179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.688 HD23 ' O ' ' A' ' 22' ' ' PRO . 3.6 mm? -94.42 114.32 26.33 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.344 -0.389 . . . . 0.28 110.867 -179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 51.27 60.41 3.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.133 -0.485 . . . . 0.22 110.798 -179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -115.87 -12.82 11.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.469 . . . . 0.46 111.369 -179.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 118.8 -25.8 7.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.701 -0.761 . . . . 0.35 112.474 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -100.61 104.51 15.85 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.787 0.327 . . . . 0.5 110.691 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HE3' ' N ' ' A' ' 36' ' ' GLY . 15.0 mtpt -57.54 96.07 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 0.42 111.086 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -87.17 -32.45 19.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.47 110.689 179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.664 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -65.08 -176.54 0.29 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.061 -0.518 . . . . 0.31 110.651 179.906 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.553 ' CB ' HG21 ' A' ' 17' ' ' THR . . . -75.74 -46.0 33.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.406 . . . . 0.33 110.889 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -120.75 31.22 6.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.9 110.727 179.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.401 ' N ' ' HE3' ' A' ' 31' ' ' LYS . . . 68.08 30.92 74.21 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.832 -0.699 . . . . 0.21 112.67 179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.664 ' HB3' ' SG ' ' A' ' 33' ' ' CYS . . . -57.94 -43.81 86.58 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.86 0.362 . . . . 0.27 111.008 179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 37.5 p30 -56.59 -28.38 60.17 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.31 110.739 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -94.69 17.72 12.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.27 111.145 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -128.61 -169.69 2.12 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.825 0.345 . . . . 0.4 111.027 -179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.771 HG13 HD23 ' A' ' 46' ' ' LEU . 1.5 mp -73.86 -26.78 21.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.105 -0.498 . . . . 0.37 110.827 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -52.22 -25.62 9.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.263 -0.426 . . . . 0.29 111.401 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.639 ' HB2' ' CE2' ' A' ' 12' ' ' PHE . . . -100.71 13.49 34.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.303 -0.408 . . . . 0.26 111.594 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 82.15 18.5 66.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.744 -0.741 . . . . 0.23 113.05 179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -106.06 92.92 4.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.835 0.35 . . . . 0.35 110.726 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.771 HD23 HG13 ' A' ' 41' ' ' ILE . 1.7 mt -97.6 -50.57 4.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.91 111.039 -179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 2.7 p90 -47.02 -37.29 9.04 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.225 -0.443 . . . . 0.48 111.352 -179.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 56.63 171.76 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.254 -0.43 . . . . 0.87 111.016 179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 1.2 p -177.25 66.98 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 1.33 110.886 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . . . . . . . . . 11.4 p . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.228 -0.891 . . . . 0.96 110.901 179.989 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 112.474 -0.25 . . . . 1.84 112.474 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.1 m 60.22 33.03 21.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.78 0.324 . . . . 0.7 110.845 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 60.43 -169.66 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.4 110.84 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -72.09 87.7 0.48 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.757 -0.735 . . . . 0.52 112.513 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -135.46 29.85 3.25 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.748 0.309 . . . . 0.5 110.977 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -102.13 -79.23 0.52 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.297 -0.411 . . . . 0.37 110.769 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' HA ' ' HB3' ' A' ' 11' ' ' SER . 16.1 m -100.21 -67.16 0.87 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.339 -0.392 . . . . 0.33 110.766 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.21 -176.92 9.37 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.63 -0.795 . . . . 0.38 112.483 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -55.31 -43.68 56.27 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.723 2.282 . . . . 0.57 112.122 179.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' SER . . . . . . . . . . . . . 83.1 p -103.29 95.57 6.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.19 -0.459 . . . . 0.49 110.782 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.403 ' HB3' ' HA ' ' A' ' 7' ' ' CYS . 0.0 OUTLIER -145.42 147.42 32.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.277 -0.419 . . . . 0.42 111.107 -179.919 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . 0.536 ' CD2' HD11 ' A' ' 26' ' ' LEU . 11.8 t80 -107.56 150.59 26.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.971 -0.559 . . . . 0.32 110.482 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' CE1' ' A' ' 12' ' ' PHE . 0.4 OUTLIER -106.08 123.98 48.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.142 -0.481 . . . . 0.41 110.834 179.922 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 37' ' ' ALA . 0.8 OUTLIER -77.28 146.64 74.74 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.25 111.221 -179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -68.09 136.84 39.03 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.798 2.332 . . . . 0.36 112.598 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 65.76 34.51 88.97 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.857 -0.687 . . . . 0.4 112.806 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.658 ' OG1' HG12 ' A' ' 19' ' ' VAL . 1.5 t 179.61 153.13 0.45 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.875 0.369 . . . . 0.39 111.017 179.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -89.69 2.65 54.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.109 -0.496 . . . . 1.13 111.342 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.855 HG13 ' HB2' ' A' ' 14' ' ' CYS . 2.5 p -57.44 123.17 8.24 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-O 120.859 0.361 . . . . 0.65 110.821 179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 15.7 p -102.94 162.71 12.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 0.26 111.083 -179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.59 HG11 ' HB3' ' A' ' 38' ' ' ASP . 3.2 p -154.96 133.93 7.41 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 116.018 -0.537 . . . . 0.22 110.649 179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PRO . . . . . 0.483 ' C ' HD23 ' A' ' 26' ' ' LEU . 56.5 Cg_endo -71.18 147.01 52.93 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.386 2.058 . . . . 0.23 111.984 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.491 ' HA ' HD23 ' A' ' 26' ' ' LEU . 2.2 tt0 -49.07 -39.13 26.6 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.422 -0.354 . . . . 0.43 110.968 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -58.24 -29.47 65.78 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.983 0.42 . . . . 0.33 110.453 179.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' TRP . . . . . 0.415 ' CG ' ' HG2' ' A' ' 22' ' ' PRO . 28.1 m0 -88.86 -25.94 21.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.923 -0.58 . . . . 0.38 110.572 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.765 HD12 ' HB1' ' A' ' 43' ' ' ALA . 4.4 mm? -56.52 113.43 1.6 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.097 -0.501 . . . . 0.28 110.952 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 4.1 m 56.23 53.52 8.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.026 0.441 . . . . 0.22 110.941 179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 p-10 -105.73 -18.13 14.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.581 . . . . 0.46 111.136 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 121.37 -15.57 9.25 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.803 -0.713 . . . . 0.35 112.655 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -108.08 107.32 17.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.744 0.307 . . . . 0.5 110.81 179.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.469 ' CE ' ' HA3' ' A' ' 36' ' ' GLY . 9.5 mttt -59.17 85.72 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.42 111.112 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -73.74 -26.32 60.62 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.001 0.429 . . . . 0.47 110.449 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 5.2 t -83.76 164.48 19.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.926 -0.579 . . . . 0.31 111.011 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -62.71 -36.29 82.49 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.159 -0.473 . . . . 0.33 110.773 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -120.58 18.07 12.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.008 -0.542 . . . . 0.9 111.04 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.469 ' HA3' ' CE ' ' A' ' 31' ' ' LYS . . . 66.42 25.83 72.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.21 112.947 179.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.871 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . . . -51.6 -38.07 52.9 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.93 0.365 . . . . 0.27 110.89 179.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.59 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.2 p30 -60.72 -22.99 64.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.143 -0.48 . . . . 0.31 110.812 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.74 20.31 13.26 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.526 -0.306 . . . . 0.27 111.22 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.11 -179.66 5.47 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.926 0.393 . . . . 0.4 111.007 -179.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.429 HD12 ' N ' ' A' ' 41' ' ' ILE . 3.0 mp -61.22 -21.73 25.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.056 -0.52 . . . . 0.37 110.864 179.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -51.16 -35.31 35.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.98 0.419 . . . . 0.29 111.14 179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.765 ' HB1' HD12 ' A' ' 26' ' ' LEU . . . -84.71 -22.3 29.79 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.932 -0.576 . . . . 0.26 111.152 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 101.66 39.4 2.97 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.711 -0.757 . . . . 0.23 112.63 179.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.7 m -98.08 -61.27 1.41 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.853 0.358 . . . . 0.35 111.064 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 70.72 34.55 2.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.065 -0.516 . . . . 0.91 110.752 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . 0.438 ' CD1' ' N ' ' A' ' 47' ' ' TYR . 4.0 m-30 -87.18 -35.03 18.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.225 -0.443 . . . . 0.48 110.839 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 4.9 t30 66.07 38.95 4.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.099 -0.501 . . . . 0.87 110.755 -179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 18.4 p -60.54 -75.41 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.126 -0.488 . . . . 1.33 110.931 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.454 ' O ' HG23 ' A' ' 50' ' ' THR . 2.5 t . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.214 -0.898 . . . . 0.96 110.874 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_